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THESIS ABSTRACT 
 
Performance Measurement and Performance Management of Innovative Products 
 
Graham Dickinson 
University of Bath School of Management 
 
Increasing interest is being shown in performance measurement, in both the academic 
literature and by practitioners. When implementing innovative products, organisations are 
facing issues of how to measure and manage the performance of the products concerned 
and how to do so in a worthwhile way. Reviewing existing literature suggests that there has 
been limited research on the value of performance measurement and management 
processes and indeed little conceptual distinction has been made between performance 
measurement and performance management. A conceptual framework is developed, 
structured around concepts from the existing literature showing two ways of distinguishing 
performance measurement and performance management. Performance management 
processes are shown as broader than performance measurement processes and the 
influences of the processes on performance are also displayed, another way of 
differentiating between the two concepts. The framework provides a structure for a pattern 
matching analysis using empirical data. 
 
Empirical data collection involved four case studies, each focusing on a medical device 
being implemented in the UK public healthcare sector. Forty-six semi-structured 
interviews explored performance measurement and performance management processes in 
the implementation of the innovative products, as well as exploring the influences of those 
processes on performance of the innovative products. The findings from the thesis 
highlight key performance measurement and performance management processes that 
occur in the implementation of innovative products, finding that the two can best be 
distinguished by their influence, or lack of influence, on performance. Performance 
reporting is also highlighted as a key concept. The findings indicate that performance 
measurement and reporting processes alone cannot be expected to have an influence on 
performance, however if performance management processes occur too then they can. 
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Part One: Research Overview, Existing Research and Conceptualisation 
 2
CHAPTER ONE: INTRODUCTION TO THE THESIS 
 
1.1. Introduction 
This thesis has been developed from research into how and why organisations measure and 
manage the performance of innovative products which they buy and sell. There is an 
increasing focus in both the academic literature and practice on measuring performance. 
When purchasing and supplying innovative products, organisations are facing issues of 
how to measure and manage the performance of the products concerned and how to do so 
in a worthwhile way. These issues form the topic of enquiry of the thesis. 
 
This first chapter describes the subject and context of the enquiry by way of background, 
then defines the fundamental problem driving the research. It describes the research aim, 
before providing an overview of the approach taken to the research and methodology used. 
Finally, the structure of the rest of the thesis is outlined.  
 
1.2. Subject and Context of Enquiry 
The subject of enquiry of the thesis draws on key issues highlighted in the existing 
academic literature. 
 
Research in the area of performance has focussed on performance measurement and 
themes such as the appropriate selection and implementation of performance measures. 
Neely (1999) refers to a revolution in performance measurement which is becoming 
increasingly topical, driven by reasons such as the changing nature of work, organisational 
roles, external demands and increasing competition, particular improvement initiatives, 
power of information technology and quality awards. The performance literature draws on 
a variety of subject areas, which themselves are increasingly focussing on issues of 
performance measurement and management, for example in operations management 
(Radnor & Barnes 2007). Indeed the diverse and fragmented literature on performance 
measurement is seeing increasing interest as a unified subject of study, with the formation 
of the Performance Measurement Association for example. 
 
Within the performance field, the research agenda is increasingly turning to whether 
performance measurement is worthwhile (Neely 2004, 1999). Although publications have 
long described appropriate performance measures (Neely 1997) and possible dysfunctional 
consequences of inappropriate measures (Ridgway 1956), researchers are now focussing 
on the influence of performance measurement on performance. Studies in this developing 
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area have tested for quantitative links between particular measures and performance 
outputs, giving conflicting results (Davis & Albright 2004, Ittner et al. 2003a, Banker et al. 
2000, Perera et al. 1997, Neely et al. 2004). Another key development in the performance 
literature is a progression to discussing not only performance measurement, but also 
performance management (Halachmi 2005, Radnor & Barnes 2007). A broadening of 
aspects of performance and unit of analysis studied has also occurred in recent research. 
While much existing work has researched performance measurement of the organisation 
amongst others, this thesis draws on the contemporary interest in evaluating the 
performance of products, a theme also of growing importance in the innovation literature. 
 
Performance measurement and management have seen increasing use in the innovation 
literature, where the focus is on the challenges and imperative of organisations innovating 
successfully (Tidd et al. 2005 pp37-44). Innovation has been found to be a difficult 
process, but essential as the various types of innovation studied involve developing an 
innovation with a novel element, which is then exploited for benefit. Existing literature has 
discussed the process of innovation, which increasingly necessitates taking an inter-
organisational perspective as the input of more than one organisation is required if 
innovation is to be successful (Chapman & Corso 2005, Ritter & Gemunden 2004, 
Grandori & Soda 1995). 
 
An interaction occurs between organisations in the innovation process where the 
organisation that has produced an innovative product supplies it to a purchasing customer 
organisation in the market place. The innovation literature has examined this interaction 
between organisations in terms of adoption or rejection of the product during its 
implementation (Biemans 1992 pp42-45) and processes such as feedback of information 
between actors which is used to improve the product (Rothwell & Gardiner 1985). The 
literature has also shed light on the issue, describing how product, financial, social and 
informational exchange between customer and supplier occur in the interaction between 
organisations (IMP Group 1982, Ring & Van de Ven 1992, Wilson & Jantrania 1994) and 
in networks of organisations interacting in the innovation process. The literature also 
describes how decisions are made to adopt or reject a particular innovation (Webster & 
Wind 1972 pp12-39), as well as some of the factors affecting uptake of innovations 
(Tzokas & Saren 1992, Phillips et al. 2007, Edquist & Hommen 1999). 
 
In practice, there has also been an increasing focus on managing innovation, purchasing 
and supply, and performance measurement and management. These issues have been 
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emphasised in the public sector context of this research. Overall, the literature suggests that 
the UK public health sector has a complex network context, with many actors, activities 
and resources that are often decentralised (Walker et al. 2006). It acknowledges that the 
NHS is a multi-levelled, complex, dynamic organisation with many differences at the local 
level (Pope et al. 2006). Across government there is a focus on performance which is 
expressed through using purchasing and supply initiatives as a lever to achieve policy 
objectives. This is evidenced by the advent of the Office of Government Commerce and 
recent policies of using procurement to reduce costs or increase value (Gershon 2004 pp5-
8, 35-36, Bourn 2006 pp2-11, H.M. Treasury 2007 p3) and a strong emphasis has been 
placed on measuring performance in such areas (Wilson 2004). Government policy has 
also concentrated on the importance of innovation in the context of a competitive global 
economy (DTI 2003 pp7-16).  
 
Performance in purchasing of innovative products has been a key issue for the NHS, which 
as a buyer can constrain or enable the process of innovation and the uptake of innovative 
products (Phillips 2007, Edquist & Hommen 1999). The NHS as a customer has been 
highlighted as slow in the uptake of innovative products from the many private sector 
suppliers that exist in the healthcare industry (Wanless 2002 p52). That many innovations 
in the NHS need to be drawn from external suppliers is typical of the literature (Axelsson 
1987 pp128-130), particularly where the customer organisation is so large (Bommer & 
Jalajas 2004). The Health Care Industries Task Force (HITF) with representatives of public 
and private sector was set up and made recommendations on promoting purchasing of new 
medical technologies and products, with benefits for industry, public health sector and 
patients (HITF 2004 pp5-7). A HITF recommendation was the creation of a new Centre for 
Evidence-based Purchasing (CEP), highlighting a focus on measuring performance as part 
of purchasing that was also emphasised in the recent evidence-based academic literature 
(Harland et al. 2007, Pfeffer & Sutton 2006). Table 1 summarises key UK Government 
policy documents for healthcare in the public sector, with implications for measuring and 
managing performance in the implementation of innovative products such as medical 
devices. 
 
The thesis draws upon literature investigating performance and innovation topics, two 
developing areas of research. In particular, the literature on performance is fragmented and 
draws on a wide variety of other literatures, including strategic management, operations 
management and others such as economics. This thesis primarily uses the performance and 
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operations literatures, as well as some publications of interest from the broader field of 
management. 
 
Source Document Issued by Key Content 
Gershon 
(2004 pp5-
8, 35-36) 
Releasing Resources to 
the Front Line. 
Independent Review of 
Public Sector 
Efficiency 
H.M. Treasury Original Gershon Report in 1999 
advocated efficiency and best value for 
money through purchasing. 2004 Report 
identified efficiency measures of £21bn 
to be achieved by 2008. The importance 
of evidence-based policy as a lever for 
improving performance 
Bourn 
(2006 pp2-
11) 
Progress in Improving 
Government Efficiency 
National Audit 
Office 
Reports that progress has been made on 
government efficiency targets, but a 
reported £4.7bn savings must be 
considered as provisional and subject to 
further verification 
H.M. 
Treasury 
(2007 p3) 
Transforming 
Government 
Procurement 
H.M. Treasury Range of public procurement reforms so 
that the UK may deliver world-class 
public services, mainly to the OGC 
which is slimmed, given new powers and 
increased staff skills. Health service 
faces growing challenges of global 
competition, changing demographics and 
resource pressures 
HITF (2004 
pp5-7) 
Better Healthcare 
Through Partnership: A 
Programme for Action 
Department of 
Health and 
Association of 
British 
Healthcare 
Industries 
Report following joint government and 
medical devices industry task force. 
Development of existing Device 
Evaluation Centre (DES) to new Centre 
for Evidence Based Purchasing (CEP) in 
DoH. New Innovation Centre to promote 
and support development of new 
technologies. 
DTI (2003 
pp7-16) 
Innovation Report: 
Competing in the 
Global Economy: The 
Innovation Challenge 
Department of 
Trade and 
Industry 
Public sector spend on goods and 
services in areas such as healthcare has 
great potential to stimulate innovation by 
acting as intelligent consumer 
Cooksey 
(2006 pp3-
8) 
A Review of UK Health 
Research Funding 
H.M. Treasury Independent review recommends 
improved coordination and coherent 
funding for medical research, including 
into medical devices 
Table 1. UK Government Policy Documents of Relevance for Public Sector 
Healthcare. 
 
1.3. Problem Definition 
Existing research has highlighted increasingly the importance of performance 
measurement and performance management, whether of organisations, products or 
processes. However the literature in the area is fairly fragmented and still developing, 
giving a lack of clarity over many concepts. In particular there has been an emphasis on 
performance measurement and management during the purchasing and supply of 
innovative products. The implementation part of the innovation process focuses on the 
supplier turning ideas into a product reality, exploitation in launching it to the market 
where the customer utilises it and finally sustaining the innovation with feedback. The 
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focus on innovation and the key activities of purchasing and supply management during 
the implementation of innovations is a key area of concern for organisations in practice and 
also for academic research, which has emphasised the imperative of taking an inter-
organisational approach when studying the innovation process. As described above, a 
further key issue emerging in the performance literature is not just the specification of 
performance measures, but gaining a fuller understanding of the influence of performance 
measurement and management. 
 
Drawing these issues from the existing literature together suggests that there are 
opportunities to investigate how the performance of innovations is measured and managed, 
particularly during their implementation. In particular, there is a need to carry out research 
analysing whether these processes are worthwhile. 
 
In response to these issues highlighted in existing research and practice, the aim of the 
thesis is: 
 
• To explore performance measurement and performance management during the 
implementation of innovative products, focusing on their performance effects. 
 
Existing research has discussed selection and implementation of performance measures, 
however little research so far has focussed on investigating performance measurement and 
management in the implementation of innovative products and there is a need to focus on 
the influence of performance measurement and management processes, by examining how 
they affect the performance of the innovative product. Investigating these issues in the 
thesis are central in making a contribution. 
 
The above aim is developed into research questions later in the thesis, as described below. 
This chapter continues by outlining the approach and research methodology used, in the 
next section, then stating the structure of the thesis in the following section. 
 
1.4. Overview of Research Methodology and Approach 
As described and justified in depth later in the thesis, the topic of the enquiry and research 
questions chosen dictated the research methodology and approach selected. 
 
The developing nature of research in the performance area, drawing on several bodies of 
knowledge means that this research is largely exploratory, dictating a case study 
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methodology as being appropriate. This is particularly useful given the complex, dynamic 
network context of inter-organisational innovation and purchasing and supply management 
(Yin 2003 p5). Multiple case studies were used to develop analytical generalisability, each 
of the four cases concentrating on an innovative product, the unit of analysis selected. 
Cases were selected from the public sector healthcare context, focussing on medical device 
innovative products. Again given the exploratory nature of the research and the lack of 
clarity over many of the concepts in the existing literature, 46 semi-structured interviews 
(Bryman 2004 pp109-129) were used as the key technique to gather qualitative, 
exploratory data. Supplementary use was made of documentary evidence and network 
mapping. 
 
The case study methodology was selected based on an interpretivist (Ramsay 1998) 
epistemological stance, recognising the role of human actors and the social construction of 
knowledge. The approach does not risk the shortcomings of a positivist stance, where an 
objective, mechanistic event-based approach does not allow for the complex interactions 
and open systems found in the topic of study of this research (Outhwaite 1987 pp19-23). 
 
The thesis has necessarily taken an iterative, theory building approach in analysing existing 
literature and the empirical data, which eventually produced the contribution of the work. 
This approach has aspects of both inductive and deductive research approaches, which has 
been referred to as abductive by Dubois and Gadde (2002), discussing systematic 
combining of theory and empirical data. As part of this abductive approach and following 
coding and generation of case descriptions, the thesis involved a pattern matching analytic 
strategy, both within and across the four cases, referring to the conceptual framework (Yin 
2003 pp109-140). Matrices were used as a key tool in pattern matching (Miles & 
Huberman 1984 pp79-118). A key further part of the methodology describes the steps 
taken in the empirical work to try and ensure the reliability and validity of the research. 
 
Having outlined the research problem, methodology and approach, the next section 
illustrates the structure of the rest of the thesis where full descriptions are explained. 
 
1.5. Structure of the Thesis 
This thesis document is divided into three parts and nine chapters, as illustrated in Figure 1 
which also shows key connections between the parts and chapters as part of the iterative 
research approach. Part One gives the background to the research, introducing the thesis, 
critically reviewing the existing literature, then developing research questions and a 
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conceptual framework. Part Two relates to the empirical part of the thesis, describing and 
justifying the selected methodology and research process, then presenting the findings 
from each of the four case studies, then from a cross case perspective. The third and final 
part discusses the empirical results with reference to existing research in the literature 
review, revising the conceptual framework. Part Three finishes by returning to the research 
questions then describing and reflecting the contribution and limitations of the thesis, with 
implications for future research. 
 
Part 1: Research 
Overview, Existing 
Research and 
Conceptualization
Chapter 1: Introduction to the 
Thesis
Chapter 2: Literature Review
Chapter 3: Research Questions 
and Conceptual Framework
Part 2: Research 
Process & 
Empirical Findings
Chapter 4: Research 
Philosophy and Methodology
Chapter 5: Findings from Four 
Case Studies
Chapter 6: Cross-Case 
Findings
Part 3: Discussions 
and Conclusions Chapter 7: Discussion of 
Findings
Chapter 8: Conclusions
Chapter 9: Implications & 
Reflections
 
Figure 1. Structure of the Thesis 
 
Following this first introductory chapter, Chapter Two reviews the existing literature. It 
sets out to define the key concepts in the topic of study and analyse the extent of existing 
knowledge by reviewing the work and models of key researchers, of relevance to pursuing 
the research aim above. The literature on performance is investigated, looking at the broad 
concept and different aspects of performance, then focussing on the key concepts identified 
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of performance measurement and performance management and finally analyses the 
influences of performance measurement and management on performance, identified as a 
key frontier for research in the area. Literature describing the context of the research in the 
implementation of innovative products is then discussed. 
 
Chapter Three presents, describes and justifies the research questions on the basis of the 
literature review. Towards development of the initial conceptual framework that 
underpinned the empirical work, it then analyses some key concepts involved in the 
research questions. 
 
Chapter Four discusses operationalization of the empirical work through selecting, and 
describing the research methodology and approach. Through analysis of the various 
options available, the chapter justifies the selection of an interpretivist approach, abductive 
research design and a multiple case study methodology. It describes data collection and 
analysis, with a focus on issues of reliability and validity. 
 
Chapter Five reports on the empirical findings from each of the four case studies in turn. 
For each innovative product case studied, it introduces the product and describes why it is 
innovative, also discussing the background and supply relationships and networks in the 
case. Each case description is structured according to the key concepts in the research 
questions and conceptual framework, based in turn on the literature, so performance 
measurement processes, performance management processes and their influences on 
performance are all discussed in turn. 
 
Chapter Six presents the findings from a cross-case perspective, following the same 
structure as in Chapter Five for consistency. Also using tools such as matrices, it examines 
the similarities and differences across the four cases, giving an overview of the main 
findings from the case studies. In doing this key tactics for generating and confirming 
findings are used, such as noting patterns, replicating findings and checking out rival 
explanations. 
 
Chapter Seven reports on a key part of the iterative research process, taking the empirical 
findings and discussing them in the context of the existing literature, using the same 
structure as in the previous two chapters. Some additional literature was needed to interpret 
the empirical findings and conceptual lessons are drawn at the end of the chapter, which 
are used to revise the conceptual framework. 
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Chapter Eight returns to the research questions, discussing how the findings of the thesis 
and results of the discussion in the previous chapter address the questions. This is 
presented by examining how the findings stand upon key publications from the existing 
literature. 
 
Chapter Nine reflects on the thesis, describing the key limitations of the work and 
contribution, particularly with respect to validity and reliability. This leads to discussing 
the implications for both future research and for practice. It concludes by suggesting 
avenues for improving and extending the research in future, paying attention to the 
limitations of this research. 
 
1.6. Summary 
This chapter has illustrated the subject and context of the enquiry, leading to a definition of 
the research problem and development of an overall aim for the research. An overview of 
the research methodology and approach, along with a structure of the thesis contributes to 
an outline of the thesis as a whole. The thesis was inspired by academic interest in how 
performance measurement and management occur and in particular whether they are 
worthwhile. The particular field of interest concerns performance measurement and 
management in the purchasing and supply of innovative products, a key area of academic 
interest as well as for practitioners. The aim of the thesis as described above provides a 
basis for taking these research issues forwards and the thesis is based upon a review of 
existing work and empirical work carried out. The next chapter analyses existing 
knowledge in the key areas of literature drawn upon for this research. 
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CHAPTER TWO: LITERATURE REVIEW 
 
2.1. Introduction 
The previous chapter outlined the research and described the context. This chapter 
investigates the existing literature, focussing on performance. Publications in the literature 
reviewed so far have taken an interest in the performance of concepts such as the 
innovation process, purchasing and supply management as a function, relationships, and 
innovative products. However there is also an increasing explicit interest in performance as 
a research topic, reflected in practice where organisations face pressure to perform 
increasingly well. This chapter begins by defining performance and investigating some of 
its key aspects from the existing literature. Performance measurement is a major theme in 
the performance literature and is discussed in the following section, with a focus on 
measuring the performance of innovative products. The next sections discuss the term 
performance management and relevant processes that are also found in the literature, then 
the influences of performance measurement and management processes. The last part of 
the chapter briefly outlines existing literature on the innovation process, which is necessary 
to understand the context of the research. Figure 2 summarises the structure and content of 
this literature chapter. Findings from the literature review are then used to provide a 
platform for conceptualization of this research in the next chapter. 
 
Section 1: Introduction
Section 2: Defining Performance
Section 3: Aspects of Performance
Section 4: Performance 
Measurement
Section 5: Performance 
Management
Section 6: Role and Purpose of Performance Measurement & 
Performance Management
Section 8: Summary
Section 7: Innovation and Innovative Products
Sections 4,5,6: 
Exploring key 
concepts within the 
performance 
literature
Sections 1,2,3: 
Exploring the 
concept of 
performance
Section 7: 
Contextual 
literature
 
Figure 2. Structure of the Literature Chapter 
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2.2. Defining Performance 
This section defines performance in general, discussing use of the term in the literature, the 
growing body of research specifically on performance and research using similar terms. 
The dictionary definition of performance is as follows: 
 
1. “the act or process of performing or carrying out” 
2. “the execution or fulfilment (of a duty) etc” 
3. “a person’s achievement under test conditions etc” 
4. “the return on an investment, esp. in stocks and shares etc” (Thompson Ed. 1995 
p1015) 
 
In using words such as ‘fulfilment’ and ‘achievement’, the definition alludes to some sort 
of attainment or reaching of a standard in the output to a process. They suggest that a wide 
range of things may perform, including processes, actors or products. 
 
2.2.1. Performance in the Literature 
The term ‘performance’ is widely and loosely used across a range of bodies of knowledge 
in the literature, including strategy, operations management and innovation. As Lebas 
(1995) comments: “Few people agree on what performance really means: it can mean 
anything from efficiency, to robustness or resistance or return on investment, or plenty of 
other definitions never fully specified”. Database searches of key journals used in the 
review so far for publications with performance in the title reveal the term has been put to 
a variety of uses. Table 2 shows examples. 
 
Research has studied the performance of manufacturing plants (Narasimhan et al. 2005), 
corporations (Melnyk et al. (2003), organisations (Day & Lichtenstein 2006) and business 
units (Morgan & Vorhies 2001). Performance of the supply chain (Paulraj et al. 2006), 
supply function (Kaufmann & Carter 2006), suppliers themselves (Millington et al. 2006) 
and relationships (O’Toole & Donaldson 2006) have been discussed. Innovation literature 
has studied performance of processes (Frishammar & Sven 2005), products (Langerak et 
al. 2004), their selling performance (Hultink & Atuahene-Gima 2000) and product 
portfolios (Cooper et al. 1999). Performance measurement or measures (Kennerley & 
Neely 2003, Kaplan & Norton 2005) and different aspects of performance (Hendricks et al. 
2001, Kaufmann & Carter 2006) are other key performance themes in the literature, 
discussed later. 
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Journal No. Publications 
with 
Performance in 
Title (10 years 
up to May ’07, 
Database: 
Business Source 
Premier) 
Examples of Publications and their Use of ‘Performance’ 
International 
Journal of 
Operations & 
Production 
Management 
106 • Millington et al. (2006): Performance of suppliers, in 
particular global suppliers 
• Narasimhan et al. (2005): Performance of 
manufacturing plants 
• Kennerley & Neely (2003): Measuring performance 
• Fynes & Voss (2002): Quality, manufacturing and 
business performance 
Journal of 
Operations 
Management 
78 • Kaufmann & Carter (2006): Supply management 
performance, performance outcomes of sourcing 
• Melnyk et al. (2003): Corporate and environmental 
performance 
• Hendricks & Singhal (2003): Financial performance of 
the organisation 
Journal of 
Purchasing & 
Supply 
Management 
11 • Paulraj  et al. (2006): Supply chain performance 
• Day & Lichtenstein (2006): Organisational 
performance 
• O’Toole & Donaldson (2002): Relationship 
performance dimensions 
Harvard 
Business Review 
30 • Kaplan & Norton (2005): Performance measures 
• Kirby (2005): High performance company 
• Augustine et al. (2001): Performance of individuals 
Journal of 
Product 
Innovation 
Management 
41 • Leenders et al. (2007): Performance of new product 
teams 
• Frishammar & Sven (2005): Innovation performance 
• Langerak et al. (2004): New product performance, 
organisational performance 
• Morgan & Vorhies (2001): Business unit performance 
• Hultink & Atuahene-Gima (2000): New product 
selling performance 
• Cooper  et al. (1999): New product portfolio 
performance 
Table 2. Examples of Use of the Term ‘Performance’ in Recent Publications 
 
Further, other existing research has studied performance in a less specific way. For 
example Carter and Ellram (2003) reviewed the most common research topics in The 
Journal of Supply Management. Papers on inventory and production management 
including forecasting, purchasing organisation and contracting including contract 
management and cost analysis all attempt to build theories about how organisations 
manage their processes or other organisations towards improving or maintaining 
performance in some form. 
 
2.2.2. Similar Terms Used in the Literature 
So far the literature suggests performance is a loosely used term, indeed other similar terms 
also appear such as ‘success’, ‘value’ and ‘effectiveness’. Ritter and Gemunden (2004) 
built a concept of product innovation success based upon measures including an 
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organisation having better market response to innovations compared with others. ‘Success’ 
is thus used in a very similar conceptual sense to performance as analyzed above, however 
Ritter and Gemunden (ibid.) give a success scale that is reverse scored: “Our competitors 
have more success with their product innovations”, demonstrating that success is a 
positive concept that is either present or absent, whereas performance may be positive or 
negative. Success has had limited use in the literature whereas performance has been used 
extensively in the concepts of performance measurement and performance management for 
example. In addition to success and the opposite concept of failure, Cooper and 
Kleinschmidt (1987) refer to new product winners and losers in the same publication, again 
suggesting that terminology is relatively loose in the field. 
 
Value is another loosely used term found in the literature of relevance to performance. 
Indeed little existing research has defined what value is and how it is created (Tzokas & 
Saren 1999). Value stems from the concept of ‘value for money’ referring to financial and 
product exchanges (Anderson et al. 2000). Further, the strategy literature describes the 
value chain (Porter 1985 pp36-52) model, illustrating the various activities of an 
organisation that make the product or service. The value chain is also focussed on cost, 
interpreting the concept of value financially. Lindgreen and Wynstra (2005) reviewed the 
limited existing literature on value in purchasing and supply and business marketing 
literatures. They found that value increasingly focuses on broader costs and aspects of 
value than simply the purchase price, highlighting the challenge of trading off the attributes 
of different products (Ketchen & Hult 2007, Wouters et al. 2005), especially as there is 
limited understanding of how customers value the use of particular products (Woodruff 
1997). A contrast can be drawn between value and performance, as definitions of 
performance refer to some form of achievement, whereas value alone does not. 
Effectiveness is a further similar term (Cormican & O’Sullivan 2004), used to describe 
particular aspects of performance. 
 
2.2.3. Literature in the Performance Field 
In addition to the various areas of knowledge that discuss performance in general, existing 
literature has a growing body of knowledge specifically on performance as the main 
research interest. Neely (1999) claims that a revolution is occurring in the field of 
performance measurement, suggesting that it has become a particularly important topic 
recently for organisations in practice, due to reasons such as increasing competition, 
changing demands, awards, the role of information technology and increased improvement 
initiatives. He points out that performance research has been spread across a range of 
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subject areas, with very few cross-subject researchers. Some of the most overarching 
performance research is from the strategy field (Simons 1995, Chakravarthy 1986), given 
the cross-functional nature of the field. Such work concentrates upon research issues of 
what drives performance, as well as how performance can be measured. Peters and 
Waterman (1982 pp3-28) is a normative example that studied organisational performance 
with the aim of unravelling the answers to achieving it. Journals in more specific fields 
such as operations management and innovation have produced special editions on 
performance, examples of its rise as a research and practical issue crossing sectors. 
Examples of special issues include those in the Journal of Operations Management 
(Melnyk et al. 2004) and the International Journal of Management Reviews (Denyer & 
Neely 2004). Meanwhile the International Journal of Productivity and Performance 
Management is a key journal in the performance field, however it has origins in fields such 
as manufacturing with an emphasis on productivity. 
 
Drawing on the diverse and loose body of knowledge on performance in the literature, the 
next section breaks down the concept of performance into various aspects to illustrate it 
further. 
 
2.3. Aspects of Performance 
The current section takes apart the general concept of performance by discussing different 
aspects found in the literature. A lot of the discussion is based upon performance measures, 
as they are often the manifestation of different descriptions of performance. However 
performance measures and the process of performance measurement are discussed in their 
own right in a later section. This section analyzes concepts of performance in general, 
towards the end of describing concepts of performance of innovative products in particular. 
It is of use in later discussion of the role and purpose of performance measurement and 
performance management. 
 
2.3.1. Financial Aspects of Performance 
Performance concepts draw on a variety of areas of research, particularly the accounting 
and operations management literatures (Neely 1999). The earliest concepts of performance 
investigated are financial and there is a substantial management accounting literature 
dealing with this area, focussing on concepts of profit and productivity, expressed in 
monetary terms (Barlev 1995, Ben-Hsien & Da-Hsien 1989). An early example from the 
general management literature that focuses on financial measures is Ridgway (1956) 
focussing upon return on investment, while later Ferguson and Leistikow (1997) discuss 
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different quantitative economic value added concepts. Hendricks and Singhal (2003) 
studied the effects of supply chain glitches or problems on performance, expressed in terms 
of a sole financial descriptor, shareholder wealth. While they address a purchasing and 
supply issue, Hendricks and Singhal (ibid.) have produced a traditional style of research in 
the performance field, as it uses quantitative methods in a causal investigation and 
concentrates on a single financial measure and description or aspect of performance.  
 
2.3.2. Broader Operational Aspects of Performance 
As literature in the performance field has developed, research has progressed from 
studying solely financial performance using a single measure to studying broader, 
operational aspects of performance, using a greater number of measures. Ittner and Larcker 
(2003b) for example, suggest that organisations wish to manage broader, operational types 
of performance, as they think that these will eventually have an effect upon financial 
performance. Bull (2007) describes the value or success of an organisation in terms of 
efficiency, effectiveness and efficacy, highlighting an operational as well as financial 
focus. The Balanced Scorecard (BSC, Kaplan & Norton 1992, 2005, Holmes et al. 2006) 
has been key to this development and was created with the realization that sole use of 
traditional financial accounting measures from the industrial era is often inappropriate for 
contemporary organisations, where processes such as innovation occur. Return on 
investment alone is unlikely to encourage innovation for example. Cornerstones of the 
BSC are its balance of measures of different aspects of performance, multiple stakeholder 
perspective including external organisations and the way it encourages setting goals for 
measures (Figure 3). Innovation and learning are recognised as important by the BSC and 
just as the previous chapter discussed how innovation is essentially an inter-organisational 
process (Tidd et al. 2005 pp52-55), the BSC suggests that performance is of interest to and 
influenced by stakeholders beyond the immediate organisation. 
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Figure 3. Conceptualization of Performance from the Balanced Scorecard. After: 
Kaplan R.S. & Norton D.P. 1992. The Balanced Scorecard – Measures That Drive 
Performance. Harvard Business Review. 70(1) pp71-80. 
 
The operations management literature has focussed on a number of parameters of 
operational processes and the product or service produced by it, presented as ways that the 
process or product may perform and helping to conceptualise performance. The most 
commonly chosen are cost, speed and quality, often supplemented with flexibility and 
dependability (Slack et al. 2007 pp39-54). The descriptors focus on technical aspects of 
products or services and their production process, from the perspective of outputs for the 
customer. Overall though, the literature so far has highlighted that performance can be 
perceived differently by customers and suppliers, both internally and externally to the 
organisation (Chenhall & Langfield-Smith 2007). Indeed the literature conceptualises 
operational aspects of performance at different parts of the transformation processes (Slack 
et al. ibid. p8-16, Godwin et al. 1989) occurring within and between organisations, 
including outputs, such as delivery reliability to the customer (Slack et al. ibid. pp39-54), 
inputs such as timely delivery from suppliers (Duffy & Fearne 2004) and the 
transformation process, such as capacity (Graham 2005). Further, operational aspects of 
performance are also discussed at various levels of analysis in the literature. These include 
a particular innovative product (Zheng Zhou 2006), process (Bendoly & Jacobs 2004), 
organisation (Ritter & Gemunden 2004), dyadic relationship (Carr & Pearson 1999), 
supply chain (Gunasekaran et al. 2004) or supply network (Straub et al. 2004). 
Financial Perspective
Goals Measures
Customer Perspective
Goals Measures
Innovation & Learning Perspective
Goals Measures
Internal Business Perspective
Goals Measures
How do we look to 
shareholders?
How do customers 
see us?
What must we 
excel at?
Can we continue to 
improve and create 
value?
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Focussing specifically on aspects of product performance, the value literature describes 
how a customer values different aspects of product performance, with the benefit of 
purchases for a supplier firm (Lindgreen & Wynstra 2005, Eriksson & Lofmarck-Vaghult 
2000). Although value is often defined in financial terms (Yadav & Monroe 1993), the 
characteristics of how the product performs for the customer are increasingly included. 
Zeithaml (1988) suggests that value can be low price, the customer getting what they want 
in a product, the customer getting quality for the price they pay or the customer getting 
value for what they give. Similarly, Miles (1961 pp3-23) describes not only cost and 
exchange values of a product, but also use value depending on how the customer uses the 
product. Broader aspects of value are also illustrated by Lemmink et al.’s (1998) 
emotional, practical and logical dimensions. The next sub-section focuses on innovative 
products. 
 
2.3.3. Performance of Innovative Products 
Some aspects of performance are particularly appropriate for describing the performance 
of innovative products, the unit of analysis in this research. Teece (1992) focuses on 
financial performance of innovations in describing strategies for capturing financial 
benefits in the healthcare market for scanners. The broadening of performance concepts to 
those that describe a variety of measures, as in the BSC is particularly relevant to 
innovative products (Kaplan & Norton 1992) as traditional financial and accounting 
measures such as return on investment were more appropriate for organisations in the 
industrial mass production era. The innovation literature also includes descriptions of 
performance that are specific to innovation, as shown by Tidd et al. (2005 pp561-569) 
giving a range of measures, as compiled and presented in Table 3. Also, Table 4 
summarises some more descriptions of performance from the innovation literature, 
breaking down the overall concept of performance of innovative products.  
 
In common with the wider performance literature, a broad range of financial and 
operational measures is evident in Tables 3 and 4. The descriptions also reflect themes in 
the definitions of innovation, discussed in the previous chapter. For example they describe 
ways of measuring the performance of something new, such as number of patents and 
scientific papers, as well as describing exploitation, for example the percentage of sales 
derived from new products. The performance of both the product and the organisation is 
described. This point is reinforced by Hauser (1998), referring to two types of metrics in 
research and development, namely market outcome metrics such as the financial metrics 
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discussed earlier, and those metrics that measure research effort more directly such as 
patents and citations. 
 
Type of Measure / 
Description of Performance 
Examples 
Input Measures • Percentage of sales committed to research & development 
• Investments in training 
• Recruitment of technically skilled staff 
Output Measures • Specific output measures: no. patents, no. scientific papers, 
no. new products introduced, % sales or profits derived from 
new products introduced 
• Output measures of process elements: Customer satisfaction 
surveys of factors such as quality, flexibility 
• Output measures comparable across sector: Cost of product, 
market share, quality performance 
• Output strategic success measures: Growth in revenue, 
market share, improved profitability, higher value added. 
Specific Measures of Internal 
Workings 
• No. new ideas generated at start of innovation process 
• Failure rates 
• No./% overruns on time and cost 
• Customer satisfaction measures – objective based 
• Time to market 
• Human hours of development per product innovation 
• Continuous improvement measures eg no. problem solving 
teams, savings accrued per worker 
Influential Conditions • Creative climate of organisation 
• Extent of clear deployment and communication of strategy 
Table 3. Compiled Descriptions of Innovation Performance. After: Tidd J., Bessant J. 
& Pavitt K. 2005. Managing Innovation: Integrating Technological, Market and 
Organisational Change. (3rd Ed.). Wiley. Chichester. UK. pp561-569. 
 
The varied subjects of the performance measures and concepts of performance show that 
the performance of an innovative product and the organisation that produce it are inter-
related and often inseparable (Chiesa et al. 1996, Lawless & Fisher 1990). For example, 
unit, production and development costs are financial aspects of performance of the 
innovative product that may influence the financial performance of the organisation. 
Indeed, organisations in the medical device field may exist to exploit a sole innovative 
product. Customer satisfaction measures may apply to both the product or organisation as a 
whole, yet are likely to be perceived in a similar way by customers, given that joint product 
service packages are often offered. 
 
Most of the research shown in Table 4 operationalised the concepts in empirical work by 
using Likert scales, reflecting the quantitative research designs used in those studies. 
However, many of the concepts themselves, as well as the empirical measures used are 
perceptual, as discovered by Wei & Morgan 2004. The Likert scales as well as the 
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instruments used by Griffin and Page (1996), Atuahene-Gima et al. (2005) and Lemmink 
et al. (1998) again highlight the perceptual nature of performance as a concept. 
 
Study Outline Concepts of Performance Used Empirical 
Implementation 
of Performance 
Concept 
Griffin & 
Page (1996) 
Assessing success or 
failure of a product 
development project 
using measures of 
performance 
concepts. 
Appropriate measures 
are contingent on 
project type. 
Success of product development 
projects is described in terms of: 
• Customer-based success (such 
as satisfaction, acceptance) 
• Financial success (such as met 
profit goal or IRR/ROI) 
• Technical performance 
success (such as met 
performance specs) 
Product 
development 
professionals 
selected most 
useful measures 
from a variety 
proposed. 
Hultink et al. 
(1997) 
Investigates the 
product development 
performance of 
various new product 
launch strategies. 
Overall, customer determined, financial 
and technical product performance. In 
particular product measures included: 
• Meeting quality goals 
• Development costs 
• Launched on time 
• Speed to market 
• Product performance 
1 to 7 Likert scale 
ratings by manager 
respondents 
regarding 
particular new 
product 
development 
projects. 
Song et al. 
(1997) 
Investigating impact 
of skills, synergy and 
design sensitivity on 
new product 
performance 
• ROI 
• Profit 
• Market share 
• Sales 
• Opportunities for technical 
leadership 
• Market dominance 
• Customer satisfaction 
1 to 5 Likert scale 
ratings by manager 
respondents 
regarding 
particular new 
product 
development 
projects. 
Wei & 
Morgan 
(2004) 
Investigating factors 
of new product 
success. 
For new product performance: 
• Management satisfaction with 
new product performance 
• Overall new product 
performance 
• Market strength attributable to 
new products 
1 to 5 Likert scale 
ratings by manager 
respondents 
regarding 
perceptions of new 
product 
performance. 
Sherman et 
al. (2005) 
Researches the role 
of cross-functional 
integration and 
knowledge 
management in new 
product development 
performance. 
• Product prototype 
development proficiency 
• Product launch proficiency 
• Product development cycle 
time 
• Design change frequency 
• Market forecast accuracy 
• Technological core 
competency fit 
 
 
 
 
 
 
 
 
 
 
 
 
1 to 5 Likert scale 
ratings by manager 
respondents 
regarding 
perceptions of new 
product 
performance, 
metrics taken from 
extant literature. 
 
 
 
 
 
 
 
 
 
 
 
Continued 
overleaf 
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Atuahene-
Gima et al. 
(2005) 
Researches the 
responsive and 
proactive market 
orientations for new 
product programme 
performance. 
New product programme performance: 
• Extrapolation of key trends for 
insight into what customers in 
current market would need in 
the future 
• Revenues from new products 
compared with business unit 
objectives 
• Profitability of new products 
compared with business unit 
objectives 
• Growth in profitability of new 
products compared with 
business unit objectives 
• Growth in sales of new 
products compared with 
business unit objectives 
Survey of 
managers ranking 
on pre-existing 
and new metric 
scales. 
Radnor & 
Noke (2006) 
Develops innovation 
audit tool for product 
innovation process in 
an organisation 
• Structure 
• Leadership 
• Teams 
• Outputs 
• Context 
Quantitative 
survey and 
qualitative semi-
structured 
interviews 
Wilson & 
Jantrania 
(1994) 
Dimensions of 
product value 
• Economic 
• Strategic 
• Behavioural 
Conceptual study, 
literature based. 
Lemmink et 
al. (1998) 
Dimensions of 
product value 
• Emotional 
• Practical 
• Logical 
1 to 11 Likert 
scale ratings by 
customer 
respondents 
regarding 
restaurant 
experience. 
Table 4. Concepts of Performance of Innovative Products in the Innovation 
Literature. 
 
So far the literature has recognised increasingly broad aspects of performance, from a 
variety of perspectives within and beyond the organisation, particularly where performance 
of innovative products is considered. Much discussion of aspects of performance has 
drawn upon the literature on performance measures and measurement. The next section 
discusses this literature in more detail. 
 
2.4. Performance Measurement 
A large part of the literature on performance concentrates on the topic of performance 
measurement. This section of the literature review defines and analyzes the concept, then 
discusses the key theme in the literature of selecting and implementing performance 
measures and measurement systems. The section also investigates literature themes on 
evidence and evidencing and measuring performance in the implementation of innovative 
products. 
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2.4.1. Definition and Concept of Performance Measurement 
A performance measure is defined by Neely et al. (2005) as: “a metric used to quantify the 
efficiency and/or effectiveness of an action”. Although this definition was produced on the 
basis of a review of the performance measurement literature, it is limited when viewed in 
the context of the broader performance literature reviewed in this research. Efficiency and 
effectiveness are broad descriptions of performance, but the literature also includes 
research on softer aspects of performance such as quality of life (Skevington 1999) and 
more qualitative aspects of performance in general (Teece 1992), that are not viewed from 
such a mechanistic, operational viewpoint. The definition presents measures as objective, 
though the human element involved in using a measure suggests that there is some 
subjectivity involved (Johnson & Kaplan 1987 pp253-262). The discussion of 
quantification is not inclusive of softer, qualitative measures and the term ‘metric’ is a 
narrower term that is often used to replace ‘measure’, alluding to quantitative, decimal 
scales. Expressing the concept of measurement, Farbey et al. (1993 pp75-94) described 
how a measurement procedure maps and preserves the difference in a set of symbols and 
the difference in attributes of a collection of entities. This expresses the same basic 
phenomena as Neely et al. (ibid.), yet reflects the broader concepts in the literature. It is 
shown in Figure 4. 
Attribute Metric
L1
L2
M1
M2
Measurement Procedure
 
Figure 4. Diagrammatic View of Measurement. After Farbey B., Land F. & Targett 
D. 1993. How to Assess Your IT Investment. A Study of Methods and Practice. 
Butterworth-Heinemann. Oxford. UK. Fig 6.2. 
 
As suggested by the Neely et al. (2005) definition and criticism of it, views of measures 
and the process of measurement in the literature come from a variety of philosophical 
viewpoints from natural science to social science. These are summarised in Table 5. The 
different perspectives of measures cover both objective natural science and subjective 
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social science measures and measurement processes. The latter tend to be more qualitative, 
taking far more account of the role of humans in the measurement process, than 
quantitative natural science views. However the qualitative aspects of subjective social 
science measures are often given numerical values and turned into quantitative measures 
(Chiesa 2007). Literature on the background to performance measures also discusses issues 
of validity of measures and  whether to use nominal, ordinal, interval or ratio scales for 
example (Bryman 2004 pp65-75, 225-227). On a broader view, the literature 
predominantly takes a rational Chandlerian, coordination and allocation view of measures 
(Chandler 1977 pp484-502), though literature on choosing and implementing measures 
suggests a more Mintzbergian view that an over-obsession with quantification is harmful 
(Mintzberg 1996). 
 
Background 
to View of 
Measurement 
Example of 
Discipline 
Where view is 
Used 
Example of 
Measurement 
Subject & 
Instrument 
Key Tenets of Approach Example in 
Literature for 
Current 
Approach 
Natural 
(Physical 
Sciences) 
View 
Physics Heat with 
thermometer 
Hard, (more objective). 
Comparison is made 
between magnitude of 
quantity of the object 
being measured, and a 
standard unit. Conditions 
controlled. Every 
measurement has an 
inherent degree of 
uncertainty, and may be 
given with an error margin 
and confidence level of 
falling within that margin.  
Hard financial and 
operational 
parameters (eg 
number of patents 
filed, ROI on 
product 
innovation). Eg 
Ridgway (1956), 
Slack et al. (2007 
pp39-54) 
Social 
Sciences 
View 
Psychology Intelligence 
with IQ test 
Soft, (more subjective), 
less tangible subjects. 
Magnitude is quantified 
using probabilistic and 
psychometric tools such as 
questionnaires or surveys. 
Human factors, 
technological 
knowledge 
necessary for 
product 
innovation. Eg 
Lamming et al. 
(1996) 
Table 5. Literature Views of Measurement from Natural and Social Science 
Backgrounds. 
 
Being a prominent part of the performance literature, discussion of performance 
measurement reflects themes in the development of the performance literature as a whole. 
For example financial performance measures are often used in the accounting based 
literature (Biddle et al. 1997, Ferguson & Leistikow 1997), the early literature (Ridgway 
1956) and often where a sole performance measure is used (Hendricks & Singhal 2003). 
However operational measures have received increasing attention, as they lead or drive 
future financial performance, whereas financial measures follow performance, showing the 
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results of management action already taken (Kaplan & Norton 1992, Ittner & Larcker 
1998a). Also there is an emphasis on using measures taking a view external to the 
organisation, focussing on customer satisfaction. Johnson & Kaplan (1987 pp253-262) also 
promote a broader description of organisational performance than the traditional financial 
measures, which they describe as rooted in nineteenth century cost accounting and 
inappropriate for the increased dynamism and competition in the contemporary business 
setting.  
 
While recent literature consistently advocates a broad range of financial and non-financial 
measures, there are differing views on how non-financial measures drive financial 
performance measures. Anderson et al. (1994) found that customer satisfaction in a sample 
of Swedish firms was related to return on investment, yet the relation was less strong or did 
not occur in service firms. Similarly, Ittner and Larcker (1998a) found that customer 
satisfaction measures were related to financial measures such as market values and revenue 
growth. However their study also shows that the extent to which non-financial measures 
drive financial performance varies or even does not exist depending upon the industry. 
 
The range of performance measures are not only becoming broader, but more diverse and 
specialised. For example, Skevington (1999) developed a set of measures of quality of life, 
with particular reference to health. The psychology based work uses measures to describe 
‘soft’ intangible aspects of quality of life, with facets including the presence or absence of 
positive feelings as well as mobility and energy measures for categorised diseases. An 
example of other subjective, qualitative aspects of performance is Parasuraman et al.’s 
(1988) SERVQUAL model of service performance, measured in terms of aspects such as 
credibility and courtesy. Further specialist types of performance measures include those of 
innovation, discussed above when defining performance of innovation (Tidd et al. 2005 
pp561-569, Chiesa et al. 1996). However Coombs and Bierly (2006) emphasise that 
performance measures in the technology field usually have shortcomings. The broad range 
of performance measures reflect the broad conceptualizations of performance found in the 
literature. 
 
2.4.2. Selection and Implementation of Performance Measures 
Having described a range of types of measures, the literature also discusses their 
appropriate selection and implementation (Hammer 2007, Purbey et al. 2007, Robson 
2005, Bititci et al. 1997, Kaplan & Norton 1992, Lea & Parker 1989, Fortuin 1988, 
Johnson & Kaplan 1987 pp253-262, Globerson 1985, Ridgway 1956), including a 
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summary of existing work in the area (Neely 1997). Table 6 summarises the literature 
concerned. 
 
Publication Recommendations for Effective Performance 
Measures 
Description of Research 
Principles 
Hammer (2007) • Decide what to measure 
• Measure the right way 
• Use metrics systematically 
• Create a measurement friendly culture 
Guidance to avoid ‘the 7 
deadly sins of performance 
measurement’, enabling 
performance improvement 
Purbey et al. 
(2007) 
• Sensitivity to changes in internal and 
external environment of organisation 
• Reviewing and reprioritising internal 
objectives when environmental changes 
are significant 
• Deploying changes to internal objectives 
and priorities to critical parts of the 
organisation 
• Ensuring that gains achieved through 
improvement programs are maintained 
Guidance for characteristics 
of a performance 
measurement system for 
healthcare processes 
Robson (2005) • Measurement system must provide 
relevant graphical information at local 
level 
• Performance measurement information 
must be in form that assists people in 
perceiving their control of performance as 
part of their job 
• Measurement system designed from the 
outset with psychological consequences 
in mind 
Examines how to 
implement a performance 
measurement system that 
creates a high performance 
culture 
Bititci et al. 
(1997) 
• System deploys corporate and stakeholder 
objectives throughout organisation 
• System defines key competitive factors, 
position of business within competitive 
environment 
• Focus on key business processes to 
manage performance 
• A measurement methodology 
differentiating between actuality, 
capability & potentiality 
• Use of proactive rather than reactive 
measures 
Presents reference model 
for a performance 
measurement system, as a 
critical system embedded 
within performance 
management as a key 
business process  
Kaplan & Norton 
(1992) 
• Use a broad based set of measures 
• Measures should have an associated goal 
• The opinions of a range of stakeholders 
should be taken into account 
Develops a practical tool 
consisting of a range of 
measures intended to avoid 
maximising performance in 
one area at the expense of 
another. Both financial and 
operational measures 
should be used, operational 
measures are the drivers of 
future financial 
performance 
Lea & Parker 
(1989) 
• Simple to understand 
• Ensure visual impact 
• Improvement focussed rather than on 
variance 
Japanese operations 
management based work 
using lean principles.  
 
 
 
 
 
Continued overleaf 
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Fortuin (1988) • Enable fast feedback 
• Provide information 
• Be exact and precise about what is being 
measured 
• Be objective not subjective 
Development of effective 
indicators, operations 
research numerical, 
objective bias. 
Johnson & Kaplan 
(1987 pp253-262) 
• Use broader range of operational 
performance measures rather than 
traditional accounting measures 
Describes the inadequacy 
of traditional management 
accounting system 
measures, advocating a 
broader, operations based 
approach to measures. 
Globerson (1985) • Be aligned with strategy 
• Provide timely and accurate feedback 
• Relate to specific, stretching but 
achievable goals 
• Based on quantities that can be influenced 
or controlled  
• Clearly defined 
• Be part of a closed management loop 
• Have an explicit purpose 
• Be based on an explicitly defined formula 
and source of data 
• Use ratios rather than absolute numbers 
• Use data which are automatically 
collected as part of a process where 
possible 
Effective performance 
measures must be 
developed as a basis for 
effective planning and 
control performance 
management. 
Emphasis on operational 
performance criteria. 
Ridgway (1956) • Both qualitative and quantitative 
performance measures must be used to 
avoid dysfunctional consequences 
• Performance measures must be chosen to 
determine the right behavioural 
consequences 
Describes and gives 
suggestions for mitigating 
the effects of dysfunctional 
consequences of 
performance measures 
Table 6. Advice for Effective Performance Measures in the Literature 
 
A repeated theme across the various publications is the need for a broad range of both 
financial and non-financial measures, though there is some conflict as to how this should 
be achieved. Fortuin (1988) proposes objective measures, which is inconsistent with 
Johnson and Kaplan (1987 pp253-262) proposing use of behavioural measures. There is 
also a focus on performance measurement systems, rather than individual measures. 
Another theme is the need for following up performance measurement, Globerson (1985) 
discusses a closed management loop, Robson (2005) referring to use of performance 
measurement information in follow up action and Fortuin (1988) describing the importance 
of feedback. In a similar vein Lea and Parker (1989) discuss performance improvement, 
alluding to some kind of feedback. Feedback is discussed further in the following sections. 
 
2.4.3. Evidence and Evidencing 
Evidence and evidencing is a growing contemporary theme in the literature on 
performance. Also the term ‘evidence-based’ is now used widely by practitioners. The 
concept originates in diverse subject areas including law, which recognises different types 
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of evidence which have different degrees of confidence (Twining 2003); as well as in 
medicine (Sackett et al. 1996). 
 
Evidence-based medicine began with observations of broad variations in clinical practice, 
lack of use of care strategies of known effectiveness and continued use of care strategies 
acknowledged to be ineffective. The rationale of evidence-based medicine involves 
combining the best available external research evidence with expertise of the clinicians 
involved in a particular patient case (Sackett et al. 1996), enabling clinicians and patients 
to make choices about the most effective strategy of care to follow (Glasziou & Haynes 
2005). Given that medical devices are a key part of many care pathways and strategies, it 
follows from the literature that evidence of their effectiveness is required from 
measurement of their performance. In practice, external evidence comes from sources such 
as clinical trials (Tonelli 2006), while internal evidence is based on experience and 
judgement of the individual clinician and the particular situation of the patient. Again, this 
highlights that performance measurement can involve harder, subjective as well as more 
perceptual, subjective approaches to evaluation (MacIntyre & Petticrew 2000). Haynes 
(1991) emphasises the varying quality and relevance of different evidence sources, while 
Sackett and Wenneberg (1997) state that evidence from the most appropriate research 
design must be used, given the variety of individual cases where evidence is required. Muir 
Gray (2004a pp11-18, 65-100, 2004b) closely associates evidence-based healthcare with 
evidence-based policymaking, a term referring to provision of evidence about effective 
public policy interventions, guiding public policy generation and implementation (Bambra 
2005). 
 
One of the most recent evidence-based terms to evolve is evidence-based management 
(Pfeffer & Sutton 2006), advocating that organisations should be managed on the basis of 
what actually works, rather than untested ideas or assumptions. They comment that many 
managers trust research less than they trust their own experience, also stating that: “Lots of 
managers, likewise, get their companies into trouble by importing, without sufficient 
thought, performance management and measurement practices from past experience.” 
(Pfeffer & Sutton ibid.).  
 
In summary, the evidence-based literature highlights that many different processes can be 
used to measure performance and that a variety of different types of information can be 
considered as evidence. The literature also demonstrates the importance of appropriate 
performance measurement, particularly in the public and healthcare settings and has a 
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focus on new or innovative products. Evidence-based approaches encourage purchasing 
decision-makers, including clinicians, to take account of a wide variety of purchasing 
decision-making criteria, from quantitative and qualitative external data from other parties, 
to their own internal assessments. This may include seeking out organisations that evaluate 
products, or testing products themselves, perhaps with the aid of the supplier. 
 
2.4.4. Measuring Performance in the Implementation of Innovative Products 
Literature discussed so far has recognised the inter-organisational context of performance 
measurement, that performance can be perceived differently internally and externally to the 
organisation (Chenhall & Langfield-Smith 2007, Kaplan & Norton 1992) and that 
performance measurement information is gathered from sources external to the 
organisation (Sackett et al. 1996, Pfeffer & Sutton 2006). 
 
Topics such as vendor or supplier assessment discuss performance measurement in an 
inter-organisational context. Vendor assessment (Timmerman 1986) is often a part of the 
broader purchasing process, where information is gathered to inform a purchasing 
decision, with information not only gathered on the product, but also on the product 
supplier. Weber et al. (1991) refer not to vendor assessment, but to vendor selection, 
showing how suppliers may be selected following assessment. The criteria for assessing 
suppliers vary from performance measures of their product as above, to specific measures 
of the supplier, such as satisfaction, flexibility, risk and confidence, as proposed by 
Humphreys et al. (2005) who focussed on measuring suppliers involved in product 
development. Ellram (1995) discusses how supplier evaluation can be used to select 
suppliers, form a basis for negotiation, monitor supplier performance and improve supplier 
performance. As the vendor or supplier assessment literature has moved towards selection 
of suppliers, the role of performance measurement in making purchasing decisions about 
which supplier and product to choose is increasingly apparent.  
 
In the last chapter analysis of the implementation part of the innovation process 
highlighted key inter-organisational processes of social and information exchange, in 
particular purchasing and supply decision making. From the perspective of the 
performance literature, the information and social exchange used to gather information for 
use in the innovation process (Tidd 2005 pp88-97, Basadur & Gelade 2006, Schoen et al. 
2006, Miaoulis & LaPlaca 1982) and on which to make a purchasing decision (Webster & 
Wind 1972 pp12-39, 77-107, Biemans 1992 p48, Zaltman et al. 1973 pp66-67) is a 
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performance measurement process. The purchasing and supply and innovation literature 
discussed in the last chapter shed light on this subject. 
 
Individuals may use a variety of criteria in their evaluation of a number of possible 
purchases, such as a potentially large amount of factual information involved in technical 
evaluation of new equipment that may be purchased. (Webster & Wind 1972 pp6-7) 
describe how: “Technical evaluation of new equipment requires a great deal of factual 
information as well as carefully studied opinions…”. In addition to performance 
measurement of technical criteria, they comment that much information is required to 
make purchasing decisions, particularly as: “Purchased products and services are 
expected to contribute dependably to the organisation’s performance over long periods of 
time…” (Webster & Wind ibid.), highlighting how product performance is often associated 
with organisational performance. 
 
Webster and Wind (1972 pp88-107) discuss how individuals learn to use particular 
information sources, interacting with others in their own organisation, supplier 
organisations or the environment to gain information to be used as part of a purchasing 
decision. Regarding psychological processes of the buyer, cognition and learning are two 
elements of particular interest to performance measurement between organisations. The 
former refers to receiving and interpreting information from the environment, while the 
latter refers to previous behaviour influencing current behaviour, for example an individual 
favouring a product because of their previous experience with it. 
 
Having analyzed the existing literature on performance measurement, another similar term 
uncovered in the literature review is criticised in the next section, on performance 
management. 
 
2.5. Performance Management 
Further to existing research on performance measurement, the term ‘performance 
management’ is also found widely. Use of the term is conceptually loose and often not 
distinguished from performance measurement (Radnor & McGuire 2004). This section 
sheds light on the concept of performance management in existing literature by referring to 
basic concepts of management, before discussing how existing literature describes 
performance management with respect to performance measurement, then considering 
some performance management processes from the literature. 
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2.5.1. Concepts of Management 
‘Management’ is a very broad and evolving concept and body of knowledge. Mintzberg 
(1990) gives ten perspectives on management, described as schools of thought for strategy 
formation given the overarching nature of strategy across various areas of management 
research. He later re-iterates these ten schools, shown in Table 7, describing how recent 
research is cutting across their boundaries (Mintzberg & Lampel 1999). The ‘planning’ 
perspective is taken in this research, as it underpins the operations management, 
purchasing and supply management field in which this research is based. Often described 
as planning and control (Slack et al. 2007 p24-25) and with a focus on operational 
processes (Slack et al. 2007 pp8-16, Godwin et al. 1989), the perspective suggests that 
performance management involves planning and control action of processes such as 
purchasing and innovation. 
 
2.5.2. Concepts of Performance Management with Respect to Performance 
Measurement 
Reviewing the literature shows that there is a lack of conceptual clarity regarding the terms 
‘performance measurement’ and ‘performance management’. Indeed some literature does 
not distinguish between the terms or uses the two interchangeably (Radnor & McGuire 
2004). Radnor and Lovell (2003) refer to performance management systems (PMS), using 
the term for combined systems that involve both performance measurement and 
performance management. This suggests an overlap in the literature between the two 
conceptually unclear terms. However some existing publications can be used to provide a 
clue as to how the respective terms are defined and might be distinguished. 
 
The concepts of management analyzed above suggest that performance management 
involves actions of planning and controlling performance, indeed wide use of the term in 
the literature reflects this. For example Bourne et al. (2003) describe how organisations are 
increasingly focussing upon managing performance improvement and drivers of 
performance, as well as measuring performance. Further, Kaplan and Norton (1996) talk 
about use of the BSC as a strategic management system in follow up work to their original 
BSC paper where it was described from a performance measurement point of view. This 
concept of performance management as some sort of planning and controlling action in 
addition to performance measurement is found widely. 
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Perspective Base Discipline Intended Message Realised Message 
Design None, architecture can 
be used as metaphor 
Fit Think (strategy making 
as case study) 
Planning Systems theory, 
operations 
management, urban 
planning 
Formalise Program (rather than 
formulate) 
Positioning Economics (industrial 
organisation), military 
history 
Analyze Calculate (rather than 
create or commit) 
Entrepreneurial Some early economic 
work 
Envision Centralise (then hope) 
Cognitive Psychology Cope or create Worry (being unable to 
cope in either case) 
Learning Some links to chaos 
theory in mathematics, 
learning in psychology, 
education 
Learn Play (rather than 
pursue) 
Power Political Science Promote Hoard (rather than 
share) 
Cultural Anthropology Coalesce Perpetuate (rather than 
change) 
Environmental Biology React Capitulate (rather than 
confront) 
Configuration History Integrate, transform Lump (rather than split, 
adapt) 
Table 7. Ten Perspectives on Management. After: Mintzberg H. & Lampel J. 1999. 
Reflecting on the Strategy Process. Sloan Management Review. 40(3) pp21-30. Table 
1. 
 
Halachmi (2005) describes performance management as: “…a broader and more 
meaningful concept than simple performance measurement”, listing processes indicative of 
broader performance management such as catering to stakeholders, attending to human 
behavioural factors and handling issues in the environment. Bititci et al. (1997) define 
performance management as a process that allows an organisation to handle its 
performance in line with strategy and objectives. Bourne et al. (2005) describe that 
whereas past research has focussed on choice and implementation of performance 
measures, future research will have to look at how performance measures are used in 
performance management processes. Agreeing, O’Neill (2006) describes a performance 
management system as using performance measures to determine whether performance 
improvements are made. By focusing on the use of evidence, or information from 
performance measurement in healthcare, policymaking and management, the evidence-
based literature includes a broader range of planning and control actions or processes than 
just measuring performance. It recognises the purpose of evidence for use in processes 
such as healthcare and management and highlights the role of feedback, where action is 
taken on evidence.  
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A key performance management process, also highlighted in the innovation chapter, is 
feedback. When analyzing performance measurement, Globerson (1985) emphasise the 
importance of a feedback loop, a broader planning and control or management process by 
which actual performance is constantly compared with performance measurement outputs. 
Similarly, Globerson (1985) discusses how feedback can lead to taking action and 
initiating changes to the organisation. Further, Argyris (1990) describes use of 
performance measurement systems as a form of control. Nanni et al. (1990) agree, 
suggesting that feedback enables managers to control performance to a defined level. 
Further to Globerson, Radnor and Barnes (2007) suggest that feedback control must be 
added to a measurement system to make it a management system. They refer to 
comparison of outputs with target values and taking corrective action, stating that a 
performance management system must communicate information, motivate appropriate 
behaviour and provide a mechanism for control, intervention and learning. Reinforcing 
Globerson’s (1985) suggestion of feedback and the proactive processes suggested by 
Halachmi (2005), Bititci et al. (ibid.) describes the objectives of performance management 
as providing: “…a proactive closed loop control system where the corporate and 
functional strategies are deployed to all business processes, activities, tasks and personnel, 
and feedback is obtained through the performance measurement system to enable 
appropriate management decisions.” They describe performance measurement as an 
information system that lies at the heart of performance management, suggesting that 
management planning and control action uses an information output from performance 
measurement. Also discussing the function of information, Chiesa and Frattini (2007) 
describe the measurement process as including gathering of data, analysis of results and 
identifying corrective actions, echoing the idea above of active control. Overall, 
publications in this area suggest that performance measurement must have an explicit 
purpose, with Globerson’s (ibid.) work for example raising the question of how 
performance measurement and performance management processes may influence 
performance, an issue investigated later. 
 
Further to the literature that can be used to define performance management, limited 
existing work has differentiated performance measurement and performance management. 
Lebas (1995) states that the first involves various types of performance measures, while the 
latter involves processes and characteristics such as training, teamwork and incentives. 
Lebas gives details of performance measurement and performance management in a table, 
reproduced here as Table 8. 
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Performance Measures Performance Management 
Measures based on key success factors 
Measures for detection of deviations 
Measures to track past achievements 
Measures to describe the status potential 
Measures of output 
Measures of input 
Training 
Team work 
Dialogue 
Management style 
Attitudes 
Shared vision 
SPC 
Employee involvement 
Multicompetence 
TQC 
Incentives, rewards 
Table 8. Processes and Preoccupations of Performance Measurement and 
Performance Management. After: Lebas M.J. 1995. Performance Measurement and 
Performance Management. International Journal of Production Economics. 41(1-3) 
pp23-35. 
 
Lebas (1995) makes a rare attempt to distinguish performance measurement and 
performance management from one another, though the descriptions given in Table 8 do 
not focus on both concepts as processes, as descriptions of performance measurement 
focus on measures used instead. Lebas (ibid.) suggests that performance management 
precedes performance measurement, that the two are complementary, yet cannot be 
separated. This is explained in an image shown in Figure 5. 
 
Lebas (1995)’ conceptualization reflects some aspects of the literature by graphically 
showing performance management as broader than performance measurement (Bititci et 
al. 1997), yet also raises some questions. Lebas (1995)’ conceptualization suggests with 
the time arrow that the latter precedes the former, which does not fit with the concept of 
follow up performance management processes, such as feedback (Globerson 1985).  
 
Further to suggesting that performance management processes are broader than or follow 
up on performance measurement processes (Halachmi 2005, Lebas 1995, Bititci et al. 
1997), some existing literature suggests that a difference can be drawn between the 
concepts on the basis of whether they influence performance. Research has highlighted that 
performance measurement alone cannot change performance, whereas planning and 
control action on the basis of performance measurement can (Halachmi 2005, Hume & 
Wright 2006). The influences of performance measurement and performance management 
processes on performance are discussed further later. 
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Figure 5. Relationship Between Performance Measurement and Performance 
Management. After: Lebas M.J. 1995. Performance Measurement and Performance 
Management. International Journal of Production Economics. 41(1-3) pp23-35. Fig 9. 
 
2.5.3. Performance Management Processes 
The performance literature has included a number of planning and control processes that 
are broader than or follow performance measurement, so can be considered performance 
management processes. More are found in the innovation and purchasing and supply 
literature from the last chapter. A selection are summarised in Table 9. 
 
The literature emphasises that the various types of exchange between interacting 
organisations and individuals underpin performance management processes. Information 
and social exchanges (IMP Group 1982) occur with exchange of information from 
performance measurement, which is then used for planning and control activities as 
investigated above. These include issuing strategic objectives, practice guidelines and tools 
(Bititci et al. 2005, 2000, Simons 1991, Hume & Wright 2006) and training (Lebas 1995). 
 
Referring back to the literature in the last chapter, many processes in purchasing and 
supply and the implementation part of the innovation process are performance 
management processes. For example feedback of information from performance 
measurement is emphasised in the performance literature (Globerson 1985) and in the 
innovation process involves a key exchange of information (Tidd et al. 2005, pp88-97, 
Zaltman et al. 1973 pp71-77) that can be used in re-innovation of the innovative product 
(Rothwell & Gardiner 1988), a planning and control action. Also, purchasing and supply 
decision making to adopt an innovative product (Webster & Wind (1972 pp28-37,89-106, 
Pfeffer & Sutton 2006, Biemans 1992 pp129-140, Ellram 1995) involves planning and 
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control processes of evaluating alternatives and making a decision on the basis of 
information gathered. 
 
Process in Literature Literature Description of Process 
Information, social exchange IMP Group (1982), 
Fortuin (1988) 
Actors exchange information in 
relationships and networks, performance 
measures should be used to provide 
information for other actors 
Feedback following 
performance measurement 
Globerson (1985) Managers use the outputs of performance 
measurement to plan and control 
Deployment of strategic 
objectives, practice 
guidelines and tools 
Bititci et al. (2005), 
Bititci et al. (2000), Hume 
& Wright (2006), Simons 
(1991) 
Management team deploys guidance and 
tools to be used to improve performance, 
ascertained in performance measurement 
Catering to stakeholders, 
attending to human 
behavioural factors, handling 
issues in environment 
Halachmi (2005) Draws on definitions of management as 
controlling behavioural aspects of 
individuals, organisation and 
management 
Training, teamwork, 
incentives 
Lebas (1995) Individuals are trained, teamworking is 
encouraged and incentives offered, as 
processes of performance management 
Using performance 
measurement systems as 
strategic management 
systems 
Kaplan & Norton (1996) Performance measurement systems are 
not only used to measure performance, 
they may be used as systems to 
strategically manage performance 
Evidence-based management Pfeffer & Sutton (2006) Combining best available internal and 
external evidence to make a decision and 
take action on evidence 
Making a purchasing decision Webster & Wind (1972 
pp28-37,89-106)  
Performance measurement is often 
carried out with the aim of making a 
purchasing decision, similar to evidence-
based management 
Making a decision to adopt 
an innovation 
Biemans (1992 pp129-
140), Zaltman et al. (1973 
pp66-67 
Adoption of an innovation includes steps 
of determining specification, comparing 
options and selecting from sources 
Supplier selection and 
improvement 
Ellram (1995) Selecting a supplier, aiding them to 
improve their performance, following 
assessment. 
Re-innovation Rothwell & Gardiner 
(1988) 
Innovation of the product after its 
invention and introduction. 
Table 9. Performance Management Processes from the Literature 
 
This section discussed concepts of performance measurement and performance 
management and how they might be differentiated, finding that the latter are broader than, 
or follow up planning and control processes to, performance measurement. The literature 
also suggests that performance management processes are those that influence 
performance, unlike performance measurement. This raises questions about the role and 
purposes of performance measurement and performance management, which are discussed 
in the next section. 
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2.6. Role and Purpose of Performance Measurement and Performance Management 
Radnor and Barnes (2007) have suggested that future performance measurement and 
management research should investigate how the processes enhance and drive performance 
improvement, indeed the literature suggests that this is one way that the two concepts 
could be differentiated. While a few publications have discussed the topic, there is limited 
literature in the area and other publications have referred to roles in passing.  
 
Neely (2004) states that a big challenge exists for research in determining whether 
performance measurement systems are worth it. In the healthcare context, Tarr (1996) 
analyses whether and how performance measurement systems are worth it. A few limited 
studies have been carried out in this area, with conflicting results. Davis and Albright 
(2004) investigated whether the financial performance of bank branches using the BSC 
was better than those branches that do not use the BSC. Using quantitative, quasi-
experimental methods, the study found better financial performance for those branches that 
had implemented the BSC. Also, Banker et al. (2000) found that using non-financial 
performance measures are associated with financial performance in the future. In contrast 
Neely et al. (2004) conducted a similar study on the performance of branches of a 
construction firm, finding in preliminary results that there was little difference in 
performance between branches that did and did not use the BSC. Similarly, Perera et al. 
1997 found that an emphasis on operations based measures in an organisation was not 
associated with enhanced organisational performance. As well as giving conflicting results, 
these studies have limited generalisability as they use quantitative research designs, mainly 
focussing on financial performance of the organisation. 
 
Other studies have touched on related areas, such as Ittner et al. (2003a), finding that 
organisations using a broader set of financial and non-financial performance measures had 
greater measurement system satisfaction and stock market performance. However the 
research used a narrow description of performance, which is not consistent with the 
contemporary thrust in the literature for broader descriptions, limiting generalisability of 
the study. Evans (2004) produced results suggesting that organisations with more mature 
performance measurement systems have better reported results in terms of financial, 
market and customer performance, the research again conducted using quantitative 
methods. In contrast De Waal and Coevert (2007) studied the effects of a new performance 
management system using qualitative methods finding different effects according to the 
way the system was used, however the research was limited to one fairly small 
organisation. 
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Some work in the performance field has described how performance measurement is used 
in performance management, to improve performance. Robson (2005) advocates designing 
measurement systems from the perspective of managing performance, suggesting that this 
is a means for obtaining performance improvement. Concurring, Neely (2004) describes a 
number of fundamental processes of setting up a performance measurement system, in 
particular a process of “managing through measures”. However these publications 
highlight that while performance measurement processes are important, broader planning 
and control processes are being used to manage performance on the basis of performance 
measurement to gain performance improvement. Globerson (1985) and Bourne et al. 
(2005) suggest that it is not just performance measurement but performance management 
that is required for measures to change performance. Melnyk et al. (2005) describe the 
importance of aligning performance measurement processes with strategic objectives for 
appropriate performance consequences, also implying that performance measurement 
alone may not have a role in performance, only when supplemented by performance 
management. Olsen et al. (2007) concur, stating that performance measurement systems 
provide the information needed for monitoring, controlling, evaluation and feedback 
functions in operations management. 
 
In applied public sector case research, Hume & Wright (2006) showed that performance 
measurement alone is unlikely to improve performance. This is described expressively in 
the article title: “You Don’t Make a Pig Fatter by Weighing It”. Similarly, Radnor and 
McGuire (2004) state how performance management intends to respond to outputs from 
measures to manage performance, implying how performance management is used to alter 
performance. In a similar vein, Robson (2005) emphasised the importance of individuals 
recognising that they are in control of performance through taking action on performance 
measurement information, if a culture of high performance is to be encouraged. Haque and 
James-Moore (2005) focused on the role of performance measurement in new product 
development, finding in accordance with other work discussed that performance 
measurement is not just used for reactive monitoring, but proactively to disseminate 
strategy and change culture. 
 
Neely and Al Najjar (2006) also emphasise a learning role, in which managers are 
challenged by measurement outputs about how best to carry out their role. Chiesa and 
Frattini (2007) describe the purposes of a performance measurement system, with a focus 
on research and development activities. Purposes include supporting decision making, 
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enhancing R&D performance, motivating personnel, supporting incentive schemes, 
fostering organisational learning, enhancing communication and coordination and reducing 
R&D risks. These results highlight that while performance measurement can enhance 
performance, it does so through backing up processes such as decision-making, learning 
and communication. 
 
The evidence-based literature suggests that for a beneficial outcome, measurement alone is 
not required, but appropriate measurement that is used to make the right decisions in a 
management process. Pfeffer and Sutton (2006) state that: “…evidence-based management 
can change how every manager thinks and acts…it proceeds from the premise that using 
better, deeper logic and employing facts, to the extent possible, permits leaders to do their 
jobs more effectively.”. This advocates using both performance measurement and 
performance management to achieve the beneficial results of evidence-based management. 
Similarly, Nilsson and Kald (2002) found that performance management systems can be 
used diagnostically and interactively, particularly pointing out their use in decision support 
at strategic and operating levels. 
 
Other literature suggests less direct ways that performance measurement alone might 
influence performance. Beyond discussing whether a performance measurement system 
has worth for an organisation by having an impact upon performance, Neely (2004) 
describes a number of other ways in which such a system may have value for an 
organisation. These include focusing minds upon what is important, communicating and 
influencing the behaviour of individuals regarding organisational targets and a framework 
to reach them, checking progress against targets and challenging organisational strategy. 
 
Bull (2007) makes a link between performance measures and their role in a model of 
performance for an organisation by recognising their contribution to the three dimensions 
of efficiency, effectiveness and efficacy. They suggest that suitably modelled performance 
measures prompt asking questions that help an organisation to perform in the dimensions 
described above. This is based on Bull’s (1999) work discussing strategic management 
from a management accounting perspective, where performance measurement and links to 
performance are described. Table 10 shows Bull’s three dimensions of performance and 
performance measures, as well as examples of some of the strategic questions that help 
link performance measures to performance. Again, both quantitative and qualitative 
measures are used. As with some of the literature discussed above, the questions allude to 
follow up management actions regarding how the organisation uses resources, responds to 
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demand and adds value or contributes to the true purpose of the enterprise. Although 
focussed on the organisation, the principles could be transferred to measuring and 
managing the performance of a product which an organisation implements instead. 
 
Dimension 
 Efficiency – the economic 
use of scarce resources 
Effectiveness – the 
production of a result 
or effect 
Efficacy – the 
production of the 
intended results 
Growth 
management 
How can we make best 
use of the distribution and 
reinvestment of profits? 
How can we maximise 
growth and value of the 
firm from the profit 
available? 
How can we optimise 
the realisation of our 
vision from the profit 
available? 
Value-add 
management 
How can we deliver our 
product or service at the 
lowest cost? 
How can we maximise 
the value that people 
receive? 
How can we optimise 
the benefit that our 
vision provides? 
Pr
oc
es
s Funding 
management 
What is the cheapest 
method of raising the 
funds we need? 
What are the most 
secure and lowest risk 
sources of funds? 
What sources of funding 
will best help us to 
sustain our firm’s 
vision? 
Table 10. Bull’s (2007) Three Dimensions of Performance and Performance 
Measurement and Strategic Questions. After: Bull R. 2007. Performance 
Measurement. Financial Management. 1 Nov 2007. pp43-44 Tables 2&3. 
 
 The literature has also highlighted issues regarding the role of performance measurement 
and management in public sector organisations, for example (Gupta et al. 1994) suggested 
that performance measurement systems may be introduced in public organisations to give 
an impression of being modern and efficient, rather than being implemented to improve 
performance. These points are reminiscent of the literature on dysfunctional performance 
consequences of measures (Ridgway 1956), where individuals change their behaviour in 
response to the measures imposed, often with unexpected consequences. In stating that 
“…what you measure is what you get” (Kaplan & Norton 1992) suggest that performance 
measurement is intrinsically reflective. They imply measures may have a role in 
performance, with the indication that this may be dysfunctional. However for these 
dysfunctional consequences to occur, the literature implies performance management 
processes are involved through the planning and control actions of the individuals 
involved. 
 
Summarising some of the literature in this section, Table 11 highlights some of the more 
specific roles and purposes of performance measurement described. As an overview of all 
the literature concepts discussed in the area, Table 12 shows some of the suggested roles 
and purposes of performance measurement and performance management with respect to 
performance, described here as influences. Although the literature has suggested that 
performance measurement has behavioural consequences, there is limited and 
contradictory evidence about the influence of performance measurement. It is doubtful that 
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performance measurement alone has a role in influencing performance. However the 
literature suggests that performance management processes can have a role in influencing 
performance by taking planning and controlling actions on the basis of information from 
performance measurement. These themes are returned to in the conceptualization chapter. 
Meanwhile the next section summarises the review of the literature. 
 
Summary of Specific Roles and Purposes 
of Performance Measurement 
Literature 
Disseminate strategy and change culture Haque & James-Moore (2005) 
Learning Neely & Al Najjar (2006), Chiesa & Frattini (2007) 
Supporting decision-making Pfeffer & Sutton (2006), Chiesa & Frattini (2007) 
Enhancing R&D performance Chiesa & Frattini (2007) 
Motivating personnel Chiesa & Frattini (2007) 
Supporting incentive schemes Chiesa & Frattini (2007) 
Reducing R&D risks Chiesa & Frattini (2007) 
Focussing minds upon what is important Neely (2004) 
Influencing individual behaviour re organisational 
targets and a framework to reach them 
Neely (2004) 
Checking progress against targets Neely (2004) 
Challenging organisational strategy Neely (2004), Neely & Al Najjar (2006) 
Aid asking questions to help organisation perform Bull (2007) 
Table 11. Summary of Some Specific Roles and Purposes of Performance 
Measurement Described in the Literature 
 
 
Influence Implied Literature Basis for Influence or Possible 
Influence 
Example of Literature Source 
Performance 
Measurement Role 
in Influencing 
Performance 
Performance measures have behavioural 
consequences and are intrinsically 
reflective. However the influence of 
performance measurement on performance 
is still unclear from limited and 
contradictory literature. Measurement alone 
is unlikely to alter performance. 
Kaplan & Norton (1992), 
Ridgway (1956), Bourne et al. 
(2005), Melnyk et al. (2005), 
Robson (2005), Davis & 
Albright (2004), Neely et al. 
(2004) 
Performance 
Management Role in 
Influencing 
Performance 
The influence of performance management 
including performance measurement on 
performance is receiving increasing 
literature interest. 
Management planning and control action 
can alter performance, identified by 
performance measurement. 
Halachmi (2005), Pfeffer & 
Sutton (2006), Hume & Wright 
(2006), Bourne et al. (2005), 
Globerson (1985), Robson 
(2005) 
Table 12. Literature Suggestions of the Influences of Performance Measurement and 
Performance Management 
 
2.7. Innovation and Innovative Products 
This section outlines literature that helps illustrate the context of the research, the 
implementation of innovative products. First, the concepts and process of innovation is 
described, followed by description of the implementation part of the process. 
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2.7.1. Concept and Process of Innovation 
 
Concepts of Innovation 
The core of innovation definitions in the literature is about the concept of something being 
new, Freeman (1992 pp59), suggesting that innovation is: “…the commercial realisation 
or introduction of a new product, process or system…to be contrasted with invention which 
is simply the bright idea for a new product, process or system”. Similarly, Tidd et al. 
(2005 pp5-13) use the term ‘change’ when defining innovation, though they too use the 
word ‘new’. They place an emphasis upon the imperative of innovating to gain or maintain 
competitive advantage. ‘Novelty’ is also used in the literature to describe innovation (Von 
Hippel 1986, Tidd et al. ibid.). Exploitation is also a key part of a definition of innovation 
(Tidd et al. ibid.). Saren (1984 pp11-12) highlights that an innovation only occurs when an 
invention has been commercialised, or exploited, as a product, process or service. 
Similarly, Roberts (1988), Freeman (ibid.) and Schumpeter (1962 pp57-94) differentiates 
invention and innovation by the latter involving commercialisation. 
 
Similar terms to innovation include new product development, differentiated by Trygg 
(1991 p4) and Wynstra (1998 pp15-19) who suggest that whereas product innovation 
covers an entire process between market need and sales, new product development only 
covers product planning, engineering design and process planning. This suggests that 
product innovation is explicitly inter-organisational as it involves supply of the product to 
the customer. New product introduction (Hines et al. 2000 pp401-418), stretches the 
product development process to the point of first introduction into the market or 
introduction into additional markets, though still does not focus on the longer term as 
innovation does. An example in contrast to this focus on the early part of the innovation 
process is the term re-innovation (Rothwell & Gardiner 1988), used to refer to innovation 
occurring after invention and introduction of the innovation. 
 
Another key concept in the innovation literature is technology, defined by Skinner (1982 
pp464) as: “…the set of physical processes, methods, techniques, tools and equipment by 
which products are made or services rendered”. Utterback and Abernathy (1975) describe 
how technology changes with time, suggesting how it has a lifecycle of increasing 
maturity. Further, Ansoff and McDonnell (1990 pp167-170) link cycles in technology with 
product life cycles when studying innovation. Similarly, Dosi (1982) describes 
technological trajectories and highlights the role of the environment for technological 
changes, influencing product design. 
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Types of Innovation 
The literature contains a wide variety of different types of innovation, reflecting different 
perspectives on focus of the innovation, degree of newness and timeframe (Moore 2004, 
Bowander & Miyake 1994). Indeed the concept of innovation varies in focus on product or 
process, as well as in degree of newness (Zaltman et al. 1973 pp7-16). A key distinction is 
made between product innovation and process innovation (Pisano 1997 pp9-10, Tidd et al. 
2005 pp5-13, Moore 2004, Bowander & Miyake 1994), where the change or element of 
newness is made to either the product (Gobeli & Brown 1987), or the process used to make 
and distribute it (Pisano ibid.) respectively. However Clarke et al. (1995), Bessant et al. 
(1994) and Pisano (ibid.) describe how the boundaries between product and process 
innovation are blurred, as changes can rarely be made to the product without making 
accompanying changes to the process used to produce it. Some innovations may be 
classified as either a product or process innovation, for example Bessant et al. (ibid.) give 
the example of a new jet powered ferry service. In addition, caution is needed when 
interpreting the innovation literature so that process innovation and the innovation process 
do not become confused. The former refers to an element of newness in the process used to 
make a product (Pisano 1997 pp9-10), while the latter refers to process based frameworks 
and models of the innovation concept (Rothwell 1992). 
 
A further type of innovation described in the literature is technological innovation, 
referring to both product and process innovation together (Utterback & Abernathy 1975). 
This type is pragmatic by involving inter-connected product and process types of 
innovation in one term, yet also refers to the key role of technology in change and newness 
in the product or service, as investigated above. Other types of innovation are defined 
according to degree of newness. Gobeli and Brown (1987) describe incremental 
innovations and radical innovations. The former involve little technical change and have 
low benefits for the customer, whereas the latter involve large technical changes and have 
high benefits for the customer. Incremental innovation is the most widespread type of 
innovation found in practice, especially those adopted from other organisations and 
developed, rather than radical innovations that were developed in-house (Freeman 1994). 
 
In summary of the above, the literature refers to various types of innovation depending 
upon the focus of what is new, the degree of newness, the application or exploitation of the 
new product or service and the technology involved. Innovation as a whole can be divided 
up into types, but there are likely to be overlaps and blurred boundaries between them. A 
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horizontal theme is that innovation is shown to be an inter-organisational process, as 
organisations increasingly need a dynamic approach to adopting and re-configuring 
technological resources beyond their organisational boundaries (Teece & Pisano 1994). 
 
In analyzing various concepts of innovation as above, previous research has referred to and 
conceptualised types of innovations as processes, for example product innovation is 
referred to as the process of producing a product, with an element of newness that is 
exploited in some way (Tidd et al. 2005 pp5-13). However the literature also contains 
many references to types of innovation that refer to the outputs of the innovation process. 
For example incremental innovation is a process often associated with continuous 
improvement (Bessant & Francis 1999), yet an incremental innovation may be the 
outcome of that process, such as an automatic needle positioning machine adaptation in 
shoe manufacture (Dewar & Dutton 1986). 
 
Literature also draws a difference between the terms product innovation and innovative 
product. Product innovation mainly refers to the innovation process producing a product, 
whereas ‘Innovative product’ focuses on the product. For example Pavitt (1990) and 
Deszca et al. (1999) describe how organisations must keep producing innovative products 
to compete in the marketplace, highlighting the role of technologies in the products. 
Thomke and Von Hippel (2002) refer to a number of innovative products in their study of 
product innovation involving customers. The term is used in the literature to describe a 
product that is an output of an innovation process and has innovative characteristics, which 
from the earlier discussion would be newness of some description and that the product is 
exploited. 
 
The literature refers to both innovative products and services (Pavitt 1990), though as 
analyzed above, the boundary between the two is blurred. Servitisation (Slack et al. 2004) 
is used to describe how products are increasingly viewed as part of a product service 
package or offering, or as a product that provides a service. When Pisano (1997) is 
considered, many of the innovative products studied in the literature include a service 
element, or are in effect innovative services with a facilitating product, despite being 
referred to as products. Biemans (1992 pp129-140) studied medical equipment 
innovations, defined as: “…a medical instrument that represents a significant (non-trivial) 
departure from previous patterns of diagnosis, treatment or prevention”. In this example 
the innovation is a physical instrument, though it is recognised as having a role in the 
process of healthcare. 
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The Innovation Process 
The innovation process is investigated now as part of analyzing the concept of innovative 
products and the inter-organisational process used to produce them. When looking at the 
existing research as a whole, two views of the innovation process are found (Voss 1984). 
The technology push view describes research driving application in product innovation 
before introduction to market, the technology pull view sees customer needs in the market 
trigger organisations to innovate, producing a product to meet the need. Process models 
(Godwin 1989 Slack et al. 2007 pp8-16) are widely used in the literature to conceptualise 
innovation, involving a series of stages of the innovation process, leading to production of 
the innovation as an output (Saren 1984). Some examples are summarised in Table 13. 
 
The models all show broadly similar stages of searching or exploring for an idea, selecting 
and developing it, then commercializing it in the marketplace. Over-arching observations 
are that many of the processes require the input of more than one organisation and that the 
unit of analysis in much of the existing research is the product. Further, many of the 
models recognise the iterative nature of innovation (Tidd 2005 pp88-97, Basadur & Gelade 
2006, Schoen et al. 2005, Booz et al. 1960 pp10-11, OECD 1992 pp25) and recognise the 
role of information in the process (Tidd 2005 pp88-97, Basadur & Gelade 2006, Schoen et 
al. 2006, Miaoulis & LaPlaca 1982). Indeed the OECD (1992 pp25) model suggests 
information exchange and feedback can occur between many different organisations and 
stages of the process. The Tidd et al. (2005 pp88-97) model best illuminates the innovation 
process overall, as it covers the entire process from initial ideas through to sustaining the 
innovation in the market, making it congruent with the definition of innovation as opposed 
to narrower product development definitions. It recognises the iterative nature of the 
process involving feedback, which is reminiscent of the concept of re-innovation (Rothwell 
& Gardiner 1988). It also highlights the role of information from inside and outside the 
organisation, reflecting the inter-organisational nature of innovation. The model is shown 
in Figure 6 and description of the activity stages are given in Table 14. 
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Innovation Process 
Model 
Process Stages Description 
Tidd et al. (2005 pp88-97) • Search 
• Selection 
• Implementation 
(Including: Acquiring 
knowledge resources, 
Executing the project, 
Launching & 
sustaining the 
innovation, Learning & 
re-innovation) 
Broad model of stages of the 
innovation process, including 
sub-stages of implementation 
stage. Process is iterative.  
Basadur & Gelade (2006) • Generating 
• Conceptualizing 
• Optimizing 
• Implementing 
Stages of the innovative 
thinking process, highlighting 
the role of knowledge in 
innovation. Process is iterative. 
Schoen et al. (2005) • Basic research 
• Invention 
• Innovation 
Cyclical model showing broad 
stages innovation progresses 
through, but breaking away 
from linear model. 
Wheelwright & Clark (1992 
pp6-9) 
• Concept Development 
• Product Planning 
• Product/process 
Engineering 
• Pilot Production/ramp-
up 
Stages are interdependent. 
Requires interaction between 
various stages of product 
development. Model is of 
product development so more 
limited than innovation. 
Booz et al. (1960 pp10-11) • Exploration 
• Screening 
• Business Analysis 
• Development 
• Testing 
• Commercialisation 
Successive stages may only be 
reached following success with 
previous stage, iteration in 
previous stages may occur. 
Simultaneous focus on product 
& process development. 
Assumes development funnel of 
screening ideas. 
Miaoulis & LaPlaca (1982) • Assessment 
• Development 
• Execution 
Model of development for high 
technology products. 
Model systematically integrates 
technological, product and 
market dimensions. Information 
has a role at each stage. 
OECD (1992 p25) • Potential Market 
Identification 
• Invention &/or 
Production of Analytic 
Design 
• Detailed Design & Test 
• Redesign & Produce 
• Distribute & Market 
Interactive model of the 
innovation process. Includes 
iterations and role of research 
and an existing corpus of 
scientific and technological 
knowledge. 
Table 13. Process Models of Product Innovation from the Literature 
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Figure 6. Innovation Process Model. After: Tidd J., Bessant J. & Pavitt K. 2005. 
Managing Innovation: Integrating Technological, Market and Organisational 
Change (3rd Ed.) Wiley. Chichester. UK. pp88-97. Fig 2.3. 
 
Activity Stage Description 
Search Detection of environmental signals of change potential. Identification, 
processing and information selection. 
Selection Selection from various technological and market opportunities. Ensuring those 
selected fit with organisational strategy. 
Turning the potential ideas into a product/service reality. Uncertainty gradually 
reduced as cyclical problem solving improvements to product/service. Includes 
the below: 
Acquiring Knowledge Resources Combination of existing and new 
intra- and inter-organisational 
knowledge. Finding, selecting and 
transfer of technology abilities. 
Executing the Project Project management activities in 
uncertain conditions, combining 
different knowledge sets. Iterative 
problem solving activities. 
Involvement of suppliers/users. 
Concurrent development. 
Launching & Sustaining the 
Innovation 
Activities of preparing the market into 
which the innovation will be 
launched. Information collection and 
problem solving. Dialogue between 
marketing and product development. 
Change management. 
Implementation 
Learning & Re-innovation Creation of new stimuli for restarting 
innovation cycle. Project review and 
audit. Feedback into new generation. 
Table 14. Activities of the Innovation Process. After: Tidd J., Bessant J. & Pavitt K. 
2005. Managing Innovation: Integrating Technological, Market and Organisational 
Change (3rd Ed.) Wiley. Chichester. UK. pp88-97. 
 
Search     Select   Implement
(Acquire/Execute/Launch/Sustain)
Learn
TIME
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Rothwell (1992) classifies innovation process models into five generations, summarised in 
Table 15. The classification shows how models have developed, increasingly recognizing 
innovation as an inter-organisational process and that interaction and feedback between a 
variety of organisations is involved. Recent literature agrees, describing innovation as an 
open (Gassmann 2006) and less linear process (Collins 2006, Schoen et al. 2005). Collins 
(ibid.) describes how organisations are increasingly accepting ideas and information from 
external sources as part of the innovation process, taking a collaborative approach to 
dealing with other organisations. Indeed, innovation is not just depicted as a process that 
cannot be carried out within one organisation, but one that requires interaction between 
organisations for success (Ritter & Gemunden 2004, Chapman & Corso 2005, Grandori & 
Soda 1995). 
 
Generation of Innovation 
Process Model 
Description 
1st / 2nd Linear process models, technology push and pull 
3rd Interactive models, involves interaction and feedback between 
stages of innovation 
4th Parallel model, involving integration within and outside the 
organisation. Linkages and partnerships are involved. 
5th Integration of systems, networking, flexibility and customisation 
Table 15. Five Generations of Innovation Process Models. After: Rothwell R. 1992. 
Successful Industrial Innovation: Critical Success Factors for the 1990s. R&D 
Management. 22(3) pp221-239. 
 
Having discussed key stages in the innovation process and the increasing role of 
information and interaction between a variety of organisations, the next sub-section 
focuses on the implementation part of the process. 
 
2.7.2. Implementation of Innovative Products 
Existing studies have often limited their research to a particular part of the broad 
innovation process, such as studies that concentrate on invention, product development or 
the inter-organisational part of the process between supplier and end customer. This 
research focuses upon this later implementation part of the innovation process and 
literature defining and discussing this part of the process is described here. 
 
Zaltman et al. (1973 pp66-67) refers to a decision making process with two broad stages 
and five sub-stages. The broad stages are initiation and implementation. Initiation includes 
knowledge awareness, formation of attitudes towards the innovation and a decision. 
Implementation includes initial implementation and then continued-sustained 
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implementation. The implementation stage is described as: “…concerned with the actual 
utilization of the innovation by organisational members as they perform their tasks”. 
Implementation here is a broad term focussing on the time at which the product innovation 
is taken up by the customer. Zaltman et al.’s (ibid.) model is suppler centric however and 
does not model the customer organisation as well. 
 
Implementation is defined differently in the Tidd et al. (2005 pp88-97 Figure 6) model, 
where they use the term to focus on turning ideas into a product reality and launching to a 
customer. Launch in this case would include adoption for example, so the use of the term 
implementation is broader. Tidd et al. (ibid.) describe how it involves drawing together 
knowledge acquired from different sources inside and outside the organisation, 
determining whether the innovation is possible and a specification of characteristics, 
launching the innovation to the market involving awareness, trial, evaluation and adoption, 
then using further information to refine it (Rothwell & Gardiner 1988). 
 
As discussed above, innovation is an inherently inter-organisational process and this is true 
of the implementation part of the process where the product is taken up for use from the 
supplier by the customer, with implications for how performance is measured and 
managed. The interaction approach to studying inter-organizational relationships provides 
some contextual details that are of use in understanding the innovation process. The early 
research of the IMP Group produced the interaction model (Figure 7, IMP Group 1982), 
consisting of the organisations and individuals on both customer and supplier sides, the 
interaction process, the atmosphere of the interaction and the environment in which the 
interaction takes place. The interaction includes recognition of both short term exchange 
episodes, or transactions, as well as the longer term relationships that develop as 
institutionalisation and adaptations occur with repeated transactional relationships. 
Product, service, information, financial and social exchanges (Ring & Van de Ven 1992, 
Wilson & Jantrania 1994) may all occur. It is recognised that the individual actors within 
each organisation have their own aims and experiences that have an influence on the 
interaction between them and their organisations and the environment is modelled as 
involving a social system amongst other elements. The atmosphere of the interaction 
process involves power and dependence of the relationship, expectations of the 
organisations and individuals, as well as closeness and co-operation. Including the 
atmosphere in the model also shows that the interaction approach takes account of extra-
organisational phenomena, consistent with contemporary open models of innovation. 
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Environment
Market structure, Dynamism, Internationalisation, 
Position in the manufacturing channel, Social system
Atmosphere
Power/dependence, Cooperation, Closeness, Expectations
Interaction Process
Organisation
Technology
Structure
Strategy
Individual
Aims
Experience
Organisation
Technology
Structure
Strategy
Individual
Aims
Experience
Product/service
Information
Financial
Social
Short Term Exchange 
Episodes:
Institutionalisation
Adaptations
Long Term 
Relationships:
 
Figure 7. IMP Interaction Model of Inter-organisational Relationships. IMP Group 
1982. An Interaction Approach. In: Hakansson H. (Ed.) 1982. International Marketing 
and Purchasing of Industrial Goods. Wiley. Chichester. UK. Chap 2. pp10-27, Figure 
2.2. 
 
Relationships have been conceptualised as the building blocks of networks (Ford & 
Hakansson 2002) or being embedded within networks (Granovetter 1973), which are 
defined as “…sets of connected exchange relationships between actors controlling 
business activities…” (Cook & Emerson 1984). The definition brings out key network 
concepts of actors, connections and exchange. Hakansson (1987 pp3-6) conceptualises 
networks as consisting of actor, activity and resource elements which are mutually 
interdependent. Relationships and networks of relationships are created as organisations 
construct actor bonds, activity links and resource ties. These network concepts influence 
the way organisations and relationships operate and are of relevance to understanding 
performance measurement, performance management and innovation. For example, 
Granovetter (1973) describes how organisations use ties to other organisations to exchange 
information and resources to gain and maintain competitive advantage. A number of terms 
have been used in the existing literature to describe the various types of inter-
organisational relationships. ‘Supply relationships’ have a particular focus on the structures 
and processes of the inter-organisational supply of products or services (Harland et al. 
1999, Lamming 1996), making them most appropriate for this research. 
 
The literature also provides a more explicit discussion of innovation from an inter-
organisational perspective, with relevance for performance measurement and performance 
management. Hakansson (1987 pp3-6) advocates that technological innovation must take 
place between and not just within organisations and that an innovation is the product of 
interaction between two or more actors in a network. As part of implementing the 
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innovative product, organisations are involved in knowledge development, resource 
mobilization and resource coordination (Hakansson ibid.). Knowledge development sees 
organisations interacting to share information on technologies or solutions that may be 
useful to the other, particularly where a customer and supplier are concerned, with novel 
ideas often occurring at the interface between organisations. This point is reminiscent of 
the role of information about the performance of a product as described in the performance 
measurement literature above. In accordance with social and informational exchange, 
Nohria (1992) pointed out social interaction as a process that occurs in networks of 
relationships, developing weak ties (Granovetter 1973, 1985) for the exchange of 
information (Uzzi 1997) about products. Indeed networking, involving numerous supply 
relationships between customer and supplier organisations is increasingly the way that 
organisations go about the process of innovation (Grandori & Soda 1995). Resource 
coordination in diverse networks of organisations such as firms, research institutes, 
universities and government bodies, is necessary to gain information and knowledge as 
contemporary organisations are increasingly specialised (Bessant 1999). This agrees with 
advanced models of innovation suggested by Rothwell (1992) and Schoen et al. (2005), 
with many linkages and opportunities for communication or social exchange and the flow 
of information between organisations. Much social and information exchange occurs in 
informal networks, in addition to formal networks (Allen et al. 2007). 
 
Key amongst information exchanges are feedback or learning loops from various stages of 
innovation process models, particularly from the end of the linear process where the 
innovative product has been launched to the customer. Feedback involves knowledge 
development, to learn about the innovative product and adapt it, as part of the iterative 
process of improving the design of the product (Tidd et al. 2005 pp88-97, Biemans 1992 
pp129-140, Basadur & Gelade 2006, Schoen et al. 2005, Booz et al. 1960 pp10-11, OECD 
1992 p25). Tidd et al. (ibid.) also recognise the importance of learning and sustaining 
activities in innovation, reinforcing the role of feedback. Feedback in innovation is 
described by Zaltman ibid. (1973 pp71-77) as “…(serving) the process of guiding and 
controlling the actual performance of a process” though he points out that “The 
information that the feedback mechanisms provide must be interpreted to become useful”. 
 
Rothwell and Gardiner (1985) coined the term re-innovation in which features of the 
innovative product are revised after the product is launched on the basis of learning from 
the original generation of the product, creating a new generation of the product (Nonaka & 
Kenney 1991). Rothwell and Gardiner (1988) refers to the importance of small incremental 
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improvements in re-designing products, these smaller design steps being responsible for 
the vast proportion of product re-design. Biemans (1992 pp129-140) studied the adoption 
and diffusion of medical devices in the Netherlands, specifically including a decision 
making stage of performance review to complete the cycle. Echoing discussion of 
information exchange above, knowledge management, involving apprehension and then its 
creative use are stated as an important part of innovation in effective organisations 
(Basadur & Gelade 2006). Altogether, the literature emphasises a key role for 
informational and social exchange between customer and supplier organisations in the 
iterative innovation process, leading to re-starting the innovation process and changes in 
the product design. 
 
A key element of the implementation part of the innovation process involving performance 
measurement and performance management is making the decision to purchase or supply 
the product. Harland et al. (2004) and Grandori and Soda (1995) highlighted the process of 
decision-making in networks of relationships. According to Harland et al. (ibid.), decision-
making involves combining information with objectives, resolving differences and the 
establishment of procedures, routines and rules. Johnston and Lewin (1996) conducted a 
substantial review of organisational buying behaviour literature, describing how Webster 
and Wind (1972 pp12-39) and Sheth (1996) amongst others developed the general 
constructs of organisational buying behaviour and influencers. Webster & Wind (1972 
pp12-39, 77-107) modelled buying behaviour by organisations and constituent individuals, 
describing how groups of individuals collectively make decisions in a buying centre or 
committee. Their model describes how the organisation communicates and searches for 
information as part of the buying process, again highlighting the role of social and 
information exchange. The organisational decision making process they describe in the 
buying process includes establishing objectives and specifications, identifying buying 
alternatives and evaluating alternative buying actions. 
 
The decision making process of individual buyers is described as similar to that of 
organisations as a whole, featuring the identification and evaluation of alternatives 
followed by a choice. Webster and Wind (ibid. pp88-107) describe how buyers have a 
variety of predispositions, preferences and decision models, influencing the outcome of the 
individual’s decisions as shown in Figure 8. The decision making process can be made in 
both formal and informal ways. The former involves looking at hard criteria such as costs 
and making a decision in a formal tender process for example. Softer or less tangible 
aspects of the decision making process include those that are environmental, organisational 
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and interpersonal (Webster & Wind ibid.). Decisions may be based on a single dominant 
dimension such as a financial performance measure, or upon multiple attributes of a 
particular purchase, using the information gained from performance measurement, as 
described above. Various weighting and scoring processes may be used where multiple 
criteria are considered (Van Weele 2002 pp52-59). However decisions may not always be 
made according to strict procedures, as factors such as the role of expert power, 
information power and reward power may affect individual influence in the buying centre 
(Kohli 1989). Berkowitz (1986) describes how product sampling by end users or technical 
staff gains their interest, yet may not always result in sales, while Nutt (1984) highlights 
that decisions may be made in the same pattern as previous decisions. 
 
STIMULI BEHAVIOUR
Personality
Learning 
Processes
Cognitive 
Structure
Motivation
Preference Structure 
and Decision Model
Perceived 
Role Set
The Individual’s “Black Box”
 
Figure 8. A Simplified Model of Individual Buying Behaviour. After: Webster F.E. & 
Wind Y. 1972. Organisational Buying Behaviour. Prentice Hall. Englewood Cliffs. NJ. 
USA. pp88-107. 
 
The innovation literature also discusses decision making by customers and suppliers in the 
implementation part of the innovation process, through concepts such as adoption and 
diffusion. Adoption is defined by Rogers (2003 p21) as: “The decision to make full use of 
an innovation as the best course of action available”. Adoption of an innovative product is 
only one option, which gives rejection as the term for the opposite action (Biemans 1992 
pp42-45). Biemans points out that rejection may occur at any stage of the innovation 
process, not only when the product is fully developed and being marketed. Adoption is a 
similar term to diffusion, which is by contrast defined as: “Communicating an innovation 
through certain channels over time among the members of a social system” (Robertson 
1971 p32). They are differentiated as adoption is an individual decision making process, 
while diffusion represents a wider series of adoption decisions by a number of individuals 
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within a system or network. The concepts describe the decision or decisions to purchase an 
innovative product from a supplier, by an individual or a number of individuals in an 
organisation. Biemans (1992 p48) gives an example of activity stages in the buying 
process, as a description of adopting an innovative product. The stages include gathering 
information about different options, analyzing it, then making a selection. Rogers (2003 
pp169-194)’ model is from a diffusion perspective and also includes similar key stages. 
Overall these stages of gathering information, comparing options against criteria then 
making a decision concur with those suggested by Webster & Wind (1972 pp12-39, 77-
107) above. 
 
Table 16 summarises the main stages in the decision making processes discussed in this 
section. Overall broad stages of gathering information, analysis and taking the decision are 
identified. Again social and information exchange is involved, but also product and 
financial exchange when the purchase decision is made and the innovative product is 
supplied to the customer. The next section summarises the review of the existing literature. 
 
2.8. Summary 
This chapter reported the findings of reviewing existing literature in the performance field. 
It found that performance is a loose concept drawing on a variety of literatures. In the 
loosest sense, performance refers to the effectiveness of some sort of achievement or 
attainment of a variety of things, including innovative products. Also, the performance of 
the product may affect how the organisation performs. The literature describes financial 
and broader operational aspects of performance at different parts of the operational 
process, according to different stakeholders. 
 
Performance measurement is a key concept in the performance literature, which has 
focussed on the appropriate selection and implementation of measures. However there is 
an acknowledged lack of clarity in differentiating the concept of performance measurement 
from performance management, another term widely and loosely used in the literature that 
refers to broader, or follow up planning and control processes than measurement. Existing 
work, and increasing interest in whether performance measurement is worthwhile, also 
suggests that performance management could be differentiated from performance 
measurement by their having different influences on performance. The literature 
emphasised that a variety of organisations and individual actors measure and manage 
performance. 
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Source or 
Model 
Focus of Literature Main Stages 
Webster and 
Wind (1972 
pp12-39) 
General model of 
organisational buying 
decision process 
1. Identification of need 
2. Establishing objectives and specifications 
3. Identifying buying alternatives 
4. Evaluating alternative buying actions 
5. Selecting the supplier 
Harland et al. 
(2004) 
Decision-making process 
issues in networks of 
supply relationships 
• Combining objectives and information 
• Resolving differences 
• Establishing procedures, routines and rules 
Bunn (1993) Created a taxonomy of 
approaches to buying 
decisions according to 
different buying 
situations. The different 
approaches make various 
use of the activities shown 
here 
• Search for information 
• Use of analysis techniques 
• Proactive focus 
• Procedural control 
Nutt (1984) Types of organisational 
decision making 
processes, described using 
framework of the 
following stages 
• Formulation 
• Concept development 
• Detailing 
• Evaluation 
• Implementation 
Biemans 
(1992 p48) 
Activity stages in the 
buying process, as 
adoption of an innovative 
product 
1. Anticipation or recognition of a problem and 
solution to it 
2. Characteristic and quality determination for the 
item needed 
3. Characteristic and quality description for the 
item needed 
4. Searching for and qualifying potential sources 
5. Proposal requisition and analysis 
6. Proposal evaluation and supplier selection 
7. Order routine selection 
8. Feedback on performance and evaluation 
Rogers (2003 
pp169-194) 
Innovation decision 
process from a diffusion 
perspective 
1. Knowledge (Including: Recall of information, 
comprehension of messages, knowledge or skill 
for effective adoption) 
2. Persuasion (Liking the innovation, discussion of 
new behaviour with others, acceptance of 
message about the innovation, formation of 
positive image of message and the innovation, 
support for innovative behaviour from system) 
3. Decision (Intention to seek additional 
information about the innovation, intention to 
try the innovation). Decision is for adoption or 
rejection, immediately and also longer term 
when it may change. 
4. Implementation (Acquisition of additional 
information about the innovation, regular use of 
the innovation, continued use of innovation) 
5. Confirmation (Recognition of benefits of using 
innovation, integrating the innovation into an 
ongoing routine, promoting the innovation to 
others) 
Table 16. Summary of Main Stages in Purchasing and Supply Decision Making in the 
Purchasing and Supply Management and Innovation Literatures 
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Discussion of existing literature on the implementation of innovative products, the context 
of this research, highlighted that innovation is a process, involving customer and supplier 
individuals and organisations for success. Between these, social, informational, product 
and financial exchange occur as part of the implementation part of the innovation process, 
including performance measurement and performance management, including where 
decision-making is involved. This research focuses on technological innovation and 
innovative products, given the focus on medical devices. It concentrates on the 
implementation part of the innovation process where the supplier’s product is developed, 
launched in the market and learning through feedback occurs. 
 
Key questions about performance measurement and performance management during the 
implementation of innovative products that were raised by reviewing the existing literature 
are now taken forwards in the next chapter. It develops research questions and uses the 
findings of the literature review as a basis for conceptualization of this research. 
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CHAPTER THREE: RESEARCH QUESTIONS AND CONCEPTUAL 
FRAMEWORK 
 
3.1. Introduction 
The last chapter examined the literature on performance and analyzed differences between 
the concepts of ‘performance measurement’ and ‘performance management’, observing the 
influences that the literature implies that they may have. This performance literature has 
implications for understanding performance measurement and management of innovative 
products during their implementation. The literature review also discussed the innovation 
process and the implementation of innovative products such as medical devices.  
 
This chapter continues the thesis by outlining a set of research questions that emerged from 
the literature review and were refined during the iterative process of the research as a 
whole. Towards development of a conceptual framework, the chapter continues by 
discussing differences between the concepts of performance measurement and 
performance management in the supply of innovative products. This work is based on the 
publications described in the literature review, but is more focussed for this research in the 
light of the research questions. The chapter also discusses conceptualisation of the 
influences of performance measurement and performance management and determines the 
most appropriate part of the innovation process for study in this research. Based upon these 
background concepts, the chapter finishes by presenting a conceptual framework, upon 
which the empirical work of the thesis was carried out. 
 
3.2. Derivation of Research Questions 
The literature review gives rise to the following over-arching research question, based on 
the original research aim: 
• How is the performance of innovative healthcare products measured and managed 
during the implementation process and what influence do these processes have on 
their performance? 
 
The question draws on the limited conceptual clarity over performance measurement and 
management, as well as the increasing interest in the purchasing and supply of innovative 
products. This over-arching research question is broken down into the following sub-
questions, summarised in Table 17 with details, examples of their basis in the literature and 
a note towards the answer strategy, discussed further in the methodology chapters. 
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Research 
Question 
Question Explanation Example of 
Literature Basis 
Answer 
Strategy 
A What processes 
are used to 
measure and 
manage the 
performance of 
innovative 
healthcare 
products during 
their 
implementation? 
The literature review 
suggested that a range of 
processes may be used to 
measure performance and 
manage performance. 
Further, existing work 
shows that there is often a 
lack of conceptual clarity in 
distinguishing the two 
concepts. This question 
explores what processes are 
used to measure and manage 
the performance of 
innovative products such as 
medical devices, by the 
variety of actors involved in 
their implementation.  
Neely et al. 
(2005), 
Globerson 
(1985), Radnor 
& McGuire 
(2004) 
Case study, 
pattern 
matching & 
cross-case 
synthesis 
B How do the 
processes used to 
measure and 
manage the 
performance of 
innovative 
healthcare 
products during 
their 
implementation 
influence their 
performance? 
The literature contains 
limited and conflicting 
evidence on the influence of 
performance measurement 
on performance. Indeed 
some research suggests that 
only performance 
management processes 
influence performance, not 
performance measurement 
processes alone. This 
question investigates if and 
how the performance 
measurement and 
performance management 
processes identified in 
question A influence 
performance of the 
innovative product. 
Davis & Albright 
(2004), Ittner et 
al. (2003), 
Banker et al. 
(2000), Perera et 
al. (1997), Neely 
et al. (2004), 
Bourne et al. 
(2005), Hume & 
Wright (2006), 
Kaplan & Norton 
(1992,1996), 
Neely (2004), 
Ridgway (1956), 
Globerson 
(1985), Webster 
& Wind (1972 
pp89-106), 
Halachmi (2005), 
Pfeffer & Sutton 
(2006), Robson 
(2005) 
Case study, 
pattern 
matching & 
cross-case 
synthesis 
C How should 
performance 
measurement and 
performance 
management 
processes during 
the 
implementation of 
innovative 
healthcare 
products be 
differentiated? 
The literature review 
highlighted a lack of a clear 
conceptual distinction 
between performance 
measurement and 
performance management. 
This question builds on the 
findings of the  previous two 
questions by investigating 
whether performance 
measurement and 
performance management 
processes can best be 
distinguished from one 
another by either the latter 
being broader, or 
influencing performance. 
Radnor & 
McGuire (2004), 
Halachmi (2005), 
Lebas (1995), 
Neely et al. 
(1997), Melnyk 
et al. (2005), 
Bourne et al. 
(2005) 
Case study, 
pattern 
matching & 
cross-case 
synthesis, 
explanation 
building 
Table 17. Details, Literature Background and Answer Strategy for Research 
Questions 
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• Research Question A: What processes are used to measure and manage the 
performance of innovative healthcare products during their implementation? 
 
The literature review suggested that a variety of processes may be used to measure 
performance (Neely et al. 2005) and manage performance (Globerson 1985) by various 
organisations and individuals. Further, existing work shows that there is often a lack of 
conceptual clarity in distinguishing the two concepts (Radnor & McGuire 2004). This 
research question explores what processes are used to measure and manage the 
performance of innovative products such as medical devices, by the variety of actors 
involved in their implementation.  
 
• Research Question B: How do the processes used to measure and manage the 
performance of innovative healthcare products during their implementation 
influence their performance? 
 
The literature contains limited and conflicting evidence on the influence of performance 
measurement on influencing performance with some existing work suggesting there is an 
influence (Davis & Albright 2004, Ittner et al. 2003b, Banker et al. 2000) while other work 
suggests there is not (Perera et al. 1997, Neely et al. 2004). It suggested that performance 
measurement alone cannot alter performance (Bourne et al. 2005, Hume & Wright 2006) 
and is intrinsically reflective (Kaplan & Norton 1992), yet also that it may have value to 
organisations in a variety of other ways (Neely 2004) and can even have dysfunctional 
consequences (Ridgway 1956). The literature describes performance management 
processes that influence performance (Kaplan & Norton 1996, Globerson 1985, Webster & 
Wind 1972 pp89-106). Indeed some research suggests that only performance management 
processes influence performance, not performance measurement processes alone (Bourne 
et al. 2005, Globerson 1985, Halachmi 2005, Pfeffer & Sutton 2006). In response to this 
literature, the question investigates if and how the performance measurement and 
performance management processes identified in question A influence performance of the 
innovative product. 
 
• Research Question C: How should performance measurement and performance 
management processes during the implementation of innovative healthcare 
products be differentiated? 
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The literature review highlighted a lack of a clear conceptual distinction between 
performance measurement and performance management (Radnor & McGuire 2004). 
Previous work suggests that performance measurement is a sub-set of broader performance 
management (Halachmi 2005, Lebas 1995) involving follow up planning and control 
action to performance measurement; or that performance management influences 
performance, whereas performance measurement does not (Halachmi 2005, Bourne et al. 
2005). This question builds on the findings of the previous two questions by investigating 
whether performance measurement and performance management processes can be 
distinguished from one another by the latter being broader, or influencing performance. 
 
The questions underpinned empirical data collection in this research. Given the limited 
existing work in the area in the literature review, their focus is largely exploratory, with 
question A focussing on gaining insights into processes that occur and question B 
exploring the influences of those processes. Question C takes a more explanatory 
approach, trying to clarify the concepts identified in the literature review with the use of 
empirical data. The research questions raise some conceptual issues towards development 
of a conceptual framework, which are discussed in the next section before a conceptual 
framework is presented at the end of this chapter. 
 
3.3. Conceptual Development 
This section builds upon the findings of the literature review by developing concepts for 
use in a conceptual framework for this research. The following sub-sections discuss a focus 
for this research within the broad innovation process, conceptualisation of performance 
measurement and performance management with respect to one another and finally some 
details about conceptualizing the influences of the processes on performance. 
 
3.3.1. Focus of this Research Within the Innovation Process 
The literature review showed that innovation is modelled as a broad process from detecting 
signals of change in the environment, through to sustaining an innovation, learning and re-
innovation (Tidd et al. 2005 pp88-97). The breadth of this innovation process has caused 
researchers to limit their studies to a particular part or phase of the innovation process, 
some of these phases having been described in the literature review.  
 
The early part of the innovation processes are not applicable for this research, as they 
frequently focus on innovations in early development, that can actually be defined as 
inventions, as they have not been exploited yet. Similarly, the new product development 
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literature also focuses on the earlier parts of the innovation process rather than products 
already in use by the end user. However the term has also been used in research that 
includes and is of interest to the innovation process in general so some of these 
publications will be relevant to the thesis. Innovation has been described as broader than 
new product development, from identifying market needs to sales (Trygg 1991 p4). The 
importance of viewing innovation as an inter-organisational process is recognised (Ritter & 
Gemunden 2004, Chapman & Corso 2005, Grandori & Soda 1995) so this research has 
also drawn on research in the purchasing and supply management field. It focuses on 
supply relationships between suppliers and the NHS as an end customer, so the latter parts 
of the innovation process are of more interest. 
 
Implementation as defined by Tidd et al. (2005 pp88-97) was found to be the broadest term 
describing the latter parts of the innovation process, recognizing the inter-organisational 
context, where the supplier turns ideas into a product reality, exploitation in launching it to 
the market where the customer utilises it and finally sustaining the innovation with 
feedback. However it does not go to the breadth of also covering invention and idea 
generation in the early stages of the innovation process overall. It enables study of the 
performance measurement and management processes during the latter stages of 
innovating, purchasing and supplying innovative products that have already been 
introduced commercially (Saren 1984).   
 
The literature review covered different conceptual approaches to the inter-organisational 
relationships and networks in the innovation process. The interaction approach (Ford et al. 
1986, Ford & Hakansson 2002) is the most illuminating for this research as it is broadly 
based, recognises both customer and supplier as active parties, has been used in innovation 
and purchasing and supply research and allows study of the more developed, longer-term 
relationships that can occur in the product innovation process. Different types of 
relationships and networks were also discussed in the literature review and this research 
refers to supply relationships and supply networks (Harland 1996), as the concept 
concentrates on inter-organisational purchasing and supply of product service offerings. As 
a whole, this research draws principally upon the operations and supply strategy literature, 
which has made use of the interaction approach in its development (Harland 1996).  
 
3.3.2. Conceptualizing Performance Measurement and Performance Management 
As discussed in the literature review, existing research as a whole has not drawn a clear 
and consistent distinction between the concepts of performance measurement and 
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performance management. While the research questions and especially question C set out 
to empirically explore this area in the context of this research, some form of 
conceptualisation of the two concepts with respect to one another is required for 
developing a conceptual model on which the empirical work is based. A working definition 
of the concepts is then given. 
 
Performance measurement and performance management are typically modelled as 
processes (Neely 1997, Halachmi 2005), consisting of actors such as the organisations and 
individuals involved in the interaction, activities for example social exchange and 
resources such as measures themselves. Much existing work suggests that performance 
management consists of a broader range of processes than performance measurement 
(Halachmi 2005, Globerson 1985, Radnor & McGuire 2004). Lebas (1995) is in agreement 
with this, graphically modelling performance measurement as a subset of performance 
management in two ovals, one nesting inside the other. However the literature is not clear 
about the relationship between the two spheres, with Lebas (ibid.) stating that performance 
management precedes performance measurement, whereas other literature suggests 
performance management involves processes that follow up, or are subsequent to 
performance measurement (Radnor & McGuire 2004, Globerson 1985). Examples include 
management making decisions on the basis of information (Pfeffer & Sutton 2006). 
Although stating that performance management has preference, Lebas (ibid.) also suggests 
that measurement and management occur in iterative cycles. A conceptualisation of 
performance measurement as a subset of a range of broader, performance management 
processes is used in this research, as shown in Figure 9, a simplified and modified version 
of Lebas (1995)’ diagram distinguishing the two concepts. The diagram is simplified as it 
is without any arrows showing precedence, which is not clear from the above literature and 
will be explored empirically. It shows performance measurement as a subset of, so 
included within, broader performance management processes as suggested by the literature 
(Halachmi 2005). The diagram here shows the larger oval and everything within it as 
performance management processes, in this research these are planning and control 
management processes in the implementation of innovative products. These performance 
management processes include the performance measurement processes in the small oval. 
The area within the large oval but not taken up by the small oval represents those parts of 
management processes other than measurement. 
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PERFORMANCE 
MANAGEMENT 
PROCESSES
PERFORMANCE 
MEASUREMENT 
PROCESSES
 
Figure 9. Conceptualisation of Performance Measurement and Performance 
Management with Respect to One Another. After: Lebas M.J. 1995. Performance 
Measurement and Performance Management. International Journal of Production 
Economics. 41(1-3) pp23-35. Fig 9. 
 
Further to conceptualizing performance management as a broader set of processes than 
performance measurement, some existing literature suggested that a difference can be 
drawn between the two concepts by their influence or otherwise on performance (Bourne 
et al. 2005, Halachmi 2005, Kaplan & Norton 1996). Research questions B and C explore 
this issue empirically, and can be represented in a conceptual framework by recognising 
that the concepts of performance measurement and performance management may 
influence performance. This conceptual issue is addressed in the next sub-section. 
 
Based on the literature review and conceptualisation, working definitions of performance 
measurement and performance management are given here, to be taken forwards in the 
empirical work.  
 
Performance measurement is defined as: Quantifying or qualifying an aspect of the 
performance of a product. This definition draws on Neely et al.’s (2005) definition and 
reflects the fundamental concept of measurement as described by Farbey et al. (1993 pp75-
94), though has been altered to recognise literature suggesting that measurement can be 
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qualitative as well as quantitative. Also the Neely et al. (ibid.) definition has been altered 
to focus on measuring performance of innovative products (Zheng Zhou 2006) rather than 
events or processes. 
 
Performance management is described as: Broader or follow up planning and controlling 
action, based on information from performance measurement, which influences the 
performance of a product. Based upon Radnor and Barnes’ (2007) suggestions of actions 
aimed at improvement, this definition includes the concept of management as involving 
planning and control actions (Mintzberg & Lampel 1999, Slack et al. 2007 p24-25). It 
highlights how these actions may involve using information from performance 
measurement (Globerson 1985, Lebas 1995) which is a part of performance management. 
The definition also reflects two key ways the literature suggests the concept can be 
differentiated from performance measurement, namely that it is broader or involves follow 
up action (Halachmi 2005, Lebas 1995), or that it influences performance (Bourne et al. 
2005, Halachmi 2005, Melnyk et al. 2005). 
 
3.3.3. Conceptualisation of the Influences of Processes in Performance 
This sub-section discusses concepts in the literature that underlie description in the 
research questions and conceptual framework of the roles of performance measurement 
and management processes. It describes why the focus of this research is on the influences 
of the processes in performance rather than on performance and outlines why the term 
‘influence’ was used. However, it then discusses the different aspects of performance that 
might be measured or that the processes may influence, with a view to implementing 
concepts of performance measurement and process roles in the empirical work. 
 
A number of studies have investigated the link between various ways of managing an 
operation and an aspect of performance, though most tend to be positivistic economics or 
operations research type studies (Hendricks & Singhal 2003). This has limited relevance 
for this research, also as the literature review highlighted that performance is a loose and 
broad concept that can be applied to a variety of things and that a variety of aspects of it 
can be measured. On the other hand, where operations management studies in the 
performance field have discussed performance, they focus mostly on the implications or 
influences of performance measurement or other operational processes and interventions. 
For example, Radnor and McGuire (2004) studied the effectiveness of performance 
management in the public sector by focussing on the influence of the systems rather than 
on links to performance. Similarly, many publications in the innovation field have studied 
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the performance of processes (Owens 2007). Such influences are often only suggested and 
again refer to a variety of aspects of performance. In the light of the existing research in the 
area this research focuses on the influences of performance measurement and performance 
management processes, rather than upon making links to performance, as reflected in the 
work in the Journal of Productivity and Performance Management for example. 
 
Whereas other terms such as ‘link’ (Gloor et al. 2008), ‘cause’ and ‘connection’ are 
usually found in conclusive, positivistic studies, ‘influence’ has been used in case-based 
research that deals with exploring concepts and building explanations (eg Garengo & 
Bititci 2007), so is chosen as being more appropriate for this research. Choosing the term 
‘influence’ is also inclusive of both positive and negative roles discovered in the empirical 
work, if the processes are found to have a beneficial effect on performance or a non-
beneficial effect, hindering performance (Ridgway 1956). Other existing research has 
referred to impacts on performance, however the term has been used where performance 
outputs are more clearly defined in terms of high performing and average performing 
business units (Bourne et al. 2005), rather than influence which is more exploratory. 
 
Although the focus of the research is on the influences of performance measurement and 
performance management, rather than performance, a conceptualisation of performance is 
useful in developing the empirical tools, to describe what aspects of performance are being 
measured and managed and provide a background to what sort of influences might be 
discovered. Reviewing the literature showed a breadth of different conceptualisations of 
performance in existing work, either in the way performance was described or empirically 
measured. For example Ahmed and Zairi (2000) reviewed literature with a number of 
performance concepts in the product innovation field. They discovered financial and 
operational performance concepts from customer, technological and product viewpoints. 
Concepts of performance used in existing literature were described in the previous chapter, 
along with a description of the study concerned and how the concept of performance was 
implemented empirically. Kaplan and Norton (1992) amongst others state that a mixture of 
financial and non-financial measures is important. Also, the recent evidence-based and 
healthcare related literature suggests that a conceptualisation of performance which 
recognises quality of care or life for the patient is necessary (Sackett et al. 1996). Whereas 
the literature review studied concepts of performance in general, here the focus is on how 
such concepts are applied empirically, with the interest of developing a concept of 
performance for a conceptual framework in this research. 
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Griffin and Page’s (1996) concept of performance on three dimensions is the most 
appropriate for this research, as it meets the requirement to be sufficiently broad, taking 
account of financial and non-financial measures (Kaplan & Norton 1992), includes three 
dimensions that are consistent with other works in the literature (Hultink et al. 1997, Song 
et al. 1997) and is specifically from an innovation relevant context. The existing literature 
on performance shows publications that conceptualise performance of a wide variety of 
things that may perform, from the organisation (Ritter & Gemunden 2004) to products 
(Tidd et al. 2005 pp561-569). The Griffin and Page (1996) framework is useful for this 
research as it takes product development, a concept closely aligned with innovative 
products as the unit of analysis in this research, yet also recognises that the performance of 
that product can be expressed in terms of the way it performs in the market place and 
financially for customer and supplier organisations. Griffin and Page (1996) summarises 
the performance concept and so can be used to describe the influence of the processes in 
financial, technical and customer performance and also to refer to financial, technical and 
customer performance measures. 
 
The concepts developed so far in this chapter are used to develop the conceptual 
framework, which is presented and described in the next section, as well as to 
operationalise the research, discussed in the next chapter. 
 
3.4. A Conceptual Framework 
The conceptual framework was developed based upon the literature review and the 
research issues and questions arising from it. The framework has developed iteratively, 
along with the concepts that are a part of it, which were discussed in the previous section. 
This section presents the framework as shown in Figure 10, which underpins the empirical 
work, while subsequent chapters present the methodology used. 
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(Research Question B)
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(Research Question A)
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MEASUREMENT 
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(Research Question A)
Innovative 
Product 
PERFORMANCE
Thesis focusDifferentiating concepts of innovative product 
performance measurement and 
performance management
(Research Question C)
Figure 10. Conceptual Framework 
 
Figure 10 shows that the conceptual framework is structured around a core of the 
performance measurement and performance management processes, represented by the 
two ovals, one nested inside the other. The ovals represent performance measurement 
processes as a sub-set of broader performance management processes, in the manner of 
Lebas (1995) and Bititci et al. (1997). As described above, the ovals show performance 
measurement as a subset of performance management, in the light of the literature 
describing performance management as broader than performance measurement (Halachmi 
2005). A simplification from Lebas’ diagram is that precedence of one set of processes is 
not shown. A clear division between performance measurement and performance 
management is shown, as in the Lebas framework and definitions above.  
 
The influences of the performance measurement and performance management processes 
are also included in the framework, as the literature also suggests the two concepts may be 
differentiated by their influence or otherwise in performance. The influences are 
represented using an arrow, leading to performance of the innovative product which is 
shown using a square. Different shapes are used to show that the influences of the 
processes above and performance do not represent processes like the ovals. The arrow runs 
to performance from both of the ovals shown in the framework, as the empirical work 
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studies whether performance measurement alone or broader performance management 
processes influence performance. The dotted circular line represents the focus of the thesis 
on the performance measurement and performance management processes and their 
influences, rather than conclusive links between the processes and performance. 
 
The conceptual framework must be accompanied by a definition of the unit of analysis 
used in the empirical work, the innovative product. The unit of analysis is described in the 
later methodology chapter, but is included in the framework which illustrates processes 
that measure and manage the performance of the innovative product, as well as a 
representation of influences of those processes in performance of the innovative product. 
 
The conceptual framework aids answering the research questions as follows. Question A 
explores the performance measurement and performance management processes of 
innovative products during their implementation, which the empirical work will address by 
investigating the processes that occur within the small and large ovals. Diagrammatically, 
Question B is represented by the arrow showing the influences of the processes in the ovals 
on performance, the question investigating if and how the influence shown by the arrow is 
found empirically. Together, Questions A and B aid answering Question C, by examining 
whether performance measurement and performance management can be distinguished 
conceptually by either the former being a subset of the latter, or by their influence on 
performance. Question C is represented on the framework as it illustrates two key ways the 
literature suggests that performance measurement and performance management can be 
differentiated; firstly by showing performance management as broader or follow up 
planning and control processes than performance measurement, and secondly by their 
influence or otherwise on performance. These concepts are used later in the thesis to 
structure the analysis, discussion and to draw conclusions. The next section summarises the 
development of research questions and conceptualisation of the framework, before the 
following chapter discusses methodology for the empirical work.  
 
3.5. Summary 
This chapter has presented research questions for the thesis, based upon the issues raised in 
existing research covered in the literature review. Focussing on the implementation of 
innovative products, questions explore the performance measurement and performance 
management processes used, how these processes influence performance and how 
performance measurement and performance management processes could be 
differentiated. These questions pick up on the interest in inter-organisational innovation, as 
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well as challenges in managing the purchasing and supply of innovative products. In 
particular, the questions explore conceptual issues from the literature review that there is a 
lack of clarity over performance measurement and performance management concepts, and 
the conceptual and practical problem of determining whether performance measurement 
and management are worthwhile. 
 
The research questions raised some conceptual issues which were addressed as part of 
developing a conceptual framework. These include concentrating on the implementation 
part of the innovation process and identifying a working conceptualisation of performance 
measurement and performance management. Given the state of existing work, it was 
decided to conceptualise the influences of the processes on performance, rather than 
performance and links to the processes. These concepts were presented in an iteratively 
developed conceptual framework which underpins the empirical work. 
 
The next chapter discusses research philosophies and methodology, identifying and 
discussing the most appropriate choices for pursuing the research questions. 
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Part Two: Research Process & Empirical Findings 
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CHAPTER FOUR: RESEARCH PHILOSOPHY AND METHODOLOGY 
 
4.1. Introduction 
This chapter presents and discusses the research philosophy and methodology used in the 
thesis. It starts by outlining various possible philosophical and epistemological positions, 
before providing a discussion of the chosen interpretivist philosophy. In line with the 
selected philosophy, the chapter continues to discuss the abductive strategy taken in the 
research. The strategy in turn dictates the research methodology, which is discussed next, 
including details on unit of analysis, sampling and data collection. At the end of the 
chapter details are given on data analysis and interpretation, including a discussion of 
research credibility. 
Research 
Philosophy
Research 
Approaches
Research 
Strategies
Time 
Horizons
Data 
Collection 
Methods
Positivism
Critical 
Realism
Phenomenology
Deductive
Abductive
Inductive
Experiment
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Case Study
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Ethnography
Action 
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Data
Observation
Interviews
Questionnaires
Interpretivism
 
Figure 11. The Research Process ‘Onion’. After Saunders M. Lewis P. & Thornhill A. 
2000. Research Methods for Business Students (2nd Ed.) F.T. Prentice Hall. Harlow 
p83. 
 
4.2. Research Philosophy and Epistemology 
The epistemological stance taken depends upon the view of how the knowledge creation 
process of research occurs in practice. The ontological position that is associated with and 
underlies the epistemological stance describes the view taken of reality and the role of 
knowledge regarding that reality. A variety of ontological and epistemological stances 
have been taken in existing research in the fields of performance, innovation and 
organisations, though Ramsay (1998) points out that there has been minimal discussion of 
research philosophy and epistemology in the purchasing and supply literature. Ramsay 
(ibid.) broadly describes two epistemological stances of positivism and interpretivism, 
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similarly Saunders et al. (2000 p83, Figure 11) present a spectrum of research philosophies 
from positivistic to phenomenological, with associated research approaches, strategies and 
data collection methods. The following sections discuss the two epistemological stances as 
described by Ramsay (ibid.) of positivism and interpretivism with reference to their 
underlying ontological approach. 
 
4.2.1. Positivistic Approaches 
Positivism originates in the study of natural sciences using so-called scientific methods to 
develop theory through hypothesis formulation and testing (Ramsay 1998 ibid.). This 
involves developing covering laws of cause and effect between parameters of the subject 
of the research, the laws then being used to explain the natural world, or in this case, the 
social world (Hume 1888 p87). Facts are emphasised, rather than values and meanings, the 
laws being assumed to give a definitive explanation. Positivism is described as a 
mechanistic worldview of closed systems operating like machines, where changes to inputs 
lead to predictable changes to outputs (Bhaskar 1978 p63-90). Examples of positivistic 
research in the field of this research include Ritter and Gemunden (2004), who investigated 
relationships between quantitative measures of innovation performance and strategy using 
structural equation modelling. The research attempted to gain empirical proof of a 
hypothesised model of covering laws, with a focus on statistical generalisation (Yin 2003 
pp1-18) to a large quantitative sample. 
However positivism has been criticised for use in the study of social systems as they are 
not closed or mechanistic. Bhaskar (ibid.) suggests that a closed system is isolated from 
external influences or any change in the influences, that its internal structure of actors and 
processes must be constant and finally that performance of the system as a whole must 
arise as a result of the performance of system components alone. The literature has shown 
that producing an innovative product is inherently an inter-organisational process (Tidd et 
al. 2005 pp52-55) and that the networks of relationships involved are actually open 
systems with only an arbitrary boundary for research purposes (Harland et al. 2004). 
Further, a huge number of factors are involved in performance and innovation as shown in 
the literature review. Additionally the discussion of network competence in Ritter and 
Gemunden (ibid.) implies that external influences are at work, suggesting that use of the 
positivistic quantitative methods would be at best blunt and forced for this research. 
Ramsay (ibid.) points out that the actors in the research subject are all human and are 
therefore not uniform, passive and unchanging. They will change as they learn and develop 
the element of newness that is essential for the innovative product. Ramsay (ibid.) and 
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Sayer (1984 p177) suggest that this ability to generate meaning is not ontologically 
compatible with a positivistic philosophy. For the above reasons a positivistic stance is 
very limited in its appropriateness for this research and the next section discusses 
interpretivist approaches. 
 
4.2.2. Interpretivist Approaches 
Whereas positivism assumes that the human actor is uniform and not implicated in the 
subject of the research, interpretivism is built on the recognition of the human actor and 
their influence (Ramsay ibid.), tending to concentrate more on qualitative data. 
Interpretivism typically works with qualitative data to generate meanings rather than rules 
and covering laws and may try and gain analytical rather than statistical generalisability 
(Yin 2003 pp1-18). Mir and Watson (2001) state that the phenomenon being researched 
exists only as far as it is interpreted by the researcher, with a lack of ultimate truth. This 
research studies performance measurement and performance management processes, a 
topic that has seen different interpretations (Lebas 1995, Halachmi 2005, Bourne et al. 
2005) and a lack of clarity about what the processes are (Radnor & McGuire 2004). This 
demonstrates a key principle of interpretivism, that the same research subject is viewed in 
different ways by different researchers, often giving different results. 
 
However interpretivist stances are subject to criticism for resulting in theories that are not a 
description of reality, but simply generated by the researcher (Mir & Watson 2001). The 
open systems involved limit theoretical generalisability of research findings because of a 
lack of objective data as the philosophical position may influence research findings 
(Ramsay ibid.), such as in the example of the inter-organisational relationships literature 
above. 
 
While there are aspects of both positivism and interpretivism that limit how appropriate 
they are for use in this research, an interpretivist stance is more suitable. Although an 
interpretivist point of view accepts realities that are created by the researcher with limited 
generalisability, they are not the sort of totally objective, blunt realities of a closed 
mechanistic system that lead to the above drawbacks in conducting research in this recent 
and developing field from a positivistic stance. Interpretivism allows some explanation of 
performance measurement and performance management of innovative products and their 
influence on performance. An interpretivist stance is also appropriate for the phenomena 
studied in this research as the organisations, individuals and relationships involved are not 
closed mechanistic systems. Later on, the chapter describes how some of the shortcomings 
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of interpretivism are mitigated, and the next section continues to develop the methodology 
by discussing further aspects of the research approach and process. 
 
4.3. Research Approach and Process 
The choice of research philosophy is reflected in the aligned research approach and 
process, examples being shown in Figure 11 (Saunders et al. 2000 p83). The key research 
approaches are found in research in the social science literature as a whole. Firstly a 
deductive approach (eg Gill & Johnson 1997 pp28-33) advocates theory development 
before empirical work, which is used to test the theory. A deductive approach fits closely 
with a positivistic philosophical stance and quantitative data, an example of deduction 
being theoretical model testing in Ritter and Gemunden (2004). Deduction may be said to 
produce more objective, unbiased empirical data because of its positivistic alignment. 
Secondly, an inductive research approach (eg Merton 1957 pp99-101) involves theory 
development after empirical work and is aligned with a phenomenological standpoint, 
frequently using qualitative data. An example is the development of the interaction model 
(Ford et al. 1986), showing how inductive research can benefit from serendipitous data and 
explanations discovered during empirical work in the social sciences. 
 
Just as positivist and interpretivist standpoints both have their drawbacks, so does 
following a purely deductive or inductive approach. Social science research has often 
shown aspects of both deduction and induction in research approach, both developing 
theories from literature that are then empirically tested, as well as refining the theory 
following empirical work where new data was gathered. Dubois & Gadde (2002) describe 
this as an iterative research process of systematic combination of existing theories and 
those discovered through the empirical work.  Ayer (1968 p85) agrees, having named this 
research process ‘abduction’. Abduction is well aligned with the chosen interpretivist 
philosophy as it both attempts to develop explanations and allows for unexpected findings 
that arise when researching organisations, individuals, relationships and innovation in open 
systems. Abduction also offers a truthful and pragmatic description of the overall research 
process in reality. The following sections continue to describe the research process, 
focusing on matters of methodology, unit of analysis, sampling and data collection. 
 
4.3.1. The Multiple Case Study Research Methodology 
A range of possible research strategies are possible, as shown by the literature review and 
Saunders et al. (2000 p83, Figure 11), with many having a background in a particular 
philosophical standpoint. The most appropriate methodological strategy for this research is 
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the case study, as it lies in the middle of the philosophical spectrum discussed above and is 
congruent with the interpretivist stance and abductive research process. Yin (2003 p5) 
discusses the relevant research situations for different research strategies, as summarised in 
Table 18. 
 
Strategy Form of Research 
Question 
Requires Control 
Over Behavioural 
Events 
Focuses on 
Contemporary 
Events 
Experiment How, why Yes Yes 
Survey Who, what, where, how 
many, how much 
No Yes 
Archival Analysis Who, what, where, how 
many, how much 
No Yes/No 
History How, why No No 
Case Study How, why No Yes 
Table 18. Relevant Situations for Research Methods. After: Yin (2003) Case Study 
Research: Design and Methods. (3nd Ed) Sage. London. UK. p5. 
 
According to Yin (ibid.), the case study is an appropriate method for answering the ‘how’ 
nature of the research questions, especially as it is not possible to have behavioural control 
over performance measurement, performance management or innovation, which may be 
contemporary events when studied empirically. Although surveys have been used to 
answer ‘how’ and ‘what’ questions, they typically do so in a quantitative, positivistic 
manner which is not appropriate for the exploration of processes in this research. Further 
justification for selection of a case study strategy comes from their widespread use in the 
existing literature in the field of this research (eg Kaplan & Norton 1992, Davis & Albright 
2004). However Seuring (2008) emphasises the importance of documenting the case study 
research process carefully in supply management research, as described in the following 
sections. According to Yin (2003 pp1-18), the case study may be used to answer 
exploratory ‘what’ style research questions, as well as for more explanatory research 
involving ‘how’ style research questions. Yin (ibid.) states that the case study is 
appropriate for investigating contemporary phenomena within their context in the real 
world, when the boundary between that context and the phenomena is not clear. In both 
cases, he describes the case study as beneficial to gaining a holistic understanding of real-
life social phenomena that are complex, such as organisational and managerial processes, 
backed up by Eisenhardt (1989), making the case study appropriate for this research. 
Yin (2003 pp19-56) describes a variety of case study research strategies involving single or 
multiple cases. While a single case study design may be used to test a pre-existing theory 
for studying unique cases, multiple case study designs are usually preferred as they often 
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provide more robust findings that are easier to generalise. Yin (ibid.) advocates replication 
of cases in a multiple design, so replicating findings between the cases through literal 
replication, as well as providing the opportunity to contrast cases with different findings 
for understood reasons through theoretical replication. Hence a multiple case design is 
used in this research. An important step in each case is defining the unit of analysis, so the 
next section describes the unit of analysis used in this research. The subsequent section on 
sampling then describes how the cases were selected. 
 
4.3.2. Unit of Analysis 
The unit of analysis chosen for the empirical work is the innovative product. A review of 
the existing literature shows that previous studies have used a variety of units of analysis. 
Some examples are given in Table 19 below, modified from Rogers (2003, pp96-98, Table 
2.2) work on diffusion of innovation, which shares a focus similar to that on 
implementation of innovations in this research. 
 
Literature Topic of Study Unit of Analysis Used 
Fliegel & Kivlin (1966) Attributes of innovation and 
rates of adoption 
Innovations 
Coleman et al. (1966, pp113-
140) 
Patterns in network links 
between actors and diffusion 
networks 
Dyadic network links 
Ryan & Gross (1943, Chaps 
5&9) 
Characteristics of members of a 
social system and consequences 
of innovations 
Members of social system / the 
innovation decision 
Table 19. Unit of Analysis in Existing Literature on the Topic (After Rogers 2003 
pp96-98, Table 2.2). 
 
The table shows just how wide the choice of possible units of analysis has been in existing 
research and that the choice is very specific to context. Further, the various types of 
innovations discussed in previous research discovered in the literature review dictated a 
difference in unit of analysis in those studies. For example, Utterback and Abernathy 
(1975) include both product and process innovation in their unit of analysis by referring to 
technical innovation. Zaltman et al. (1973 pp16-31, 52-77) describes innovation as one of 
three concepts, with implications for unit of analysis. The concepts are: 
1. Process of developing a new item (developing unit perspective) 
2. Process of adopting new item (adopting unit perspective) 
3. New item itself (perspective of product itself) 
 
The three concepts suggest a unit of analysis that is based on either the organisations 
involved in the implementation part of the innovation process, or on the innovative 
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product, focussing on its implementation. The latter is most suitable for this research as it 
enables an inter-organisational study, which is important, as innovation is inherently an 
inter-organisational phenomenon. 
 
The innovative product is chosen for this research. In the chosen healthcare context this is 
known as a medical device. ‘Innovative’ implies an element of newness that is exploited 
(after Tidd et al. 2005 pp10-77), describing the necessary elements for definition as a 
technological innovation. While ‘innovative product’ focuses on product innovation, the 
literature shows that there is a blurred overlap between product and process innovation 
(Tidd et al. 2005 pp10-11) with an unclear distinction between the two (Clarke et al. 
1995), meaning that both will necessarily be studied in practice. For example a new 
medical device takes the form of a physical good or product, yet it inherently offers a 
service to the patient in caring for their health. The term ‘product’ alone is used in the unit 
of analysis however, as previous research shows that the product name provides a focus 
around which to base the research for practitioner respondents and is also practical to 
bound empirically. 
 
The literature review showed that innovative products are often studied from the point of 
view of the innovation process used to produce them (Tidd et al. 2005 pp10-77) or a 
product lifecycle (Utterback & Abernathy 1975). Existing literature often focuses on one 
part of the overall innovation process such as invention or development of the new product 
(Saren 1984 pp11-12), or implementation (Rogers 2003 pp96-98). This research studies the 
latter side of the overall innovation process or life cycle, as this takes account of the inter-
organisational interaction involved in exploiting the product, the latter being a core part of 
the innovation definition. Implementation as defined by Tidd et al. (2005 pp88-97) and 
analyzed in the last chapter was selected as being most suitable for this research as the 
broadest term describing the latter parts of the innovation process, recognizing the inter-
organisational context, where the supplier turns ideas into a product reality, exploitation 
occurs in launching it to the market and where the customer utilises it and finally 
sustaining the innovation with feedback. 
 
Each innovative product case study occurs in a broader context. In this research the context 
for the unit of analysis is the network of supply relationships that are needed for producing 
innovative products according to Tidd et al. (2005 pp10-77), Axelsson (1987) and Von 
Hippel (1976 pp220-221). This research refers to supply relationships and networks 
(Harland 1996, Lamming 1996) as dyadic relationships or networks of relationships 
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between customer and supplier interacting (Ford et al. 1986) to produce the innovative 
product. In practice the main customer and supplier organisations researched in the current 
study, the supplier or manufacturer of the innovative product and the public sector national 
health organisation in the UK buying it are composed of a number of sub-organisations and 
individuals. 
 
4.3.3. Case Selection 
In their discussion of sampling, or case selection, Miles and Huberman (1984 pp36-41) 
state that case selection parameters may be based on settings, actors, events or processes 
and are driven by the research question. However they describe how the researcher will 
have to consider most of these parameters due to the nature of qualitative research with no 
hard and fast boundaries for a sample. This research uses the innovative product unit of 
analysis as the sampling parameter.  
 
A number of innovative products are selected as case studies in this research, but here too 
the boundaries of the case study are not fixed. Empirical research on supply in the 
healthcare sector has often focussed on product categories or supply of a particular type of 
product, though the definition of product categories is quite general. This research focuses 
on a particular named innovative product, yet recognises that this will require some 
gathering of general information on the product type or category. For example “blood 
glucose meter” is the (anonymised) name of one innovative product case in which 
empirical work was carried out with the supplier of that particular innovative product alone 
and a customer who considered implementing that particular innovative product. However 
broader data on the supply of the product can only be obtained in the form of data on 
supply of products in that category from some organisations and individuals who measure 
the performance of the product or consider implementing it, such as evaluation centres, 
purchasing policy makers and some buyers undertaking a tender process. Gathering this 
broader empirical data is both necessary where data does not exist for the particular 
innovative product alone, as well as providing what Miles and Huberman (ibid.) describe 
as important information that helps understand the peripheries of the case. 
 
A wide variety of case choices were possible, given the large number of innovative 
products supplied to the NHS. The sector was chosen because of the inherently innovative 
nature of many of the products in a dynamic industry, as well as existing access for 
research, which helps facilitate progress and the ability to gain quality results. The large 
number of potential cases is demonstrated by the Centre of Evidence Based Purchasing 
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having to develop a prioritisation process for evaluations of new products. Access to the 
chosen cases was largely gained by networking with stakeholders, including within each 
innovative product case to gain access to individuals in both supplier and customer 
organisations. Networking was carried out at a variety of research centre events, project 
team meetings and exploratory interviews. The networking aspect of gaining access is 
similar to judgemental or snowball sampling in a more quantitative study. These case 
selection methods represent an improvement in generalisability over the basic convenience 
selection or sampling often used in extant research in the area (for example Ritter & 
Gemunden 2004). 
 
Yin (2003 p47) advocates that multiple case studies should be used to develop replication 
and analytical generalisability, rather than be seen as a sample size for statistical 
generalisability. He suggests that multiple case study research designs have greater 
generalisability, by adding cases to give the possibility of replicating findings from an 
initial case. This avoids the vulnerability of single case study research designs. There is 
also the possibility of drawing inter-case contrasts, as the innovative products selected are 
different in nature. Four innovative product case studies were chosen to allow sufficient 
scope for inter-case analysis, yet to ensure that a reasonable number of interviews could be 
accomplished for each, given resource constraints. The cases were chosen to share 
characteristics of being innovative products that are at the stage of being implemented by 
the customer and end user, to be from the same sector and to all involve a supply 
relationship between the supplier and NHS as a customer. However the cases were also 
chosen to contrast in terms of factors such as the cost of the innovative product, number of 
patients who would benefit and the impact of the product on the patient. The four 
innovative products cases selected were a multi-slice CT scanner, a blood glucose meter, 
an electrocardiogram (ECG) monitor and a standing frame for children. Table 20 gives a 
brief outline of the characteristics of the cases selected. The names of all products and 
suppliers have been made anonymous to ensure confidentiality of data gathered. While 
research on the cases was largely conducted concurrently, the CT scanner case was 
expedited and used as a pilot, with each step of the work carried out first on this case. 
 
 
Practical implementation of case and stakeholder selection involved contacting 
organisations and individuals by email or telephone using a clear and persuasive statement 
of intent, having researched their background. Follow up emails and telephone calls were 
frequently required to encourage and gain access to the most appropriate individuals. To 
ensure valid cases and contacts were selected, stakeholder respondents were screened using 
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the initial questions in the instrument, enquiring about the newness and exploitation to 
ensure the product was innovative for example. 
 
 Multi-Slice CT 
Scanner 
(Case 1 & Pilot Case) 
Blood Glucose 
Meter 
(Case 2) 
ECG Monitor 
(Case 3) 
Standing Frame 
(Case 4) 
Innovative 
Product 
A 64 slice CT 
scanner package of 
scanner, workstation 
and software for 
imaging patients 
A portable device to 
test the level of blood 
glucose in diabetic 
patients 
A halter 
recorder that 
stores and 
classifies heart 
arrhythmia 
A frame to assist 
children aged 8-14 
with a disability to 
attain or maintain 
standing posture 
Product 
Category 
Radiotherapy and 
imaging 
Pathology Cardiology Assistive technology 
Supply 
Relationship 
Context 
Between the medical 
systems division of 
the 
manufacturer/supplier 
and the NHS, mainly 
hospital Trusts 
Between the 
manufacturer/supplier 
and the NHS Primary 
Care Trusts, hospital 
Trusts 
Between the 
supplier and the 
NHS, mainly 
Primary Care 
Trust GPs 
Between the 
manufacturer/supplier 
and the NHS, mainly 
Primary Care Trust 
and hospital Trust 
paediatric 
physiotherapists 
Table 20. Outline Characteristics of Cases Selected 
 
4.3.4. Semi-Structured Interview Data Collection 
Case study research has used a variety of data collection methods in practice, Yin (2003 
pp83-108) for example referring to six potential sources of evidence. This research used 
stakeholder interviews as the central method, with some supplementary use of 
documentation and direct observations, as well as drawing network pictures. 
 
Interviews were used as the main method as they have the potential to catch the qualitative, 
exploratory data dictated from the ‘what’ and ‘how’ nature of the research questions, being 
flexible in gathering data from the real individual actors involved with the innovative 
products studied (Yin ibid.). By contrast the widely used survey alternative would only 
have been appropriate for a conclusive, descriptive or explanatory study, as the closed 
questions typically involved do not allow for gathering of exploratory data of the type 
proposed by the research questions. Interviews may have varying degrees of structure in 
the questions asked of respondents. Semi-structured interviews (Bryman 2004 pp109-129) 
were used as they provide a balance between structure to satisfy the line of enquiry 
dictated by the research questions and allowing for exploration. Bryman (ibid.) describes 
key aspects that are desirable in semi-structured interviewing. These include using an 
interview guide with enough structure to aid cross-case comparisons, yet loose enough to 
promote flexibility in questioning.  
 
An interview guide was developed, piloted, refined and updated throughout the course of 
the empirical work as part of the abductive process. It can be found in Appendix A and 
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includes screening questions on the innovative product, organisations and supply 
relationship involved, as well as questions on performance measurement and performance 
management of the innovative product. Actual questions used descend from the research 
questions and are annotated in the guide shown in Appendix A according to a root in the 
existing literature upon which they were based. Table 21 highlights how questions in the 
interview guide were based upon the research questions and existing literature. Some 
questions explored the general concepts found in the literature and others aimed to gather 
longitudinal contextual data. Questions were designed according to Bryman (ibid.), for 
example not to be leading the respondent into a particular answer. They also contain 
prompts in case the interviewer sensed the need to delve deeper into some aspect of the 
responses, or if the respondent needed additional triggers. As such, the interviews were 
conducted in the style of a guided conversation. 
 
Question in 
Interview Guide 
(found in Appendix 
A) 
Research 
Question 
Example of Literature Basis 
A1-9, B1-4 All, screening 
questions 
Oberg et al. (2007), Tidd et al. (2005) pp88-97, Harland et al. 
(2007) 
C1 A,C Neely et al. (2005), Farbey et al. (1993 pp75-94), Zheng Zhou 
(2006) 
C2 A,C Exploratory question 
C3 A,C Hendricks & Singhal (2003), Kaplan & Norton (1992), Ittner 
and Larcker (1998a), Skevington (1999),  
C4 A,C Kaplan & Norton (1992) 
C5 A,C Exploratory question 
C6 A,C Exploratory question 
C7 A,C Longitudinal question 
C8 A,C Exploratory question 
D1 A,C Radnor & McGuire (2004), Mintzberg & Lampel (1999), 
Halachmi (2005), Lebas (1995) 
D2 A,C (Halachmi 2005, Lebas 1995) 
D3 A,C Longitudinal question 
D4 A,C Exploratory question 
E1 B,C Lebas (1995) 
E2 B,C Exploratory question 
E3 B,C Exploratory question 
E4 B,C Griffin & Page (1996) 
E5 B,C Griffin & Page (1996) 
E6 B,C Griffin & Page (1996) 
E7 B,C Halachmi (2005), Bourne et al. (2005) 
E8 B,C Longitudinal question 
Table 21. Interview Guide Questions and Their Basis in the Research Questions and 
Literature. 
 
A variety of individuals from both customer and supplier organisations in the supply 
relationship were interviewed, with the network pictures (described below) helping to 
identify a spread of key actors across the cases to interview. Respondents were selected 
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and screened with the initial interview questions on the basis of their involvement and 
knowledge of the subject matter. Job roles are given in Appendix B, though it should be 
noted that roles are given different titles, especially in the smaller suppliers. Forty-four 
semi-structured interviews were carried out and a listing of key details about respondents, 
length and place of the interview can be found in Appendix B. Between eight and eleven 
interviews were carried out per case, the difference depending upon the size of the 
organisations and number of actors involved in the case of the particular innovative 
product. A number of additional interviews had over-arching relevance to all four cases, 
particularly from strategic respondents from the customer. Some interview respondents 
became what Yin (ibid.) refers to as informants, where they suggested other individuals 
and organisations to contact in the form of a snowball sample. This has the benefit of being 
able to see if the account of a subsequent, recommended respondent corroborated the 
account of the first. Caution was exercised to ensure that no informant alone became 
dominant in directing the research. In practice there were sufficient respondents that this 
was not a risk. 
 
The majority of interviews were carried out face to face, however many were also carried 
out by telephone, largely through the choice of busy respondents who were more prepared 
to find time for telephone interviews in their schedule. Average duration of the interviews 
was an hour, though this masks some extremes. Though they were very important to 
include, interviewing influential clinician buyers in their clinical setting often forced a 
shorter duration, for example as they were called away to conduct a scan on a trauma 
patient, whereas many office based buyers and lab based evaluators had more time to 
spare. Interviews were digitally recorded as ‘.wav’ files on a digital sound recorder and 
transferred to a computer hard drive. Semi-structured interview sound files were saved on a 
computer hard drive with the file name annotated to include the respondent name and date. 
Files were indexed in a folder system according to the case. Target notes were also taken 
by the interviewer throughout the interview to back up the sound recordings and to note 
any additional observations. Some respondents were concerned about confidentiality of the 
interview data, in which case they were informed how it would be used, as well as that 
they and the innovative products concerned would be made anonymous. Given this, 
respondents were sometimes surprisingly open and controversial, with only two instances 
over the course of the empirical work where the recording had to be paused for a short 
period, though notes were still made. 
 
 82
As part of the semi-structured interviews, additional data was gathered from the 
respondents by involving them in drawing network pictures (Oberg et al. 2007, Iacobucci 
1994 pp93-97) in which they were asked to draw their organisation, other organisations 
who were also involved with the same innovative product and the links between them. 
Organisations were represented as nodes and ties between them were differentiated 
according to the type of activity they represent. This enabled a network of actors and 
interaction to be built up for each case (Ford et al. 1986). As respondents found it 
challenging to draw the network from scratch, subsequent respondents were asked to 
improve upon, change or otherwise verify the previous network picture produced in the 
case of each innovative product. Sub networks and various levels can be identified when 
drawing the network (Iacobucci ibid.). 
 
Documentary evidence was gathered where possible to substantiate the accounts of semi-
structured interview respondents by triangulation. For example, tender guidelines for blood 
glucose meter national framework contracts were provided by the relevant NHS category 
specialist following an interview. Additional data observations formed part of what 
Lincoln & Guba (1985 pp279-281) refer to as informational residue. The main example in 
this research is the information garnered from evaluation project meetings attended at the 
Centre of Evidence-based Purchasing (CEP). The meetings were an opportunity to gather 
data on the context of the cases, which was very dynamic given changes in public sector 
purchasing and the NHS in particular. Notes made at the meetings were typed up into text 
files. 
 
4.3.5. Time Horizons 
The time horizon of the research is important as the research studies innovative products 
that are associated with a process of innovation or technological lifecycle, as discussed 
above. Ideally the research would have a longitudinal horizon to gather data on the 
temporal processes studied, however access and time implications prohibit this for PhD 
research. For example the CEP standing frame evaluation took several times the length of 
the main empirical stage of the empirical work in this research. Thus the case studies were 
cross-sectional, in common with much extant research in the area (eg Davis & Albright 
2004, Bourne et al. 2005). However empirical investigation of the present enabled some 
gathering of data from the past, so some longitudinal context was gained. Semi-structured 
interviews were carried out over a period of about 6 months, allowing for piloting and 
access, though attendance of evaluation project meetings at CEP lasted longer. 
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As discussed previously, performance measurement and performance management of 
innovative products occurs at a variety of stages in their lifecycle. As the focus of this 
research is on the implementation of innovative products, cases were all selected from the 
range of potential products to be those that had been implemented by the customer and end 
user. 
 
4.4. Data Analysis and Interpretation 
This section outlines the techniques used to analyze and interpret the empirical data. The 
first section describes how pattern matching and explanation building are used, while 
subsequent sections describe how analysis occurred between and across cases. 
 
4.4.1. Analytic Strategy and Technique 
Yin (2003 pp109-140) describes reliance on theoretical propositions as a preferred 
analytical strategy, so analysis related the empirical data back to the research questions. To 
start with, a case description was generated for each of the four cases to gain some overall 
clarity and cohesion with all the data gathered. Pattern matching (Yin ibid.) is used to 
determine whether empirically identified processes of performance measurement and 
performance management and any identified influences they have on performance of the 
innovative product are matched with the conceptual model. The model may then be refined 
according to the patterns discovered in practice. In analysing patterns, comparisons were 
made between cases and any outliers investigated. As the research is largely exploratory, 
there was an aspect of explanation building (Yin ibid.) in terms of iterative development of 
understanding and the conceptual model. However the development of causal links is not 
appropriate for this research as described above and was not used when trying to build an 
explanation of the cases. Another of Yin’s (ibid.) analytic techniques is cross-case 
synthesis, which is discussed below. 
 
Yin (ibid.) advocates developing rival explanations to those in the conceptual model, to 
test if the empirical data supports the conceptual model or not. For example the analysis 
investigated processes that did not have an influence on performance, as well as those that 
did. Rival theories were also used in analysis of the empirical findings by investigating 
different rationales from existing literature as to how performance measurement and 
performance management could be differentiated. 
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4.4.2. Intra-case Analysis 
HyperResearch 2.6 qualitative coding and theory building software was used to analyze the 
data. The software has similar functions to NVivo and other qualitative data analysis 
packages for social science research, but is different as it can use multi-media data 
including digital sound files, as opposed to only text files. Hesse-Biber et al. (1991) state 
that using HyperResearch as a qualitative analysis tool can aid the validity, reliability and 
generalisability of analysis. They describe how the tool allows coding of time specific 
segments of sound files and to sort codes by their incidence within and across cases. 
HyperResearch has been described as challenging the researcher intellectually and 
conceptually (Staller 2002).  
 
Empirical data segments were coded by extensive listening to the sound files, the segments 
then being annotated with one or sometimes more of a number of codes. Codes were 
developed from the literature underlying the research questions and questions used in the 
semi-structured interview guide, to assist in pattern matching the data with the conceptual 
model. A list of the codes used at the end of the analysis can be found in Appendix C. The 
list mainly includes descriptive codes to answer the ‘what’ research questions about 
performance measurement and management processes, as well as a few interpretive codes 
developed during analysis, the latter being used to answer research questions on the 
influence of the processes. In addition a number of codes were added to the list during 
analysis as new themes, ideas and processes emerged from exploring the data. This 
iterative coding process from a start point of the conceptual model was recommended by 
Miles and Huberman (1984 pp54-65) and reflects the interpretivist philosophy of research 
and abductive approach discussed above. A further recommendation on coding the data as 
soon as it was gathered, before subsequent interviews, was also followed. HyperResearch 
enabled codes to be combined, split or segments to be re-coded or coded multiple times. 
As such, coding the data was an iterative process of sense making. Interview data was 
considered together with the documentary data and informational residue. 
 
HyperResearch allows the raw interview data to be kept as time annotated sound files, 
which gives good data provenance and traceability from the coded segments identified for 
each case and used in the analysis. The use of digital recording and HyperResearch ensure 
the data is accurately preserved in the original format for any subsequent analysis or 
repetition of the analysis. While transcription and coding of paper transcripts or text 
documents is commonly used, transcribing puts another stage into the analysis process into 
which inaccuracies often occur (Poland 1995). Not only is the analysis further distanced 
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from the raw data, the transcripts cannot convey the richness of expression and context to 
the words used that are captured on the digital sound files. For example, HyperResearch 
enabled the researcher to replay segments of the interview recording many times, listening 
for nuances in expression in the respondent. 
 
The coded data for each semi-structured interview and respondent was entered into 
matrices to gain an overview of the cases by categorising the codes at a high level 
according to the research questions, with a succinct descriptive phrase. Role order matrices 
were used, though the categories used also meant that parts of the matrix were ordered by 
effects. Matrices are advocated in the literature as a summarising table display as they aid 
the researcher in drawing conclusions from the data (Miles & Huberman 1984 pp79-118). 
The matrices were used to compare and contrast the data from the different respondents 
within each case and then develop a summary description of the overall data for each case. 
Matrices of various lengths were produced and those which were ultimately used were 
found to contain the best amount of data in terms of a trade off between being concise to 
aid analysis, but also to contain sufficient detail. The final examples and rules used to 
construct them can be found in the Appendices. 
 
Semi-structured interview data was described in the text along with contextual information 
from the network pictures and informational residue. Quotes from the semi-structured 
interview data were used to illustrate the data in the main body of the text, ensuring that 
they were representative of the mainstream of the data gathered and shown in the matrices. 
Network pictures were cleaned and tidied from their raw form using Microsoft PowerPoint 
9.0 software, using coloured lines to illustrate the different flows identified in the empirical 
work. 
 
4.4.3. Inter-case Analysis 
Having analyzed the data within each case, meta-matrices (Miles & Huberman 1984 
pp151-167) were used to analyze the data across the cases. The matrices were site ordered 
descriptive matrices and were used to show similarities and differences between cases. 
Identification of similarities in the matrices was aimed at providing generalisability of the 
individual case study findings (Yin 2003 p47). Cross case analysis also gives the 
opportunity to draw contrasts between the cases by looking for differences, identifying any 
particular contingencies in the nature of the innovative products or the context of the cases. 
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Development of the matrices was an iterative process of sense-making drawing on the 
various sources of data, trying to develop explanations of the nature and structure of 
performance measurement and performance management of the innovative products, given 
the open system and context. This strategy was in line with the chosen interpretivist stance 
and abductive approach. The following section outlines the steps taken to ensure the 
credibility of the research methodology, data analysis and interpretation. Figure 12 
summarises the data analysis and interpretation process. More detailed descriptions of 
construction and interpretation of the matrices are given as they are presented in the 
findings chapters. 
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Figure 12. Summary of Data Analysis and Interpretation Process 
 
4.5. Research Credibility 
The credibility of the research design is established by four tests proposed by Yin (2003 
pp33-39) for empirical social science research. Construct validity, internal validity, 
external validity and reliability are all outlined below in relation to this research. The 
limitations section returns to them at the end of the thesis. 
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4.5.1. Construct Validity 
Construct validity is concerned with whether the research uses good or appropriate 
operational measures for the concepts studied empirically, a challenge in qualitative 
research where measures are developed and there is an element of the subjectivity of the 
researcher involved in analysis. To ensure construct validity, Yin (2003 pp33-39) states 
that the research must have specified specific phenomena to study and have selected 
measures of the phenomena that do actually reflect the phenomena. In this research, the 
concepts and questions used in the semi-structured interviews were based on concepts 
identified from existing research in the literature review. Yin (ibid.) recommends further 
tactics to ensure construct validity, which are used in this research. This includes using 
multiple sources of evidence, namely semi-structured interviews backed up with 
documentary, network pictures and informational residue sources. Another 
recommendation is to establish a clear chain of evidence which is achieved in this research 
by documenting procedures and particularly the strong link between findings and data 
enabled by the digital recordings and digital analysis software, HyperResearch. Yin (ibid.) 
also proposes having a respondent or other researcher review the data and findings. This 
occurred in this research through the feedback from PhD supervisors and other researchers 
on the broader research project of which the current PhD research is a part. A fellow 
researcher was asked to trace the provenance of randomly chosen findings in the main 
results matrix, back to the original data. The worksheet in Appendix D shows the results of 
this validation exercise. Further, the first draft of each case descriptions was sent to a 
respondent in the CEP Evaluation Centres who had an overview of each case, to validate 
them. A small number of amendments were made following the comments. Also, an NHS 
PASA respondent in a research related role had an overview of all cases and was asked to 
validate the case descriptions. An example of feedback can be found in Appendix E. 
Further, the broader project involved a number of feedback meetings with stakeholders in 
the public sector and their suppliers where this research was discussed and opinions 
gathered. 
 
4.5.2. Internal Validity 
Often associated with causality in quantitative, explanatory studies, internal validity has a 
different emphasis in qualitative, exploratory studies. It involves ensuring that the data and 
findings drawn from it within the study are coherent (Sykes 1991). To this end, this 
research also tested rival explanations (Yin 2003 pp109-140) especially the various ways 
of differentiating performance measurement and performance management from the 
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literature, progressed an initial case as a pilot and iteratively improved the semi-structured 
survey instrument and analytical techniques in the coding software and matrices. 
 
4.5.3. External Validity 
External validity concerns whether findings of the current study are applicable to a broader 
context or reality than the one studied. As described in the selection of case study 
methodology, Yin (2003 pp1-18) states that analytical, not statistical generalisability is 
appropriate. To achieve this, a multiple case study design studying a variety of medical 
devices was used, so that there is a greater potential that findings replicated in all four 
cases could by replicated further outside this research. In addition to comparison across the 
four cases, the findings are discussed later in relation to the literature to see if similar 
findings have occurred in past, related research (Eisenhardt 1989). 
 
4.5.4. Reliability 
The final test involves showing that the processes used to carry out this research would 
achieve the same results if they were repeated, such as by another researcher. Yin (ibid.) 
describes the key defence against poor reliability as careful documentation of all 
procedures. This was aided in the current study by the use of a very structured software 
programme from which reports could be printed, so detailing the progress of the analysis. 
HyperResearch also required a very structured filing system on the computer hard drive for 
keeping the data and files were annotated with the date and new versions made after every 
major change. Reliability was also aided by the numerous discussions of the research with 
colleagues who were involved in the broader research project to which this PhD research 
contributed, as well as the tracing exercise above. 
 
4.6. Summary 
This chapter has investigated a range of possible research philosophies and methodologies, 
then determining the most appropriate for this research. An interpretivist research 
philosophy is adopted as it allows the development of explanations about the phenomena 
studied, yet recognises that the context of the research is complex and open rather than a 
simple, closed mechanistic system. An abductive research strategy was chosen in light of 
the philosophy and iterative nature of the research. These in turn determined that a multiple 
case study methodology is appropriate, enabling exploration and the opportunity to 
replicate explanations across cases studying complex contemporary phenomena in the real 
world, where the researcher had no control over the subject and the boundary with context 
was not clear. 
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The innovative product was chosen as a unit of analysis based upon existing literature and 
practical considerations. The sampling rationale, initial details of four cases and key semi-
structured interview instrument as well as supplementary network mapping and gathering 
of documentary evidence were described. The analytic strategy and techniques were also 
discussed, involving pattern matching with the conceptual model, both within and across 
cases. Techniques stated included developing case descriptions, matrices and use of 
qualitative data coding and analysis software. This chapter finished by describing steps 
taken in the empirical work to try and ensure the credibility of the findings, which are 
described in the next two chapters. 
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CHAPTER FIVE: FINDINGS FROM FOUR CASE STUDIES 
 
5.1. Introduction 
This chapter reports findings of each of the four case studies in turn, following a brief 
contextual background to purchasing and supply of innovative products and medical 
device evaluation in the NHS. Each case is described in a linear analytic structure (Yin 
2003 pp152-153), in accordance with the structure used in the interview guide and key 
concepts in the conceptual framework, which were in turn based upon the existing 
literature. The innovative product, the unit of analysis, is introduced for each case with a 
description of why each product is innovative. Some background to its implementation and 
management of purchasing and supply is also given, outlining the key organisations and 
processes involved. Performance measurement and performance management processes 
discovered in each case are outlined in the next section. Processes are differentiated here 
according to their definitions in the conceptualisation, focussing on performance 
management as being broader. Their influences on performance are then reported. The CT 
scanner case was progressed faster than the others as a pilot, and lessons from this are 
drawn in the summary of that case. The identities of organisations, products and 
individuals involved in the cases have been made anonymous for confidentiality. 
Following description of each case in this chapter, the next chapter focuses on inter-case 
descriptions and findings are then discussed in the context of the existing literature in the 
following discussion chapter. 
 
5.2. Background to Purchasing and Supply and Medical Device Evaluation in the 
NHS 
Each case features an innovative product purchased by the NHS as customer, from a 
private sector supplier organisation. The NHS as a customer buys a huge variety of 
products and services, such as capital equipment, food, fuel, syringes, drugs, property and 
staffing. Current total spend by the NHS on products and services excluding pay is in the 
region of £15 billion (HITF 2004 p17). Purchasing and supply management in the NHS 
involves a wide variety of organisations and individual actors who are part of the NHS as a 
whole. Purchasing is executed through buy groups or individual buyers on various levels, 
from local to national. 
 
The NHS consists of 438 Trusts that have responsibility for local level care. Various types 
of Trust run services such as hospitals, General Practitioner (GP) surgeries and outpatient 
clinics. Individual clinicians or groups of multiple clinical and managerial individuals from 
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the Trusts execute NHS purchasing on a local level. A large proportion (78.5% in 2004/5) 
of the NHS budget was allocated to PCTs, signifying their spending power (HITF 2004 
p18). 
 
Recent years have seen some NHS purchasing occurring on a regional level, where a 
number of Trusts get together to purchase goods and services, negotiating contracts on a 
collective basis. This has been formalised through setting up Collaborative Procurement 
Hubs (CPHs) (HITF 2004 pp15-20), to achieve savings and involve clinician input in 
purchasing decisions. There are CPHs at various stages of development for each regional 
NHS Strategic Health Authority (SHA), through which the Department of Health (DH) 
manages the NHS. On a national level, the NHS Purchasing and Supply Agency (NHS 
PASA), an Executive Agency of the DH, has played a key role. The organisation has 
developed purchasing advice, guidelines and national framework contracts for a large 
number of products and services, largely organised according to categories. NHS PASA is 
a strategic, rather than trading organisation and has been involved in developing and 
implementing purchasing and supply policy. 
 
A number of changes in the structures and processes of NHS purchasing and supply have 
occurred in the recent past, many still being underway at the time of data gathering and 
thesis writing. Many of the national level purchasing and supply processes have been 
outsourced to the private sector from 1 October 2006, with the aim of achieving cost 
savings. DHL hold the contract for the category management processes, forming a new 
organisation called NHS Supply Chain, including many former PASA purchasing staff. A 
core of strategic supply management functions remains with NHS PASA. There is a long 
history of such changes, highlighting that purchasing and supply management in the NHS 
has always been dynamic. NHS buyers may buy through using the services of NHS Supply 
Chain, or alternatively individuals and Trusts may deal with suppliers independently.  
 
As a customer and user, the NHS measures the performance of medical devices. 
Traditionally, this occurred in the Device Evaluation Service (DES), a part of the 
Medicines and Healthcare products Regulatory Agency (MHRA), an Executive Agency of 
the DH. DES outsourced evaluation work to a number of specialist evaluation centres 
based in hospitals and universities. From the 1 September 2005, the DES was transferred 
from the MHRA to NHS PASA to form the new Centre for Evidence Based Purchasing 
(CEP). Creation of this new Centre was recommended by the HITF, which advocated 
developing closer links between product evaluation and purchasing, providing evaluation 
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outputs that reflect broad aspects of product value for a range of stakeholders across the 
NHS and industry (HITF 2004 pp1,35-36). CEP has been undergoing a change programme 
to achieve these aims, developing new evaluation report types in response to buyer’s 
wishes and accepting a variety of proposals for evaluations from any source. Many of these 
new evaluations are one off projects, rather than ongoing evaluations of new generations of 
incremental product innovations in a particular category. 
 
5.3. Multi-Slice CT Scanner 
 
5.3.1. Introduction and Background to the Multi-Slice CT Scanner Case 
Findings from the interviews in the multi-slice CT scanner case are summarised in 
Appendix F in an un-ordered meta-matrix, showing respondents in the rows and 
conceptual clusters in the columns, driven by the research questions, as recommended by 
Miles and Huberman (1984 pp79-80). It is a reduced version of the table compiled from 
the HyperResearch data, reduction having occurred according to a decision rule where cell 
entries in the original table were standardised to a more generic descriptor and taking the 
modal response where necessary (Miles & Huberman 1984 p104). This is in accordance 
with the pattern matching analytic strategy (Yin 2003 pp116-120), as priority is given to 
concepts described by more than one respondent in the case. Performance measurement 
processes sometimes had to be included in the table by the measures used, firstly for 
brevity, secondly because measurement procedures have been described as mapping and 
preserving the difference in a set of symbols and a collection of entities (Farbey et al. 1993 
pp75-94), and finally because many respondents answered the questions about 
performance measurement processes by listing the measures that are used. Frequencies of 
the codes used in HyperResearch are shown in Appendix G. 
 
Interview respondents in the CT scanner case, along with the others are shown in Table 22 
and in more detail in Appendix B, including respondents whose interview data is relevant 
across all the cases, shown at the bottom of the table. Respondents are referred to by job 
role, organisation and type of role as a stakeholder. Roles are broadly described according 
to whether the respondent is from the NHS customer or supplier organisation sides of the 
supply relationship, with more detailed customer roles given according to the buying 
centre roles described by Webster and Wind (1972 pp77-80). 
 
The Multi-Slice CT Scanner, referred to here as the ‘CT scanner’ is a hospital based 
medical device for taking internal images of patients for diagnosis and treatment planning. 
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The scanner consists of a patient couch, an array of x-ray beams, receptors and associated 
software to operate the scan, process and display image information. CT scanner 
technology now enables multiple ‘slice’ scanning of patients, in which successive x-rays 
are taken along the patient’s body. 
 
Respondent (Job Role) Organization Type of Stakeholder Role 
Head of Medical Physics Hospital Trust Customer. Influencer (national 
level) 
Head of Group Evaluation Centre, Imaging 
Equipment 
Customer. Influencer (national 
level) 
Category Manager, 
Radiotherapy & Imaging 
NHS PASA / NHS Supply 
Chain 
Customer. Buyer, Influencer 
(national level) 
Category Manager, Medical 
Maintenance 
NHS PASA Customer. Buyer, Influencer 
(national level) 
Consultant Radiologist, Clinical 
Lead Radiology 
Hospital Trust Customer. User, Buyer, Decider 
(local level) 
Consultant Gastrointestinal 
Radiologist 
Hospital Trust Customer. User, Buyer, Decider 
(local level) 
Consultant Cross-sectional and 
Radionucleide Radiologist 
Hospital Trust Customer. User, Buyer, Decider 
(local level) 
CT Superintendent 
Radiographer 
Hospital Trust Customer. User, Buyer, Decider 
(local level) 
Radiology Business Manager Hospital Trust Customer. Buyer, Decider (local 
level) 
Purchasing Manager Hospital Trust 2 Customer. Buyer, Decider (local 
level) 
Account Executive, Southern Multi-Slice CT Scanner 
Supplier 
Supplier (regional level) 
Account Executive, South West 
& Wales 
Multi-Slice CT Scanner 
Supplier 
Supplier (regional level) 
Respondents Interviewed for all Cases 
Policy and Innovation Director NHS PASA Customer. Influencer (national 
level) 
Senior Collaborative 
Development Manager 
NHS PASA Customer. Influencer (national 
level) 
Head of R&D NHS PASA Customer. Influencer (national 
level) 
Senior Manager for Technology 
Introduction 
NHS Institute for Innovation 
and Improvement 
Customer. Influencer (national 
level) 
Table 22. Interview Respondents in the Multi-Slice CT Scanner Case 
 
The particular CT scanner studied in this case, referred to here as the ‘CT scanner’ is 
produced by one of four suppliers in the UK market. It has novel technological features 
representing incremental improvements on previous models as the latest version scans in 
64 slices on two axes, as well as having increased scanning speed and software 
enhancements when compared with competitors. The improvements compared with 
previous models, which scan with fewer slices, enables cardiac scanning applications that 
were not previously possible because of the size and movement of the heart. The software 
enhancements and a gantry angulation feature to enable helical head scanning are unique to 
the scanner compared with other scanners. The workstation was also described as novel by 
clinicians, such as a new feature for locating the area of the scan on the patient’s body. The 
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supplier sells the scanner for commercial gain, while the NHS as a customer benefits from 
opportunities given by the scanner to provide improved healthcare. In summary the CT 
scanner is innovative as it has novel features and is exploited for commercial and 
healthcare benefits. 
 
The network picture in Figure 13 shows the main actors and flows between them (Oberg et 
al. 2007, Iacobucci 1994) in the case, as depicted by the interview respondents. The 
organisations of the interview respondents are highlighted in yellow, to provide a link with 
Table 22 above. It was compiled by each subsequent respondent developing the picture 
through improving, altering and verifying it. Detailed notes on the key to the picture are in 
Appendix H. Implementation of the CT scanner has involved interaction between various 
actors from the supplier and the NHS as customer on different levels. Purchasing and 
supply of the CT scanner currently only occurs at the local level by NHS Hospital Trusts, 
though previously there were national level bulk purchases using funding from the 
National Cancer Plan. In the empirical research the Hospital Trust that the majority of the 
clinicians interviewed came from, was in the process of preparing to purchase two CT 
scanners and formed a purchasing team, consisting of actors including Trust finance and 
purchasing managers, staff from the Medical Physics Department and clinicians in the 
Radiology Department. Currently collaborative procurement hubs and NHS Supply Chain 
are taking an interest in CT scanner purchasing, but have not yet made any purchase 
decisions. Respondents discussed other national level public sector actors that have a role 
in the purchase and evaluation of CT scanners, such as the NHS III, MHRA and NICE. 
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Figure 13. Network Picture for the Multi-Slice CT Scanner Case  
 
5.3.2. Performance Measurement and Performance Management 
This section reports the performance measurement and performance management 
processes described by the interview respondents, in the following two sub-sections. 
Initially performance measurement processes are discussed, focussing on those processes 
that meet the basic definitions of performance measurement outlined previously in the 
thesis (Neely et al. 2005, Farbey et al. 1993 pp75-94) and conceptualisation. Then broader 
(Halachmi 2005, Globerson 1985, Lebas 1995) or follow up (Globerson 1985, Ellram 
1995) processes are described in the performance management sub-section. The discussion 
chapter analyzes differentiating performance measurement and performance management 
processes on the basis of their influence or otherwise on performance (Bourne et al. 2005, 
Halachmi 2005) which are reported later in this chapter. Figure 14 at the end of this case 
description shows the conceptual framework illustrated with the findings of the CT scanner 
case. 
 
Performance Measurement Processes 
A variety of performance measurement processes, focussing on a range of performance 
measures were discussed by interview respondents. These include an Evaluation Centre 
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technical evaluation, assessments of the performance of the scanner by Trust buyers as part 
of the tender process, national level budgeting in the NHS and gathering user opinions 
about the scanner by the supplier. The findings are described here in terms of the key 
concepts discovered and explored with respondents, assessed through the analytical 
process of coding and constructing matrices. 
 
Comprehensive technical evaluations of CT scanners are carried out by the evaluation 
centre on behalf of CEP, usually involving two or three medical physicist staff visiting a 
scanner and running a series of tests. Although each evaluation is a one off, successive 
generations of scanners with incremental innovations have been evaluated by the 
Evaluation Centre, giving an ongoing aspect to evaluation. The technical measures used 
focus on the clarity of image versus the radiation dose, a crucial concern in using the 
scanner. Radiation dosimeters and ionisation chambers are used for measuring radiation 
dose. New features of the scanner are also described and evaluated. Phantom test objects 
are used to test technical parameters of over 10,000 scanner images taken during the 
evaluation. Financial measures are not used and quality of life measures are not involved, 
partly as the CT scanner is used in the diagnosis and treatment of so many different 
diseases that it is difficult to generalise about its benefits financially or for quality of life. 
The Evaluation Centre communicates frequently with the supplier during evaluations, 
requesting information, involving supplier representatives in conducting the evaluation and 
feeding back results. 
 
Performance measurement was also found to be part of the process of purchasing new CT 
scanners, by the purchasing team in the Hospital Trust. Data is gathered on the technical 
and financial performance of the CT scanner and competing products from the various 
suppliers in the market, by clinicians and managers as part of the tender process. 
Interactions also included clinicians visiting examples of the scanners at other hospital sites 
to see a demonstration, talk to users or try using it themselves. Clinicians use these 
processes to learn about how the scanner might perform for their particular clinical needs 
in the Trust, while supplier representatives take the opportunity to learn what the Trust is 
looking for in a particular purchase: 
 
“…the invitation to tender would come out, I would find someone to contact and go and 
have a chat and say, look, what exactly are you looking for…you go and see them, what 
are you looking for, what type of work…what would they like to see, what have they got at 
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the moment, and then from that I would assess with the Applications Manager the best site 
to take them to, to view the system” (Account Executive South West & Wales, Supplier). 
 
 Social exchange occurs on an individual level in many relationships, for example a 
radiologist on the Trust purchasing team described calling former colleagues for their own 
experiences with different models of CT scanners being considered in the tender: 
 
 “…what I did at the beginning was I picked up the phone and phoned my mates in 
Bournemouth and wherever else who’ve used [a CT scanner from the Supplier] and asked 
them how’s it been? And these are people I know, who I trust, I’ve trained with them…” 
(Consultant Cross-sectional and Radionucleide Radiologist). 
 
 Most of this data gathering involved the clinician making subjective assessments of how 
the CT scanner could be used for the particular interests of the Trust, though the 
Procurement Manager in Hospital Trust 2 described how clinicians are asked to score 
aspects of the scanner when making this assessment. In the first Trust, radiologists were 
particularly interested in cardiology and virtual colonoscopy software packages, given the 
Trust’s amount of work in these areas. 
 
Technical performance of the scanner is also measured, using similar measures of image 
quality and radiation dose as the evaluation centre, by the supplier. The focus is also on 
measuring technical aspects such as data acquisition speed and data processing speed. The 
CT scanner went through alpha and beta testing in hospitals prior to market introduction, 
after which feedback on the CT scanner from the point of view of the user is continuously 
gathered by supplier sales and applications staff through their contact with Trust staff and 
tenders in the field. 
 
NHS PASA Category Managers have also been involved in performance measurement of 
CT scanners, as part of their buying role. Key measures used on national contracts in the 
past are technical and operational focussed upon reliability and maintenance costs, in 
particular the up time and down time of the CT scanner, expressed as a percentage figure. 
Maintenance has a significant role in this up time down time balance and a performance 
measurement survey has been sent out to Trust staff to determine their perception as 
customers of supplier maintenance performance. The cost of maintenance contracts are 
also measured, though the impact is on revenue budgets, rather than capital budgets as with 
the purchase of the CT scanner. 
 98
 
Performance Management Processes 
A variety of performance management processes were described by respondents in the 
case, mainly involving using the data from the performance measurement processes 
already described. The findings are described in terms of the key themes identified 
empirically and reported in the existing literature, including data analysis and 
dissemination, making purchasing decisions and improving the design of the product. 
 
After measuring performance in the technical evaluation, the large number of images taken 
in the technical evaluation are investigated by Evaluation Centre actors in a semi-
automated software analysis and compiling data into tables. For example, an image ‘Q’ 
figure is calculated, based upon a variety of underlying technical image parameters that 
were measured. Reports of data from performance measurement of the scanner are issued 
and disseminated by the Evaluation Centre to CEP as well as purchasers and clinicians 
within the NHS. Reports have focussed on both the individual CT scanner and in 
comparison with peer scanners. Also, equivalent data is requested from the supplier and 
has been compared with that obtained by the Evaluation Centre in a data comparison 
report. Technical evaluation information is also disseminated through a website including 
an online database tool, mailing lists and detailed training and development courses offered 
by the evaluation centre. 
 
Another process that followed up performance measurement is the supplier tailoring the 
scanner package in the tender return to the needs of users. The supplier responds to Trust 
tender requests by a formal tender return, in which a price is given for a scanner package 
put together for the particular Trust’s needs. A Supplier Account Executive gave the 
example of offering three workstations in a package with two 64 slice CT scanners for 
optimal workflow. A particular package may also include additional software packages for 
cardiac work or virtual colonoscopy for example. The supplier offers a training process to 
all clinical staff at the Hospital using the product and holds an annual meeting between 
their applications support staff and Trust staff, relaying the latest product information. 
 
In addition to tailoring the scanner package to particular customers, the supplier is also 
continuously improving the design of the scanner. Problems and issues with the product 
are picked up by supplier staff during the tender process as well as visits before and after, 
these issues then being fed back to the research and development team in the Japanese 
factory which operates on principles of continuous improvement, efficiency, waste free 
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production and satisfaction of the end customer. At the factory, it seems that feedback is 
used to improve the design of the product, normally through re-engineering the software 
packages, with the improved versions then being released onto the market. Target 
specifications for the scanner and associated software and workstations are set, then actors 
set out to exceed these in product development. 
 
Respondents also described performance management processes that use information 
gathered in performance measurement for purchasing purposes. The Hospital Trust 
purchasing team described performance management processes in the tender process, 
especially decision making by the purchasing team regarding which of the tenders received 
from the various suppliers to choose. Processes include subjective discussion of the 
attributes of the various CT scanners in committee, comparing performance measurement 
against the tender specification and then making a decision on the basis of maximum utility 
gained for the fixed budget available. Utility varies according to different members of the 
purchasing team, so a process of compromising on attributes of the scanner package occurs 
in the committee. A scoring and weighting system is used in the committee to analyze 
performance measurement data provided by the suppliers in their tender returns. The 
committee’s decision is sent for approval by the finance department, suppliers are 
debriefed as to their success or failure in the tender process and an acceptance testing 
procedure occurs once the new CT scanner has been installed. While there are efforts to 
procure medical equipment maintenance at the national level, many Trusts still handle their 
own maintenance budgets and contracts. The Category Manager for Radiotherapy and 
Imaging was previously involved in purchasing CT scanners on a national level and has 
now been transferred to NHS Supply Chain, though discussed a lack of clarity as to their 
current role. 
 
While issuing purchasing advice, guidelines (NHS PASA Procurement Guidance) and 
templates (NHS PASA Workbook) from NHS category staff are broader processes than 
measuring performance during purchasing, respondents at the local levels did not refer to 
them in the discussion of performance management beyond including them on the network 
picture. Indeed a supplier respondent had not heard from NHS PASA or Supply Chain 
since the end of the National Cancer Plan purchases. Meanwhile National Consortia 
Contracts for Medical Equipment Maintenance (NHS PASA Procurement Guidance pp12-
14) with each key medical equipment supplier, including the supplier of the CT scanner in 
the current case are currently being developed by the Category Manager for Medical 
Maintenance. Respondents showed NHS PASA and NHS III as having a role in developing 
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and implementing policy with implications for purchasing of innovative products such as 
the multi-slice CT scanner.  
 
5.3.3. Influence on Performance 
This section reports on data from the respondents that describes or suggests the influence 
of performance measurement and performance management processes, described above, 
on performance of the CT scanner. The findings are described in terms of the key themes 
that arose through the analysis process of coding and constructing matrices and are linked 
to key processes described in the previous two sections. 
 
Table 23 summarises the influences found in the case, based upon the effects matrix (Miles 
& Huberman 1984 pp114-118) compiled from respondent data, which can be found in 
Appendix I. It summarises the ways in which respondents have described an influence of 
the above processes in performance of the CT scanner, stating the influence and the 
processes. In some instances, the processes were not made apparent by the respondent, 
however Miles and Huberman (1984 p114) point out that there must always be an implicit 
predecessor and this is also shown in the table. The cell entries are brief phrases 
highlighting influences that were coded in the case study and shown in the data in the 
original matrix of findings from respondents in the CT scanner case. Only those influences 
that were seen in a pattern across more than one respondent in the code occurrences by 
respondent in the case are included. As recommended, researcher’s explanations are given 
and an asterisk used to denote an influence inferred by the researcher, rather than one 
specifically described by the respondent. Where the processes were described as having a 
beneficial influence (+), non-beneficial influence (-), both (+/-) depending on the actor 
concerned, or no influence (none) this is shown in the first column of the table. The 
influences are also annotated as to their influence on financial (F), technical (T) or 
customer (C) performance (Griffin & Page 1996). In a similar example of a matrix, Miles 
and Huberman (1984 p116) point out that such a matrix will include intended outcomes or 
influences, or those that the respondent states will occur. 
 
The main influence of performance measurement and performance management processes 
that were observed in the case, was in whether the CT scanner or another competing CT 
scanner was purchased. All but two respondents in the case described this influence on 
over fifty instances in the text, referring to the purchasing decision makers using 
information from performance measurement to make a purchasing decision, with the result 
that the CT scanner is purchased or not. If the product was purchased, the processes had a 
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beneficial influence on performance for the supplier who made sales of the product and 
therefore money if a profit margin was involved, and for the customer who gained the 
benefits of the product for use in healthcare. If the product is not bought on the other hand, 
the influence is non-beneficial for the supplier that loses sales to a competitor, though the 
customer gains the benefit of using the competing product in healthcare. 
 
Influence Type Researcher Explanation 
Product is purchased or not +/- 
F/C 
The decision to purchase the product or not on the basis of 
performance measurement information gives the supplier sales 
or not and the customer the benefit of a product that performs 
best for healthcare. 
The best product for the needs 
of the user is purchased 
+ 
C 
The tender process of assessing performance of the various 
scanners available and decision-making gives the Trust the 
best CT scanner for their particular needs. 
Product can be purchased or 
not for short-term, cost based 
rather than broader reasons 
- 
C 
The product is bought or not in a decision made on the basis of 
cost performance measurement information with a short term 
view. Evidence of broader aspects of performance is not used 
proactively or integrated back to buyers. 
Information not used in the 
purchasing decision 
None Information from performance measurement and management 
processes is not used in the purchasing decision. The product 
may be bought for all sorts of reasons other than on the basis 
of performance measurement information. Technical 
evaluation reports are too late, clinicians know already or do 
not have time to use info. 
Product design improved + 
T 
The design of the CT scanner and associated package is 
permanently improved, for example through new software 
releases, an improved service package. 
Feedback to the supplier is not 
used 
None Feedback on performance measurement information given to 
the supplier is not used. Customer is small. 
Used in acceptance testing + 
T 
Performance measurement outputs such as technical 
evaluation reports are used to ensure a scanner meets the 
promised specification on installation, before full payment is 
made to the supplier. 
Useful for repairs + 
T 
Customer’s own performance data makes the case to the 
supplier to come and make repairs to the scanner. 
Supplier ensures product 
performs to their specification 
& regulations, as it will be tested 
and then purchased or not 
+ 
T 
Performance measurement and management processes mean 
that the supplier know and ensure that the product must meet a 
certain standard. 
Supplier shows concern over 
performance measurement 
* 
+/- 
F 
Suppliers show concern that performance measurement data 
will affect their competitive position or sales. 
Table 23. Summary of Influences Identified in the CT Scanner Case 
(KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial 
performance, ‘T’ is an influence on Technical performance and ‘C’ is an influence on Customer performance 
(After Griffin & Page 1996). ‘None’ means there is no influence on performance. ‘*’ denotes an influence 
inferred by researcher rather than specifically described by respondent). 
 
The variety of performance measurement processes involved in whether the CT scanner 
was purchased or not vary, including the members of the Trust buying team assessing the 
performance of the CT scanner and the technical evaluation carried out by the Evaluation 
Centre. Performance management processes centre around the purchasing tender process, 
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involving scoring and weighting, comparing supplier’s tender returns against the desired 
specification and making a decision in committee. The decision involves some amount of 
scoring and weighting, though also subjective discussion amongst committee members and 
compromise between them: “…it will come down really to local negotiations amongst 
ourselves of what we feel is the best, it may be that there, there will be compromises…” 
(Consultant Radiologist, Clinical Lead Radiology, Hospital Trust). There were some 
differences between the Trusts in use of the scoring system however, in the second Trust 
the decision was made on the basis of the scoring system, whereas in the first Trust it was 
described how: “…we have actually got the scoring thing…we will do that, but I would like 
that to be done on the basis of our own assessment” (Consultant Radiologist, Clinical Lead 
Radiology). Once the decision has been made to purchase a CT scanner, the Evaluation 
Centre reports have been used in acceptance testing of the scanner, to ensure it performs as 
expected and promised in the tender return. 
 
Having made a decision to purchase the CT scanner or a rival product, the Trust concerned 
will have selected a product that will perform for them in a particular way: “We’ve got to 
work on this machine, all of us, for many years and going to have to pin our service quality 
on our choice and our service delivery on that choice and our names are on the bottom 
line, our service, the quality of the service we provide is going to be judged partly on our 
choices…”  (Consultant Radiologist, Clinical Lead Radiology, Hospital Trust). Since 
finishing the main data gathering of the case, the purchasing decision was made in favour 
of a competitor CT scanner, rejecting the CT scanner tender from the supplier studied in 
the case. The supplier of the CT scanner chosen instead is the supplier of the existing CT 
scanners at the hospital and according to the Evaluation Centre, the purchasing team were 
keen to continue using the existing supplier for the known quantity of their service support 
and engineers. Respondents discussed the influence of performance measurement and 
performance management processes not only in purchasing the CT scanner or not, but 
more specifically in purchasing a CT scanner package that is tailored to be most 
appropriate for the particular needs of the Trust: “I think it [performance measurement] 
helps us buy the piece of equipment that’s most appropriate for us at that time in so far as 
what our needs are and what we hope to do in the next few years.” (Consultant Cross-
sectional and Radionuclide Radiologist). 
 
Some respondents described how information from performance measurement and 
performance management processes did not have an influence. While some had stated that 
technical evaluation reports had been used in making the purchasing decision, others such 
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as a Purchasing Manager in a Trust that had recently completed a CT scanner purchase 
stated that the reports had not been any use because they were published too late and 
contained information that clinicians in the sector already knew: “No [evaluation reports 
are not used], because again they came out sort of slightly during and after.”  and: “…it’s 
a fairly incestuous market…most of the radiologists, and say, the CT stroke MRI techies 
and clinical people, are fully aware of what’s going on in the market place, because there 
aren’t that many machines and that many companies, it’s not as if you’ve got to read 
hundreds of reports and look at hundreds of pieces of equipment or loads of technical 
literature” (Purchasing Manager, Hospital Trust 2). When validating these case 
descriptions, a PASA respondent stated that these comments may relate to old style DES or 
CEP reports and that those produced more recently have addressed these concerns to be 
more user friendly. However PASA have an interest in seeing their reports as useful and 
the analysis here relates to the cross-sectional data gathered before many new CEP 
products had been fully introduced. 
 
In addition to those processes that did not have an influence, respondents described how 
purchasing decisions were often driven largely by cost, suggesting that measurement of 
broader aspects of performance did not have an influence on the decision: “The problem is 
the price is a fairly big issue for us, we’ll have to take it into account.” (Radiology 
Business Manager, Hospital Trust). This was echoed by national level respondents, 
commenting how measurement and management of broader aspects of performance than 
financial aspects was not considered and that users of evaluation information must be able 
to make sense of it: “CT can do all the value stuff that you like, but unless you’ve got an 
organisation in the NHS that can make sense of that and it remains close to what their 
value framework is, there’s just no point in doing it” (Policy & Innovation Director, NHS 
PASA). 
 
Other influences described by respondents are also concerned with whether the CT scanner 
was purchased or not, especially where suppliers were described as paying close attention 
to information from performance measurement for competitive reasons. Suppliers were 
keen that the technical evaluation report for example, showed their CT scanner in the best 
light to potential buyers, suggesting that suppliers think the information is used by 
customers and affects their sales: “…if they [supplier] don’t like the data and they don’t 
come top of the list in our image quality performance index, we get a lot of aggro”. (Head 
of Group, Evaluation Centre). Indeed suppliers have pointed out performance issues with 
competitor products as shown in the Evaluation Centre data and used evaluation data in 
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their own marketing materials. This sheds new light on the above conflicting findings of 
whether technical evaluation data is used. Perhaps unsurprisingly Evaluation Centre 
respondents suggested that reports and the website were appreciated by respondents, useful 
in making the decision and subsequent acceptance testing for example. However the Head 
of Medical Physics suggested that many uses of the information would be implicit and not 
through CEP. 
 
Another influence discussed by many customer and supplier respondents was that of 
information from performance measurement being used by the supplier in a process of 
technological innovation, giving improvements in the design of the CT scanner. This 
occurred on the basis of information from the Evaluation Centre technical evaluation fed 
back to the supplier as well as information gathered by the supplier themselves throughout 
the tender and applications support processes. Following feedback from customers, the 
supplier has achieved a lower radiation dose for the image quality compared to their 
previous CT scanners, as they have traditionally been known as a ‘high dose’ brand. 
Reinforcing this finding, the technical evaluation reported that all four 64-slice CT 
scanners currently on the market have a similar technical performance in terms of the 
fundamental image quality and radiation parameters discussed by the Evaluation Centre 
(Lewis et al. 2006 pp3-15). 
 
From the point of view of the Supplier, an Account Executive also stated that their 
feedback from the customer to the research and development team in their Japanese factory 
improved the technical performance of the CT Scanner: “Customers will feed back 
problems, wishes, suggestions for improvement, that gets fed back to the factory and they 
work on the software and hardware” (Account Executive Southern, Supplier). The 
Account Executive described how most changes are made through releases of new 
improved software, though respondents also described improvements to hardware and the 
service package. The latter involved the supplier on-shoring a previously offshored service 
centre, in response to national level feedback on customer performance of the service 
package by NHS PASA. However, feedback from customer users to the supplier was not 
always used, respondents stating that the UK NHS is a very small customer for the supplier 
internationally, so much feedback is required before technical changes are made to the 
product. 
 
In addition to an influence in acceptance testing described above, respondents said that the 
knowledge that the CT scanner will be subject to various evaluations or assessment by the 
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customer encourages the supplier to ensure the CT scanner performs as claimed: 
“…evaluate what the scanner does and what the supplier says it does and make sure it 
does do what the supplier says it does, and I think [the Evaluation Centre] has improved 
that from the early stages of their assessing the scanners, I think that has improved it, I 
think feedback from Trusts will also again improve the scanners and having that done in a 
more structured way will improve the reliability of their equipment.” (Category Manager, 
Radiotherapy & Imaging, NHS PASA / Supply Chain). There is also an influence of the 
technical evaluation in ensuring the performance of the CT scanner is as expected during 
the life of the scanner, the customer using information such as that from the technical 
evaluation to justify any problems with the scanner to busy supplier engineers. This aids 
getting the scanner repaired, according to the Head of Group at the Evaluation Centre and 
the Radiology Business Manager.  
 
Findings of the CT scanner case are illustrated in Figure 14 and the next section draws 
together a summary for the CT scanner case. 
 
5.3.4. Summary from the Multi-Slice CT Scanner Case 
The CT scanner case describes an innovative product that is implemented in the context of 
a complex network of supply relationships. Hardware and software features on the scanner 
studied make it novel in the market. 
 
The case highlights that a variety of performance measurement and performance 
management processes occur during implementation of the scanner in NHS Hospital 
Trusts, including the purchasing, or tender, process. Actors variously measure technical, 
customer and financial aspects of performance and the case showed that as well as formal, 
quantitative processes, many are subjective and involve social and informational exchange. 
 
In many examples performance measurement is followed up by varied performance 
management processes, such as analysis and dissemination of performance measurement 
information to other actors, making a decision about which CT scanner to purchase and 
making changes to the product package or scanner design. 
 106 
ROLE IN PERFORMANCE
Role in financial performance: 
Scanner bought or not. Cost or 
other, local reasons may 
influence purchase. Suppliers 
concerned about technical 
evaluation results, suggesting 
they affect sales.
Role in technical Performance: 
Software has been re-engineered 
and radiation dose reduced. 
Performance data assists 
maintenance, getting repairs. 
Reports may be used but late, 
clinicians know already
Role in customer performance: 
Scanner purchases are suitable 
for Trust needs.
PERFORMANCE 
MANAGEMENT 
PROCESSES
Information Dissemination: 
Technical evaluation reports and 
tools produced. Feedback to 
supplier. Supplier trains users.
Purchasing: Trust procurement 
tender process, scoring, ranking, 
decision making.
Product innovation: Continuous 
improvement of scanner software 
design. Supplier tailors scanner 
package to Trust needs.
PERFORMANCE MEASUREMENT 
PROCESSES
Financial: Purchase, maintenance costs 
measured.
Technical: Technical evaluation of 
technical parameters by Evaluation 
Centre.
Customer: Trust clinicians determine if 
package meets their clinical needs and 
functionality for Trust. Actors gather and 
survey user opinions. Site visits, talking 
to users, demos, clinicians try scanner, 
supplier learns about needs.
Innovative 
Product 
PERFORMANCE
Thesis focus
 
Figure 14. Conceptual Framework Illustrated with Findings of the CT Scanner Case 
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Respondents also discussed the influences of some of the processes they had described. 
Some processes had beneficial and non-beneficial influences on performance and some 
had no influence at all. Often two or more processes were described or implied as having 
an influence together, for example the supplier made technical design changes to their 
product in response to user feedback. In contrast to the performance measurement 
processes, more of the performance management processes were described as having an 
influence on performance, such as making a purchasing decision and improvement of the 
product design. In particular, the data suggests that where processes had beneficial or non-
beneficial influences rather than no influence, the performance management processes 
involved proactive, decision-making use of performance measurement information by 
buying or innovating actors. A non-beneficial influence described by respondents involved 
partial use of performance measurement information, with a focus on cost performance 
only. Alternatively where no influence occurred, performance management processes 
involved less proactive use of performance measurement information, such as limited use 
of performance measurement information due to issues of mutual understanding and 
timing. 
 
Lessons from the Pilot Case 
This case was progressed faster than the other cases, as a pilot. The pilot brought up a few 
conceptual and methodological issues that were addressed as this and the other cases were 
taken forward.  
 
Key conceptual issues highlighted by the case are the complexity of the network of supply 
relationships and particularly the NHS as a customer organisation, with actors on many 
levels. The dynamism of purchasing and supply management in the NHS is evident, with 
national level purchasing having a much reduced role since the end of National Cancer 
Plan funding. Roles of national level actors have changed with the advent of NHS Supply 
Chain and were not totally clear from the respondents. In response, the interview guide was 
changed to include more questions to gather contextual information on the background to 
the case in the network of supply relationships, which may be of use in analysing complex, 
dynamic cases. 
 
Methodological issues were also raised, for example the accounts of respondents differ in 
places, as to the use made of technical evaluation reports. In response to this, documentary 
evidence was gathered to triangulate accounts where possible, in this and subsequent cases. 
Respondents were also encouraged to give examples. The differing accounts may also be 
 108
due to the variations in practice at a local level, reinforcing the need for screening 
questions. 
 
The case also highlights that some actors identified by respondents in the network pictures 
referred to the CT scanner studied as a focus in this case, while others referred to, for 
example, evaluating CT scanners in general, or the product category. Although this is a 
lesson in itself, the interviewer became increasingly aware of the need to clarify when 
comments made by a respondent referred to, say, evaluation of CT scanners in general, or 
the CT scanner studied here in particular. 
 
The data reported above is described again from a cross case perspective in the next 
chapter, then discussed in detail in the context of existing knowledge in the subsequent 
chapter. First however, the other cases are discussed in the remainder of the current 
chapter.  
 
5.4. Blood Glucose Meter 
 
5.4.1. Introduction and Background to the Blood Glucose Meter Case 
A summary of interview respondents in the blood glucose meter case are shown in Table 
24 and in more detail in Appendix B, their roles being described further in the following 
sections. In Appendices J and K are a matrix of findings from the respondents interviewed 
in the blood glucose meter case as in the previous case, and further detail showing 
frequencies of the codes used in HyperResearch. 
 
The blood glucose meter is a medical device that a patient user in the home can use to 
determine their blood glucose level. The product consists of an electronic meter that 
chemically analyzes a capillary blood sample and displays the level of blood glucose, 
consumable product specific test strips that use an enzyme required for the chemical 
analysis and an associated service package. 
 
The blood glucose meter studied here is from one of six to eight main suppliers in the UK 
market (Device Evaluation Service 2005 pp1-3). It can be considered innovative as it is 
being commercially exploited by the supplier for financial gain and contains new to the 
market and firm features, which are exploited for purposes of improving healthcare. The 
meter comes with a novel service package including help lines staffed by diabetic 
specialist nurses (DSNs) who can interpret test results uploaded by the patient to the 
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internet, lifestyle advice, training courses and even access to recipes for diabetics, all 
provided by the supplier. For example, software that can be downloaded for use with the 
blood glucose meter enables users to tabulate and graph results, helping them to manage 
their disease. In addition to these novel features of the specific product, the meter and other 
contemporary meters on the market feature incremental improvements, being physically 
smaller, requiring a smaller blood sample (1μL) and producing test results faster than 
earlier products. 
 
Respondent (Job Role) Organization Type of Stakeholder Role 
Head & Biochemistry Director Evaluation Centre, Pathology 
Devices 
Customer. Influencer (national 
level) 
Technical Evaluation Leader Evaluation Centre, Pathology 
Devices 
Customer. Influencer (national 
level) 
Category Manager, Pathology NHS Supply Chain Customer. Buyer, Influencer 
(national level) 
Category Specialist, Pathology NHS Supply Chain Customer. Buyer, Influencer 
(national level) 
Pharmaceutical Services 
Manager 
NHS Prescription Pricing 
Division 
Customer. Decider, Gatekeeper 
(national level) 
Manager, Point of Care Testing 
Team 
Hospital NHS Foundation Trust Customer. Influencer, Buyer, 
Decider (local level) 
Diabetic Specialist Nurse Hospital NHS Foundation Trust Customer. User, Decider (local 
level) 
Diabetic Specialist Nurse Primary Care Trust Customer. User, Decider (local 
level) 
Service Development Manager Pharmacy Plc Customer. Buyer, Decider 
(national level) 
Director Care and Policy Diabetes UK Patient Body. (national level) 
Senior Marketing Manager Blood Glucose Meter Supplier Supplier (national level) 
Director General British In-Vitro Diagnostics 
Association 
Supplier Industry Body 
(national level) 
Respondents Interviewed for all Cases 
Policy and Innovation Director NHS PASA Customer. Influencer (national 
level) 
Senior Collaborative 
Development Manager 
NHS PASA Customer. Influencer (national 
level) 
Head of R&D NHS PASA Customer. Influencer (national 
level) 
Senior Manager for Technology 
Introduction 
NHS Institute for Innovation 
and Improvement 
Customer. Influencer (national 
level) 
Table 24. Interview Respondents in the Blood Glucose Meter Case 
 
Figure 15 shows the network picture for the blood glucose meter case, again with the 
organisations of the interview respondents are highlighted in yellow, to provide a link with 
Table 24 above. Meters are supplied to both the home and hospital markets. The meter 
studied here is used predominantly in the home market by patients themselves, though this 
also involves interacting with clinicians in outpatient clinic and hospital settings. 
 
 110
KEY to flows
Product
Assignment
Commissioning
Finance
Information
Care
HOSPITAL
PATIENT BODY
MANUFACTURER BODY
EVALUATION 
CENTRE
PPD 
(NHS 
BSA)
NHS III
PASA / CD
INTERNATIONAL 
IMPORTS
PRACTICE 
NURSES
HIGH ST. 
CHEMIST
WHOLESALER / 
DISTRIBUTOR
PATIENT / USER
DoH
CEP
MANUFACTURER
GPs
PCTs
SHAs
ACUTE 
TRUSTs
DIABETES 
CLINIC
COLLABORATIVE 
PROCURE HUBS
NHS 
SUPPLY 
CHAIN
PROFESSIONAL 
BODY
MHRA
OGC
INNOVATION  
HUBS
NIC
DISTRICT 
NURSES
MEDICAL 
DEVICES
HOSPITAL 
CONSULTANTS
PROCUREMENT
 
Figure 15. Network Picture for the Blood Glucose Meter Case 
 
In Primary Care Trusts (PCTs), District Nurses, Practice Nurses and General Practitioners 
(GPs) are all involved in diabetes care for the patient and commission care from diabetes 
clinics in Acute or Hospital Trusts where Consultants and Diabetic Specialist Nurses 
(DSNs) also care for the patient. The blood glucose meter is given to the NHS clinicians 
and patient user free by representatives from the supplier, who then charge for the 
consumable strips, though in some instances the patient will buy the meter directly from 
the high street pharmacy. Strip purchase and supply is shown in Figure 16, simplified from 
the network picture. The supplier sells strips to a wholesaler or distributor, who then sell 
them to pharmacies and a margin is made on each sale. GPs issue patients with a 
prescription for strips, which they redeem at a pharmacy for strips. The chemist sends the 
prescription to the PPD (Prescription Pricing Division of the NHS Business Services 
Authority) for reimbursement, which is given at the cost of the prescription at the drug 
tariff price, plus an extra amount for dealing with the prescription. The PPD bills the PCT, 
which in turn bills the GP for the strips prescribed. The GP then sends the money due to 
the PPD, from their budget. The PCT tenders the strip price with the supplier. Before 
reimbursement could occur, the PPD had to assess its suitability and include the strip on 
the NHS Drug Tariff, making it available on prescription in the UK. Strips are supplied to 
the clinicians such as DSNs who give patients the blood glucose meter and teach them how 
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to use it. Other actors shown include Diabetes UK, a charitable patient body that works for 
the benefit of people with diabetes, drawing membership from patients and clinicians 
shown on the picture and an industry body for suppliers, the British In-Vitro Diagnostics 
Association (BIVDA). 
 
  
Figure 16. Purchasing and Supply of Blood Glucose Meter Strips 
 
5.4.2. Performance Measurement and Performance Management 
This section describes specifically the performance measurement and performance 
management processes described by respondents, reported in the following two sub-
sections. 
 
Performance Measurement Processes 
Interview respondents discussed a number of performance measurement processes, 
measuring a variety of different types of performance of the blood glucose meter. 
Processes have included technical evaluations by an Evaluation Centre, clinical trials, 
assessment of the meter for individual patients by DSNs, ease of use and quality assurance 
assessment at the local level, measurement of costs to the NHS and measurement of sales 
and various user forums. 
 
Technical evaluations of blood glucose meters on the market, including the product studied 
in this case have been carried out by the Evaluation Centre, assigned by CEP. This has 
traditionally involved measuring technical parameters of the product, for example clinical 
assays that are performed on capillary blood samples from a variety of patients with 
various blood glucose levels, measurement being made with a reference analyzer. No 
financial performance measures are used other than listing the cost of the meter, though 
this is an estimate as price is affected by quantity and strips are typically the main cost. 
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Few specific customer measures are used, though evaluation outputs make a general 
comment on the contribution of blood glucose testing to quality of life and issues such as 
finger pricking. Respondents discussed how CEP are now requesting a new ‘Buyer’s 
Guide’ product from the Evaluation Centre, containing more purchasing and economic 
information. Meanwhile, the pharmacy also measure technical performance using similar 
criteria as the Evaluation Centre. 
 
Technical measures are also used by the supplier’s research and development team and the 
meter has been sent for clinical trials to determine technical efficacy. Technical measures 
include reliability, using generic tools, for example the yellow instrument scale and are 
aimed at ensuring product certification at the European level with CE marking.  
 
The purchasing guide issued by PASA Category Managers and Specialists (NHS PASA 
2005 pp10-16) recommends measuring technical and clinical product aspects such as test 
strip compatibility checks, the risk of cross infection and declared accuracy, as well as 
various cost aspects. Local level evaluations were also carried out by the Hospital 
Foundation Trust, which conducted a bench analysis looking at technical measures for 
quality assurance purposes, with a particular emphasis on product safety features. 
Measures relevant to the customer in the home market, such as display clarity were also 
involved. 
 
Strip costs are assessed by the NHS on a national level, by the PPD and by PASA staff, 
and a cost effectiveness study has been carried out. The PPD also gathered technical 
performance measurement information from suppliers for assessing suitability of the meter 
for inclusion on the NHS drug tariff. The onus is on the supplier to provide the information 
required. The pharmacy also focuses on financial performance measures, studying the 
profit per line and sales per annum of the blood glucose meter and others on sale in their 
branches. The supplier also measures financial performance of the meter, the key financial 
measure being sales per year, where year on year targets are made, with market share also 
used as a leading indicator. 
 
Performance measurement occurs when diagnosis is made by clinicians at the local level, 
or during a routine appointment. A patient may be given a blood glucose meter by a 
clinician, so the decision about which of the meters on the market is chosen will be made 
by the clinician on behalf of the patient. However the DSNs interviewed described how 
they discuss the various meters available with the patient and make a joint decision with 
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them about the most appropriate one for the particular needs of the patient: “…it’s really 
horses for courses and that’s why we offer the whole range, we wouldn’t just go with [the 
supplier], [the supplier] are very good, but there are other meters that would fit the criteria 
for the patient, so we try to fit the meter to the patient”  and: “…we go on what the patients 
are telling us really” (DSN, Hospital NHS Foundation Trust). In this way the performance 
of the blood glucose meter is measured in a less formal manner by DSNs, who check 
through its operation with the patient. DSNs hold discussions with colleagues to 
supplement their own experience in using the meter with patients. On a local level, there is 
information sharing and two-way communication between supplier and individual clinician 
actors. Supplier representatives frequently visit clinicians in the field to give free samples 
of the meter and discuss any product issues with the user. Other sources that are sometimes 
consulted for performance measurement information about the meter are medical journals, 
information from the supplier sales representatives and Diabetes UK.  
 
Many of the performance measurement processes used by the supplier focus on the 
performance of the meter for the customer, with key performance indicators including 
accuracy and ease of use. Questionnaires and focus groups are used, with some work 
outsourced to a dedicated market research organisation. Measures focus on ‘soft’ quality of 
life elements such as feelings of positivity or depression of the patient on being diagnosed 
with diabetes and having to manage their disease. Many of the measures look at feelings of 
patients both before and after an intervention. The supplier runs a series of symposia and 
motivational skills sessions with healthcare professionals as part of the blood glucose 
meter service package, these also being a chance to discover consumer opinions about the 
product. A database is kept of logged customer reports from the customer care team.  
 
Performance Management Processes 
In addition to performance measurement processes, a number of broader performance 
management processes were evident in the case. These include processing of data from the 
performance measurement processes just described above and various follow up 
management activities, such as use of the performance measurement outputs in 
determining whether to give the blood glucose meter to a particular patient or approve it 
for listing on the NHS drug tariff. Feedback was gathered and led to changes being made 
to the product design, as described below. 
 
The technical data gathered by the Evaluation Centre in their technical evaluations was 
processed including the use of a statistician and double checks for accuracy, compiled in 
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the form of error grids, comparative graphs and tables with other meters and assay and is 
checked with the supplier for any errors. Evaluation reports have then been produced and a 
variety of other materials, a particularly popular recent output being a short portfolio 
comparing key technical parameters selected for clinicians, patients and other stakeholders 
of blood glucose meters on the market (Device Evaluation Service 2005 pp1-3). While the 
Evaluation Centre will state that technical results in their outputs for a particular blood 
glucose meter are acceptable to varying degrees, according to generic scales, they will not 
issue prescriptive advice on whether to procure a product such as the blood glucose meter 
or otherwise. As for the purchasing guide produced by NHS PASA, scoring and weighting 
of the various performance measurement data gathered is advocated with the aim of 
reaching a purchasing decision. The guide includes sample letters and worksheets for 
administrating and managing contacts with suppliers throughout a tender process, though 
no clinicians interviewed described having used the guide. The pharmacy respondent also 
described how a formulary of blood glucose meters has been produced by a DSN working 
in practice. At the national level, NHS PASA actors produce a purchasing guide for blood 
glucose monitoring equipment (NHS PASA 2005 pp1-17). In practice it is predominantly 
aimed at longer term contracts for blood glucose monitoring in the hospital market, though 
still has some relevance. 
 
As described above, DSNs play a key role in helping the patient decide on the most 
appropriate meter for their needs, a process that not only involves determining the 
performance of the meter for a particular patient and drawing on knowledge gained from 
other sources, but also taking part in a decision-making process about whether the meter or 
another is appropriate, a performance management process. This is part of a purchasing 
process, as the patient or NHS will subsequently buy the strips for the particular meter 
chosen. Other decisions in purchasing the product are made by the high street pharmacy, 
who make the decision to choose to list the meter for sale and the PPD, who choose to 
make it available on prescription. 
 
The high street pharmacy has a committee of clinicians and buyers who discuss various 
performance measurement data, then make a collective decision about which meters and 
strips to stock for patients to purchase. Feedback is then given to the supplier about 
decisions made. The PPD also have a number of key management processes which were 
involved in assessing whether the blood glucose meter strips should be listed on the NHS 
Drug Tariff. This involves ensuring the blood glucose meter, or in practice the strip, is 
safe, of good quality and of appropriate price to be available on prescription. They checked 
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that the product is CE marked for suitability for listing on the tariff, then the strip price was 
compared with average prices of comparator products as a benchmark. A recent 12% cut in 
the reimbursement of strip costs of all blood glucose meter strips on the drug tariff was 
spearheaded by the PPD, who originally wanted a 15% reduction and were involved in 
negotiations over the price cut, particularly with BIVDA. PPD decisions to list a product 
such as the blood glucose meter on the drug tariff are made by internal committee and the 
decision to list the product is made once, rather than in the ongoing management or 
monitoring processes used by some actors in the case. However the supplier now has to 
declare the contents of their service package to the PPD, as there were concerns that 
services would be cut with the strip price reduction and a 15% cut was avoided if the 
packages from suppliers were kept constant. 
 
As described above, the supplier holds regular review meetings and forums with various 
customer stakeholders. They see these and the training sessions for patients and clinicians, 
support lines, website and materials, symposia with healthcare professionals as an 
important part of managing the performance of their product in practice, making sure that 
patients and clinicians use the product effectively to manage their disease and are satisfied 
with it. Diabetes UK also provide help lines which receive 40,000 calls per annum and 
advice to patient users, for example an annual publication showing the meters available in 
the UK. The organisation facilitates regular meter calibration, as well as occasional tests 
where the meter is sent to a laboratory for accuracy testing. Information is distributed to 
stakeholders, such as in the strip price reduction issue above and recall issues below. 
 
This case also involved some performance management processes concerning technical 
issues with the design of the product that were encountered in practice. The previous 
generation of the product was referred to the MHRA who issued a device alert (MHRA 
2006a), based on reports from users that the decimal point in the screen display was too 
small and that blood glucose results could be misinterpreted, particularly by those diabetics 
with poor eye sight. As a result of the device alert management process, the supplier went 
through processes of recalling the product, redesigning the screen and replacing the 
recalled products with the current generation of the meter, free of charge: “[The supplier] 
conducted a recall situation on our [blood glucose meter] because previous to that most 
meters in the market place weren’t hard locked in milimols per litre, they could be 
switched between milimols per litre and milligrams per decilitre, because they’re being 
provided to a number of different countries…We had some reports there that, you know, 
patients had, you know, they thought they’d tested in milimols per litre, they hadn’t, it was 
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milligrams per decilitre, may have been taking some inappropriate action… So we took the 
proactive stance of recalling all the meters in the marketplace that were soft locked and 
replacing them, made them all hard locked.” (Senior Marketing Manager, Blood Glucose 
Meter Supplier). Performance management processes were also involved in raising similar 
concerns about a software function that the previous generation of the product used to 
change between different metric and imperial scales, the MHRA issuing another device 
alert (MHRA 2006b). Users found that the product could reset to a default scale following 
a battery failure, so the supplier underwent a process of improving the design of the 
product by introducing a hardware scale lock. 
 
5.4.3. Influence on Performance 
This section reports on the influence of performance measurement and performance 
management processes on performance of the meter. As in the previous case, Table 25 
summarises the influences found in this case, based on an effects matrix compiled from 
respondent descriptions of influences of the processes as shown in Appendix L. 
 
A key influence discussed many times by almost all respondents in the case was the 
influence of information from performance measurement being used in performance 
management processes, affecting the outcomes of the purchasing decision. Information 
from performance measurement was used to inform decisions about whether to purchase 
the blood glucose meter or a competing product. In this case, the various parts of the 
product are purchased, or given, separately so several decisions were involved. Firstly the 
strip had to be approved by the PPD following an evaluation, to make it available on NHS 
prescription. Later decisions involve the pharmacy deciding to stock the meter, or the DSN 
and patient deciding together which of the free meters given to the Trust by the supplier is 
preferred. The measurement and management processes vary from subjective assessment 
of customer preferences by the DSN and patient, through to more formal committee 
decision making on cost and technical evidence in committees by the PPD for example. 
Some respondents also went further, describing how the influence of processes in 
purchasing ensured that the patient user gets the product they prefer. 
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Influence Type Researcher Explanation 
Product is purchased or not 
 
+/- 
F/C 
The decision to purchase the product or not on the basis of 
performance measurement information gives the supplier sales 
or not and the customer the benefit of a product that performs 
best for healthcare. 
Selection of a free meter will mean the patient then buys the 
strips for the meter, while decisions to list the meter on the 
NHS drug tariff and for sale in the pharmacy also enable sales 
of strips or meters to users to take place. 
The best product for the needs 
of the user is purchased 
+ 
C 
Assessment with patient enables the patient to choose their 
preferred meter from the options available to take away. 
Performance measurement 
information is not involved in 
the purchasing decision 
None There is little use of information from the technical evaluation 
in the purchasing decision. 
Supplier shows concern over 
performance measurement 
 
* 
+/- 
F 
Reports are a good sales device for suppliers, or for competing 
suppliers. Suppliers have a good relationship with Eval Centre 
when results are good and vice versa. 
Supplier ensures product 
performs to their specification 
& regulations, as it will be tested 
and then purchased or not 
 
+ 
T 
Performance measurement and management processes mean 
that the supplier knows the meter must perform as promised 
and to regulations it must meet if it is to be sold – IVD, CE 
marked. 
CE marking does not 
necessarily signify a product 
that performs to a sufficient 
standard 
 
- 
F/T/C 
Although some respondents suggested processes help the 
meter meet standards and perform well, other respondents 
suggested that the standards are not a good guide to 
performance and a product that does not perform well may be 
bought on the basis of limited information. 
Used to reduce product cost 
 
+/- 
F 
A % reduction in strip price on national drug tariff was 
negotiated and achieved on the basis of cost information 
measured by the NHS on a national level. 
Product can be purchased or 
not for short-term, cost based 
rather than broader reasons 
 
- 
F/T/C 
The product is bought or not in a decision made on the basis of 
cost performance measurement information with a short term 
view. Evidence of broader aspects of performance is not used 
proactively or integrated back to buyers. 
Compliance with use of the 
product is needed 
 
None The meter can be bought, but if the patient does not use it or 
the patient does not act upon the blood glucose meter results 
given by the meter, it will have no benefit for their health. 
Training is necessary for patient 
to gain benefits of product use 
 
+ 
C 
Users require training on the meter if they are to gain the 
correct results and be able to interpret them, benefitting their 
health. 
Currently little evidence on the 
effectiveness of the healthcare 
procedure the product uses 
 
None There is currently limited evidence of the effectiveness of 
blood glucose testing as a discipline in gaining beneficial 
health outcomes, so effort in measuring and managing the 
performance of the meter may mean that a useless product is 
procured. 
Product design improved 
 
+ 
T 
The design of the blood glucose meter is permanently 
improved with a new display and hard locked scale. 
Table 25. Summary of Influences Identified in the Blood Glucose Meter Case 
(KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial 
performance, ‘T’ is an influence on Technical performance and ‘C’ is an influence on Customer performance 
(After Griffin & Page 1996). ‘None’ means there is no influence on performance. ‘*’ denotes an influence 
inferred by researcher rather than specifically described by respondent). 
 
However there were varying accounts of the use made of different performance 
measurement outputs in the purchasing decision. A respondent from Diabetes UK 
commented how technical evaluation reports have limited use: “I’m not convinced that the 
NHS always use blue cover [Technical Evaluation] reports hugely…” (Category Specialist 
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Pathology, NHS Supply Chain) and “One of the problems with [the Evaluation Centre] is 
they do these lovely blue technical reports and nobody reads them. So, you know, how 
often you can drop it and put it in an oven and whatever, and how accurate they are…the 
reports just really weren’t widely read and that’s when we first started working with [the 
Evaluation Centre], a long time ago now, to try and take that information and try and put it 
into a more accessible format.” (Director Care and Policy, Patient Body). Another 
respondent commented that technical evaluation information was useful, yet could be hard 
to get hold of: “I think we need a larger independent, we need a larger, much more 
responsive evaluation system…sometimes evaluation papers are not easily available, or 
you have to pay a lot of money.” (Service Development Manager, Pharmacy Plc). On the 
other hand, some respondents described how technical evaluation outputs such as leaflets 
with key performance figures have been well received, the centre running out of stock: 
“…that was amazing, we couldn’t dish out enough…” (Technical Evaluation Leader, 
Evaluation Centre). 
 
Further suggestion that the evaluation reports have an influence is that suppliers of other 
blood glucose meters are keen to view evaluation and other performance measurement 
outputs, to describe their own product favourably by comparison to the NHS customer. 
Respondents from the Evaluation Centre commented that the supplier was willing to take 
part in technical evaluation because they must gain some sort of benefit from the process: 
“There’s got to be an advantage for them, to me it’s an independent endorsement.” (Head 
and Biochemistry Director, Evaluation Centre). 
 
From the customer side of the relationship, respondents suggested that performance 
measurement gives buyers confidence that the product will meet the description: “…any 
ongoing performance monitoring should either improve or at least ensure that what you’re 
getting is what they say you’re getting.” (Category Manager Pathology, NHS Supply 
Chain). Not only must the meter perform to specification, it must also meet regulatory 
standards required for listing on the NHS drug tariff and for sale in the UK. Respondents 
described the In-vitro Diagnostic Medical Devices (IVD) Directive, as well as CE marking. 
Although the latter is required to sell the product in the UK, several respondents cautioned 
against relying on it as evidence of good performance. Indeed it was discussed how buyers 
of blood glucose meters often only look for a CE mark when assessing the performance of 
the product prior to making a purchasing decision and may end up buying a product with 
poor performance, highlighting that these processes can have a non-beneficial influence on 
performance. 
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From the point of view of the PPD, the decision to list the product was made following 
their own assessment of suitability, but as it is always made by benchmarking against 
existing products, it does not encourage a better performing product: “…they’re [PPD 
evaluation processes to approve product on NHS drugs tariff] sort of designed to compare 
it against what’s currently available, and in a way they don’t encourage advances in 
technology, I mean we would be accepting of advances in technology, we would accept, 
you know, some additional information to evaluate, but I suppose the process at the 
moment is more geared up to accepting things that are the same as, but cheaper than 
currently available products.”  (Pharmaceutical Services Manager, PPD). Further, the 
twelve per cent reduction in strip price reimbursement by the PPD followed negotiations 
between industry and the NHS on a national level, the latter having decided that 
expenditure on strips was too high. Indeed many of the respondents described how the 
meter is bought on the basis of cost and that broader evidence of the performance of the 
product is not used when purchasing decisions are made, making it hard for products that 
are not low cost, but have other benefits, to be taken up. 
 
The case also showed the influence of the above processes in re-designing the product. As 
described above, product recalls, re-design and replacement led to permanent changes in 
the design of the blood glucose meter and free replacement for the customer. Indeed 
respondents commented how performance measurement and management processes in 
general require more minds to concentrate on the meter, so producing a better product: 
“…more minds solving a problem will give you a much more rounded result.” (Manager, 
Point of Care Testing Team, NHS Foundation Hospital Trust). 
 
Another key issue when analyzing the influence of the above processes, as described by a 
variety of respondents, was that whatever performance measurement processes occur, the 
meter must be used if it is to perform for the patient by benefiting their health. Also, the 
patient needs to know how to act properly on meter results if need be: “Blood glucose 
testing on it’s own doesn’t make a patient better, ok, you’ve got to tie that in with them 
acting on the result or kind of reviewing the result, so you know, it’s part of that.” (Head & 
Biochemistry Director, Evaluation Centre). Further, some respondents in the case focused 
on the influence of the patient in performance of the meter, rather than the influence of 
evaluations. A DSN described how the meter and competing products performed in a fairly 
similar manner, compared to possible differences from the influence of the patient in using 
it: “I think there are differences [in performance of meters on the market], I think they’re 
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less significant than the level of the patient’s understanding, not only of the meter but of 
the principles involved in blood glucose monitoring.” (DSN, PCT). 
 
Studies have suggested that a very small percentage of patients regularly monitor their 
blood glucose (Evans et al. 1999). Indeed one clinician respondent claimed that many of 
the blood glucose meter results patients present are made up on the bus on the way to the 
clinic. The customer performance of the blood glucose meter ultimately depends upon the 
patient user actually using the device in the recommended way to manage their disease. 
The evaluation centre expressed some frustration that they measure performance and issue 
reports, yet this alone cannot improve healthcare outcomes, this requires motivated 
purchasing and healthcare professionals to act on the information. Training the patient in 
using the meter correctly and interpreting test results was described as important by 
customer and supplier actors. Indeed the supplier respondent described how their 
innovative service package was aimed at empowering the patient to manage their disease 
through training and support, rather than just monitoring their blood glucose levels: “…if 
you look at the market now, the blood glucose monitoring market, it’s really about 
measurement, measuring the blood glucose for example, we want to move that to more of a 
management organisation” (Senior Marketing Manager, Blood Glucose Meter Supplier). 
 
A challenge described by a number of respondents, including Diabetes UK and DSNs was 
that there is currently a very limited evidence base on the benefits of blood glucose testing 
for health. A Health Technology Assessment report and publication (Coster et al. 2000a 
pp70-72, Coster et al. 2000b) suggested a lack of evidence of the clinical effectiveness of 
self-monitoring of blood glucose for the Type 2 form of the condition and that it may not 
be necessary in all patient cases. However the National Institute of Clinical Excellence 
guidelines (NICE 2002) state that self-monitoring can be used as part of a wider therapy 
package. Given the complexity of the disease, care pathway and patient involvement in 
using the product, it is a challenge to measure and manage the performance of meters in 
this context: “…there’s so many factors – this is why research is so difficult to actually 
show the body of evidence on blood glucose monitoring” (DSN, PCT). This suggests the 
performance measurement and management processes may have no influence on 
performance of the meter. 
 
5.4.4. Summary from the Blood Glucose Meter Case 
Findings for the case are illustrated in Figure 17. The blood glucose meter case describes 
an innovative product, with the predominant novel aspect being the accompanying service
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ROLE IN PERFORMANCE
Role in financial performance: 
Meter given or bought, strips 
bought. Drug tariff, IVD approval 
enables prescription, purchase. 
Pharmacy decided to stock meter 
for sale. 12% cut in strip price.
Role in technical performance: 
Improved display, scale. Many 
use reports. 
Role in customer performance: 
More evidence of glucose testing 
benefits needed. Litt le follow up 
action is taken after testing. 
Training benefits users.
PERFORMANCE 
MANAGEMENT 
PROCESSES
Information Dissemination: 
Evaluation Centre publications. 
Feedback to supplier. Supplier 
educates users, offers advice, 
help lines.
Purchasing: DSN choosing 
meter with patient, PPD 
evaluating strip for inclusion on 
drug tariff, pharmacy deciding to 
stock.
Product innovation: MHRA 
referral, recalling, re-designing 
and replacing meter.
PERFORMANCE MEASUREMENT 
PROCESSES
Financial: Sales and trends measured 
by supplier. Strip price measured and % 
reduction discussed.
Technical: Technical evaluation, of eg
accuracy, reliability, requires a lot of 
resources.Quality assurance testing of 
technical aspects. Trials by supplier.
Customer: DSN subjectively assesses 
product suitability with particular patient. 
Service package measured nationally.
Communication and information sharing 
between actors, user forums.
Innovative 
Product 
PERFORMANCE
Thesis focus
 
Figure 17. Conceptual Framework Illustrated with Findings of the Blood Glucose Meter Case 
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support package. Again the case shows that the product is implemented in a complex 
network of supply relationships and actors. As with the previous case, a broad variety of 
performance measurement processes take place by the various organisations and actors 
involved. Technical, financial and soft customer or quality of life aspects of performance 
were all measured. Again, measurement processes varied from formal, quantitative trials 
and financial assessments, to informal and subjective assessment and exchange of 
information by individuals, often oriented to particular user needs as part of the many 
different purchasing and supply decisions during the implementation of the product. 
 
A number of performance management processes were reported in the case. These 
included dissemination of performance measurement information and its use in describing 
how the product performs to make a decision about whether to choose the meter for a 
particular patient, to sell it in a high street pharmacy, or for approval of the strips for 
inclusion on the NHS drug tariff. The case also described a couple of instances of 
performance management processes in identifying the need for and carrying out product 
re-designs. 
 
The influences of performance measurement and performance management are also 
suggested by the case, many of which are similar to the influences discussed in the 
previous case. As in the CT scanner case, a key influence discussed by respondents was 
whether the meter, or a competing product is adopted for use by NHS clinician and patient 
users. However the blood glucose meter case showed the influence of processes in a more 
complex purchasing and supply situation, for example how the PPD decided to list the 
strips, while DSNs make a decision with the patient to use the best product for their 
particular needs, which would then lead to subsequent strip purchases. Another influence 
that was described was that of improving and permanently changing the design of the 
product, following identification of issues with the display and scales. However this case 
highlighted the issue of a lack of evidence surrounding blood glucose testing as a whole 
and that, above and beyond selecting a meter with good performance, that it is no use 
unless used by a trained user and action taken on the results. 
 
Overall the case is similar to that of the CT scanner, as respondents described the influence 
of both performance measurement and performance management processes on 
performance. Also, the findings describe proactive performance management processes of 
purchasing and innovating the product as having beneficial or non-beneficial influences, 
however some performance measurement information and outputs are not used in 
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purchasing decisions and have no influence, as in the previous case. Cost is again a key 
driver of some purchases and information on broader aspects of performance not used. 
This case also raises challenges that may hinder processes having a beneficial influence, 
namely compliance with use, training and having sufficient evidence and rigorous 
standards in the first place. This chapter continues to discuss the next case. 
 
5.5. ECG Monitor 
 
5.5.1. Introduction and Background to the ECG Monitor Case 
Findings from the interviews and the respondents to the interviews in the ECG monitor 
case are shown in Table 26 and in more detail in Appendix M, their roles being described 
further below. Frequencies of the codes used in HyperResearch are shown in Appendix N. 
 
Respondent (Job Role) Organization Type of Stakeholder Role 
Director Evaluation Centre, General 
Medical Devices 
Customer. Influencer, Decider 
(national level) 
Category Manager, Cardiology NHS Supply Chain Customer. Buyer, Influencer 
(national level) 
Category Specialist, Cardiology NHS Supply Chain Customer. Buyer, Influencer 
(national level) 
General Practitioner GP Surgery Customer. User, Buyer, Decider 
(local level) 
Practice Nurse GP Surgery Customer. User (local level) 
CEO ECG Monitor Supplier Supplier (national level) 
Chief Technology Officer ECG Monitor Supplier Supplier (national level) 
Chief Technology Officer ECG Monitor Supplier Supplier (national level) 
Respondents Interviewed for all Cases 
Policy and Innovation Director NHS PASA Customer. Influencer (national 
level) 
Senior Collaborative 
Development Manager 
NHS PASA Customer. Influencer (national 
level) 
Head of R&D NHS PASA Customer. Influencer (national 
level) 
Senior Manager for Technology 
Introduction 
NHS Institute for Innovation 
and Improvement 
Customer. Influencer (national 
level) 
Table 26. Interview Respondents in the ECG Monitor Case 
 
The ECG monitor is a medical device that monitors the electrical activity of the heart over 
a period of time, recording an electrocardiogram (ECG). The product is intended by the 
supplier for use in a primary care setting for first investigation of patients with symptoms 
that may suggest cardiac arrhythmia. It is an ambulatory device, meaning that it is worn by 
the patient for a period of time while recording takes place. The product consists of a small 
portable monitor worn by the patient on a belt, pads to attach to the patient and software 
for interpretation. 
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The ECG monitor has features that are different from other holter ambulatory recording 
systems that are mainly used in hospital and cardiology clinic settings. Whereas traditional 
monitors record a continuous ECG that is subsequently downloaded and analyzed in a 
semi-automated manner by a cardiologist, the ECG monitor studied here uses neural 
networking technology, developed at Brunel University, to analyze the ECG in real time as 
it is recorded by detecting and classifying arrhythmia. The device keeps a summary of the 
recording that may then be downloaded in a GP surgery. The neural networking 
technology is novel, suggesting that the ECG monitor is an incremental or modular 
innovation. The supplier claims that the ECG monitor has the potential to change the care 
pathway for patients with symptoms suggesting possible cardiac problems, by classifying 
and analysing data at the GP surgery level, aiding correct diagnosis and appropriate referral 
decisions by the GP. They claim that waiting times for a test could be reduced, with 
reduced travelling time and anxiety for patients and faster referral to a consultant if the GP 
does decide to refer the patient. In the traditional pathway there are risks of expensive false 
positive referrals to consultants, or of detrimental consequences to patient health with false 
negative diagnoses. The ECG monitor is exploited for commercial gain by the supplier, a 
company set up specifically to exploit the technology. Being both novel and exploited, the 
product is technologically innovative in the light of the literature. 
 
The network picture compiled by respondents in the ECG monitor case is shown in Figure 
18. The network of interactions shown is fairly small compared to some of the other cases, 
including purchasing of the product from the single supplier by a sole customer type within 
the NHS, the GP surgery. This involves exchange of information, the product and finance 
in return. A large number of actors on the customer side are involved in influencing the 
process, particularly by evaluation of the product as it is fairly new to the NHS. The 
collaborative procurement hubs (CPHs) and NHS Supply Chain are potential purchasers of 
the ECG monitor on behalf of GP surgeries at the regional and national levels. Other actors 
keep them informed about the products, though they have not bought any yet and no 
national framework agreement exists for the ECG monitor from NHS Supply Chain. The 
ECG monitor is very much the sort of candidate product the NHS III and innovation hubs 
aim to help gain entry to the NHS, yet the supplier and NHS III are not connected. 
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Figure 18. Network Picture for the ECG Monitor Case 
 
5.5.2. Performance Measurement and Performance Management 
Performance measurement and performance management processes described by 
respondents in the ECG monitor case are reported in the following two sub-sections. 
 
Performance Measurement 
During implementation, the ECG monitor has undergone performance measurement based 
on standards and regulations. The supplier has carried out technical measurement to 
comply with ISO13485 on Medical Devices, US Food and Drug Administration (FDA) 
Current Good Manufacturing Practice (CGMP) regulations, the Medical Devices Directive 
(93/42/EC), CE marking and the supplier as a whole is compliant with ISO9000 quality 
standards that involve measurement of technical performance. Measures focus on safety 
and quality based aspects of the product, having an emphasis on the procedures followed in 
producing it. The Medical Devices Directive focuses on the product instead, listing 
essential requirements that a medical device must meet. Examples of quality measures 
include the number of defect products overall and measures as precise as the number of dry 
solder joints in the circuit board. Development project measures of cost, time and quality 
are also used by the supplier. The supplier also undergoes an annual assessment to meet 
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US FDA requirements, which involves a documentary audit by a notified body. An 
independent audit is also conducted for the ISO13485 standard and then sent to the 
MHRA.  
 
A key performance measurement exercise conducted by the supplier was a clinical trial in 
a PCT, involving 419 patients over a period of a year (Standing et al. 2001). The trial 
involved independent analysis of data and was published in the British Journal of 
Cardiology. Other clinical and technical trials involving the ECG monitor have been 
published with the aid of the supplier (Gamlyn et al. 1999, Mandal et al. 2004). 
 
The evaluation centre was requested by CEP to evaluate the ECG monitor for use in the 
NHS (Menes et al. 2006 pp15-22). PASA had requested an evaluation of the product to 
verify the impressive claims made by the supplier: “It was a classic case of a company that 
saying that they’ve got this wonderful thing and, you know, you could cut waiting lists by 
60%…there never was anywhere you could take these things and say is it true or not, so 
that’s where the power of CEP comes in.” (Policy and Innovation Director, NHS PASA). 
A protocol for a technical evaluation was developed based upon British and International 
Standards for medical devices. Technical performance measures included construction 
quality, frequency response and accuracy of heart rate measurement. Additionally a 
literature review was carried out because of the innovative nature of the ECG monitor and 
calculations were made of the financial impact of the ECG monitor in changing care 
pathways. A user assessment was conducted, involving a structured questionnaire about 
usage, costs and training provided, with satisfaction ratings calculated. Taking a variety of 
clinical criteria into account, as well as commercial criteria is advocated in national level 
purchasing guidance by Category Managers. However respondents reported little 
performance measurement of the ECG monitor by national level buyers, the device not 
currently having a framework agreement at NHS PASA or Supply Chain. 
 
Financial performance measures are also important to the supplier, especially sales and 
profitability of the product as a one-product company. Production costs are measured, in 
particular the supplier has produced an economic model of the changes to the care pathway 
and associated costs that the ECG monitor could cause. The claims made as part of this 
model caused the NHS to measure the financial performance of the product by creating 
their own model, as described above. 
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Communication occurred between customer and supplier as part of purchasing and 
supplying as well as evaluating the product. The GP Surgery where respondents that were 
interviewed had purchased their ECG monitor when the product was very new to the 
market and the first of its kind, respondents stating that there was very little performance 
measurement data available. The supplier visited the GP Surgery to demonstrate the ECG 
monitor and the GP consulted a Cardiologist colleague in the local hospital for his opinion 
of the product, also wearing the ECG monitor himself for a 24-hour period. Users are also 
involved in performance measurement by the supplier, testing the product twice during 
development. 
 
Performance Management 
As well as performance measurement processes, some broader performance management 
processes were described by respondents in the ECG monitor case, involving 
dissemination of information, purchasing and supply and improving the product. 
 
The performance measurement data from the evaluation centre evaluation has been 
disseminated, mainly through publication of the evaluation report for CEP. The evaluation 
centre involved was prepared to be prescriptive about product performance unlike many 
others, advising clinicians and purchasers on suitable products to buy when asked, as well 
as producing more conclusive reports than other centres. Also, the evaluation centre 
regularly publishes review issues of products in the ECG monitoring field. The supplier 
has tried many ways to publicise the product, including as a case in the HITF report for 
example (HITF 2004 pp14). Also, the supplier has distributed information about the 
product and performance claims over a wide audience, such as at academic seminars, in 
journal publications (Standing et al. 2001), as well as sending audit data to the MHRA. As 
described above, NHS PASA or Supply Chain Category staff provide purchasing advice. 
 
The supplier has also used processes to manage sales of the ECG monitor. The supplier has 
introduced a ‘try before you buy’ scheme, allowing GPs in practice, who make the decision 
to buy the product or not, to use the ECG monitor free for 30 days before having to make a 
decision. A business case for GPs has been produced by the supplier and interview 
respondents stated that their GP surgery was given an early ECG monitor free by the 
supplier in return for feedback for developing the product. Once the ECG monitor has been 
purchased, the supplier offers training for clinicians in its use and calibrates the product. 
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In addition to sorting out teething problems experienced by the GP surgery, the supplier 
has continued to innovate the product, changing several design features. A Corrective and 
Preventative Action (CAPA) system is used, as part of the ISO9000 compliance. The 
system involves logging and categorizing customer complaints in files, enabling areas 
where product improvement is required to be flagged up. In response to information from 
the CAPA system and feedback from users, the supplier has re-designed aspects of the 
product such as the battery and electrode systems, permanently changing the design of 
subsequent products supplied. Also, the supplier annually recalibrates the device as 
described above, with the aim of ensuring ongoing technical performance. 
 
5.5.3. Influence on Performance 
This section reports on the influence of performance measurement and performance 
management processes as described by respondents. As in previous cases, Table 27 gives a 
summary, based upon an effects matrix shown in Appendix O. 
 
Many of the influences described were to do with whether the ECG monitor was purchased 
or not, giving the customer the healthcare benefits of either the device and a new care 
pathway or their existing care pathway, and giving the supplier revenue or not from sales. 
Almost all respondents described this influence, referring to a variety of performance 
measurement and performance management processes. Performance measurement 
processes having this influence included communication about the device between the GP 
buyer and supplier, the GP calling a cardiologist colleague to learn more about the device 
and also testing the device upon himself in a 24 hour period and the supplier carrying out a 
clinical trial and other technical performance measurement. Also the Evaluation Centre 
carried out a technical evaluation with the purpose of influencing whether the product was 
purchased or not: “The purpose of our evaluation is to help the health service decide 
whether it wants to buy it or not. Quite frankly I don’t really care whether a particular 
manufacturer benefits or not.” (Director, Evaluation Centre General Medical Devices). 
 
As for performance management processes, the GP on a local level in the NHS makes a 
decision based upon the information gathered to purchase the product, for example: “Yes I 
did [look at information from the supplier], they have quite a hard sell and we fall into it, 
and I can say that I never regret that, it’s a very good tool for diagnostic…no doubt of it.” 
(GP, GP Surgery). Performance management processes that may have an influence on the 
customer making the decision to purchase the product or not include the supplier’s try 
before you buy scheme resulting in 90% subsequent sales, the supplier giving GPs a 
 129
business case to win funding from PCTs, and other dissemination of performance data by 
the supplier in journals and Evaluation Centre in reports. Respondents described how sales 
have been low so far, some suggesting that the supplier’s evidence is not believed by 
clinician buyers, while the supplier suggested that NHS funding sources were to blame. 
 
Influence Type Researcher Explanation 
Product is purchased or not 
 
+/- 
F/C 
The decision to purchase the product or not on the basis of 
performance measurement information gives the supplier sales 
or not and the customer the benefit of a product that performs 
best for healthcare by offering a new care pathway, or 
remaining with the existing pathway if better.  
So far sales have been low. 
Product design improved 
 
+ 
T 
The latest ECG Monitor comes with improved battery life, 
ability to interface with NHS patient records and automated 
connectivity checking to ensure electrodes are attached. 
Suppliers get better by evolution after technical evaluation. 
Teething problems also sorted by the supplier 
Performance measurement 
information not used in the 
purchasing decision 
 
None Information from the technical evaluation is not always used 
in the purchasing decision. Product well publicised but not 
bought. Easy for supplier to get overburdened with 
measurement procedures that do not add value. 
Feedback to the supplier is not 
used 
None The supplier ignores or does not use technical evaluation data 
as it is not dynamic. 
Product can be purchased or 
not for short-term, cost based 
rather than broader reasons 
 
- 
F/T/C 
The product is bought or not in a decision made on the basis of 
cost performance measurement information with a short term 
view. Evidence of broader aspects of performance is not used 
proactively or integrated back to buyers, hindering uptake. 
Budget silos. Difficult for supplier to cost training at varied 
local level. 
Supplier shows concern over 
performance measurement 
 
* 
+/- 
F 
Evaluation data is of interest to competitors. Evaluation Centre 
conclusions were not acceptable to supplier. 
Supplier ensures product 
performs to their specification 
& regulations, as it will be tested 
and then purchased or not 
+ 
T 
Performance measurement processes mean that the supplier 
knows the meter must perform to regulations, as policed by a 
notified body -  ISO13485, MDD (42/93/EU). 
Table 27. Summary of Influences Identified in the ECG Monitor Case 
(KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial 
performance, ‘T’ is an influence on Technical performance and ‘C’ is an influence on Customer performance 
(After Griffin & Page 1996). ‘None’ means there is no influence on performance. ‘*’ denotes an influence 
inferred by researcher rather than specifically described by respondent). 
 
The evaluation report by the Evaluation Centre did not show the ECG monitor in a 
favourable light, stating that the evaluation centre does not support purchase of the ECG 
monitor as a replacement for existing technologies and care pathways following 
performance measurement, that it could only supplement them. No respondents in the case 
described using the report from the Evaluation Centre in deciding whether to purchase the 
ECG monitor or not, however the lack of favourable information about the performance of 
the ECG monitor and the concerns of the supplier about publication of the report suggest 
that it will not have a beneficial effect on sales. 
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Further, the influences of the supplier and Evaluation Centre in both trying to affect the 
results of the evaluation, trying to manage performance suggest that respondents believe 
the processes have a performance implication.  
 
The supplier and Evaluation Centre disagreed over the wording of the evaluation report. 
The supplier did not accept the results of the technical evaluation and also requested 
different wording in the report: “The conclusions that we reached weren’t entirely 
acceptable to [the Supplier].” (Director, Evaluation Centre General Medical Devices). 
Indeed there was a lot of debate between the organisations: “…so there was a lot of debate, 
you can imagine, between us, CEP central and the company” (Director, Evaluation Centre 
General Medical Devices). The supplier complained at the short-term view taken by the 
evaluation, stating that current evaluation protocols do not allow opportunity for product 
issues identified and inherent in any innovative product in evaluation to be rectified. The 
evaluator could not reproduce all the performance measurement claims made by the 
supplier from their own evaluation. An example is the claim that the device could change 
the care pathway for patients presenting with symptoms that could be caused by 
arrhythmia due to a lack of information on false negative results provided by the ECG 
monitor, which were not measured in many trials by the supplier: “We provided everything 
that we’d got, they then said but we need more information and we don’t have that type of 
information. The trials were never run to their standards, because they introduced some 
interesting approaches to trials which we’d never seen before in our lives.” (Chief 
Technology Officer, ECG Monitor Supplier). Also the supplier and evaluation centre used 
different economic models: “We put an economic analysis together showing the costs of 
doing our tests compared with common practice, but they introduced a Markov model 
which said well these are all the possible ways in which you can do things…” (Chief 
Technology Officer, ECG Monitor Supplier). 
 
There was also the suggestion that the supplier had tried to market the device as a tool for 
improved diagnosis, however the performance measurement data suggested that the 
supplier would have more justification and success in marketing the device as a speed of 
referral tool, according to a respondent at PASA. The comments show the influence of 
performance measurement data on informing purchasing decision-makers about the 
product. 
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Further to the influence of processes in purchasing decision-making as described above, 
respondents in this case again discussed how information from performance measurement 
is not always used in purchasing decisions, or that decisions are only made for short-term, 
cost based reasons on the basis of limited information. As in previous cases, some 
respondents described how technical evaluation data was not used in purchasing decisions. 
The supplier stated that the technical evaluation reports are no use to purchasers, as they 
are not updated to reflect frequent changes to an innovative product. Additionally, the 
Evaluation Centre respondent also described how the supplier was not prepared to use the 
evaluation report. NHS national level respondents commented that despite lots of publicity 
of the product, it was not bought, suggesting that performance measurement information 
was not used. Mainly national level NHS respondents referred to NHS actors making 
purchasing decisions for short-term, cost based reasons, where broader evidence of product 
value is not taken into account by purchasing decision makers. The supplier also discussed 
the focus on cost, describing the challenge of costing product training where needs vary so 
much at the local level. 
 
Other influences to do with purchasing of the device were also described. Respondents 
reported how performance measurement ensures compliance of the product with rules and 
regulations which enables sales, and that the supplier knows the product must perform to 
those regulations and declared specifications. Supplier respondents described how 
technical information is kept and audited by an approved external body to ensure 
compliance with necessary ISO standards and European regulations. 
 
A key influence described a high number of times by several respondents was the influence 
of the processes in improving the design of the product. Respondents from the supplier and 
the customer on both the local and national levels described how feedback to the supplier 
following the various trials and communications with users highlighted issues with the 
ECG monitor which were then improved in re-innovation, permanently changing the 
design of the product. The supplier’s CAPA system was key to gathering feedback and 
triggering design changes. For example, users found that the ECG monitor had heavy 
battery usage and that the electrode pads attaching to the patient could come adrift, 
stopping the product from working. These issues were picked up by the CAPA system, as 
well as the Evaluation Centre report in the example of the batteries and the battery usage of 
the ECG monitor was reduced. The latest versions of the monitor have also been 
redesigned to automatically check for electrical connectivity through the electrode pads, so 
the user may tell if they are properly secured. 
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When asked about the influence of performance measurement and performance 
management, respondents made a number of comments. The Chief Technology Officer at 
the supplier stated that, on the one hand, measurement is an essential part of evolution and 
product innovation, helping the company change or die: “Yes, it [performance 
measurement and performance management]’s essential to strive to improve the product’s 
performance.” (Chief Technology Officer, ECG Monitor Supplier). On the other hand he 
commented that measurement is a cost and must add value to be worthwhile. 
 
5.5.4. Summary from the ECG Monitor Case 
The ECG monitor is a product containing novel neural network technology found in no 
other competing product. A company has been set up specifically to exploit the product 
and it is used in healthcare settings for diagnosis, so being both exploited and novel it is an 
innovative product. Findings from the case are illustrated in Figure 19. 
 
Technical and financial evaluations or clinical trials were carried out by both the supplier 
and Evaluation Centre, as the product has only been implemented in the market fairly 
recently. There was some disagreement over methods and results. Informal consultation of 
colleagues and self-testing the product by the GP buying decision-maker was found, in 
addition to considering product information given by the supplier, who also assessed 
customer performance.  
 
Performance management processes involved producing reports and dissemination of 
information from performance measurement as in the other cases, however in this instance 
the Evaluation Centre were prepared to offer prescriptive advice on the performance of the 
product. The supplier used a CAPA system for flagging up design issues, triggering a 
product re-design, a free product given to the GP Surgery in return for feedback on the 
performance of the product, while initiatives such as ‘try before you buy’ are used to try 
and encourage sales by customers trialling products themselves and making purchasing 
decisions.
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Figure 19. Conceptual Framework Illustrated with Findings of the ECG Monitor Case 
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Respondents discussed a number of influences of performance measurement and 
management processes, concerning their influence on the ECG monitor being adopted or 
rejected, as well as in making design improvements. Respondents described the influence 
of performance measurement and management processes on the outcome of purchasing 
and supply decisions and improving product design, but also in a less direct way of 
encouraging the supplier to ensure the ECG monitor meets necessary regulations to sell the 
product in the market. Further, a key feature of the case was that the supplier and 
Evaluation Centre were both found to be competitive about the processes, implying an 
influence. 
 
In summary, the case highlights issues of measuring and managing the performance of a 
largely unproven innovative product. It also displays the differences between customer and 
supplier in the processes used and outputs. Overall, it reinforces the suggestions of the 
previous cases that not only performance measurement processes but more proactive 
performance management processes are required if they are to influence performance, 
whether for the better or worse. 
 
5.6. Standing Frame 
 
5.6.1. Introduction and Background to the Standing Frame Case 
Respondents to the interviews in the Standing Frame case are shown in Table 28 and in 
more detail in the appendices, where a matrix displays the findings from the interviews for 
this case and frequencies of codes used in HyperResearch are also shown. 
 
The final case studied the standing frame, a medical device designed to assist children with 
a range of disabilities to gain or maintain standing postural position. The frame consists of 
a tubular metal frame, wheels, supports and pads for the child and various features to 
adjust the frame to fit the child and the child within the frame when in use. The frame has 
cross and chest girths to secure the child into it and a range of optional extras for support 
and operation are available. It is available in three sizes and can be tailored to the needs of 
the individual child. Standing frames are used in clinical home and other settings, such as 
special schools. The standing frame supplier is one of over 70 in the UK market. Fairly few 
standing frames are bought by the NHS per annum and the cost of the product studied here 
is usually between £1500 and £2500 per unit. 
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Respondent (Job Role) Organization Type of Stakeholder Role 
Research Director Evaluation Centre, Assistive 
Technology 
Customer. Influencer (national 
level) 
Centre Manager Evaluation Centre, Assistive 
Technology 
Customer. Influencer (national 
level) 
Centre Manager / Occupational 
Therapist 
Evaluation Centre, Assistive 
Technology / University 
Customer. Influencer (national 
level) / User, Buyer, Decider 
(local level) 
Lead Category Manager, 
Assistive Technology, Special 
Projects 
NHS PASA & DoH Customer. Buyer, Influencer 
(national level) 
Category Specialist, Mobility & 
Telecare 
NHS PASA Customer. Buyer, Influencer 
(national level) 
Paediatric Physiotherapist Hospital NHS Foundation Trust Customer. User, Buyer, Decider 
(local level) 
Paediatric Physiotherapist Primary Care Trust Customer. User, Buyer, Decider 
(local level) 
Physiotherapist Primary Care Trust 2 Customer. User, Buyer, Decider 
(local level) 
Managing Director Standing Frame Supplier Supplier (national level) 
Director General British Health Trades 
Association 
Supplier Industry Body 
(national level) 
Chairman of Seating & 
Positioning Division 
British Health Trades 
Association 
Supplier Industry Body 
(national level) 
Respondents Interviewed for all Cases 
Policy and Innovation Director NHS PASA Customer. Influencer (national 
level) 
Senior Collaborative 
Development Manager 
NHS PASA Customer. Influencer (national 
level) 
Head of R&D NHS PASA Customer. Influencer (national 
level) 
Senior Manager for Technology 
Introduction 
NHS Institute for Innovation 
and Improvement 
Customer. Influencer (national 
level) 
Table 28. Interview Respondents in the Standing Frame Case 
 
The standing frame in this case is considered to be technologically innovative as it is 
commercially exploited by the supplier and has features that are novel to the market, such 
as the ability to adjust the frame between prone and supine positions using an electric hand 
control. These features represent incremental design improvements. Therapists also 
described novel features of the Frame as including two different split knee blocks for 
improved adjustment and the tilt table type frame, which enables a larger child to be 
hoisted into the frame. 
 
The network picture in Figure 20 shows the main actors and flows between them, 
identified by respondents in the case. 
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Figure 20. Network Picture for the Standing Frame Case 
 
Actors at the local level such as therapists and parents make decisions about whether to 
purchase the standing frame for either a particular child, or a group of children attending a 
special school for example. The supplier has a team of field based sales representatives 
who visit potential purchasers in Trusts with the products. On the regional and national 
levels, the collaborative procurement hubs, NHS Supply Chain and PASA are active in 
buying assistive technology products, however there are currently no national framework 
contracts for the standing frame and no purchases have been made, although actors have 
information about products. 
 
Other actors in the network who influence the implementation of the product include the 
British Healthcare Trades Association (BHTA), an industry body representing the interests 
of the supplier and others in two-way communication with the customer. Community 
Equipment Service Provision also provides the frame, care and assistive technology 
products at the local level, being commissioned by Trust actors. The National Association 
of Equipment Providers is an association representing actors involved in community 
equipment provision. 
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5.6.2. Performance Measurement and Performance Management 
Performance measurement and performance management processes described by the 
interview respondents are described in this section, under the following two sub-headings. 
 
Performance Measurement 
Technical evaluation also occurred in the standing frame case, where the Evaluation Centre 
carried out a comprehensive technical evaluation of standing frames, including the frame 
studied here, on behalf of CEP. The standing frame was evaluated as part of a group 
evaluation of frames suitable for children (Daniels et al. 2004) in which the features of 
frames were evaluated, rather than the frames themselves, so although the group evaluation 
featured a number of frames, it was not a comparative test. Evaluation centre respondents 
stressed this approach is important in the assistive technology field where the performance 
of a product depends upon the particular patient who uses it and the particular use to which 
they put it: “I couldn’t say that, it will never be, we will never be comfortable with a 
Which? Guide where it says that the [standing frame] size 3 is the best...it isn’t that simple 
unfortunately.” (Research Director, Evaluation Centre). A literature review was then 
carried out, a product sample was borrowed from the supplier and a multi-disciplinary 
technical assessment was carried out according to the requirements of a standing frame. 
This takes the form of physical tests on support of various parts of the body, 
manoeuvrability, stability, storage and aesthetics. Technical performance measures on 
product parameters such as stability are also used by the supplier as part of research and 
development of the product. The supplier gathers clinical evidence of the benefits of 
standing with products such as their own frame. 
 
To carry out the technical evaluation by the Evaluation Centre, a consultation group of 
stakeholders was convened who developed an evaluation protocol through consultation to 
determine what the market needs are for a standing frame. Indeed the methodology used 
was multi-disciplinary and also involved measuring aspects of customer performance. The 
‘QUEST’ method of determining user satisfaction was used, as well as in user diaries that 
were used as a performance measurement methodology. Customer performance 
information is also gathered by supplier sales representatives working in the field with 
children and clinicians. 
 
Another process discussed by many respondents concerned clinicians measuring customer 
performance of the standing frame at the local level. Users at the local level such as 
physiotherapists measure the performance of the frame for the needs of a particular child, 
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by helping the child to try out the frame, often with the help of a supplier representative 
and often with another couple of competing products. The assessment is subjective rather 
than objective, for example the therapist will look at the alignment of the child in the frame 
and will largely be able to tell from experience whether it is correct or not: “They [aspects 
of performance of the standing frame for a particular child]’re mostly subjectively 
assessed, because an assessment isn’t really long enough to know for certain about any of 
these things or to measure them really, but you are just simply looking at, how does that 
look…we are just simply looking at do they look better in this standing frame or that 
standing frame.” (Physiotherapist, Primary Care Trust 2). Assessing comfort could involve 
talking to the child, or if the child has difficulty communicating, measures such as their 
temperature, facial expression and vocalisation are observed. Established measurement 
tools and scales are used, such as a goniometer for assessing angles and the Waterlow 
Scale for assessing pressure sore risk. The ability to use the product for more than one 
child is also important to many users, so adjustability is a key aspect of customer 
performance measured. As part of the assessment the therapist may also look at patient x-
rays for example, which while not strictly a performance measure of the frame as a 
product, is a part of determining its performance for the child in question. Additional 
measurement tools include digital photography to record the fit of the frame for a particular 
child. 
 
Therapists stated that they get to know supplier sales representatives as they exchange 
information and the representatives pay visits when the frame is assessed. The supplier 
sales representatives work with therapists, who described them as supportive and driven by 
the need to get the best product for the child in question, sometimes even concluding that it 
is not an appropriate product, despite missing out on a sales opportunity as a result: “We’ve 
got a good working relationship, but I don’t think they’re in your face, and the other thing 
about [the supplier] which I like as a company is that if the product does not work for the 
child, they will not sell it.” (Paediatric Physiotherapist, Hospital NHS Foundation Trust). 
 
A number of sales and profitability of the product line are recorded by the supplier. 
However, financial performance measures were not used in the Evaluation Centre 
evaluation other than noting the product price in the report, once performance 
measurement had taken place. National level actors in NHS PASA and NHS Supply Chain 
focus on financial performance measures, especially cost. 
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Performance Management 
In addition to the performance measurement processes, broader or follow up performance 
management processes were identified by respondents in the case. 
 
Many performance management processes involve disseminating performance information 
from measurement. The evaluation centre are not prescriptive on the basis of their 
evaluation and do not recommend or otherwise any products in particular. However a 
number of reports on the evaluation are issued to CEP, through whom they are made 
available to other customer or supplier actors. There is a main evaluation report (Daniels et 
al. 2004 pp5-6), a lay summary and a number of published articles (Daniels et al. 2005) in 
both double-refereed academic and professional journals. Further methods of 
dissemination of information include conference presentations and training and 
development programmes for clinicians and users. Participants in the evaluation study are 
asked what kind of feedback they would like and suppliers are asked for written feedback, 
which is then published in the main evaluation report. In addition to the evaluation reports, 
a number of performance management tools are provided by the evaluation centre to 
enable other customer actors to determine whether the standing frame or other competing 
products are the most appropriate for their needs. This includes a comprehensive website 
with an online database that is searchable for frame features and then links through to the 
appropriate standing frames. Recent advances to this database have included a funding 
algorithm and a decision tree. 
 
Another performance management process involving dissemination of information that 
was described in this case, as in the previous ones, was national level NHS actors issuing 
advice and guidance to purchasers. Category Managers and Specialists in NHS PASA or 
Supply Chain pointed out how they issue information such as template documentation. 
These respondents also described how information from performance measurement of the 
product against standards and regulations is checked to ensure assistive technology 
products such as the standing frame are suitable for purchase. For example, the presence of 
a CE mark is checked before a purchase can take place. 
 
Purchasing the standing frame also heavily involves performance management processes. 
As for therapists, assessing the suitability of the Standing Frame for a particular child is 
part of not only a performance measurement process but one of managing performance as 
well, as the standing frame is adjusted to tailor the product to the needs of the child. 
Therapists consult with other colleagues, clinicians, carers and the children themselves, 
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following making their own assessment, to determine the best standing frame for a 
particular child. Supplier products and catalogues as well as outputs from the Evaluation 
Centre are also kept in hospital departments for reference. In addition to these performance 
management processes of purchasing and supply decision-making, therapists also 
discussed the broader processes involved in ensuring the product is purchased. Therapists, 
special school staff and other users have used performance measurement data to create 
funding justification documents, with information from the supplier. For example, one 
physiotherapist, having decided on the most suitable standing frame, will approach the 
relevant hospital consultant for funding with evidence of the effectiveness of the frame for 
the child: “What happens within this department is you approach the consultant for some 
money for a standing frame…” (Paediatric Physiotherapist, Hospital NHS Foundation 
Trust). 
 
Feedback occurs during the communication and visits between supplier representatives and 
clinicians. Supplier staff have a weekly meeting to discuss the feedback gathered from 
users as described above, also discussing possible product changes. Many respondents 
stated that the supplier has modified the frame following user feedback, such as by 
introducing the electric tilt control and split knee blocks. Further, the supplier has 
customised the product for individual users following attending user assessments with the 
physiotherapist and a particular child, for example one physiotherapist stated how a 
customised head support had been sourced by the sales representative. In addition, the 
supplier operates product training and support through their network of sales 
representatives, to ensure that the users of the frame operate it correctly for their needs. 
 
5.6.3. Influence on Performance 
This section reports on the influence of performance measurement and performance 
management processes as described by respondents. A summary is shown in Table 29 
based on an effects matrix in Appendix R, as used in the previous cases. 
 
Many respondents described the influence of performance measurement and management 
in whether the standing frame was purchased or not, discussing how therapists are 
influenced to choose the standing frame or a competitor product and use information to 
justify funding for the frame once that choice has been made. The main processes that 
therapists described as having this influence were the subjective assessment and decision 
making about how suitable the frame was for the needs of a particular child. However a 
focus on cost, rather than broader aspects of performance, by purchasing decision makers 
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on the national level of the NHS was discussed by several respondents. Some described 
how standing frames are viewed as commodity products, whereas therapists discussed how 
they can have selected the frame that performs best for a particular child, only to be 
refused funding to purchase it. 
 
Influence Type Researcher Explanation 
Product is purchased or not 
 
+/- The decision to purchase the product or not on the basis of 
performance measurement information gives the supplier sales 
or not and the customer the benefit of a product that performs 
best for healthcare by offering a new care pathway.  
So far sales have been low. 
The best product for the needs 
of the user is purchased 
 
+ The performance information used and the process of making 
the purchasing decision gives a particular child the best 
standing frame for their individual needs.  
Product meets needs of 
individual user as it has been 
customised with special features 
for the particular purchase 
+ Supplier customises the frame with features such as alternative 
headrests and straps to tailor it to meet the needs of a 
particular child. 
Product can be purchased or 
not for short-term, cost based 
rather than broader reasons 
 
- The product is bought or not in a decision made on the basis of 
cost performance measurement information with a short term 
view. Evidence of broader aspects of performance is not used 
proactively or integrated back to buyers. 
Information not used in the 
purchasing decision 
 
None Information from performance measurement and management 
processes is not used in the purchasing decision. The product 
may be bought for all sorts of reasons other than on the basis 
of performance measurement information. Technical 
evaluation outputs may be late, not prescriptive enough. 
Assessing the frame for children’s diverse and changing needs 
is challenging. 
Product design improved 
 
+ The design of the standing frame has been permanently 
improved, for example through new split knee blocks in 
response to user feedback. 
Feedback to the supplier is not 
used 
 
None If feedback of performance measurement information to the 
supplier is not used proactively, it will not have an influence 
on performance. 
Compliance with use of the 
product is needed 
 
None If the standing frame is to perform for a child and be effective 
in aiding their health, it must be used once purchased.  
Training is necessary for patient 
to gain benefits of product use 
 
+ Training of users is important if the standing frame is to be 
used correctly and the child is to gain the healthcare benefits 
of using the frame. 
Supplier ensures product 
performs to their specification 
& regulations, as it will be tested 
and then purchased or not 
+ Checking performance against regulations mean that the 
supplier know and ensure that the product must meet a certain 
standard. Evaluation by the customer encourages the supplier 
to ensure the frame performs as they claim. 
Supplier shows concern over 
performance measurement 
 
* 
+/- 
Suppliers show concern that performance measurement data 
will affect their competitive position or sales. Supplier use 
evaluation information to make their product more competitive 
compared to others 
Technical evaluation raises the profile of assistive technology 
and organisations involved. 
Table 29. Summary of Influences Identified in the Standing Frame Case 
(KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial 
performance, ‘T’ is an influence on Technical performance and ‘C’ is an influence on Customer performance 
(After Griffin & Page 1996). ‘None’ means there is no influence on performance. ‘*’ denotes an influence 
inferred by researcher rather than specifically described by respondent). 
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The challenges of measuring the performance of a specialist product category that 
respondents representing the industry believed should not be treated like a commodity 
were described. Further, the NHS PASA Category Specialist described a 12-month budget 
period over which the books must be balanced, giving the relationship a short-term view: 
“…if their [children’s] needs are actually addressed immediately and to the best of ability, 
obviously there’s potential long-term savings there. Now I appreciate that that in some 
kinds of eyes is perhaps not the way things are actually looked at, because the way that 
budgets are set and everything it needs to be looked on a 12 month period...” (Category 
Specialist, NHS Supply Chain). 
 
Once purchasing had taken place, a point discussed by both Evaluation Centre and 
therapist respondents was that compliance with use of the frame by children and carers is 
essential if the frame is to perform for that child, improving their health. This may involve 
training users. 
 
Respondents had mixed views about the influence of outputs from the evaluation 
conducted by the Evaluation Centre. One therapist who had been involved in the 
evaluation commented that she had changed her clinical practice as a result of the process, 
helping to purchase the most appropriate frame for the needs of a particular child: “…my 
clinical practice changed as a result of the work that I did at [the Evaluation Centre] 
around the questions that I ask the children, personally I got an awful lot out of having 
done that piece of research work, because I’d never done any research previous to that…I 
think I probably don’t make as many assumptions now as I used to.” (Paediatric 
Physiotherapist, Primary Care Trust). Respondents involved in the evaluation also 
commented that it exposed products to them of which they were previously unaware and 
that the evaluation raised the profile of assistive technology patients and products such as 
the standing frame in particular, which are sometimes perceived as a ‘Cinderella’ product. 
 
However another therapist who did not take part in the evaluation suggested the report was 
not used much: “…although we did read that, it wasn’t enormously helpful to us, because I 
think the number of products that we used had evolved since they’d done all the, I mean a 
department somewhere had gone to a lot of lengths doing it, the other thing that it didn’t 
take account of was the individual situation with respect to specific patients…” (Paediatric 
Physiotherapist, Hospital NHS Foundation Trust). Other physiotherapists were not aware 
of the evaluation centre report, so could not use any of the performance measurement 
information in their decision-making on purchasing and finding a suitable product for the 
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child. A respondent at the supplier suggested that the evaluation outputs were no use as 
they were not prepared to be prescriptive: “…it was disappointing in the way that we were 
all hoping for much more definitive conclusions to come out of the study, for both what we 
call prone and supine standing…while they came to some conclusions they finished it off 
by saying it was inconclusive which really negated the whole exercise.” (Managing 
Director, Standing Frame Supplier). Again, the post change programme outputs from CEP 
and the Evaluation Centres are intended to be more prescriptive, however the findings here 
refer to the outputs available at the time of the cross-sectional study. Overall respondents 
also stated that performance measurement could have an effect on purchasing and supply 
decision making to adopt the product: “It can have a very dramatic effect on sales, good 
and bad.” (Chairman of Seating & Positioning Division, BHTA). 
 
In addition to the processes of assessing the suitability of the frame for a particular child 
and then making a decision on the basis of the assessment, the supplier and therapists have 
made other technical changes to the design of the frame. Two dedicated staff at the 
supplier and a system for customer feedback are involved, including meetings between 
R&D and marketing staff to review and prioritise feedback at the supplier’s head office. 
For example, feedback from representatives and as part of the technical evaluation process 
has resulted in a new split knee block being added to the frame in response to user wishes. 
Other respondents commented how feedback must be used for the information involved to 
have an influence on performance, for example by making design changes, reinforcing the 
previous point. 
 
On a related note, the process of the supplier CE marking the Standing Frame, as well as 
any associated regulatory reporting processes was described as important to ensure 
production of products that perform well and to meet performance claims and regulations: 
“The CE marking procedure and the issue you have in terms of reporting, particularly of, 
obviously accidents or anything of that nature, or failures, product failures are vital to the 
industry as a sector to make sure it gets right.” (Director General, BHTA). 
 
As well as describing an influence in changing the design of the product, respondents also 
discussed how the standing frame is modified for individual users on a sale by sale basis. 
Therapists gave examples of the supplier customising the frame by using alternative 
headrests and straps, making the product more appropriate for the needs of a particular 
child: “They [the supplier]’ve certainly done one off alterations to things, I’ve had different 
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straps made for particular children, some different types of head support…” (Paediatric 
Physiotherapist, Primary Care Trust). 
 
As in previous cases, respondents from the supplier and evaluation centre described how 
the supplier takes an interest in the results of the technical evaluation for example, being 
concerned how this affects the competitive position of their product, such as in the above 
quotes from the BHTA respondents. Additionally, respondents involved in the technical 
evaluation described how it had raised the profile of the Trusts involved and assistive 
technology in general, as described above. 
 
5.6.4. Summary from the Standing Frame Case 
Findings from the case are illustrated in Figure 21. The standing frame case studies a 
medical device with novel features, such as the design of the knee blocks and electric 
control, which is exploited for profit by the supplier and for benefiting the health of 
children with a range of disabilities. As with other cases, most interaction and purchasing 
and supply decision making occurs on the local level, though respondents described a large 
range of organisations involved in implementation of the standing frame. 
 
Performance measurement of the standing frame occurs at the local level, where therapists 
try out the suitability of the product for individual children in a subjective manner with 
information and visits from the supplier. The assessment is driven by the unique nature of 
every patient case and child’s needs and focuses on customer and technical performance. 
This issue also drove measurement of technical and customer aspects of performance on a 
national level by the Evaluation Centre. Financial performance of the frame was measured 
on the national level, focusing on cost. 
 
Performance management processes were also described by respondents, such as the 
purchasing and supply decision making process and the adjustment of the standing frame 
by therapists and supplier representatives to fit a particular child, as well as longer term 
modifications to the product, such as the new split knee block. Performance management 
processes also included the preparation and dissemination of outputs from performance 
measurement. 
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ROLE IN PERFORMANCE
Role in financial performance: 
Frame bought or not, is compliant 
with regulations. However short-
term reasons, cost influence 
buying as well as measurement 
outputs. Suppliers sensitive to 
evaluation.
Role in technical performance: 
Design improved with split knee 
block. Feedback must be used if 
technical changes are to be 
made. Mixed report use, may be 
late, inconclusive. 
Role in customer performance: 
Frame that is most appropriate for 
a particular child is bought. 
Compliance in use needed if 
product is to perform for user.
PERFORMANCE 
MANAGEMENT 
PROCESSES
Information Dissemination: 
Evaluation Centre publications, 
database tool, feedback to 
supplier, national level advice to 
buyers.
Purchasing: Therapist makes 
buying decision.
Product innovation: Product 
design changed by supplier with 
new split knee blocks. Supplier 
tailors frame to individual child, by 
adding head rest, straps for 
example.
PERFORMANCE MEASUREMENT 
PROCESSES
Financial: Cost and budget are 
assessed on national level.
Technical: Technical evaluation by 
Evaluation Centre, also including user 
evaluation. Evidence of clinical benefits 
is scarce and being investigated.
Customer:  Therapists assess suitability 
of frame for individual child, a mainly 
subjective process. Supplier reps visit 
clinicians with product to try it out for a 
particular child. Communication between 
actors.
Innovative 
Product 
PERFORMANCE
Thesis focus
 
Figure 21. Conceptual Framework Illustrated with Findings of the Standing Frame Case 
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Influences of the performance measurement and performance management processes on 
performance of the standing frame include a beneficial or non-beneficial effect on sales, as 
well as technical improvements that were made to the product at various stages of 
implementation of the innovation. For the frame to perform well for the user, the influence 
of purchasing decision making in ensuring the most appropriate product for the particular 
child’s needs and ensuring compliance with use were described. Respondents also 
described a number of processes with influences that are involved with the other influences 
above, such as the influence of a funding justification letter or ensuring that the frame 
meets supplier’s claims in purchasing the frame. As in previous cases, the roles suggested 
by respondents highlight that not only performance measurement but also more proactive 
performance management processes are involved if there is to be an influence on 
performance of the standing frame. While influences of performance measurement 
processes were described, such as the technical evaluation opening the eyes of a therapist 
to new products, additional performance management processes would be required for an 
influence on performance to occur, such as the clinician procuring the product as a result. 
 
The final section of this chapter briefly draws together a summary from all four case 
studies. 
 
5.7. Summary from the Four Case Studies 
This chapter has reported findings from the four empirical case studies. Four different 
innovative products were described, all of which have a novel feature and were exploited 
by customer and supplier actors in some manner.  
 
All the innovative products were implemented in a network of supply relationships, in 
particular between the supplier and NHS as customer. A broad variety of organisations and 
actors were described in all four cases. The interaction between many actors includes 
exchange of information about the products and social exchange. Purchasing and supply 
decision-making to adopt the product mainly occurs by actors on a local level in Trusts at 
the current time, however national level actors and organisations are also involved. 
Purchasing decision-making leads to exchange of the product and finance. 
 
The cases highlighted that a broad range of performance measurement processes occur. 
Actors measured financial, technical and customer aspects of the performance of the 
products, with some actors often focussing on one or two of these. The processes 
particularly occur at the point of purchasing and supply by the end customer, though also at 
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other times throughout the implementation of the innovative product. They are variously 
objective, formal and regulation driven such as technical evaluations or clinical trials, or 
subjective, informal and user driven, frequently involving social and informational 
exchange between local level actors.  
 
Respondents in the cases also discussed a broad range of performance management 
processes that follow up or are additional, broader processes than the performance 
measurement processes described. All cases discussed disseminating information from 
performance measurement and showed how the design of the product has been 
permanently changed following performance measurement. Respondents in all cases 
described making the decision of whether to purchase the product or not, possibly against 
another competing product. The particular nature of many of the broad processes 
sometimes differed by case, for example making the purchasing decision involved a formal 
tender process in committee as in the CT scanner case, or alternatively subjective decision 
making by individual clinicians, as in the standing frame case. 
 
Respondents described a number of influences of the performance measurement and 
management processes, such as in the outcome of the purchasing decision and changing 
the design of the product permanently. On a similar theme, processes were also described 
as having an influence in purchasing the best product for a particular customer and in the 
product being purchased or not for short-term, cost based reasons. Influences were also 
described with respect to compliance with product use, training, feedback and actors 
showing concern over performance measurement results. 
 
Some of these influences were described as having a beneficial or non-beneficial effect, for 
example the use of performance measurement information in purchasing decision-making 
helps buying a product that performs better for the customer and results in sales for the 
supplier, though if the product of another supplier is chosen, then the process will have a 
non-beneficial effect for the supplier of the product studied. A non-beneficial influence 
could occur for both supplier and customer if the decision is made on the basis of cost 
information alone. The cases also showed that some of the processes described by 
respondents may not have had an influence on performance, there being conflicting 
evidence of whether technical evaluation outputs were of use to decision makers or not. 
Also, the importance of using feedback was highlighted if it is to be of use. Respondents in 
the blood glucose meter and standing frame cases highlighted the importance of 
performance management processes of training and use of the product by the patient or 
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clinician if it is to perform for that patient. Additionally a limited body of evidence on the 
effectiveness or performance of these products exists, suggesting limitations to the 
influence of performance measurement and management processes on performance. 
 
Overall, the cases suggest that in comparison to the performance measurement processes, 
more of the performance management processes were described as having an influence on 
performance. This suggests that both performance measurement and performance 
management processes are required if they are to have an influence on performance. 
Especially, the data suggests that those processes described as having a beneficial or non-
beneficial influence involve proactive, decision-making use of information from 
performance measurement processes, by buying and selling or innovating actors. Non-
beneficial influences were described as occurring when only limited use of performance 
measurement information, with a focus on cost, was made in the purchasing decision. The 
customer does not buy a product that performs in a broader way than just being low cost. 
Non-beneficial influences also occurred when the supplier lost sales by the customer 
deciding not to purchase their product, though the customer had the benefit of a competing 
product. In contrast to the influences just assessed, where no influence occurred processes 
involved less proactive use or no use of performance measurement information by buying 
and innovating actors. Again, this suggests that both performance measurement and 
performance management processes are required if they are to influence performance. 
 
Whereas this chapter has reported on the data gathered within each of the four case studies 
separately, the next chapter of the thesis continues by taking a cross-case view of the data 
gathered, before discussion in the light of existing work in the following chapter. 
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CHAPTER SIX: CROSS-CASE FINDINGS 
 
6.1. Introduction 
The previous chapter described the findings from each of the four empirical case studies. 
This chapter continues the thesis by reporting on the findings across the four cases. It 
compares the findings from each case, illustrating similarities and differences between 
them. The headings used to structure this chapter are the same as those used in the 
individual cases and are based on the research questions, which were in turn based on 
concepts in existing work. Key findings from across the cases about the background of the 
innovative products, performance measurement and performance management processes 
are reported. As in the last chapter, processes are differentiated according to their 
definitions in the conceptualisation, concentrating on performance management as being 
broader. Their influences on performance are then reported and several alternative 
groupings of this exploratory data from across the cases are tried. A summary is drawn 
from the cross-case analysis, before the next section of the thesis discusses the findings 
with regard to existing literature and knowledge. 
 
6.2. Introduction and Background to the Innovative Product Cases 
The innovative products in the cases vary in a number of characteristics, including the 
novel features, though they are all exploited by the supplier for financial gain and by the 
NHS for use in healthcare. Key features of the innovative products are summarised in 
Table 30. 
 
All the products have some novel feature and are exploited in some form or another. Novel 
features vary from physical features of the product (standing frame), technologies in the 
product (ECG monitor) to the associated service package (blood glucose meter). The 
products all feature incremental innovations introduced since the original launch, whether 
the development of a new version of the product, or additional features. There are 
differences in how widespread implementation of the product has been, from the blood 
glucose meter which is one of the most popular products in a huge UK market, through to 
the ECG monitor which has currently only been bought by a minority of GP surgeries. The 
unit price of the products varies greatly, highlighting the challenges of evaluating products 
financially given their differing use rates, numbers of patients who could use the product 
and whether they are paid for per use or outright at the time of purchase. The individuality 
of each product is also emphasised by the diversity of care areas and the finding that 
products such as the multi-slice CT scanner can be used across a variety of care areas. All 
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four case study products are innovative, but there are many contrasts between them in level 
of implementation, care areas, cost, application and confidence in the effectiveness of the 
clinical activity that they are involved in. 
 
Product Multi-Slice CT 
Scanner 
Blood Glucose 
Meter 
ECG Monitor Standing Frame 
Novel feature Software package 
enhancements 
compared to 
competitors. 
Gantry angulation 
that enables 
helical head 
scanning. 
workstation 
features. 
Accompanying 
service package 
including DSN 
staffed help lines, 
lifestyle advice, 
training courses. 
Neural network 
technology that 
analyzes and 
classifies heart 
arrhythmia during 
the test  
Standing Frame 
adjustable 
between prone 
and supine 
positions using 
electric hand 
control and tilt 
table type frame. 
Split knee blocks. 
Exploitation Profitable product 
for supplier 
Diagnosis and 
treatment 
planning 
healthcare 
benefits for NHS 
customer. 
Product profitable 
for supplier until 
costs of recall 
were incurred 
Possible improved 
control of the 
disease for 
patients and 
clinicians. 
Company set up 
specifically to 
exploit product 
Faster, cheaper 
patient diagnosis 
in GP Surgery 
setting, claims of 
improved 
accuracy of 
referrals. 
Profitable product 
for supplier, 
claimed physical 
and physiological 
benefits for 
patients. 
Time Product has 
been Launched 
The Scanner is the 
latest version of 
the supplier’s 
multi-slice CT 
scanner, with 
more ‘slices’ and 
package 
enhancements. 
Latest version on 
the market since 
2005. 
Latest version of 
the supplier’s 
blood glucose 
meter, has been 
on the market 
since late 
2005/early 2006 . 
On the market 
since about 2000, 
though upgraded 
versions have 
been produced in 
that time. So far 
bought by a small 
minority of GP 
Surgeries. 
On the market 
since about 1995, 
though has been 
upgraded in that 
time. 150 to 200 
sold per annum. 
Care Areas Many 
applications, 
including trauma, 
cardiac, oncology 
Diabetes Patients 
presenting with 
symptoms of 
cardiac problems 
Assistive 
technology for 
children, range of 
disabilities 
Approximate Cost £500,000 to 
£750,000 
12-17pence per 
strip 
£1,000 to £1,500 £1,500 to £2,500 
Table 30. Key Features of the Innovative Products from the Empirical Cases 
 
A meta-matrix (Miles & Huberman 1984 pp151-167) summarising the findings across the 
four cases was developed from the coded data and can be found in Appendix S. The matrix 
is a conceptually clustered, un-ordered type, the conceptual clusters being based on 
question forming areas of the interview guide, the research questions and the conceptual 
framework, driven in turn by the existing literature. A table in Appendix T also shows 
occurrences of codes used across the four cases, both as a total for the case and for the total 
number of respondents whose accounts were given a particular code. Figure 22 in the 
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conclusion of this chapter shows the conceptual framework illustrated with cross-case 
findings. 
 
The network maps shown in the previous chapter highlight that all the innovative products 
are supplied by a private sector supplier and bought by the NHS as a customer. Purchasing 
and supply decisions about the four products were made at the local level in Trusts, with 
only approval of blood glucose meter strips for inclusion on the NHS drug tariff by the 
PPD and the Pharmacy decision to stock the meter for sale in the blood glucose meter case 
as exceptions.  Purchases of the CT scanner were previously made on the national level, 
but are now made on the local level. Respondents who helped construct the network maps 
also described a number of national and regional level organisations that are, or could be, 
common to all networks. These similarities include the Department of Health (DH), 
Strategic Health Authorities (SHAs), the Purchasing and Supply Agency (PASA), other 
policy setting and implementing organisations such as the Medicines and Healthcare 
Products Regulatory Agency (MHRA), as well as more distant organisations with a policy 
based role in the supply network, such as the Office of Government Commerce (OGC). 
NHS Supply Chain and the Collaborative Procurement Hubs (CPHs) are both new 
organisations acting for the NHS in a buying role on the national and regional levels 
respectively. However the roles of these organisations was unclear to respondents in all 
four cases, given the recent changes in NHS purchasing and continuing uncertainty. NHS 
Supply Chain Category Managers and Specialists offer purchasing advice and guidelines, 
though there was limited use of these at the local level where purchasing decisions were 
being made and none of the four products is available on a national framework contract. 
CEP and the evaluation centres have a role in each case. This is not surprising as the cases 
were initially accessed through the centres, however the fieldwork discovered that the 
centres were widely networked within each case and respondents who were contacted 
independently acknowledged the existence of the centres. Respondents in all cases 
discussed the role of representative bodies, such as the trade associations, the role of which 
was described in the blood glucose meter and standing frame cases, as well as charities 
which are involved with all kinds of stakeholders, such as Diabetes UK in the blood 
glucose meter case. 
 
6.3. Performance Measurement and Performance Management 
This section reports on the similarities and differences in performance measurement and 
performance management processes described by respondents across the four cases, in the 
following two sub-sections. 
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6.3.1. Performance Measurement 
The previous chapter described performance measurement processes in each of the four 
cases, showing similarities between them, as well as a number of contrasts. The cross case 
findings matrix in Appendix S and Figure 22 later in the chapter show the performance 
measurement, as well as performance management processes and their influences. In all 
four cases a variety of performance measurement processes concentrating on a range of 
different types of performance measures were described by respondents. As in the previous 
chapter, this section describes processes that measured key aspects of performance (Griffin 
& Page 1996) and key themes identified empirically, following the analytic process of 
coding and developing matrices. 
 
Financial Performance Measurement Processes 
Cost of the products was measured by actors in all four cases, including all four suppliers, 
involving measures such as sales and profitability of the product line. The ECG monitor 
supplier was the only one who discussed developing an economic model of the 
performance of their product, studying cost savings the product could make for the 
customer by changing care pathways. Cost of the product was also measured by purchasing 
decision-makers from the NHS. Local level decision-makers described checking the cost of 
the product against a budget, however costs were also measured on the national level, 
including trying to ascertain maintenance or lifetime costs in the CT scanner and ECG 
monitor cases. In the blood glucose meter case performance measurement of the cost of 
strips was carried out on the national level by the PPD as part of cost cutting in the 
prescription reimbursement process, where the percentage reduction in strip cost became 
the key measure for negotiation with the supplier. Also on a national level, NHS Supply 
Chain and PASA Category Managers produced purchasing advice, guidance and document 
templates for performance measurement as part of the purchasing process, including 
guidance on measuring product costs (NHS PASA Procurement Guidance pp12-14, NHS 
PASA 2005 pp1-17), though they do not carry out this measurement themselves. 
 
Technical Performance Measurement Processes 
In each case the supplier measures technical aspects of performance of the product as part 
of developing and improving it such as alpha and beta site testing in the CT scanner case, 
though respondents in the ECG monitor case also emphasised that this was driven by the 
need for the product to meet regulatory standards. Also, the ECG monitor was submitted 
for a performance audit by an independent external organisation other than the Evaluation 
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Centre and the supplier carried out a clinical trial in a local Trust studying referral rates. 
The suppliers of the blood glucose meter and ECG monitor also arranged clinical trials for 
their products. In all cases the evaluation centres have measured the technical performance 
of the innovative products focussing on traditional laboratory measures such as accuracy or 
stability for example, though those involved in the blood glucose meter and multi-slice CT 
scanner cases are moving towards producing ‘buyer’s guide’ type outputs based on 
inclusion of more purchasing and economic performance measurement information. The 
evaluation of the standing frame also included some customer, but not financial, 
performance measurement. This evaluation contrasted with the others by measuring the 
performance of product features rather than the product, as part of a multiple-product 
evaluation. Although the products in all cases were innovative and had novel features, all 
except the ECG monitor had their performance measured at the same time as other 
competing products, either in a group evaluation or as part of a purchasing process. 
 
Customer Performance Measurement Processes 
In all cases, customers or users of the innovative products measured various aspects of the 
performance of the product for them as customers. The performance of all the products 
was also assessed by local level social exchange between the customer and supplier, where 
supplier representatives visited the customer to demonstrate the product, or arranged for 
clinicians and users to try using the product on a visit. In the case of the CT scanner, 
clinicians from the purchasing team visited examples of the scanner and competing 
products, and tried examples of the workstation brought to the Trust by the supplier. The 
performance measurement process involved a subjective evaluation of technical and 
consumer aspects of the performance of the CT scanner for them as customers, assessing 
how the product would perform for their particular clinical interests in the Trust. Individual 
actors would often become well known to each other and develop a long-term relationship. 
In the ECG monitor case, the GP interviewed stated that he had tried the product out on 
himself at the time of purchase. In all four cases, clinicians consulted colleagues about the 
performance of the product, though only in the CT scanner and ECG monitor did this 
involve going outside their own organisation. In the case of the blood glucose meter, DSNs 
additionally described gathering information about the performance of the product from 
industry and patient organisations, such as Diabetes UK. However in all cases 
communication between the supplier and customer occurred to exchange information about 
the performance of the product, this being a key way respondents discussed how they 
assess the performance of the product. A contrast was seen between the cases of the CT 
scanner and ECG monitor and the cases of the blood glucose meter and standing frame, the 
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latter two involving clinicians assessing the appropriateness of the product with particular 
patients for their individual needs, in many different purchasing decisions. The former two 
cases involved clinicians measuring the performance for purchasing a product, which 
would then be used over a longer-period of time with a patient population.  
 
All suppliers also assessed how their own products performed for customers, though the 
ways in which this was done varied. All gathered some kind of feedback from users and 
buyers, often informally and through their sales representatives. The supplier in the blood 
glucose meter case stood out as using many different methods, such as focus groups, a 
third party market research organisation and questionnaire samples to gather softer, quality 
of life aspects of consumer performance. 
 
Actors Measuring Performance by Social and Information Exchange 
Across all four cases, a key finding was that respondents described assessing or measuring 
the performance of the innovative products through social and information exchange 
between actors. Examples mentioned include clinicians calling or visiting colleagues, 
asking for their opinions on the products and social exchange between supplier sales 
representatives and clinicians who were prospective purchasers of the product. 
 
Measuring Performance as Part of the Purchasing Process 
Many of the most prominent examples of performance measurement described by 
respondents involved measuring performance during the purchasing process, with the aim 
of informing decision-making in purchasing. As described above, clinicians and other 
actors with a buying role would assess various aspects of the performance of the product to 
determine whether to purchase it or not, or possibly a rival product on the market, whether 
for a particular patient in the case of the blood glucose meter and standing frame, or for use 
with a variety of patients in the other two cases. Other performance measurement by the 
PPD, and pharmacy for example was also related to decision-making about whether the 
blood glucose meter strips should be available on prescription and therefore purchased by 
the NHS. Overall, much performance measurement occurred with the aim of informing 
decisions about purchasing and supply of the product, rather than ascertaining performance 
of the product once purchase or adoption had taken place as part of the broader 
implementation of the innovation. 
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Use of Both Objective and Subjective Measures 
Across the variety of different aspects of performance measured, use of both hard objective 
measures can be seen, such as measurement of costs, conducting clinical trials and 
customer satisfaction surveys in various cases. However all cases showed softer, subjective 
performance measurement processes where users gathered information about the product 
and communicated with other actors, often in an informal way. 
 
6.3.2. Performance Management 
In addition to similarities and differences in performance measurement processes across 
the four cases, the previous chapter also shows similarities and differences in broader 
(Halachmi 2005, Globerson 1985, Radnor & McGuire 2004, Lebas 1995), or follow-up 
(Globerson 1985, Ellram 1995) performance management processes across the four cases. 
Again these are shown in the cross case matrix in Appendix S, Figure 22 and the code 
frequencies in Appendix T. In addition to these broader or follow-up performance 
management processes, the literature review suggested that performance management 
processes can be defined with respect to performance measurement processes as those that 
have an influence in performance (Bourne et al. 2005, Halachmi 2005) and these are also 
shown. 
 
A variety of performance management processes were found across the four cases, and are 
discussed here in terms of the key concepts identified in the analysis, as in the previous 
chapter. A number are similar to all cases, involving the dissemination of output 
information from the performance measurement process, use of that information in 
purchasing decision-making and product innovation. 
 
Dissemination of Information from Performance Measurement 
Dissemination of information from performance measurement involved report production 
amongst other outputs, feedback to other actors and training. Evaluation centre respondents 
in all four cases described how output information from technical evaluations was used in 
producing reports and other outputs, however the nature of these reports and other outputs 
varies between cases. In all cases except the standing frame, data from the suppliers was 
compared with data obtained in the centre’s own performance measurement. All evaluation 
centres except that in the ECG monitor case have produced product comparison reports, 
comparing performance measurement data from the product in question with other 
competing products. These three centres also produced some creative outputs, such as short 
colour tables of key product features for buyers in the case of the blood glucose meter, 
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searchable databases of product features in the case of the CT scanner and decision trees in 
the case of the standing frame. Evaluation Centre outputs are all available online for 
dissemination to interested stakeholders. Different processing of the evaluation information 
also occurs, all cases tabulating and compiling data in some form to give it greater 
meaning, however in the case of the CT scanner an overall image score was compiled, 
whereas in other cases no overall scoring was given. However only the evaluation centre in 
the ECG monitor case would give prescriptive advice about whether the product should be 
bought or not, others refusing to do so. 
 
In each case supplier staff gathered and fed back to the wider organisation ideas, issues or 
problems with the product, ascertained through social and information exchange with 
customers or users. This was often an informal process, however the suppliers in some 
cases used more formal procedures, such as the ISO 9000 CAPA process in the ECG 
monitor case. In the ECG monitor case, the supplier gave a free product to the customer, in 
return for feedback on product performance. 
 
Training was described as a process using performance measurement information, though 
in the ECG monitor case this was not a finding substantiated across more than one 
respondent. In all cases, supplier staff worked with clinician and patient users to ensure 
that they operated the product correctly, whether through formal training courses in the CT 
scanner and ECG monitor cases, offering help lines and training for DSNs in the blood 
glucose meter case, or advising the therapist and child when assessing the standing frame 
for the child’s needs. 
 
Making the Purchasing Decision 
A key use of performance measurement information discussed by many respondents in all 
four cases was in purchasing and supply decision-making by buying actors, a follow up 
performance management process. Despite a lack of formal purchasing decision-making 
processes, all four cases featured subjective discussion amongst members of the buy group 
as to the merits of the product to be purchased, whether this was the Hospital Trust 
purchasing team, or a DSN sitting down with a patient to discuss and make the decision 
whether the blood glucose meter or a competing product is the most appropriate for their 
particular needs. Only in the CT scanner case was a formal tender process used. A key 
feature of this process that was not found in other cases is the scoring and weighting of 
performance measurement data on each scanner, as part of the decision-making process 
about whether to purchase the CT scanner studied in the case or a competing product. This 
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case was also the only one to involve formalised debriefing to the supplier following the 
purchasing decision and a dedicated period of acceptance testing when the purchased 
product is installed, to ensure performance is as described by the supplier in the tender.  
 
Further to making the purchasing decision, performance measurement information was 
also used in broader parts of the purchasing and supply or adoption process. In two cases, 
performance measurement data was used to justify funding to purchase the innovative 
product, once the purchasing decision had been made. Clinicians and supplier staff in the 
standing frame case have compiled justification documents with details of the benefits of 
standing with the standing frame and clinical details about the individual child concerned. 
The ECG monitor supplier also stated how some GPs present data on the performance of 
the product to their PCTs when making a case for funding. The technical performance of 
the ECG monitor was also audited, involving checking of the supplier’s performance data, 
by an MHRA notified body as part of meeting standards for sale. In addition to purchasing 
decisions by clinicians in Trusts, the blood glucose meter case showed that benchmarking 
the strip performance against existing strips on the NHS drug tariff was a process 
influencing the decision to list the strip on the tariff, thereby making it available on 
prescription. Further, the PPD and BIVDA industry body representing suppliers were 
involved in negotiations over strip prices on the NHS drug tariff, following the PPD’s 
measurement of strip prices and costs of reimbursement. The prescription reimbursement 
process gave rise to another process only found in the blood glucose meter case, that of the 
supplier regularly having to declare to the customer the contents of the service package for 
consistency. 
 
Other performance management processes by the supplier were also aimed at making sales 
of the products to the purchasing actors. Suppliers in all cases except the standing frame 
distributed product information through means such as seminars and journals, trying to 
gain recognition of their products amongst stakeholders in the market, in addition to 
standard marketing materials such as brochures. However the ECG monitor supplier was 
the only one with a process of a free 30-day trial of the product to allow clinicians to try 
using it before committing to make a purchase. The case also saw the supplier give the GP 
surgery customer a free product upgrade without being requested, a process that was also 
seen in the blood glucose meter case, though in the latter it was tied to a product recall and 
replacement issue.  
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Product Innovation 
Another key performance management process that was described in all four cases 
concerned innovation. Suppliers in all cases discussed how feedback from customers or 
users influences product design and development. Respondents described specific 
examples where a certain product design change was made following feedback; the screen 
and scale changes made to the blood glucose meter, the battery life and automated 
connectivity checking introduced to the ECG monitor, software alterations and dose 
reduction over previous models of the CT scanner and availability of new split knee blocks 
on the standing frame. In the example of the blood glucose meter, the redesign was part of 
a process of product recall and replacement, triggered by other feedback processes of 
referral of a safety issue to the MHRA and issuing a device alert warning. 
 
Further to the permanent innovative changes to the products just described, one-off 
individual changes were also described in two of the cases. The suppliers in the standing 
frame and CT scanner cases made technical changes to the product for the needs of 
particular customers or users who purchase the product. In the case of the standing frame, 
therapists gave examples of the supplier fitting an alternative head support and additional 
straps for particular children, following assessment of the frame with the therapist and 
child. The contents of the CT scanner package is tailored to the particular Trust that issued 
the tender. The supplier discussed a package of additional cardiac and virtual colonoscopy 
software, on two CT scanners and three workstations with the Trust where many 
respondents in the case worked. 
 
6.4. Influences of Performance Measurement and Performance Management in 
Performance 
This section takes a cross case view of the findings where respondents described or 
suggested the influence of performance measurement and performance management 
processes in influencing the performance of the innovative products. It begins by 
illustrating the key influences described by respondents in the four cases as explored in the 
previous chapter and discussing them, then continues by grouping the influences into 
overarching types. 
 
6.4.1. Influences of Performance Measurement and Performance Management from the 
Individual Cases 
Studying the effects matrices in the previous chapter that show the influences described by 
respondents in each case, a number of influences are observed to be similar across all the 
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cases, while others were only discussed in a subset of the cases. In addition to an 
illustration of the influences on the conceptual framework (Figure 22), the influences 
described in the four cases are summarised in an effects matrix which can be found in 
Appendix U. As before, the influences are annotated according to the type of influence, 
with predecessor performance measurement and performance management processes and a 
researcher explanation of the influence at a generic level for all the cases where it occurred. 
The matrix also displays which influences occurred in which case. Table 31 summarises 
the effects matrix in Appendix U, showing types of influences and which cases they 
occurred in. 
 
This section continues the pattern matching analytic approach by identifying which of the 
observed influences were repeated across the cases, aiming to improve the internal validity 
of the research by identifying literal replications (Yin 2003 pp116-120), aiding matching 
the empirical findings with the conceptual framework. As the processes often take a 
different form in each case, for example the way a purchasing decision is made, the roles 
and processes are described at a fairly high level. Where an influence is observed in 
particular subsets of cases, distinguishing features of those cases are discussed, developing 
theoretical explanations for the different outcomes. Possible rival explanations for the 
influences described are discussed. 
 
Product is Purchased or Not 
A strong influence of performance measurement and performance management processes 
that was described by many respondents in all four cases was that the product is purchased 
or not following measuring its performance, then a decision made to purchase it, or a 
competing product, or not to make a purchase at all on the basis of the information from 
performance measurement. Fourteen, thirteen, eight and eleven different respondents in the 
four cases in order described how the product is purchased or not following a purchasing 
decision where the buyer uses performance measurement information to make a decision.  
 
Whether buy group decision makers were the purchasing team in a Hospital Trust in the 
CT scanner case, an individual GP in the ECG monitor case or individual clinicians 
making a decision with patients in the blood glucose meter and standing frame cases; the 
purchasing decision determined whether the product was bought or not. In purchasing 
decisions where the product is bought, money is exchanged in the supply relationship, with 
a beneficial influence in financial performance of the product for the supplier, when it is 
not bought there will be no benefit to the financial performance of the product. In all four 
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cases, respondents from the supplier associated sales of the product with good financial 
performance for that product. Meanwhile respondents described how the NHS customer 
gains the benefit of using the best product for healthcare, whether that is the product in the 
case or a competing product that is more suitable for their needs. 
 
 
Cases Where Found Influence 
(Described by semi structured interview 
respondents.) 
CT BGM ECG SF 
Type of 
Influence 
No. of 
Cases 
Where 
Role 
Observed 
(out of 4) 
Product is purchased or not Y Y Y Y +/- 
F/C 
4 
Supplier shows concern over 
performance measurement 
Y Y Y Y +/- 
* 
F 
4 
The best product for the needs of the 
user is purchased 
Y Y N Y + 
C 
4 
Used in acceptance testing Y N N N + 
T 
1 
Supplier ensures product performs to 
their specification & regulations, as it 
will be tested and then purchased or not 
Y Y Y Y + 
T 
4 
Performance measurement information 
not used in the purchasing decision 
Y Y Y Y None 4 
Product can be purchased or not for 
short-term, cost based rather than 
broader reasons 
Y Y Y Y - 
F/T/C 
3 
CE marking does not necessarily signify 
a product that performs to a sufficient 
standard 
N Y N N - 
F/T/C 
1 
Used to reduce product cost N Y N N +/- 
F 
1 
Product design improved Y Y Y Y + 
T 
4 
Feedback to the supplier is not used Y N Y Y None 3 
Useful for repairs Y N N N + 
T 
1 
Product meets needs of individual user 
as it has been customised with special 
features for the particular purchase 
N N N Y + 
C 
1 
Compliance with use of the product is 
needed 
N Y N Y None 2 
Training is necessary for patient to gain 
benefits of product use 
N Y N Y + 
C 
2 
Currently little evidence on the 
effectiveness of the healthcare procedure 
the product is part of 
N Y N N None 1 
Table 31. Summarised Influences of Performance Measurement and Performance 
Management Processes as Described by Respondents and Cross Case Patterns. (KEY: 
‘Y’=Yes, influence found in case, ‘N’= No, influence not found in the case. ‘+’ is a beneficial influence, ‘-‘ 
is a non-beneficial influence. ‘F’ is an influence in Financial performance, ‘T’ is an influence in Technical 
performance and ‘C’ is an influence in Customer performance (After Griffin & Page 1996). ‘None’ means 
there is no influence on performance. ‘*’ denotes an influence inferred by researcher rather than specifically 
described by respondent). 
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Some of the cases showed how other customer actors in the supply networks also made 
decisions that influenced the purchasing decision assessed above, using underlying 
performance measurement and performance management processes. The NHS PPD 
approved the blood glucose meter strips for inclusion on the NHS drug tariff, enabling 
prescription reimbursement and the product to be bought on the NHS. The pharmacy also 
used a committee to decide whether to stock the blood glucose meter for sale in their 
branches. Although some patients buy their own blood glucose meter from the pharmacy, 
many are given the meter free at a clinic by a DSN and the strips are already available on 
prescription so the influence of the pharmacy committee decision making on performance 
may be less than that of the PPD, enabling it to be sold in the first place. 
 
The performance management processes of making the purchasing decision followed up 
the performance measurement processes of gathering data for the purchasing decision in all 
the cases. Indeed the processes of assessing the performance of the product for a particular 
patient then making a purchasing decision, often occurred at the same meeting with the 
patient in the blood glucose meter and standing frame cases. Respondents also described 
broader performance management processes of processing the raw data once they had 
measured performance. Processes discussed included tabulation, statistical analysis, 
comparison between products and comparison against data from the supplier. Some were 
case specific, such as the economic modelling of the impact on care pathways in the ECG 
monitor case. In addition to processing the performance measurement data, broader 
processes of producing and disseminating reports and other outputs were discussed. The 
influence of the traditional evaluation reports was discussed by respondents in all four 
cases and some respondents described how they were useful in making purchasing 
decisions. Although some of these respondents were unsurprisingly from the evaluation 
centre and had an interest in saying so, others in the blood glucose meter case such as a 
DSN and the pharmacy respondent agreed. 
 
The free thirty day ‘try before you buy’ offer from the ECG monitor supplier was 
described as encouraging GPs to buy the product, having an influence according to the 
supplier as less than 10% did not buy at the end of the period. Performance measurement 
data from the supplier was used in their marketing materials to present it as a diagnostic 
tool, the product being featured as a case in the HITF report for example (HITF 2004 p14). 
However the supplier would have been more successful to market the product as a speed of 
referral tool given the performance suggested by the information according to a respondent 
at NHS PASA, also suggesting the influence of performance measurement outputs. These 
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are further examples of how performance measurement information used in follow up 
performance management processes have an influence on performance of the product. 
However other cases were not as explicit about the use of performance measurement 
information in marketing the product and sales. 
 
Supplier Shows Concern Over Performance Measurement 
In addition to the influence just discussed in whether the product was purchased or not, a 
code developed during the coding described suppliers showing concern over performance 
measurement, becoming interested or even competitive over the results.  
 
The code was found across all four cases, and can be interpreted by the researcher to 
suggest that suppliers show concern over performance measurement because it has an 
influence on performance of the product, affecting sales. Although not an influence 
explicitly described by respondents, it reinforces the finding that performance 
measurement processes have an influence on performance of the product. 
 
The Best Product for the Needs of the User is Purchased 
Further to describing an influence of whether the product was bought or not, respondents 
in all but one case discussed how the best product for the needs of the particular user is 
purchased. In the CT scanner case respondents described how clinician assessments and 
the tender process aided buying the best scanner for the particular needs of the Trust, while 
clinician assessments and purchasing decisions made with the patient in the blood glucose 
meter and standing frame cases resulted in the best meter or frame for the patient being 
purchased. The ECG monitor case is an outlier here, as this influence did not occur, 
however this case may be deviant because there were no competing products for the ECG 
monitor in the GP setting so there is not a best product. This suggests that the case is 
deviant for a reason that does not lessen the strength of the finding suggested by the other 
three cases (Miles & Huberman 1984 pp237-238), at least for situations where there are 
competing products on the market. 
 
Used in Acceptance Testing 
In the CT scanner case, respondents described how performance measurement reports from 
the evaluation centre technical evaluation are used in acceptance testing, ensuring that the 
CT scanner performs as expected when it arrives following purchase. The technical 
performance of the scanner is checked against the description in the tender specification 
with reference to the evaluation centre report. If performance is satisfactory, the balance of 
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payment is given to the supplier. In short, performance information is used in a checking 
process to ensure the technical performance of the CT scanner is as promised. Formal 
acceptance testing procedures were not described in the other three cases, however the 
processes that constitute the purchasing process vary from case to case as stated above and 
this acceptance testing process is found in the only case where a tender process occurs. 
 
Supplier Ensures Product Performs to Their Specification and Regulations 
Whereas only one case formally described acceptance testing, respondents in all four cases 
highlighted that supplier knowledge that the customer carries out performance 
measurement and performance management processes means that the supplier will ensure 
their product performs technically to the specifications in the way claimed and also meets 
regulations in the field. In describing this influence, respondents mainly referred to use of 
data from the technical evaluation by the Evaluation Centre and that the performance 
measurement of the product is checked against the claims made for it as part of making the 
purchasing decision. 
 
Performance Measurement Information is Not Used in the Purchasing Decision 
While a key finding repeated across all cases above was that performance measurement 
and performance management processes result in the product being bought or not, another 
key finding reported across all four cases was that information from performance 
measurement is sometimes not used in purchasing decision-making, so the information 
from performance measurement does not have an influence in whether the product is 
bought or not. In particular, it was stated that limited or no use was made of the technical 
evaluation outputs. The Evaluation Centre outputs were variously described as not 
prescriptive enough to be useful, not timely, expensive and difficult to access for use in 
purchasing decisions. Further, respondents described how many other things can influence 
a purchasing decision than information on the product, such as organisational factors. 
Similar to the lack of use of technical evaluation outputs, none of the buy group 
respondents in any of the cases described using the purchasing guidance and tools provided 
by NHS PASA and Supply Chain. The finding agrees with that above that the purchasing 
decision influences whether the product is bought or not, however it shows that 
performance measurement processes may or may not be used, suggesting two patterns, the 
first where the product is bought or not on the basis of information from performance 
measurement, the second where the product is bought or not regardless. 
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The Product Can be Purchased or Not for Short-term, Cost Based Rather than Broader 
Reasons 
Another key finding describing the influence of processes in whether the product is bought 
or not is that, in all cases, the decision is often made for short-term reasons on the basis of 
information about cost performance, rather than made with a longer term view and on the 
basis of information of broader value than cost. Respondents suggested that this had a non-
beneficial effect on the performance of the product, as low cost products are bought rather 
than innovative products with features that benefit healthcare. The NHS buys a product 
that may not perform as well as an alternative technically, from their point of view as a 
customer, or in terms of the lifetime costs of the product or treatment pathway it is part of. 
The supplier loses sales to lower cost products that are not innovative. This influence and 
finding reinforces the first, that performance measurement and performance management 
processes have an influence on whether the product is bought or not, however it suggests 
that that influence is non-beneficial where the information from performance measurement 
is too limited to financial performance. 
 
CE Marking Does not Necessarily Signify a Product That Performs to a Sufficient 
Standard 
Respondents in the blood glucose meter case only highlighted that product buyers often 
just look for a CE mark, described as a poor guide to product performance, before making 
a purchasing decision. They suggested that this could have a non-beneficial influence, as 
the product bought may not perform to a sufficient standard in terms of a variety of aspects 
of performance. 
 
Used to Reduce Product Cost 
The blood glucose meter case alone found that the processes are used to reduce cost of the 
product, in the example of the PPD negotiating a cut in strip prices with the supplier. This 
had an influence in the NHS buying the same strips that performed identically technically 
with the same customer support package, yet for a lower cost, improving financial 
performance of the product for them. However this had a non-beneficial effect on the 
financial performance of the product for the supplier, reducing their profit margin on the 
identical product. There was no evidence of negotiating cost reductions in the other three 
cases and the influence is similar to the last, where the product is purchased or not for cost-
based, short term reasons, with the added twist that the NHS have not lost out in technical 
or customer performance of the product as it is a repurchase situation. 
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Product Design Improved 
A strong pattern across all four cases was seen in the influence of the processes in 
improving the design of the product. Following the various actors assessing the 
performance of the products, feedback to the supplier occurs, who then make innovative 
changes to the product, with the outcome that the technical performance of the product is 
improved. Whether the feedback came from supplier representatives gathering information 
about the product, or via the MHRA device alert, in all cases the suppliers took proactive 
action to re-innovate features of their product. The ECG monitor supplier was the only one 
to discuss using a formal CAPA system, in which feedback from customers and users is 
stored in a database and issues are prioritised for action to address them. However in the 
other three cases, respondents stated that their sales and applications representatives who 
interact with customers and users on an individual level seek and gather the information in 
a less formal, subjective way, which is then fed back to the company as a whole. 
 
Feedback to the Supplier is Not Used 
In contrast to the finding in all four cases where performance measurement and feedback 
were used to improve the design and technical performance of the product, all but the 
blood glucose meter case found that feedback to the supplier is sometimes not used and 
that the information concerned does not have an influence on performance of the product 
as it is not used. This finding not only reinforces the above, that both performance 
measurement and performance management are necessary for an influence on 
performance, but also highlights that the performance management processes must involve 
proactive re-innovation, rather than the less proactive dissemination of information in 
feedback. It was not commented that feedback in the blood glucose meter case was not 
used, which corroborates with the finding above that it was used in re-designing the 
display and scale. 
 
Useful for Repairs 
Another influence with a beneficial effect on the technical performance of the product was 
observed in the CT scanner case alone. Respondents described how the technical 
evaluation enables the Trust to check the performance of the CT scanner against the 
expected during its operation, which helps make the case to the supplier to come and make 
repairs. The finding is not strong as it appears in only the one case, possibly as it is the case 
where the ongoing maintenance of the product by the supplier was most thoroughly 
described. However, it is similar to the influence of evaluation centre reports in acceptance 
testing of the CT scanner, having a beneficial influence on technical performance. In both 
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findings, the performance management processes involve checking performance against 
the expected, rather than the subsequent purchasing decision or maintenance which 
actually changes the performance of the product. 
 
Product Meets the Needs of the Individual User as it has been Customised with Special 
Features for the Particular Purchase 
Innovation in the design of the products also occurs on a more immediate and local scale 
for the needs of a particular user as exemplified in the standing frame case, where 
therapists and supplier staff who work together to assess whether the standing frame is the 
most appropriate or not for the needs of a particular child have customised the product with 
different components in response to their assessment. The result is that the processes have 
improved the customer performance of the product. Although not represented in the 
findings at this level, there was some evidence that the CT scanner package offered by the 
supplier was also tailored to the needs of the particular Hospital Trust. Supplier 
respondents stated that the package will change from tender to tender. On the other hand, 
the blood glucose meter and ECG monitor are standard products and there was no process 
of changing their performance for particular customer’s needs. These products are not 
customised, so the performance management process of customisation noted in the 
standing frame and CT scanner cases does not have an influence on their performance. 
This reinforces the finding that in cases where customisation occurs it has an influence on 
performance, in contrast to those control cases where it does not and there is no influence. 
 
Compliance With Use of the Product is Needed 
A finding in two of the four cases highlighted an issue regarding use of the product, 
namely that performance measurement and performance management processes may have 
no role in performance if the patient does not use the product. The blood glucose meter 
case highlighted an issue that the product was often not used by patients when instructed to 
do so by a DSN. The issue highlights that, whatever the performance of the blood glucose 
meter as a product and whatever performance measurement and management processes 
have occurred, it cannot perform for the consumer and play a part in their healthcare if it is 
not ultimately used. A similar point was made in the standing frame case. A contrast can be 
drawn with the CT scanner and ECG monitor cases where this finding did not occur. In 
these cases the products were used by the clinician who either conducted scans or fitted the 
patient with the ECG monitor, whereas the blood glucose meter and standing frame were 
for use by the patient themselves when independent of the clinician. Compliance, or use of 
the product by the patient can be considered a performance management process, as it 
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follows performance measurement and indeed some other performance management 
processes such as the purchasing process. However it was not explicitly discussed by 
respondents as a performance management process, only when referring to the influences 
of the other various performance measurement and performance management processes. 
Again, the finding that the product must be used to perform for the customer suggests that 
it is the most proactive performance measurement and performance management processes 
that have an influence on performance. 
 
Training is Necessary for the Patient to Gain Benefits of Product Use 
In addition to finding that the product must be used for the processes to have an influence 
on performance, findings from the blood glucose meter and standing frame cases highlight 
that if customers are not just to use their products but to use them correctly and gain 
healthcare benefits, training is necessary. Training was described as improving the 
customer performance of the products by aiding customers to use them correctly. Training 
was also discussed in the CT scanner case, by three respondents and in the ECG monitor 
case, though only by one respondent; however the influence of training in these cases was 
not discussed, weakening the finding as the pattern is only matched over half the cases. 
 
Currently Little Evidence on the Effectiveness of the Healthcare Procedure the Product is 
Part of 
The blood glucose meter case highlighted an issue with the influence of performance 
measurement and performance management processes, that there is currently limited 
evidence on the effectiveness of blood glucose monitoring as a clinical activity, rather than 
the effectiveness, or performance of the particular blood glucose meter. This raises the 
issue that the processes may have no influence on the customer performance of the 
products for the NHS, whatever the performance of the particular meter. If blood glucose 
monitoring does not benefit the patient, then the meter will not, no matter how well the 
device performs. This lack of an influence was not described in the other three cases, 
perhaps highlighting that medicine is currently focussing more on the effectiveness of 
blood glucose monitoring as a discipline than on the other clinical activities. 
 
Having discussed the influences found in the four cases, the next sub-section investigates 
how these influences may be grouped. 
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6.4.2. Grouping the Influences of Performance Measurement and Performance 
Management Processes 
This sub-section generates meaning by grouping the influences into overarching types of 
influences that the performance measurement and performance management processes 
have, considering rival groupings based on the various types of influences (Miles & 
Huberman 1984 pp216-229). As assessed when describing the influences above, many are 
conceptually similar, suggesting that the number of influences can be refined, as follows. 
 
The influence of the processes in whether the product is bought or not is found in all cases 
and is conceptually similar to a number of the other influences. It is reinforced by the 
implied influence that suppliers show concern about performance measurement, also found 
in all cases. Another strong influence found in all four cases that is conceptually similar is 
that the best product for the needs of the user is purchased. It refers to the beneficial 
customer performance the NHS gains from the product, bought following performance 
measurement and taking the purchasing decision. A further influence that is conceptually 
similar is that the supplier ensures the product meets their claims and regulations in terms 
of technical performance, as they know the product will be tested before purchase. This 
finding refers to another way in which performance measurement and management 
processes have an influence on the technical performance of the product the customer 
buys. Also, the influence that performance measurement information is used in acceptance 
testing can be grouped with the influence of whether the product is bought or not. 
Although only described in the CT scanner case, the case with the formal tender process, 
the influence describes the outcome of part of the broader decision to purchase the CT 
scanner or not, as payment is only made when the acceptance testing has been completed. 
The non-beneficial influence discussed in all cases where the product is bought for short 
term cost based reasons and the lack of an influence where performance measurement 
information is not used in the purchasing decision also refer to the purchasing decision, but 
are left separate as they represent non-beneficial or no influences respectively. The weaker 
finding of buyers only using a CE mark to buy the product also refers to a non-beneficial 
influence arising through using limited information in making the purchasing decision so 
could be grouped with the non-beneficial influence about buying the product for short-term 
cost based reasons, though is left separate here as it refers to measuring technical rather 
than financial performance. Described only in the blood glucose meter case, the influence 
of processes in reducing cost of the product also involves the outcomes of performance 
measurement and the decision to purchase the product. Although similar to the influence 
where the product was bought on cost, this influence is more similar conceptually to 
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whether the product was bought or not, as the product remained the same in technical 
terms as well as in the way it performed for the customer, with a beneficial influence for 
the customer. Overall, these conceptually similar influences suggest that there is a strong 
finding of one influence in whether the product is bought or not. 
 
The influence of performance measurement and performance management processes in 
improving the product design is also conceptually broad enough to cover some of the less 
strong findings. For example, that the product meets the needs of the customer following 
customisation is also an example of improving the product design by making innovative 
changes to the design of the product. 
 
Meanwhile, some of the different types of influences reinforce the same conceptual 
finding. For example, although findings that information from performance measurement 
processes such as the technical evaluation both does and does not have an influence in 
purchasing decision-making is conflicting, it reinforces the concept that performance 
measurement has an influence when it is used and has no influence when it is not used. 
Another example is that of feedback being one of the performance management processes 
with an influence on improving product design with a beneficial influence, however the 
finding that feedback is often not used and has no influence reinforces the influence of 
feedback on performance. The influences describing the importance of compliance with 
use of the product and training for correct use were found in the same two cases, 
suggesting that these influences occurred where the patient used the product for 
themselves, rather than a clinician, a distinguishing feature of those two cases. Both 
influences refer to the use of the product to ensure it performs for the customer. 
 
 The rows in Table 31 can be grouped according to the attributes in the column that shows 
the type of influence. Table 32 shows the influences grouped according to their influence 
in financial, technical or customer performance of the product. Where influences had no 
influence on performance, they are grouped according to the type of performance they 
could have influenced, for example feedback to the supplier was discussed in terms of the 
influence it could have on technical performance. 
 
The table demonstrates a cluster of processes with an influence on financial performance 
of the product, involving making the purchasing decision on the basis of information from 
performance measurement. However performance measurement information is not always 
used in making the purchasing decision. Another cluster of influences are those on 
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technical performance of the product, including improvement of the product design, and 
that the supplier ensures the product performs to specifications and regulations. The 
weaker findings of ‘used in acceptance testing’ and ‘useful for repairs’ have an influence 
on technical performance, while one case highlighted that performance measurement is not 
always a sign of the technical performance of the product. Influences that cluster as they 
refer to the customer performance of the product include the best product for the needs of 
the user being purchased, that use of the product by the patient, training in use is needed 
and in some cases that the customised product meets the needs of the user. The lack of 
evidence for the clinical activities described in one case highlights how processes may not 
have an influence on the performance of the product for the customer. 
 
Influence 
(Described by semi structured interview respondents.) 
Type of 
Influence 
No. of Cases 
Where 
Influence 
Observed 
(out of 4) 
Influence on Financial Performance 
Supplier shows concern over performance measurement F 4 
Used to reduce product cost F 1 
Performance measurement information not used in the 
purchasing decision 
None 4 
Influence on Technical Performance 
Product design improved T 4 
Supplier ensures product performs to their specification & 
regulations, as it will be tested and then purchased or not 
T 4 
Used in acceptance testing T 1 
Useful for repairs T 1 
Feedback to the supplier is not used None 3 
Influence on Customer Performance 
The best product for the needs of the user is purchased C 4 
Training is necessary for patient to gain benefits of product use C 2 
Product meets needs of individual user as it has been 
customised with special features for the particular purchase 
C 1 
Compliance with use of the product is needed None 2 
Currently little evidence on the effectiveness of the healthcare 
procedure the product is part of 
None 1 
Influence on Financial & Customer Performance 
Product is purchased or not F/C 4 
Influence on Financial, Technical & Customer Performance 
Product can be purchased or not for short-term, cost based 
rather than broader reasons 
F/T/C 3 
CE marking does not necessarily signify a product that 
performs to a sufficient standard 
F/T/C 1 
Table 32. Summarised Influences of Performance Measurement and Performance 
Management Processes, Grouped According to Type of Performance in Which They 
Have an Influence. (KEY: ‘F’ is an influence on Financial performance, ‘T’ is an influence on 
Technical performance and ‘C’ is an influence on Customer performance (After Griffin & Page 1996). 
‘None’ means there is no influence on performance. ‘*’ denotes an influence inferred by researcher rather 
than specifically described by respondent). 
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However the influences do not all group clearly by type of performance influenced. 
Whether the product is purchased or not has an influence on both financial and customer 
performance for supplier and customer actors respectively. Purchasing the product for 
short-term, cost based reasons can hinder financial performance for an innovative product 
supplier and mean that the NHS misses out on products that perform better technically, for 
them as a customer and longer-term financially. 
 
Given that the influences do not all group neatly by the type of performance they have an 
influence on, or according for example to some of the performance management processes 
involved, other criteria can be used for clustering. Table 33 shows the influences grouped 
according to whether they have an influence on performance or have no influence on 
performance. Further, those with an influence on performance are grouped according to 
whether they have a beneficial or non-beneficial influence on performance. 
 
Table 33 highlights that the performance measurement and performance management 
processes which have an influence on performance involve using information from 
performance measurement in performance management processes such as making a 
purchasing decision and innovation. Additionally, performance management processes of 
disseminating performance measurement information, including through feedback and 
checking performance against expected levels are involved. Most of the influences were 
described as beneficial, where sales had been made, the product technically improved or 
the customer receiving the product that performs best from their point of view. Another 
example was the influence of training in aiding users to operate the product correctly, 
improving its customer performance for them. However some influences had both a 
beneficial and non-beneficial effect on performance, illustrating that if particular processes 
had a certain outcome performance would be improved for both customer and supplier 
actors, whereas if the processes had a different outcome there would be a detrimental 
influence on performance of the product for the supplier, while there was still a beneficial 
influence on performance for the customer who had chosen the best product for their 
needs. The influence was beneficial or non-beneficial according to the actor concerned. If 
the decision was made to purchase the product for example, it performed for both the 
customer and supplier, however if that product was not purchased, the supplier lost sales as 
the process had a non-beneficial influence, though the processes still had a beneficial 
influence on performance for the NHS, buying the best product for healthcare.  
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Influence 
(Described by semi structured interview respondents.) 
Type of 
Influence 
No. of Cases 
Where 
Influence 
Observed 
(out of 4) 
Beneficial or Non-beneficial Influences 
Supplier shows concern over performance measurement +/- 
* 
4 
Product is purchased or not +/- 4 
Used to reduce product cost +/- 1 
Beneficial Influences 
Product design improved + 4 
The best product for the needs of the user is purchased + 4 
Supplier ensures product performs to their specification & 
regulations, as it will be tested and then purchased or not 
+ 4 
Used in acceptance testing + 1 
Useful for repairs + 1 
Product meets needs of individual user as it has been 
customised with special features for the particular purchase 
+ 1 
Training is necessary for patient to gain benefits of product use + 2 
Non-beneficial Influences 
Product can be purchased or not for short-term, cost based 
rather than broader reasons 
- 3 
CE marking does not necessarily signify a product that 
performs to a sufficient standard 
- 1 
No Influence 
Performance measurement information not used in the 
purchasing decision 
None 4 
Feedback to the supplier is not used None 3 
Compliance with use of the product is needed None 2 
Currently little evidence on the effectiveness of the healthcare 
procedure the product is part of 
None 1 
Table 33. Summarised Influence of Performance Measurement and Performance 
Management Processes, Grouped According to Whether They Have a Beneficial, 
Non-beneficial or No Influence. (KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. 
‘None’ means there is no influence on performance. ‘*’ denotes an influence inferred by researcher rather 
than specifically described by respondent). 
 
In addition to the possible beneficial or non-beneficial influences just described, solely 
non-beneficial influences were found across most of the cases where a decision was made 
to purchase the product on the basis of cost information with a short term view, and in the 
blood glucose meter case where the product was bought solely on the basis of a CE mark. 
Evidence of broader performance of the product was not used in the decisions described, 
with the influence in the first example that the supplier of the innovative product lost sales 
to low cost rival products, while the customer lost the technical and customer benefits by 
buying a product that was simply cheap. Very little information from performance 
measurement was used in making the purchasing decision, only that concerning cost. In the 
CE mark example only limited technical information was used in making the purchasing 
decision. 
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Finally a set of influences can be grouped where respondents described how the processes 
do not have an influence on performance. Strong findings across all four cases described 
how performance measurement information is not used in purchasing decisions and how 
feedback to the supplier is not used to improve the product. These findings describe that 
where performance measurement has occurred, but no broader or follow up performance 
management processes have occurred, there is no influence on performance. Further, the 
finding that the product must actually be used to perform for the customer reinforces that 
proactive, performance management processes are required if there is to be an influence on 
performance. There is also limited evidence from one case that both the performance 
measurement and performance management processes may have no influence on 
performance at all where there is little evidence of the effectiveness of the clinical activity 
that the product is involved in. 
 
Overall, clustering the various influences as to whether they were beneficial, non-
beneficial or had no influence on performance highlights some general findings about the 
influences of the processes. Where a beneficial or non-beneficial influence occurred, both 
performance measurement and performance management processes were found, with the 
latter focussing on proactive decisions about purchasing and supply, or innovation of the 
product. The influence may only be beneficial for one of the organisations involved 
however. A non-beneficial influence occurred when the decision was made to purchase the 
product using only limited information, often about cost, highlighting that little or limited 
performance measurement that is followed by performance management may have a non-
beneficial influence on performance. Finally, the data highlights that where performance 
measurement occurs, but not performance management, no influence on performance of 
the product occurred. However some of the less proactive performance management 
processes, such as dissemination of performance measurement information and feedback to 
the supplier are also found, raising a question as to their influence on performance when 
they are also found to have a beneficial influence with the more proactive processes 
described above. For example, dissemination occurred before the decision was made to 
purchase the product, however it also occurred where the performance measurement 
information was not used by the customer. This suggests that the less proactive 
performance management processes such as dissemination and feedback are more 
conceptually similar to performance measurement processes as they do not have an 
influence on performance unless supplemented by a more proactive purchasing and supply, 
or innovation process. The influence of these processes is discussed more thoroughly in the 
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following discussion chapter. Findings from this sub-section are summarised in Table 34, 
showing the overall findings of the influences of performance measurement and 
performance management processes. The table shows the stronger findings that are 
repeated across more than one case in Table 31 in bold and also groups the findings that 
are conceptually similar, as described above. 
 
6.5. Summary 
This chapter has reported on the findings of the four case studies from a cross-case 
perspective, focussing on cross case patterns of their similarities and differences. Figure 22 
summarises the cross case findings by illustrating them on the conceptual framework. The 
products studied in each case were all identified as being innovative, though the level of 
implementation and length of time varied, as did the care areas and cost. 
 
There were also similarities in the performance measurement and performance 
management processes discussed by respondents in each case. In all cases, actors variously 
measured financial, technical and customer aspects of the performance of the product, with 
all cases showing information and social exchanges between customer and supplier 
organisations as a way of gathering information or evidence about the performance of the 
product. Processes varied from quantitative laboratory measurements to subjective 
assessments by users and stakeholders. In all cases performance was measured as part of 
the purchasing and supply process. 
 
Some key performance management processes were found across all the cases, such as 
dissemination of information from performance measurement, using it in making a 
decision to purchase the product or not and processes involved with identifying and 
rectifying product faults. Within this broad picture however, some processes were only 
found in some or even one of the cases, such as assessing the performance of a product for 
inclusion on the NHS drug tariff, for example. The particular nature of processes also 
varied in the different cases. For example, purchasing decision-making included tender 
processes involving a purchasing team, scoring, weighting and subjective discussion, as 
well as individual clinicians making subjective decisions with patients about the product to 
use. In addition to these proactive performance management processes, dissemination of 
information, checking of performance, feedback, training and product customisation were 
also described by respondents in some, if not all of the cases. Respondents also emphasised 
the importance of patients complying with use of the product, a further performance 
management process. 
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• Product is 
purchased or not. 
(The best product 
for the needs of the 
user is purchased, 
Supplier shows 
concern over 
performance 
measurement, Used 
in acceptance 
testing, Used to 
reduce product 
cost, Supplier 
ensures product 
performs to their 
specification & 
regulations, as it 
will be tested and 
then purchased or 
not) 
Pattern observed across all four cases. 
Confirmed by evidence of strong patterns 
across respondents within each case, with 
many uses of the ‘Buyers Use’ code 
(14,13,8,11 respondents per case). 
Many influences described by 
respondents refer to influences with the 
same concept of the product being 
purchased or not following measurement, 
dissemination and purchasing decision 
making (influences shown in brackets). 
A comparison with the finding that 
performance measurement information 
may also not be used, with no influence 
or that limited performance measurement 
information may be used with a non-
beneficial influence, reinforces this 
finding. 
• Product design 
improved. 
(Product meets 
needs of individual 
user as it has been 
customised with 
special features for 
the particular 
purchase) 
Pattern observed across all four cases. 
Confirmed by evidence of strong patterns 
across respondents within each case, with 
many uses of the ‘Re-designed Product 
Improved’ and ‘Tailored Appropriate 
Codes’ (6,4,5,5 respondents per case for 
both codes). 
A comparison with the finding that 
feedback may also not be used, with no 
influence, reinforces this finding. 
• Training is 
necessary for 
patient to gain 
benefits of 
product use 
Pattern observed across two of four 
cases, those where product was used by 
patient, not clinician, suggesting pattern 
should only be found in those two cases.  
The finding shows that a beneficial 
influence occurs when information from 
performance measurement is followed up 
by proactive performance management 
processes. 
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• Useful for repairs Pattern only observed in one case, a 
weaker finding. Differentiated from 
‘Product design improved’ as it refers to 
maintenance of a particular example 
rather than innovation. Although weaker, 
the finding still shows that a beneficial 
influence occurs when information from 
performance measurement is followed up 
by proactive performance management 
processes. 
Continued overleaf 
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• Product can be 
purchased or not 
for short-term, 
cost based rather 
than broader 
reasons. 
Pattern observed across all four cases. 
A comparison with the finding that 
performance measurement information 
may also not be used, with no influence 
or that performance measurement 
information is used with a beneficial 
influence, reinforces this finding of a 
non-beneficial influence where limited 
information from performance 
measurement is used. 
• Product is 
purchased or not. 
(The best product 
for the needs of the 
user is purchased, 
Supplier shows 
concern over 
performance 
measurement, Used 
in acceptance 
testing, Used to 
reduce product 
cost, Supplier 
ensures product 
performs to their 
specification & 
regulations, as it 
will be tested and 
then purchased or 
not) 
As described in the beneficial influence 
of whether the product is purchased or 
not (above), the finding highlights that 
this influence on performance may be 
perceived as beneficial by one 
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• CE marking does 
not necessarily 
signify a product 
that performs to a 
sufficient standard 
Pattern only observed in one case, a 
weaker finding. A comparison with the 
finding that performance measurement 
information may also not be used, with 
no influence or that performance 
measurement information is used with a 
beneficial influence, reinforces this 
finding of a non-beneficial influence 
where limited information from 
performance measurement is used. 
• Performance 
measurement 
information not 
used in the 
purchasing 
decision. 
Pattern observed across all four cases. 
A comparison with the finding that 
performance measurement information is 
used, with a beneficial influence or that 
limited performance measurement 
information may be used with a non-
beneficial influence, reinforces this 
finding. 
• Feedback to the 
supplier is not 
used. 
Pattern observed across three of four 
cases. 
A comparison with the finding that 
feedback is also used to improve the 
design of the product, with a beneficial 
influence, reinforces this finding. No
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• Compliance with 
use of the product 
is needed 
Pattern observed across two of four 
cases, those where product was used by 
patient, not clinician, suggesting pattern 
should only be found in those two cases. 
The finding shows that no influence 
occurs when information from 
performance measurement is not 
followed up by proactive performance 
management processes. 
Continued overleaf
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• Currently little 
evidence on the 
effectiveness of the 
healthcare 
procedure the 
product is part of 
Pattern only observed in one case. This 
weak finding suggests that no influence 
occurs when information from 
performance measurement and follow up 
performance management are not used in 
an effective clinical process. 
Table 34. Summary of Overall Findings about the Influences of Performance 
Measurement and Performance Management Processes 
 
Respondents in all cases described the influence of performance measurement and 
management processes in performance. The case findings were consistent in describing 
various influences of the processes in whether the product was bought or not, in improving 
the design of the product or not and those cases where the patient uses the product 
themselves highlighted the influence of use of the product once bought. Processes were 
described as variously having an influence on financial, technical or customer 
performance, as well as that the influence could be beneficial or non-beneficial, also that 
there might not be an influence in some examples. Influences were grouped according to 
conceptual similarity, then various alternative clusters according to the types of 
performance were illustrated. The data from respondents suggested that, with different 
occurrences of performance measurement and performance management processes, there 
may be a beneficial influence on performance, the opposite, or no influence on 
performance at all. The findings about the performance measurement and performance 
management processes and their various influences on performance are used in the rest of 
the thesis to analyse how performance measurement and performance management can be 
differentiated, in the light of the suggestions made in the existing literature. 
 
Having reported the findings from across four cases, the next chapter of the thesis 
continues by discussing the findings in the context of the existing body of knowledge 
discovered in the literature review. 
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INFLUENCE ON PERFORMANCE
Influence on financial performance: 
Product is bought. Supplier makes 
sales, NHS customer pays for product 
purchased. Performance measurement 
information not always used, especially 
evidence of broader aspects than cost. 
Suppliers concerned processes and 
information affect competitiveness.
Influence on technical performance: 
Product design permanently changed. 
Influence on customer performance: 
NHS customer buys the product which 
can then be used to improve healthcare. 
Tailored product meets needs of a 
particular customer, through altered 
product features or configuration of 
product-service package. Compliance 
with use needed if product is to perform. 
More evidence of efficacy of some 
procedures is needed.
PERFORMANCE 
MANAGEMENT 
PROCESSES
Information Dissemination: 
Issuing reports, tools and advice 
following performance 
measurement. Training product 
user. Feedback to supplier.
Purchasing: Purchasing 
decision-making on basis of 
performance measurement 
information.
Product innovation: Re-
innovation of the product in 
response to performance 
measurement information. 
Tailoring product to needs of 
particular customer.
PERFORMANCE MEASUREMENT 
PROCESSES
Financial:  Costs assessed on national, 
local levels
Technical : Technical evaluation by 
Evaluation Centre. Trials and technical 
measurement of product by supplier.
Customer: Clinicians assess whether 
product suitable for the particular Trust or 
patient where it will be used. 
Communication & visits between actors, 
trial use & demos, gathering user 
opinions.
Innovative 
Product 
PERFORMANCE
Thesis focus
 
Figure 22. Conceptual Framework Illustrated With Cross-Case Finding 
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Part Three: Discussions and Conclusions  
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CHAPTER SEVEN: DISCUSSION OF FINDINGS 
 
7.1. Introduction 
This chapter discusses the empirical findings reported in the previous two chapters, in the 
context of the existing bodies of knowledge analysed in the earlier literature review 
chapters. 
 
The structure of the chapter is based upon the key concepts under investigation in the 
conceptual framework, which was based on the literature. The discussion starts by 
focussing upon the performance measurement processes discovered in the exploratory 
empirical work and how they relate to the current knowledge base in the literature. The 
performance management processes found in the empirical work are then examined in the 
same way. The discussion focuses on performance measurement then performance 
management as this reflects existing frameworks used in the conceptualisation (eg Lebas 
1995) and a key conceptual issue identified in the literature (Radnor & McGuire 2004). 
The chapter then concentrates on discussing the influences of the performance 
measurement and performance management processes that were discovered empirically in 
the light of the existing literature, followed by an investigation of the conceptual 
differences between performance measurement processes and performance management 
processes. From cues in the literature, this discussion investigates whether the concepts can 
be differentiated by the latter being broader (Halachmi 2005, Lebas 1995), or by the latter 
involving taking action on measures where a performance change occurs (Bourne et al. 
2005, Halachmi 2005). Having drawn some conceptual lessons, discussion then returns to 
the conceptual framework, which is examined, revised in terms of the lessons from 
viewing the empirical findings in the context of existing work and used in creating a 
graphical display of concepts from the findings. As part of this discursive section, the key 
concept of performance reporting is identified. 
 
A summary is presented, before the next chapter returns to reflect on the research questions 
in the light of the discussion in this chapter. 
 
7.2. Performance Measurement Processes 
The empirical work identified a variety of performance measurement processes that are 
found in the literature, as well as a number of additional processes. Given the wide variety 
of processes discovered in the empirical work, the section is structured around the key 
aspects of performance measured, after Griffin and Page (1996) as described in the 
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conceptualisation chapter. It then continues to discuss some key exploratory observations 
about the processes from the empirical work and findings chapters, that many processes 
involved communication between actors, occurred before making a purchasing and supply 
decision and were informal and subjective, as well as formal and objective. 
 
7.2.1. Financial Performance Measurement Processes 
The performance literature concentrated on performance measurement and selection and 
implementation of measures in particular (Neely 1997), portraying different types of 
measures. Many of these different types of measure were found in the empirical data, 
where respondents described assessing not only physical aspects of the device, but also 
how the device performed financially and for the users concerned. Actors in all cases such 
as the suppliers and the NHS on a national level measured the financial performance of 
their products, focusing on sales, market share and internal accounting measures (Johnson 
& Kaplan 1987 pp253-262). In the innovation literature, Tidd et al. (2005 pp561-569) 
discussed measuring sales, profits and market share with respect to specific innovative 
products. The NHS as customer focussed on the cost of the product whether at the point of 
initial purchase or over the product lifetime. The more complex economic modelling 
carried out regarding changes to the care pathway seen in the ECG monitor case is 
reminiscent of the literature which discusses the costs and benefits of particular treatment 
interventions, for example (Thompson & Duintjer Tebbens 2006). 
 
7.2.2. Technical Performance Measurement Processes 
The literature advocates measuring broader, operational aspects of performance as well as 
using traditional financial performance measures (Ittner & Larcker 1998a, 1998b, Kaplan 
& Norton 1992, Bull 2007), a concept that was in evidence in all of the cases. Both 
supplier and customer actors measure technical parameters of the design and function of 
the product. This is reflected in two parts of the literature. Firstly the literature discusses 
quality as a performance objective, with Hayes & Wheelwright (1984 pp361-371) referring 
to defect prevention and awareness or monitoring. While they refer to an operational 
production process, the role of the evaluation centres was described as one of verification 
of supplier claims about the performance of their product. Suppliers also used technical 
performance measurement towards meeting regulatory standards. On a broader level, Slack 
et al. (2007 pp39-54) also refer to quality, or the ability to be able to do things right, 
suggesting the evaluation centres are measuring the technical quality of the products. 
Secondly, the literature describes performance measures for innovation (Tidd et al. 2005 
pp561-569), which is oriented towards the firm producing the product and describes 
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aspects such as literature publications in the particular technical field or application for the 
product. These specialist publications were drawn on by the evaluation centres in the 
process of measuring the technical performance of a product, for example in the ECG 
monitor case (Gamlyn et al. 1999). The literature also describes some of the specific tools 
used by individual clinicians to measure product performance, such as the Waterlow Scale 
as used by therapists in the standing frame case (Pancorbo-Hidalgo et al. 2006). Chiesa et 
al. (1996) also focus on measuring technical performance from the supplier’s point of 
view. Some suppliers also discussed carrying out clinical trials to measure the performance 
of their product, as described in the evidence-based medicine literature (Belsey & Snell 
2003 pp1-6). 
 
7.2.3. Customer Performance Measurement Processes 
Actors in the cases also measured the way the products performed for the customer, again 
reflecting the literature concept of measuring broader aspects of performance than those 
which are financial. Supplier actors in the cases were keen to understand how their product 
performed from the point of view of the customer, with customer testing frequently being 
an element of implementing an innovation (Tidd et al. 2005 pp393-394). The blood 
glucose meter supplier for example provided particularly diverse examples of measuring 
customer performance, conducting market research reminiscent of the service quality 
literature (Parasuraman et al. 1988) and also measuring softer, quality of life performance 
of the type described by Skevington (1999). Further customer performance measurement 
occurred as part of the purchasing process, described below. 
 
7.2.4. Actors Measuring Performance by Social and Information Exchange 
Individual actors in the relationship between customer and supplier were involved in many 
informal performance measurement processes. Interactions occurred between individuals 
from the suppliers, such as sales representatives or product specialists and individuals from 
the customer at the local level such as clinician decision makers. Visits were arranged and 
exchanged, with opportunities to see and trial the product. These are represented in the 
interaction model as short-term episodes in which information and social exchange occur 
and even the exchange of products, though not on a sale basis (IMP Group 1982). Social 
exchange is also described as occurring to gather information (Uzzi 1997). Reviewing the 
finding in the light of the literature suggests that social and information exchange to 
measure performance could actually be considered as a performance management process, 
as it is broader than the fundamental process of performance measurement (Lebas 1995) as 
described by Farbey et al. (1993 pp75-94). In other words, they are used to gain 
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information that has already been measured by another actor. The discursive sections in the 
latter part of this chapter will assess whether social and informational exchange is a 
performance measurement or a performance management process, towards the end of 
refining the conceptual model. Social and informational exchange is discussed further in 
the next section on measuring performance as part of the purchasing process. 
 
7.2.5. Measuring Performance as Part of the Purchasing Process 
Many of the performance measurement processes occurred as part of a purchasing process, 
to which the purchasing and supply management literature provides some background. 
Performance measurement processes in purchasing are described by Webster and Wind 
(1972 pp28-37,89-106). As part of their general model of organisational decision 
processes, they describe how organisations evaluate alternative buying actions, before 
eventually selecting a supplier in a purchasing decision. At the fundamental level they 
describe the process as one of: “…comparing the characteristics of the available 
alternatives against the criteria established when specifications and schedules were set.” 
(Webster & Wind 1972 p32). This implies that performance measurement occurs in a 
formal tender process as in the CT scanner case.  
 
A less formal side to the purchasing decision-making process is seen in Webster and 
Wind’s discussion of the buying behaviour of individuals in the buy group, indeed they 
comment that all organisational buying behaviour is actually individual buying behaviour. 
As part of this model they refer to cognition, described as a process of receiving and 
interpreting information from the environment. Cognition is followed by decision models. 
The overall model of buying behaviour describes the less formal process by which many of 
the individual clinician decision makers, such as DSNs, therapists, GPs or the clinician 
members of the purchasing team in the CT Scanner case, gather and store information from 
the environment on the performance of the innovative products, for use in a purchasing 
decision. As above, Uzzi (1997), Nohria (1992) and Granovetter (1973, 1985) all 
highlighted the role of social exchange in weak ties between organisations which are used 
to gather information from performance measurement. Similarly, Zaltman et al. (1973 
pp60-66) refers to knowledge and awareness by potential adopters of an innovation, who 
then go on to form an attitude towards the innovation before a decision is made to buy or 
implement the innovation or not. These less formal processes are described further in 
behavioural literature from fields such as psychology, where concepts such as reward are 
discussed. Key research in the area studies how different types of reward are processed 
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over different timescales and how this influences the behaviour of individuals, such as 
purchasing decision makers (Cohen & Blum 2002). 
 
The evidencing literature has also focussed on decision-making, with regards to medical 
(Sackett et al. 1996), public policy (Muir Gray 2004a pp11-18, 65-100) or management 
(Pfeffer & Sutton 2006) decisions. The purchasing decisions made in the cases could be 
considered a management decision in the light of Pfeffer and Sutton (ibid.), however those 
made by individual clinicians are also decisions about medical treatments and techniques, 
as discussed by Sackett et al. (ibid.). In both fields the evidence-based literature describes 
how the best available information from within and outside the organisation must be 
gathered, information about the performance of the product. The different types of 
evidence discussed in the various evidence-based fields also emphasise the breadth of 
types of evidence, or performance measures that can be used. Indeed, the findings 
highlighted how actors gather information from other organisations, make assessments on 
the basis of their own experience or internal evidence and use a wide variety of types of 
evidence. This is not to say that the approaches observed were all evidence-based as 
defined by the literature, but that many of the performance measurement processes 
identified empirically are reflected in the emerging literature stream. 
 
7.2.6. Use of Both Objective and Subjective Measures 
A look at the performance measurement processes identified in the empirical work, 
particularly those involved as part of the purchasing process, shows that many were not 
formal, explicit processes but softer and more subjective. The literature goes some way to 
explaining this in the different views of measures and measurement it contains. For 
example the technical measures used by the evaluation centre were mostly hard, objective 
and carried out from a natural sciences viewpoint. On the other hand, many of the softer 
measures in the cases at the point of purchase, such as clinicians determining the most 
appropriate product for a particular patient were softer, qualitative measures of intangibles, 
being carried out from a social sciences viewpoint. The different approaches to 
measurement reflect the contrast between Chandlerian objective planning and control 
views (Chandler 1977 pp484-502) and Mintzbergian view (Mintzberg 1996) which 
emphasises softer aspects. 
 
To summarise, Table 35 shows observations about performance measurement as described 
by respondents in the case studies, interpreted in the light of the existing literature where 
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possible. The next section then continues the chapter by describing the performance 
management processes observed in the cases, in the context of the existing literature. 
 
Performance 
Measurement Process 
From Cases 
View of the Existing Literature Empirical Finding in 
Context of Existing 
Literature 
Performance Measurement Processes 
Measurement of 
financial 
performance of 
product; sales, market 
share, internal 
accounting measures. 
Cost of purchase and 
over lifetime, effects 
on care pathway. 
• Financial performance measures 
have long history (Ridgway 1956). 
• Management accounting focuses on 
financial measures (Johnson & 
Kaplan 1987 pp253-262).  
• Cost-benefit modelling (eg 
Thompson & Duintjer Tebbens 
2006). 
As suggested by literature, 
measurement of the 
financial performance of 
products occurred. 
Measurement of 
technical 
performance of 
product; technical 
evaluation by 
customers, supplier 
measures technical 
performance during 
innovation process. 
• Hayes & Wheelwright (1984 pp361-
371) defect prevention and awareness 
or monitoring. 
• Slack et al. (2007 pp39-54) refer to 
quality as performance objective. 
• Tidd et al. (2005 pp561-569) and 
Chiesa et al. (1996) measure the 
performance of innovation.  
• Belsey & Snell (2003 pp1-6) 
describe medical evidence. 
Actors measure broader 
aspects of product 
performance, as suggested 
in the literature. 
Respondents measured 
technical performance for 
their need, reminiscent of 
measuring quality and the 
evidence based medicine. 
 
Measurement of 
customer 
performance of 
product; customer 
assesses performance 
of product for their 
needs. 
• Testing customer performance of 
product in product implementation 
(Tidd et al. 2005 pp393-394). 
• Measuring quality of life aspects of 
performance (Skevington 1999). 
Actors measure broader 
aspects of performance, as 
in the literature. Actors 
measured performance of 
the product for customer 
needs. 
Additional Observations on the Performance Measurement Processes 
Actors assess product 
performance by 
communicating and 
making visits 
• Social, information and product 
exchange occurs (IMP Group 1982). 
• Role of social ties to gain 
information (Uzzi 1997, Nohria 1992 
& Granovetter 1973, 1985). 
Findings highlighted 
exchange of information 
between actors in literature 
as a way of measuring 
performance. 
Measuring 
performance as part 
of the purchasing 
process; by buy group 
members 
• Organisations evaluate alternative 
buying actions in decision processes. 
Individual buying behaviour involves 
cognition, decision-making. 
Individuals measure performance. 
(Webster & Wind 1972 pp28-37,89-
106).  
• Behavioural aspect to assessing 
rewards (Cohen & Blum 2002). 
Performance is measured as 
part of the purchasing 
process. Returning to the 
literature confirms product 
information is gathered as 
part of purchasing process. 
Performance 
measurement 
processes focus on 
both harder, 
objective and softer, 
more subjective 
measures 
• Views on measurement reflect either 
objective planning and control 
approaches (Chandler 1977 pp484-
502), or softer aspects (Mintzberg 
1996). 
Empirical findings 
emphasise the qualitative, 
subjective nature of many 
processes that have 
received less emphasis in 
literature. 
Table 35. Summary of Observations About Performance Measurement Processes 
from the Cases Interpreted with the Literature. 
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7.3. Performance Management Processes 
As in the previous section, the variety of performance management processes that were 
observed in the empirical work are discussed in the light of the performance, innovation 
and purchasing and supply management literatures. The processes were identified 
empirically in the light of the existing literature as being planning and control processes 
that are broader than, or follow up performance measurement (Halachmi 2005, Lebas 
1995). They are discussed broadly in terms of key themes identified empirically in the 
analysis and also discussed in the literature, which are dissemination of information from 
performance measurement, purchasing and supply decision making or re-innovation of the 
product. 
 
7.3.1. Dissemination of Information from Performance Measurement 
Following the performance measurement processes described above, the cases displayed a 
follow up process where the information produced was processed and disseminated to 
other actors or organisations. Similarly, actors shared information on the performance of 
the product by offering training and giving feedback to other actors or organisations. 
 
As discussed above, the literature describes informational exchange between customer and 
supplier (IMP Group 1982), including the customer gathering information about the 
performance of the product from the supplier, or the supplier giving the customer 
information about the performance of the product. Social exchange also occurred with a 
similar purpose of disseminating performance measurement information, for actors to 
gather information about the performance of the product. Indeed social and information 
exchange can be considered a performance management process, as it involves 
disseminating information from performance measurement, a broader process (Lebas 
1995). Further, the evidence-based literature advocates building a range of evidence from 
both inside and outside the organisation in a format upon which to make an informed 
decision. This process inherently involves the transfer of information between 
organisations and the creation of databases, for example, to store the information (Bambra 
2005). Processes of data analysis, tabulation and comparison are widespread in the 
literature. The research methods literature as a whole describes processes and protocols for 
data analysis in various scientific and social scientific fields, underlying many of the 
processes carried out by the evaluation centres. Also, the more specific management 
literatures drawn upon in this study include tools for analysing performance measurement 
data by collating, tabulating and displaying it, for example the Balanced Score Card (BSC) 
(Kaplan & Norton 1992), though use of the BSC was not discussed by any of the 
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respondents. A theme in the literature on performance measurement as a whole advises 
how information from measures should be displayed. For example, discussion of 
performance measurement in the literature focuses on appropriate selection and 
implementation of measures (Neely 1997), the latter including recommendations that 
measures should for example provide information rather than raw data (Fortuin 1988) and 
ensure visual impact (Lea & Parker 1989). The latter is reflected in the improved outputs 
for the end user developed by the Evaluation Centre in the blood glucose meter case where 
a shortened colour table buyer guide was introduced (Device Evaluation Service 2005). 
The outputs of the Evaluation Centre evaluations were also disseminated using the internet, 
including in online tools and databases. The literature describes the use of tools to manage 
performance following performance measurement (Hume & Wright 2006). Further to these 
processes of disseminating information from performance measurement, only one of the 
evaluation centres in the four cases was prepared to offer prescriptive advice on the basis 
of their evaluation as to whether the product should be bought or not. In this vein, Webster 
and Wind (1972 pp28-37) refer to members in the buy group with an influencing role, such 
as the evaluation centre in question, upon the decision-makers, such as the GPs in the ECG 
monitor case. The NHS Supply Chain or PASA staff issues purchasing advice to buyers at 
the local level. This was another form of influencing within the buy group, again involving 
informational exchange between customer and supplier actors. 
 
Feedback was another follow up process to performance measurement that is also found in 
the literature. Many of the models of innovation discussed in the literature review feature a 
feedback loop, by which information from the latter stages of the innovation process, those 
that often involve customer actors is fed back to the earlier stages. Zaltman (1973 pp71-77) 
describes feedback as part of the innovation process, while Tidd et al. (2005 pp88-97), the 
OECD (1992 p25) and other models have also featured feedback loops between the various 
stages of the process. Indeed, Rothwell’s (1992) five generations of innovation models 
recognise that feedback loops occur from the different elements in the models from the 
third generation onwards. Feedback is a concept found in the performance literature as well 
as the innovation literature, where research has highlighted that effective performance 
measurement systems involve feedback of information on the performance of the product 
(Fortuin 1988, Globerson 1985). The latter describes how feedback closes the management 
loop, again suggesting that information is exchanged between organisations and actors as 
in the innovation literature and as was observed empirically. 
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Training was another form of exchanging information on performance measurement 
between actors (Lebas 1995). While literatures beyond the scope of this study such as 
human resource management refer to training extensively, there is less discussion in the 
literatures drawn on here. However the innovation literature refers to training of 
individuals in organisations to cope with operating a new piece of equipment and training 
has been associated with innovation capability in much existing research (Leonard Barton 
1992, Robinson & Schroeder 1993). Much of this literature concentrates on the individual 
actor, as was observed in the empirical work where the training was given to the patient or 
clinician user of the innovative product. The empirical work found that much training 
occurred between individual actors, which was also found to be a key influence upon 
adoption of new technologies in the supply literature (Reunis et al. 2004), though in this 
example from an intra-organisational perspective. 
 
7.3.2. Making the Purchasing Decision 
The purchasing and supply management, and the innovation theory bodies both shed some 
light on making the purchasing decision. 
 
Making the Purchasing Decision in the Purchasing and Supply Management Literature 
The purchasing and supply literature includes a lot of work on the strategy of purchasing 
and supply with implications for purchasing decisions, though a smaller amount has 
studied making the purchasing decision. Additionally, the emerging evidence-based 
literature highlights how the performance literature refers to using performance 
measurement information in making a purchasing decision. Much of the work on decisions 
has involved strategic decision making from an economics and operations research 
standpoint (Tamura 2005), rather than a purchasing and supply or organisational behaviour 
viewpoint. Overall, information that had been gathered was analyzed and a decision then 
taken, as highlighted in the literature review (Webster & Wind 1972 pp12-39, 77-107, 
Harland et al. 2004, Biemans 1992 p48, Rogers 2003 pp169-194). As stated in the cross 
case findings, making the purchasing decision can take the form of a tender process, or 
decision-making by an individual clinician or user. The tender process is discussed in the 
purchasing literature, with a focus on tendering in public purchasing and compliance or 
non-compliance with the process (Gelderman et al. 2006). Key parts of the tender process 
include scoring and weighting of performance measurement data, decision-making 
involving a committee of clinicians and managers set up especially for the task as a formal 
buy group (Webster & Wind 1972 pp28-37) and debriefing of suppliers. The roles of 
members of the buy group were identified amongst the interviewees in the four cases, 
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however they can also be applicable to the members of the buying committee in the CT 
scanner case. Webster and Wind (1972 pp77-87) refer to the buying committee as a group 
decision-making process, as well as to decision stages and roles in the buying centre. 
Members interact with inter-personal influence occurring as part of making the purchasing 
decision. 
 
Less formal decision-making about whether to purchase the innovative product or not, or 
which product to purchase from a range of competing products, also occurs. The most 
useful literature in this respect is that covering behavioural decision-making, a number of 
examples of which are given here. Lindgreen and Wynstra (2005) reviewed literature 
describing how customers trade off different value offerings in making the decision of 
which product to purchase. As discussed above, Webster and Wind (1972 pp28-37, 89-
106) describe not only how individuals evaluate the various options in purchasing, but also 
how the decision is made, with relevance for the processes carried out by the individual 
clinicians in the cases. Webster and Wind (ibid. pp88-107) described how buyers have a 
variety of predispositions, preferences and decision models, influencing the outcome of the 
individual’s decisions as shown graphically in the literature review. The description sheds 
some light on the subjective nature of the decision-making that many clinicians and other 
purchasing decision-makers were observed to be undertaking. It describes how the 
individuals responded behaviourally to various stimuli, including information from 
performance measurement and the input of supplier sales representatives. 
 
Having reviewed the behavioural decision-making literature, Mantel et al. (2006) highlight 
that the key factors of decision making with relevance to supply managers are task related 
characteristics of the decision, personal characteristics of the decision maker and 
contextual characteristics for the decision. Different information used to make the decision 
can be emphasised or discounted in the process and the way in which performance 
measurement information is presented to the decision maker may result in them noticing or 
ignoring it (Tversky & Kahneman 1974). The ease of the individual visualising a possible 
outcome of the decision and their response to risk, including when making decisions about 
medical treatment (Tversky & Kahneman 1986) also influence the decision. Mantel et al. 
(2006) discovered the importance of individual humans, rather than organisations in 
making decisions in a supply context, where the source and nature of information plays a 
role in its take up, with informal information being used in particular. This backs up the 
empirical observations that many of the purchasing decisions were made by local level 
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clinicians in the NHS on the basis of their own subjectivity and experience and further that 
some performance measurement information was used and others not. 
 
Decision-making is described as a key part of networking (Grandori & Soda 1995). 
Harland et al. (2004) point out that much less research has looked at the process in supply 
relationships and networks than in the organisational behaviour field, however decision-
making can be a challenge where information is dispersed and there is a lack of a clear 
structure of authority. Further, decision-making processes often take the form of 
combining objectives and information, with established routines and processes emerging, 
as found empirically with the decision making of individual clinicians or the Trust tender 
process in the CT scanner case. Puto (1987) reinforces the point about objectives, but 
describes reference points which individuals use to compare performance, which is 
reminiscent of the empirical data where buyers compared the performance of the product 
against a particular standard. The network pictures and range of decision making 
respondents highlight the lack of authority structure in the cases, while the various 
exchanges of performance measurement information that occurred reinforce the suggestion 
that information for decision making is dispersed. The environment and atmosphere of the 
firm also influences decision making in relationships (IMP Group 1982), though the 
literature is not clear about the role of factors such as organisational climate (Qualls & 
Puto 1989), so the NHS context is perhaps better understood through Mantel et al.’s (2006) 
concept of supply context. 
 
From the performance literature, work on evidence-based themes also describes making 
the purchasing decision, using information from performance measurement. The focus is 
on the application of evidence in decision making (Kovner & Rundall 2006). The 
performance literature in general does not refer specifically to the purchasing decision, 
only to performance measurement and systems of performance management (Radnor & 
Barnes 2007), though the latter is sufficiently loose to cover processes of purchasing 
decision making. 
 
In summary, the literature reinforces the empirical observations that much decision-making 
making was carried out locally by actors in a subjective manner, using limited information 
from the network. 
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Making the Purchasing Decision in the Innovation Literature 
The innovation literature also discusses the decision to purchase the product through 
concepts such as adoption, diffusion and implementation, as discussed in the literature 
review. In studying the process of buying medical devices, Biemans (1992 pp129-140) 
gives eight steps, including recognising a problem, determining characteristics of the item 
needed, searching for and evaluating potential sources, then selection from those sources. 
The steps describe how performance measurement information is used in subsequent 
purchasing decisions. Rogers (2003 p170) also describes decision making stages in the 
innovation process and although it is predominantly from a supplier perspective, it 
demonstrates adoption or rejection options for the customer. 
 
Zaltman et al. (1973 pp53-55) reinforce Harland et al.’s (ibid.) point that decision making 
involves combining objectives and information, but with a specific focus on decision 
making individuals and the uncertain conditions in the innovation field. They describe how 
individuals will select different innovations by generating subsets of courses of action 
available, attaching consequences to each, ordering preferences and selecting the first 
choice that meets the minimum satisfaction sought in each of the preferences. The steps 
bear a similarity to Biemans (1992 pp129-140) in that they involve selecting from options 
against criteria, using performance measurement information. Although many buyers in the 
empirical work were attempting to choose the best product, not one that just satisfies the 
criteria, Zaltman et al. sheds some light on the subjective process the decision makers go 
through by identifying the consequences of their purchase decision. This suggests that 
clinicians generate an alternative course of action when communicating with others about 
the product or testing it, then evaluate the various types of performance consequences and 
deciding to buy or not buy the product or perhaps a competing product instead.  
 
Zaltman’s behavioural view of buying decision making by clinicians and others is 
consistent with the subjective assessment of various types of performance in the 
behavioural literature as described by Cohen and Blum (2002), above. Further, the 
behavioural studies of individual actors in supply relationships have discussed 
psychological contracts that develop trust and commitment (Kingshott & Pecotich 2007), 
as found at the local level in many cases between the supplier representatives and 
clinicians. 
 
The original literature review highlighted that there was limited knowledge on specific 
performance management processes. However a renewed look at the literature following 
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the empirical findings about making the purchasing decision has suggested that this is 
indeed a performance management process (Radnor & Barnes 2007) and has described it 
in more detail through existing research. To summarise, Bazerman (2005 pp1-10) 
describes the anatomy of a decision, involving problem definition, criteria identification 
and weighting, generation of alternatives, rating of alternatives on each criterion and 
finally computing the optimal decision. Given that the model assumes rational decision 
makers, he then points out the concepts of bounded rationality and simplifying 
assumptions or heuristics that are used by individuals in practice, reinforcing points made 
by other researchers, described above. Overall, the decision process reflects both formal 
processes such as the tender process in the CT scanner case, as well as shedding light on 
the way that individual buyers in other cases went through a similar process but in a more 
subjective manner influenced by heuristics in a bounded rationality. 
 
7.3.3. Product Innovation 
The literature provides plenty of background to the finding that performance of the 
innovative projects are managed by a process of product innovation. Although the 
innovative products studied in the cases had all been implemented in the marketplace, 
subsequent innovation occurred. This sub-section returns to the literature to look at how 
changes are made to the product during implementation as part of the innovation process 
and also at customisation of the product, as was observed in the empirical work. 
 
The process models of innovation discussed in the literature review describe how changes 
are made to the design of the product in both the initial implementation stage and once 
implementation has occurred and the product is in the marketplace. In their generic model 
of the innovation process, Tidd et al. (2005 pp88-97) referred to launching the product as 
involving sequential collection of information and problem solving towards the point of 
final launch. Some of the process models of innovation include stages of 
commercialisation (Booz et al. 1960 pp10-11, Adams et al. 2006), describing the activities 
of getting the innovative product accepted for implementation by the market. Studying 
medical devices, Shaw (1985) found that many or continuous interaction between suppliers 
and users were important for understanding the needs of the user through trials, to make a 
successful product.  An example from the empirical work is the alpha and beta testing with 
users carried out by the CT scanner supplier. 
 
Once the product has been launched, process models of innovation describe how learning 
from the performance of the product in the marketplace and the customer is used to sustain 
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the innovation (Tidd et al. 2005 pp88-97). This takes the form of learning from the 
performance of the product at the latter, implementation stages of the innovation process 
and then using that information to make more improvements to the design of the product or 
service package. This fits with recent literature describing innovation as an open 
(Gassmann 2006) and less linear (Collins 2006, Schoen et al. 2005) process. In the case 
studies, all suppliers were seen to gather information from the customer or user, even if 
only informally, which was then fed back to the head office or design team. Rothwell and 
Gardiner (1985) refer to subsequent improvements once the innovation has been launched 
as ‘re-innovation’ and point out the role of the user in this process, reinforcing seminal 
innovation literature on the role of lead or key users in product innovation (Von Hippel 
1986). 
 
Feedback is a key theme of the process models of implementation (Tidd et al. 2005 pp88-
97, Rogers 2003 pp169-194, Zaltman et al. 1973 p62-78) with the latter work having 
reviewed several such models, as well as in the performance literature (Globerson 1985). 
Feedback is also described as an important part of the purchasing process (Van Weele 
2002 pp14-17). Feedback involves gathering information about how the product performs 
from the customers, so that the lessons learnt can be used to improve the next generation of 
the product (Nonaka & Kenney 1991). The literature on feedback gives a context to the 
findings that information is gathered about performance of the products, before being fed 
back to the supplier. Schein (1970 p120) stresses that feedback is used to help 
organisations adapt, highlighting that feedback is used to then make changes to the 
product, or control the innovation process (Zaltman et al. ibid.). 
 
Indeed, many of the cases suggested that continuous improvement or continuous 
innovation (Boer & Gertsen 2003, Cole 2002) was occurring, as the supplier described a 
constant process of gathering feedback from customers and users and using this to improve 
the product. Imai et al. (1985) provide a neat summary of the point by suggesting that 
innovation is a dynamic process that is incremental, iterative and involves continuous 
learning about the product and adaptation of it to changes in the environment. This was 
seen in practice, where the product in every case had either been produced in several 
successively improved versions, or was an updated version of a previous, similar product. 
Boer et al. (2001) also refer to continuous innovation and reinforce the discussion of 
making product changes at different parts of the innovation process, above. They make the 
point that competition is encouraging companies such as the suppliers in the empirical 
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work to both learn and then apply the knowledge gained at an increasingly wide number of 
stages of the innovation process. 
 
In addition to the general literature on product innovation, customisation is discussed and 
helps illustrate the observations of suppliers customizing the product package for customer 
needs. This can be seen as a type of experiental innovation (Moore 2004) in which surface 
modifications are made to the product to improve the experience for the customer. Also, 
implementation (Tidd et al. (2005 pp88-97) of the product focuses upon changes made for 
particular customers.  
 
The literature on customisation is dominated by mass customisation in large scale 
manufacturing industries (Jiao et al. 2003), however some previous work has discussed 
customisation of products for individual customers. Stump et al. (2002) describes how 
suppliers frequently customise product offerings as part of the broader adaptation 
processes that occur in a relationship with the customer. In line with the social and 
informational exchange that occurred between customer and supplier individuals in the 
cases where customisation was noticed, Stump et al. (ibid.) point out that customisation: 
“…usually requires considerable seller-buyer interactions aimed at matching the seller’s 
technological capabilities with the buyer’s needs…”. As the relationships observed in the 
empirical work were found to be more collaborative between individuals at the local level, 
Hallen et al. (1991) comment that customisation is part of adaptation in collaborative 
relationships. Easton and Rothschild (1987) describe how organisations reach a limit where 
customisation is used so that the product is no longer supplier specified, but customer 
specified. Spring and Dalrymple (2000) concur that customisation involves exchange 
between customer and supplier actors, especially where the product is not just custom built 
as in the CT scanner case, but custom designed as in the example of the standing frame 
headrest. 
 
To summarise the discussion of performance management processes, Table 36 shows key 
performance management processes described by respondents in the case studies, 
interpreted in the light of the existing literature where possible. The processes identified in 
this section and the last section on performance measurement as well as in tables one and 
two are closely related, presenting the challenge of differentiating between the concepts of 
performance measurement and performance management. The processes have been 
included here in the findings as performance measurement or performance management 
according to the definitions given in the conceptualisation, focussing on performance 
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management as broader. On reflection however it is not clear whether some are 
measurement or management processes. For example communication with other actors to 
gather information about performance could involve gathering opinions to measure product 
performance, or could be a follow up or management process. Differentiating the two is 
further discussed as part of the next section on influences of the processes. 
 
Process From Cases View of the Existing Literature Empirical Finding in 
Context of Existing 
Literature 
Performance Management Processes 
Dissemination of 
Performance 
Measurement 
Information; Processing 
& disseminating of 
performance 
measurement data, 
Advice, Feedback, 
Training 
• Information exchange between actors 
(IMP Group 1982, Bambra 2005). 
• Tabulating and processing of 
performance measurement data (eg 
Kaplan & Norton 1992). Measures 
should provide information (Fortuin 
1988), be presented with impact (Lea & 
Parker 1989). 
• Feedback promoted following 
performance measurement (Globerson 
1985, Rothwell 1992). 
• Training of individuals (Leonard 
Barton 1992). 
Disseminating 
information from 
performance 
measurement often 
occurred after 
performance 
measurement, 
including feedback, 
training. Literature 
describes information 
exchange between 
actors, feedback and 
training.  
Making the Purchasing 
Decision; Purchasing 
decision made on the 
basis of performance 
measurement 
information, Purchasing 
tender process, decision 
making by individual 
actors at customer 
• Tender processes guided by 
regulations, compliance varies 
Gelderman et al. (2006).  
• Decision-making in the purchasing 
team, or by individual (Webster & 
Wind 1972 pp28-37, 89-106). 
• Information gathered, analyzed and 
decision taken (Harland et al. 2004) 
• Behavioural view of decision making 
(Bazerman 2005 pp1-10). 
• Key factors of decision-making for 
individual supply managers (Mantel 
2006).  
• Factors affecting, nature of decision 
making (Tversky & Kahneman 1986, 
Puto 1987, IMP Group 1982, Kovner & 
Rundall 2006. 
• Decision-making steps in adoption of 
innovation (Biemans 1992 pp129-140). 
Empirical findings 
identified making the 
purchasing decision as 
a key management 
process.  
Literature gives some 
information reinforcing 
how individuals use 
information in making 
purchasing decisions. 
 
Product Innovation; 
Product re-designed in 
response to performance 
measurement 
information, Supplier 
customises product 
package for needs of 
particular customer or 
user 
• Innovation is a dynamic process (Imai 
et al. 1985). 
• Feedback is gathered to improve the 
product (Nonaka & Kenney 1991). 
• Sequential information collection, 
problem solving (Tidd et al. 2005 
pp88-97).  
• Re-innovation (Rothwell & Gardiner 
1985).  
• Customisation involves considerable 
customer-supplier interactions (Stump 
et al. 2002). 
Findings showed 
process of innovating 
product does not finish 
after implementation, 
is improved with 
feedback on the 
performance of the 
product. 
Literature refers to 
iterative process, re-
innovation, 
customisation. 
Table 36. Summary of Key Performance Management Processes and Observations 
from the Cases Interpreted with the Literature 
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7.4. Influences of Processes in the Context of the Literature 
The influences of the performance measurement and performance management processes 
were identified in the exploratory empirical work and subsequent analysis, however 
returning to the literature provides some background to the empirical findings. This is 
highlighted first, followed by discussion of the empirical findings in the light of a key issue 
stated in the literature, namely how the empirical findings can be used to draw a conceptual 
distinction between performance measurement and performance management processes. 
Findings are discussed with respect to literature concepts that performance management is 
broader than or involves follow up planning and control action on performance 
measurement (Halachmi 2005, Lebas 1995); or that performance management influences 
performance, unlike performance measurement (Bourne et al. 2005, Halachmi 2005, 
Melnyk et al. 2005). 
 
7.4.1. Influences of the Performance Measurement and Performance Management 
Processes 
The previous chapter highlighted a number of overall influences which the performance 
measurement and performance management processes had in performance of the 
innovative product. The particular influences described by respondents were first described 
conceptually, then grouped in various ways until groups of beneficial, non-beneficial and 
no influences were identified as the clearest clusters. This sub-section discusses the 
conceptual influences identified from respondents across the cases in the light of the 
literature. Only influences identified in a pattern across more than one case are included 
here, as stronger findings. Discussion of the clusters takes place as part of examining 
conceptual distinctions between performance measurement and performance management 
in the following sub-section. 
 
Product is Purchased or Not 
Many of the influences discussed by respondents are to do with the purchasing decision 
and using the performance measurement information in that purchasing decision. In their 
success measures for product development, Griffin and Page (1996) describe aspects of 
success that actors in the cases derived from the outcome of the purchasing decisions 
taken. For example, ‘met profit goals’ and ‘return on investment’ describe some of the 
financial performance outcomes for the suppliers if the decision was made to purchase the 
product. Also, ‘customer satisfaction’ and ‘customer acceptance’ describe some of the 
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customer performance outcomes that the clinician and patient users of the NHS gain from 
the product if it is bought. 
 
Some of the literature referred to above, describing the use of performance measurement 
information in purchasing decisions also implies the influence of these processes in 
performance of the product. Indeed, the process based models of buying behaviour 
(Webster & Wind 1972 pp12-39) and innovation (Zaltman et al. 1973 p62-78) assume an 
operations management ‘planning and control’ view of a process with inputs and outputs 
(Godwin et al. 1989). The outputs of the buying behaviour models described by Webster 
and Wind (ibid.) are whether particular tasks were completed or problems solved. In 
innovation models, the literature refers to whether a product was adopted or rejected 
(Rogers 2003 p170) and its implications for a successful innovation and either the supplier 
to gain a competitive edge with competitors, or for the NHS customer to get a better edge 
when tackling healthcare problems (Tidd et al. 2005 pp39-41). Most of the innovation 
literature concentrates on innovative product performance at the level of the firm rather 
than the product, however literature reviews studying success of new product development 
(Ernst 2002) and new industrial product performance (Lilien & Yoon 1989) suggest that a 
successful innovation is one that leads to success for the organisation as an innovator. 
Yoon and Lilien (1985) refer to a successful product as one that achieves good sales 
performance, while Maidique and Zirger (1984) suggest that successful innovative 
products are better matched to the needs of the user, amongst other aspects of performance. 
 
The literature discussed in preceding sections has described how the source and nature of 
information dictates whether it is used or not in the purchasing decision by a particular 
decision maker (Mantel et al. 2006). When this is considered along with the various 
influences on a purchasing decision in the behavioural literature, the previous research has 
described how the purchasing decision and the information on which it is based has had an 
influence in the performance of that product for the various actors involved. 
 
Product Can be Purchased or Not for Short-Term, Cost Based Rather than Broader 
Reasons 
Respondents in all cases described how the product could be purchased, but for short-term 
reasons with a focus on cost. In this finding a different influence of the purchasing decision 
and information involved occurred, in buying a lower cost product. Referring back to the 
behavioural decision-making literature, this suggests that the decision taken was different, 
that the information involved was different or perhaps something in the decision context. 
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Melnyk et al. (2005) found that actions that encourage reducing costs can adversely affect 
broader actions intended to promote innovation, unintentionally. The evidence-based 
literature also sheds light on the issue, illuminating the role described by many of the 
respondents. It suggests that decisions should be based on the best available evidence and 
logic from both inside and outside the organisation (Pfeffer & Sutton 2006). If a product is 
bought for short term reasons on the basis of cost evidence alone, rather than broader 
aspects of technical or customer performance, the evidence-based literature suggests that 
the decision made is not evidence-based, through using insufficient or inadequate 
performance measurement information or the context of the organisation where that 
decision was taken. Gershon (2004 pp5-8, 35-36) and others highlighted the need to 
achieve cost efficiencies in public purchasing and many of the cases indeed showed that 
cost of the innovative product limited whether it could be bought or not, for example the 
standing frame, while Tzokas and Saren (1992) suggested that customer receptivity to 
innovations is a factor affecting their uptake. However the context in which the decision 
was taken is something that was not sufficiently described in the empirical data and is 
discussed in the limitations part of the next chapter. Purchasing decisions that are not 
evidence-based may have a non-beneficial effect on performance, as the product chosen is 
not the one that performs optimally for the particular need according to the best available 
evidence. 
 
Performance Measurement Information is Not Used in the Purchasing Decision 
Just as the empirical work found that performance measurement information was used in 
purchasing decisions, so too were there instances described across the cases where 
performance measurement information was not used when a purchasing decision was 
taken. Explanation is provided by Mantel et al.’s (2006) finding that the importance of the 
source and nature of the information available affect it’s take up in decision making. For 
example, Evaluation Centre reports were variously used or not for diverse reasons such as 
their format, availability, cost and timeliness. Lengel and Daft (1988) describe how 
impersonal media such as static reports are less rich than more personalised media. In 
short, the behavioural decision-making literature suggests that the nature of the 
performance measurement information, coupled with other contextual influences of the 
decision, can mean that information may be used in some purchasing decisions but not 
others. Accordingly, in each case, performance measurement information was used for 
some purchasing decisions, but not others. 
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Product Design Improved 
The literature discusses how the innovation process including re-innovation and 
customisation processes changes the design of the resulting products. Rothwell and 
Gardiner (1988) describe states of technical change of a product, which progresses from 
the basic idea, through invention to innovation and then finally to re-innovation. The last 
step, reflecting the empirical data, involves a process of re-design, meeting the central 
design issue of whether the product can be made: “…better or cheaper or both…”. 
Feedback loops in the innovation process have been described as important so that 
emerging problems with products, such as the design issues with the blood glucose meter 
and ECG monitor, can be dealt with effectively (Zaltman et al. 1973 pp70-78). Similarly, 
Olsen et al. (2007) referred to the importance of performance measurement in monitoring, 
controlling, evaluation and feedback management functions. Further, it is not only design 
problems that are resolved by performance measurement, feedback and re-innovation, but 
the design of the product is continuously improved. Boer et al. (2001) describes how 
organisations can improve their competitive advantage from product innovation by moving 
from isolated projects to continuous innovation, utilising learning and knowledge from 
within and outside the organisation. 
 
Customisation, as observed in the standing frame and CT scanner cases, is also described 
in the literature as improving performance of the product for particular customers or users. 
Athaide & Stump (1999) point out the benefits of customisation from the point of view of 
suppliers, who can gain a source of competitive advantage and the means to offer 
improved value to the customer. Stump et al. (2002) highlights that customised products 
are beneficial as they more closely meet idiosyncratic needs from the point of view of the 
customer. Spring and Dalrymple (2000) relate customisation to performance, by its 
influence in improving the operating characteristics of the product. 
 
Feedback to the Supplier is Not Used 
Feedback was found to be a key process with an influence in improving the design of the 
product as described above. However, the empirical data also found that feedback was not 
used. Given that feedback involves the dissemination of information from performance 
measurement, the finding that use of feedback to improve the product varies is similar to 
the findings that use of performance measurement information in making the purchasing 
decision varies. The innovation literature promotes action on feedback to improve the 
product, suggesting that many organisations do not act upon their feedback, however the 
above finding suggests otherwise for the organisations in the case studies. Again, Mantel et 
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al.’s (2006) finding is of relevance, that the type and source of information influences how 
it is used by decision makers in the innovating organisation. The point about the source of 
information is of interest, as feedback was gathered through the supplier’s own 
representatives, as well as being given by customers themselves. It is possible that supplier 
actors as behavioural actors are more likely to use information from staff in their own 
organisation. Zaltman et al. (1973 pp70-78) do not only state the importance of feedback in 
the innovation process as described above, they emphasise that: “…although the creation 
of feedback mechanisms is a prerequisite for adequate handling of emerging 
implementation problems, it is not in itself a “safeguard” assuring such handling. The 
information that the feedback mechanisms provide must be interpreted to become useful.” 
(p77). This makes the point that measuring the performance of the product and 
disseminating that information is only of use if action is then taken. 
 
Training is Necessary for Patient to Gain Benefits of Product Use 
The empirical findings emphasised the importance of training for the user to gain the 
benefits of using the product. Training is discussed in the literature, though largely from 
the point of view of a supplier organisation training staff, rather than product users. 
However the work makes the point that staff in organisations must utilise knowledge and 
skills about a product or process for the organisation to make the most effective use of the 
innovation (Pfeffer 1994). This point could apply to the NHS actors who make use of 
innovative products purchased by the organisation. Indeed, Bessant and Buckingham 
(1993) state that training is a key determinant of whether an innovation is implemented 
successfully. The article has relevance for innovative products that are potentially used 
throughout the NHS, such as those in the empirical case studies. 
 
The finding about the importance of training also highlights the importance of using the 
product, or action. The performance literature in particular emphasises action on feedback 
by closing the management loop (Globerson 1985) and the broad concept of performance 
management as taking action on measures (Neely et al. 1997). At a fundamental level, the 
use of the product represents a proactive part of a planning and control view of 
management (Mintzberg 1990). 
 
Compliance With Use of the Product is Needed 
Further to the above point that action must be taken on feedback, the findings raised the 
issue that not only must a suitably performing product be bought for the customer, but it 
must actually be used. Again this picks up on the concept of action on performance 
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measurement from the performance literature, but also touches on the concept of 
compliance in medicine. Cramer et al. (2008) reviewed research into patient compliance 
with a variety of clinical treatments, including in the diabetes and cardiac areas. They 
found that good compliance beneficially influenced clinical outcomes in 73% of the studies 
reviewed, yet there is a significant problem presented by non-compliance, particularly for 
cardiovascular and diabetes medications. This influence highlights compliance, or using 
the product, as a further performance management process involving taking action 
(Halachmi 2005, Neely et al. 1997, Globerson 1985), that is important if the previous 
performance measurement processes and performance management processes such as 
purchasing the product are to have an influence on performance. 
 
To summarise the discussion of the influences, Table 37 shows the key influences 
identified in the cross case empirical findings, interpreted in the light of the existing 
literature. 
 
7.4.2. Conceptual Distinctions Between Performance Measurement Processes and 
Performance Management Processes 
The original literature review highlighted that there is little clear conceptual distinction 
between the terms performance measurement and performance management. This sub-
section discusses conceptual distinctions between the terms in the light of the empirical 
findings. Firstly, it looks at performance management as broader processes than 
performance measurement, then it looks at another literature theory of performance 
management as taking follow-up planning and control action upon measures, where a 
performance change occurs. 
 
Performance Management as Broader then Performance Measurement 
The existing literature suggested that performance measurement is a sub-system of 
performance management (Halachmi 2005), a concept also developed by Lebas (1995) and 
used in the conceptual framework. If performance measurement is defined as: “…the 
process of quantifying the efficiency and/or effectiveness of an action.”  (Neely et al. 
2005), then any process broader than that quantification must be performance 
management. Actors measured technical aspects of the products using instruments to gain 
a quantification of the way that they acted, such as testing the radiation dose of the CT 
scanner using a dosimeter, which gave a quantitative score of the amount of radiation 
emitted by the product, a key parameter of interest to clinicians operating it. Financial 
performance was also measured by the actors according to this definition, for example 
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calculating the sales levels or return on investment, a quantification of the efficiency and 
effectiveness of a commercial product. Customer performance was measured, an example 
being the market research carried out for the blood glucose meter supplier involving 
quantitative surveys of opinion of product users. 
 
Influence, From 
Cases 
View of the Existing Literature Empirical Finding in 
Context of Existing 
Literature 
Product is 
Purchased or Not 
• Success measures the organisations gain or 
lose when product is purchased or not 
(Griffin & Page 1996). 
• Outputs of buying behaviour models are 
whether tasks completed or problems solved 
(Webster & Wind 1972 pp12-39). 
• Whether a product was adopted or rejected 
by customer (Rogers 2003 p170). 
• Source and nature of information dictates 
use or not (Mantel et al. 2006). 
Many of processes have 
an influence on whether 
the product is purchased 
or not. Literature 
reinforces that purchasing 
decision, using 
information from 
performance 
measurement determines 
whether product is 
purchased or not. 
Product Can be 
Purchased or Not 
for Short-Term, 
Cost Based 
Rather than 
Broader Reasons 
• Evidence-based decisions are imperative, 
they are based on the best available 
evidence and logic from inside and outside 
the organisation (Pfeffer & Sutton 2006). 
Short-term, cost based 
reasons can influence 
whether the product is 
purchased or not. 
Evidence-based literature 
suggests explanation. 
Performance 
Measurement 
Information is 
Not Used in the 
Purchasing 
Decision 
• Source and nature of performance 
measurement information dictates use or not 
in purchasing decision by a particular 
individual (Mantel et al. 2006). 
Literature also reinforces 
the finding, as the nature 
of information dictates 
use. 
Product Design 
Improved 
• Re-innovation see if product can be made 
better, cheaper or both (Rothwell & 
Gardiner 1988). 
• Feedback deals with emerging product 
problems (Zaltman et al. 1973 pp70-78). 
• Customisation gives competitive advantage, 
means to offer improved value (Athaide & 
Stump 1999), products that more closely 
meet needs (Stump et al. 2002). 
Findings are supported 
by literature concepts of 
re-innovation on the basis 
of feedback, and 
customisation. 
Feedback to the 
Supplier is Not 
Used 
• Information from feedback mechanisms 
must be interpreted to become useful 
(Zaltman et al. 1973 pp70-78). 
Both suggest information 
from performance 
measurement, including 
feedback may not be 
used. 
Training is 
Necessary for 
Patient to Gain 
Benefits of 
Product Use 
• Training is key to implement successfully 
(Bessant & Buckingham 1993). 
• Importance of action on measures (Neely et 
al. 1997, Globerson 1985). 
Literature concurs with 
empirical findings that 
training is important for 
successful use of an 
innovation. 
Compliance With 
Use of the 
Product is 
Needed 
• Importance of action on measures (Neely et 
al. 1997, Globerson 1985). 
• Compliance beneficially influences clinical 
outcomes (Cramer et al. 2008). 
Literature reinforces 
empirical findings that 
action on measures is 
important. 
Table 37. Summary of Key Influences of Performance Measurement and 
Performance Management Processes from the Cases Interpreted with the Literature. 
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Many broader processes than those suggested by Neely et al. (2005) were encountered in 
the empirical work, while the literature is explicit about feedback (Globerson 1985) and 
follow up action (Neely et al. 1997, Zaltman et al. 1973 pp70-78). A tighter definition of 
what Neely et al. (2005) might mean by quantification, yet allowing for qualitative 
measures described by others (e.g. Kaplan & Norton 1992) is given by Farbey et al. 
(1993), describing a system preserving the difference between a set of entities by using a 
set of symbols. Farbey et al. (ibid.) give a more limited description of the actual process 
measurement consists of and again many of the processes described by respondents in the 
empirical work were broader than this, such as disseminating information from 
performance measurement, gaining feedback from suppliers and various types of action on 
the information. However a criticism of the work is that it does not reflect the subjective 
nature of many performance measurement processes as found in the empirical work and 
discussed elsewhere in the literature (Baker et al. 1994), such as social exchange between 
actors (IMP group 1982). Such processes go against many of the recommendations on 
measuring performance, such as being objective rather than based on opinion (Fortuin 
1988) and being clearly defined (Globerson 1985). However it still involves a process by 
which aspects of product performance are measured according to Farbey et al. (1993), 
aspects that are often eventually scored, or quantified in the CT scanner case for example. 
Given the subjective nature of many of the measurement processes observed in the 
empirical work and having observed that many interview respondents used the two terms 
interchangeably, implies that the boundary between the two concepts is not clear cut. For 
example, there is the challenge of determining where a subjective performance 
measurement process, of social exchange between a supplier representative and clinician, 
instead becomes a broader performance management process of disseminating information. 
Also, feedback can be interpreted in the light of existing literature as a way of measuring 
performance as it involves quantifying or qualifying an aspect of the performance of a 
product. However the literature could also be used to interpret it as a broader management 
process. 
 
Defining performance management as a broader concept than performance measurement 
reveals performance measurement to be a narrow and limited subset of performance 
management. However the empirical data suggests that the boundary between the two 
concepts is blurred so another theory from the literature of differentiating the two concepts, 
on the basis of their influence on performance, is discussed next. 
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Performance Management as Taking Action on Measures, Where a Performance Change 
Occurs 
As discussed above, performance management has been described as taking action upon 
performance measures (Neely et al. 1997, Zaltman et al. 1973 pp70-78), with the literature 
suggesting that performance management processes are those that have an influence on 
performance (Halachmi 2005, Bourne et al. 2005, Kaplan & Norton 1996) through the 
action taken. Halachmi (ibid.) writes: “…to challenge the notion that simple performance 
tracking by itself is capable of improving performance…in order to advance performance 
there is a need to manage performance rather than simply measure any given aspect of 
it…”, going on to describe management as involving decisions about using resources 
efficiently and effectively, planning and controlling to achieve results that are desired. 
Melnyk et al. (ibid.) implies follow up processes of performance management by stressing 
the importance of linking performance measurement metrics with value drivers and 
strategy. They quote Ittner et al. (2003a) as having found that improved alignment 
improves performance of the firm. Kaplan and Norton (1996) move on from their original 
focus on performance measurement to look at how to use their balanced scorecard as part 
of a strategic management system. Robson (2005) concurs, emphasising the importance of 
following performance measurement with action as part of a control and process system if 
improvements in performance are to be achieved. Overall, these definitions of performance 
management concern processes that organisations use to control performance, as reflected 
in overall views of the concept of management as involving planning and control 
(Mintzberg 1990, Slack et al. 2007 p24-25). 
 
The processes that are broader than performance measurement alone as discussed above 
involve some sort of action that follows performance measurement and can therefore be 
described as performance management processes in the light of the literature just 
discussed. These processes include disseminating information from performance 
measurement, feedback (Globerson 1985, Fortuin 1988, Van Weele 2002 pp14-17), 
making the purchasing decision (Webster & Wind 1972 pp28-37, 89-106, Bazerman 2005 
pp1-10) and re-innovation of the product (Rothwell & Gardiner 1985) for example. 
Globerson (ibid.) emphasises the necessity of feedback as part of effective management 
planning and control for example, while Rothwell & Gardiner (ibid.) describe re-
innovation in the manner of management as a planning and control process. However the 
empirical data gathered shows that the performance measurement and performance 
management processes vary in the influence they have on performance. 
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Where an influence on performance occurred, the empirical data suggested that both the 
basic performance measurement processes (Farbey et al. 1993, Neely et al. 2005) and 
follow up performance management processes involving action on performance 
measurement data were present. For example, information from performance measurement 
processes was used in making the purchasing decision, the processes together having an 
influence on whether the product was bought or not. Information from performance 
measurement processes was also used in a re-innovation process, the processes together 
having the influence of improving the design of the product. Further emphasising the 
importance of performance management processes, action had to be taken to comply with 
use of the product and train the user if the product was to perform for the customer or user, 
highlighting that more, proactive performance management processes are needed as well as 
performance measurement processes if they are to have an influence on performance 
(Halachmi 2005, Bourne et al. 2005, Melnyk et al. 2005). If information from performance 
measurement is used in a purchasing decision and they together have an influence on 
performance, the empirical findings suggest the breadth of information used will influence 
whether the influence on performance is beneficial or non-beneficial (Pfeffer & Sutton 
2006). 
 
On the other hand, where performance measurement processes occurred alone without 
many, proactive performance measurement processes, there was not an influence on 
performance. For example information from performance measurement was not used in 
making purchasing decisions or in making improvements to the product. According to 
Halachmi (2005): “The basic premise of the concept of performance management is 
simple: great performance…is unlikely to happen on its own”. 
 
That some of the performance management processes do not have an influence on 
performance would suggest that they are performance measurement processes instead. 
However, disseminating performance measurement information and feedback are broader 
than the basic process of measuring performance (Farbey et al. 1993, Neely et al. 2005). 
These processes can also be viewed on a blurred dividing line when defining performance 
measurement and broader performance management (Lebas 1995). Radnor and Barnes 
(2007) present an answer to this issue by conceptualizing not only performance 
measurement (“…quantifying, either quantitatively or qualitatively, the input, output or 
level of activity of an event or process.”) and performance management (“…action, based 
on performance measures and reporting, which results in improvements in behaviour, 
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motivation and processes and promotes innovation.”), but an intermediate concept of 
performance reporting: “…providing an account, and often some analysis, of the level of 
input, activity, or output of an event or process usually against some form of target.”. 
Radnor and Barnes (ibid.)’ definitions suggest that those processes in the empirical work 
with an influence on performance are performance management processes, whereas those 
that do not have an influence on performance on their own are performance measurement 
and reporting processes. The next section draws out the conceptual lessons from the 
discussion in this and preceding sections of the chapter, returning to the conceptual 
framework. 
 
7.5. Dialogue on Findings and Conceptual Lessons 
This section cultivates the dialogue about the findings and develops key lessons learned 
from the research, regarding the conceptual structure. The study has identified a range of 
performance measurement processes and performance management processes from the 
empirical work, as well as their influence on performance. These are discussed in the 
following sub-sections and the conceptual framework is then revised, illustrating 
conceptual lessons. To do this, the two ways of differentiating performance measurement 
and performance management in the literature are reviewed as part of the discussion about 
drawing a distinction between the processes discovered in the empirical work. 
 
7.5.1. Performance Measurement and Performance Management Processes 
Performance measurement processes in the empirical work varied in terms of the methods 
used and the aspects of performance that they measured. Both formal, objective and less 
formal, subjective performance measurement processes were used by actors in the cases. 
Given that the literature tends to focus on the former, the high occurrence of the latter was 
of particular interest. The aspects of performance measured also varied a lot and the Griffin 
and Page (1996) dimensions of product success measures are used as a framework, broadly 
representing the financial, technical and customer aspects of performance of the product 
that were measured. 
 
Further to the processes that were involved in actually measuring performance according to 
fundamental definitions (Farbey et al. 1993 pp75-94), processes such as dissemination and 
feedback of the information from performance measurement were observed as occurring. 
The empirical work also highlighted the role of social and information exchange as a more 
subjective and often less formal performance measurement process. However this finding 
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raises the question of whether social and informational exchange is a performance 
measurement process, as described so far in the findings, or not. It has been assumed to be 
a performance measurement process throughout the findings chapters as it involves 
gathering information, however it can also be seen as a broader, or follow up (Lebas 1995) 
process. Remembering the Lebas graphical depiction, it involves those parts of 
performance management other than performance measurement, so some sort of planning 
(Mintzberg & Lampel 1999) or planning and control (Slack et al. 2007 p24-25). The 
networks literature (Nohria 1992, Uzzi 1997) also suggests that social exchange to gather 
information is a broader process than performance measurement, though it is used in 
broader, performance management, processes such as innovation (Grandori & Soda 1995). 
However there is little evidence that social and informational exchange alone could 
influence performance and therefore be a broader performance management process 
(Halachmi 2006). The strongest steer from the literature that aids understanding social and 
information exchange is again performance reporting (Radnor & Barnes 2007). This allows 
that social and information exchange can indeed be broader than performance 
measurement, while satisfying the concern that it is not conceptually similar to those 
performance management processes that influence performance, such as re-innovation for 
example. 
 
This discussion has highlighted that processes discovered in the empirical work, such as 
feedback, dissemination of information and social and informational exchange, are 
performance reporting processes. These processes must be reflected in a revision of the 
conceptual model to highlight that they are fundamentally different to performance 
measurement processes, yet do not have an influence on performance as the performance 
management processes do. With respect to their influence, these performance reporting 
processes (Radnor & Barnes 2007) are grouped with the performance measurement 
processes, due to their lack of influence on their own on performance, as described above. 
However the framework is modified below to distinguish performance measurement from 
performance reporting. 
 
Overall, understanding of the concepts of performance measurement and performance 
management has been clarified through comparing the empirical results with the literature. 
The nascent nature of the performance literature means that some interesting ideas are 
generated here, as the network and strategy literatures have been considered together for 
example. However the discursive process has highlighted that research in the area needs a 
bolder appreciation of new concepts in the area, such as performance reporting and the 
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overall concepts of management. Revisions to the conceptual framework and the future 
research discussed in the last chapters of the thesis offer opportunities to take this further. 
 
The case studies also identified some key performance management processes. Information 
gathered through the performance measurement and performance reporting processes was 
then fed back through the innovation process, where re-innovation of the product occurred. 
Much of the information from performance measurement and reporting was also used in a 
broader or follow up process of making purchasing and supply decisions, a way in which 
the performance of the product was managed.  
 
Further, if the preceding performance measurement and performance management 
processes are to have an influence on performance, there must be compliance with use of 
the product. Although not explicitly described by respondents as a performance 
management process, compliance or use of the product is broader than (Lebas 1995), and 
involves follow up action (Globerson 1985, Neely et al. 1997) on performance 
measurement. Also, it is necessary if those products used by patients themselves are to 
have an influence on performance for the patient. These arguments suggest that 
compliance or use of the product is added to the conceptual framework as a performance 
management process. Although only described in two cases, clinicians were responsible 
for using the CT scanner and ECG monitor in the other two cases where there was no 
compliance issue. The finding is found in a pattern across all relevant cases, increasing its 
strength.  
 
7.5.2. Influences of the Performance Measurement and Performance Management 
Processes 
Respondents described influences of the various processes already discussed, detailing 
how they can have an influence on financial, technical or customer aspects of performance. 
The key influences from all the cases have been used to illustrate the revised conceptual 
framework, as shown below. The various influences described were grouped conceptually, 
according to whether they had a beneficial, non-beneficial or no influence on performance. 
This grouping helped inform lessons for drawing a conceptual distinction between 
performance measurement and performance management processes, as discussed next. 
 
Making a conceptual distinction between performance measurement processes and broader 
performance management processes in the empirical findings can be attempted, though it 
does not allow a distinct boundary to be drawn between the two, as described above. 
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However the empirical findings suggest it is possible to conceptually distinguish 
performance measurement and reporting on the one hand and performance management on 
the other according to their lack of influence or their influence on performance. Viewing 
the empirical findings in the light of the literature (such as Halachmi 2005, Bourne et al. 
2005, Melnyk et al. 2005, Kaplan & Norton 1996, Neely et al. 1997, Robson 2005) 
suggests that performance measurement and reporting alone of innovative products do not 
have an influence on performance of the product. For there to be an influence on 
performance, performance management processes are also required.  
 
So far the thesis has conceptualised performance measurement as a subset of and therefore 
a part of performance management (Lebas 1995). Similarly, performance reporting is 
suggested as a sub-set of performance management, though can be considered to be 
broader than performance measurement. However the finding of a non-beneficial influence 
for both customer and supplier where there was less performance measurement but 
performance management still occurred puts a focus on those parts of performance 
management excluding performance measurement and reporting. Returning to the 
literature highlighted that performance improvement is a term used by Slack et al. (2007 
pp582-607), who discuss measuring and improving performance. As such, performance 
improvement refers to the non-measurement parts of their planning and control perspective 
of performance management. 
 
The definitions of performance measurement and performance management given in the 
conceptualisation still hold, but can be updated with an additional definition of 
performance reporting, on the basis of the conceptual lessons. Performance measurement 
can still be defined as: Quantifying or qualifying an aspect of the performance of a 
product. Radnor and Barnes’ (2007) definition of performance reporting “…providing an 
account, and often some analysis, of the level of input, activity, or output of an event or 
process usually against some form of target” is appropriate as it represents the concept 
with respect to performance measurement and performance management, also grouping it 
conceptually with performance measurement in terms of not specifying that an influence 
on performance occurs. With respect to performance measurement and performance 
reporting, performance management can still be defined as: Broader or follow up planning 
and controlling action, based on information from performance measurement, which 
influences the performance of a product. The definition highlights that performance 
management does indeed involve using information from performance measurement and 
performance reporting processes in broader or follow up planning and controlling action, 
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but can be differentiated more clearly as it has an influence on performance. This 
definition also focuses on the performance improvement parts of performance 
management, which aids clarification of the distinction between performance measurement 
and performance reporting on the one hand and performance management on the other. 
 
Figure 23 shows the revised conceptual framework illustrated with the processes 
discovered in the empirical work and the influences identified. The basic structure of the 
framework is the same, showing performance measurement processes and broader 
performance reporting processes as a subset of performance management processes that 
are broader still. It has been updated to show key performance measurement processes, 
performance reporting processes, performance management processes and influences as 
identified in the empirical work in the previous two chapters and discussed in the current 
chapter. An additional oval shows the performance reporting processes that were identified 
above as being distinct from performance measurement and performance management, 
namely dissemination of information, feedback and social and information exchange. The 
difference shown between performance measurement, performance reporting and 
performance management processes in the blue ovals is based upon their respective 
influences on performance (Halachmi 2005), the clearest way of distinguishing the 
concepts in the empirical work out of the two possible ways of drawing a difference 
suggested in the existing literature. Those processes shown in the measurement and 
reporting ovals have no influence alone on performance so are coloured the same shade of 
blue, however those in the performance management oval do and are coloured a lighter 
shade of blue. The arrow shape illustrates the types of influences discovered in the 
empirical work, showing beneficial, non-beneficial and no influences. Where examples of 
the processes are given, these are summarised from the cross case findings matrix in 
Appendix S, as discussed in the previous chapter. 
 
Further to the main, revised conceptual framework, Figures 24 to 26 give diagrammatic 
summaries about when there is likely to be an influence on performance or not according
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•Influence on Performance (+): 
-Product is purchased or not
-Product design is improved
-Training is necessary for patient to 
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Figure 23. Revised Conceptual Framework, Illustrated from the Conceptual Findings 
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 to whether performance measurement and performance reporting processes on the one 
hand and performance management processes on the other are limited or extensive.  
 
PERFORMANCE 
MANAGEMENT 
PROCESSESPERFORMANCE 
MEASUREMENT 
PROCESSES
+/-
INFLUENCE ON 
PERFORMANCE
PERFORMANCE 
REPORTING 
PROCESSES
 
Figure 24. Conceptual Framework Illustrating Performance Measurement and 
Performance Reporting, as well as Performance Management Having an Influence on 
Performance 
 
 
NONE
PERFORMANCE 
MEASUREMENT 
PROCESSES
PERFORMANCE 
MANAGEMENT 
PROCESSES INFLUENCE ON 
PERFORMANCE
PERFORMANCE 
REPORTING 
PROCESSES
 
Figure 25. Modified Conceptual Framework Illustrating that No Influence on 
Performance Occurs When Performance Management is Limited or Does Not Occur 
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PERFORMANCE 
MANAGEMENT 
PROCESSES
PERFORMANCE 
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PROCESSES
INFLUENCE ON 
PERFORMANCE
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REPORTING 
PROCESSES
 
Figure 26. Modified Conceptual Framework Illustrating that a Non-beneficial 
Influence on Performance Occurs when Performance Measurement and Performance 
Reporting are Limited or Do Not Occur 
 
From the findings and as discussed above, an influence on performance occurred where 
performance measurement and performance reporting, as well as broader or follow up 
performance management processes occur, as shown in Figure 24. The findings show that 
in many such examples where there was an influence it is a beneficial influence, however 
in some instances the influence may be beneficial for one organisational actor and non- 
beneficial for another. The findings also showed that when only performance measurement 
and performance reporting, and no performance management processes occurred, then 
there was no influence on performance, as represented in Figure 25. This figure shows the 
conceptual framework with the performance management oval reduced in size to represent 
no or limited performance management processes occurring, and the role arrow faded out 
to show that there is no role. The absolute size of the ovals compared to one another is not 
significant, however the reduction in size of the performance management oval compared 
to the original conceptual framework is used to illustrate the finding. Empirical findings 
showed another combination of performance measurement and reporting with performance 
management occurred where the influence was non-beneficial, namely where there was 
less performance measurement and reporting but performance management still occurred. 
Unlike the examples of beneficial influences above where in some instances a beneficial 
influence for one organisation was a non-beneficial influence for another, in this finding 
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the influence is distinguished by always being non-beneficial for both customer and 
supplier organisations. A modified conceptual framework in Figure 26 is again used to 
show the negative influence where less performance measurement and reporting occur, but 
performance management still occurs. 
 
Figures 24 to 26 illustrate the beneficial, non-beneficial and lack of influence found when 
more or less performance measurement and performance reporting, as well as performance 
management occur. A two by two matrix can be used to display the types of influences that 
occur when more or less of performance measurement and reporting on the one hand, and 
performance management on the other are found (Figure 27). The axes show limited or 
extensive performance measurement and reporting as well as performance management. 
The axes are split with those processes that do not have an influence in performance alone, 
namely measurement and reporting on one dimension, while the other shows performance 
management processes that do have an influence. The terms limited and extensive are used 
because, as found in the empirical data, a number of different performance measurement, 
reporting and management processes may be required for there to be an influence on 
performance. For example compliance with use as well as making the purchasing decision 
are two performance management processes that are required. The extensive end of the 
axis indicates, given the non-causal nature of the exploratory data, that more of the 
performance management processes needed for there to be an influence on performance 
have occurred. If the non-beneficial influence for both customer and supplier is to be 
shown, the non performance measurement and reporting part of performance management 
must be emphasised, so the term performance improvement is included on the vertical axis 
in parenthesis to state the non-performance measurement and reporting aspects of 
performance management, rather than viewing performance measurement and performance 
reporting as a subset of performance management. This enables the matrix to depict 
situations where performance management or improvement processes are extensive, yet 
use limited performance measurement and reporting. 
 
In the top right box, extensive performance measurement and reporting as well as 
extensive performance management both occur, with an influence on performance. This 
influence is beneficial for at least one organisational actor, though in some instances may 
be non-beneficial for another actor. In the bottom right box, extensive performance 
measurement and reporting occur, but little or no performance management occurs using 
information from performance measurement to influence performance. In the top left box 
extensive performance management occurs, but on the basis of limited performance 
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measurement and reporting, with a non-beneficial influence in performance. The matrix 
also shows a fourth box on the bottom left where no performance measurement, reporting 
and management processes occurred. No data was gathered for this box, however as no 
processes occurred they cannot have an influence on performance. The space in the matrix 
represents a control, where no influence would be expected to occur and would be a wise 
place to gather data for a future extension of the research to improve validity. 
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Figure 27. Matrix Illustrating Types of Influences Found With More or Less 
Performance Measurement, Performance Reporting and Performance Management. 
 
Figure 28 shows the same two by two matrix, but with descriptions of the four boxes 
highlighting examples from the empirical work and relevant existing literature that 
reinforces the finding. The matrix is shown with examples from the empirical work by way 
of illustration, however the limitations of the research and data mean that the matrix should 
be used as an illustration of the conceptual lessons in the main conceptual framework, 
rather than a conceptual outcome in itself. 
 
Having now discussed the empirical findings in the context of the existing literature and 
looked at some conceptual lessons presented by the work, the next chapter concludes the 
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thesis by returning to the research questions, setting the outputs of this research against the 
context of key existing knowledge in the field that triggered the research questions. The 
contribution of the work, limitations and implications are then discussed in the final 
chapter. 
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Figure 28. Matrix Illustrating Types of Influences Found With More or Less 
Performance Measurement, Performance Reporting and Performance Management, 
Showing Descriptions and Examples. 
 
7.6. Summary 
Discussing the findings involved returning to the literature underpinning the research, part 
of the iterative process that helped revise and improve the conceptual model with the 
benefit of the conceptual lessons identified. Although many concepts identified in the 
literature were also found in the empirical work, the exploratory nature of the empirical 
data uncovered some concepts that required investigating additional new literature. Again, 
research in the performance field was found to draw piecemeal on a variety of sources, 
with limited overall structure. 
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Performance measurement involved both objective and subjective measurement of a broad 
variety of aspects of performance as suggested by the literature. Much information was 
disseminated between actors and organisations following performance measurement and 
social informational exchange was identified as part of this dissemination, or reporting, 
process. Key performance management processes observed in the empirical work of 
making the purchasing decision, product innovation and compliance with using the product 
are backed up by the existing literature, which highlights how these broader or follow-up 
planning and control processes take action on performance measurement information so 
can be considered to be performance management processes.  
 
The empirically identified influences of the performance measurement and performance 
management processes could be grouped a number of ways according to the existing 
literature. However the clearest groups were according to whether a beneficial, non-
beneficial or no influence occurred. Returning to the literature reinforced empirical 
findings that performance measurement processes alone have little influence on 
performance, however an influence does occur if performance management processes 
occur. Evidence suggests that beneficial influences on performance occur for at least some 
actors if information from performance measurement processes is used in performance 
management processes. However performance management on the basis of little 
information from performance measurement has a non-beneficial influence on 
performance, as suggested by the evidence-based literature. These findings were presented 
graphically and displayed on a revised conceptual model. The additional concept of 
performance reporting, drawn from existing literature was fundamental in interpreting why 
some broader or follow up processes did not have an influence on performance. This 
clarified the empirical findings and rationale for differentiating performance measurement 
and performance management, as well as introducing a third concept of performance 
reporting to the revised conceptual framework. The model shows the processes explored 
and how although performance management processes are usually broader than or follow 
performance measurement and performance reporting processes, the two concepts can best 
be differentiated according to their influences on performance.  
 
The next chapter continues the process of reflection by considering how the empirical 
research has answered the research questions, in the light of key existing work in the area 
that prompted the research questions. 
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CHAPTER EIGHT: CONCLUSIONS 
 
8.1. Introduction 
The overall conclusions of the thesis are described in this chapter. Firstly the overall 
research aim is revisited, then the specific research questions are revisited in the light of 
the research carried out. This involves returning to key existing pieces of research in the 
literature review that triggered the thesis. The findings of this research are concluded in the 
light of examining these existing works. In particular, concluding the thesis focuses on 
conceptualizing performance measurement and performance management, using 
suggestions from existing research and the empirical work to do this. 
 
8.2. Revisiting the Research Aim 
The research set out to explore how the performance of innovative products is measured 
and managed and whether these processes are worthwhile by having an influence on 
performance or not. A variety of concepts in the previous literature commenced this 
research interest. Firstly, the innovation literature emphasises the challenges and necessity 
of organisations innovating successfully (Tidd et al. 2005 pp37-44) and measuring 
performance of innovation and innovations (Tidd et al. 2005 pp561-569). Innovation 
increasingly requires taking an inter-organisational perspective (Chapman & Corso 2005, 
Ritter & Gemunden 2004, Grandori & Soda 1995), including a focus on purchasing and 
supply during implementation of the product (Biemans 1992 pp42-45) where product 
performance is measured. The fragmented performance literature has discussed concepts of 
performance measurement and increasingly focuses on performance management, with 
little clear difference drawn between the two (Radnor & McGuire 2004). Also, the research 
agenda is turning towards investigating whether performance measurement is worthwhile 
(Neely 2004, 1999) and the influence or impact of performance measurement on 
performance. In the light of these issues raised in the existing work, the overall research 
aim was: 
 
• To explore performance measurement and performance management during the 
implementation of innovative products, focusing on their performance effects.  
 
The research aim was addressed through a literature review, development of the conceptual 
framework and empirical case studies. Data from the case studies was analyzed through 
pattern matching against the conceptual framework, then cross-case synthesis. Following 
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discussion of the findings, the conceptual framework has been revised as part of the 
iterative, abductive approach that has been taken to the research.  
 
With respect to the research aim, the empirical findings of the thesis describe performance 
measurement and performance management processes during the implementation of 
innovative products. In particular, the findings have highlighted how the performance of 
medical devices, which are all examples of innovative products, is measured and managed 
during their implementation. These findings stand on the existing literature that emphasises 
the importance of innovation, especially as an inter-organisational process and measuring 
performance in the innovation field. Through the analysis and discussion of the findings, 
performance measurement and performance management processes have been 
differentiated, clarifying these concepts that are not clearly distinguished in the literature. 
To do this, the empirical findings also included information about the influences of the 
performance measurement and performance management processes on performance, 
reflecting the increasing interest in existing literature about the worth of measuring and 
managing performance. The concept of performance reporting emerged as a key part of 
understanding performance measurement and performance management concepts. 
 
The above research aim was broken down into the research questions, which were 
addressed as described in the next three sections. Again, the findings of this research are 
examined with respect to key pieces of existing research that triggered the questions. Table 
38 below summarises the response of the thesis to the research questions, positioning this 
against existing knowledge. 
 
8.3. Revisiting Research Question A: What processes are used to measure and manage 
the performance of innovative healthcare products during their implementation? 
 
Given that existing research has discussed a range of performance measurement and 
management processes in general (Neely et al. 2005) involving a variety of stakeholders 
and focussing on measuring a variety of aspects of performance, this first research question 
explored the processes that are used to measure and manage the performance of innovative 
products. It described how both customer and supplier organisations are involved in 
measuring financial, technical and customer aspects of performance. In addition to 
performance measurement, the literature also described broader performance management 
processes (Globerson 1985) involving follow up action to measurement or planning and 
control as suggested by Mintzberg and Lampel’s (1999) planning and control view of 
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management. The literature review highlighted a wide variety of processes that can be 
considered as performance management processes. In particular, it highlighted 
performance management as occurring as innovation (Rothwell & Gardiner 1988) and 
purchasing decision making (Webster & Wind 1972 pp28-37, 89-106, Biemans 1992 p48). 
Further to the literature review igniting an interest in what processes are used to measure 
and manage the performance of innovative products during their implementation, this data 
about performance measurement and performance management processes occurring in 
practice was used for a later research question in differentiating the two concepts. 
 
As with all the research questions, Question A was addressed through a combination of the 
literature review and the empirical investigation. The literature discusses performance 
measurement and performance management with respect to organisations, processes and 
products. The empirical work focussed on the product as the unit of analysis, investigating 
four different case studies using an instrument studying the processes and types of 
performance measured and managed. 
 
Findings from the empirical work reflected some themes in existing research investigated 
in the initial literature review, but also exposed some less expected information about 
performance measurement and performance management processes. The work identified 
that financial, technical and customer aspects of the performance of the products are 
measured by various actors, reflecting the literature (Neely et al. 2005). Many performance 
measurement processes were found to be formal as suggested by the literature, such as 
clinical trials and tender processes. However the empirical data also highlighted informal 
performance measurement processes. These emphasised that subjective assessment of the 
performance of a product by a clinician for a particular purpose was a key performance 
measurement process and that much information and social exchange occurred. While less 
formal, subjective performance measurement processes still reflect the fundamental 
concept of measurement (Farbey et al. 1993 pp75-94), they show that performance 
measurement is a more diverse concept in practice than many of the quantitative, 
positivistic approaches emphasised in much of the existing literature (Neely et al. 2005). 
However returning to the broader literature highlighted such subjective, informal 
performance measurement processes by purchasing decision-makers (Zaltman et al. 1973 
pp53-55). Subsequent review of the literature and discussion also suggested that reporting 
of performance measurement information, including processes such as dissemination of 
information, feedback, advice, training, social and informational exchange can be grouped 
with performance measurement, being conceptually similar. Again, many of these are less 
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formal, more subjective processes than those suggested in much of the existing literature 
on performance measurement. 
 
Taking the literature cue that performance management is broader than, or involves follow 
up planning and control action on performance measurement, the empirical work found a 
variety of performance management processes, including some of those suggested in the 
literature review. The processes of making the purchasing decision, re-innovation of the 
product and additionally compliance with use of the product were found to be key 
performance management processes. As highlighted in the discussion, these broad 
processes overarch some of the processes noticed within and across individual cases, such 
as different processes of decision making in group tendering and individual decision-
makers, and customisation of the product for individual users. Making the purchasing 
decision on the basis of information from performance measurement was highlighted in the 
empirical work as a performance management process as it is a controlling action that is 
broader than or follows performance measurement and reporting. Returning to the 
innovation and purchasing and supply literatures also reinforced that making the decision 
to implement the innovative product (Biemans 1992 pp129-140) or making the purchasing 
decision (Zaltman et al. ibid.) is a broader or follow up process involving planning and 
control actions (Mintzberg & Lampel 1999) and so is a performance management process 
in the light of the performance literature (Globerson 1985). 
 
Re-innovation was also highlighted in the empirical work and analysis as a broader or 
follow up management process that uses information from performance measurement and 
reporting in changing the design of the product, to improve its performance. This finding 
stands on the existing literature that discusses the importance of feedback (Globerson 
1985) and a cyclical innovation process (Tidd et al. 2005 pp88-97), describing 
performance management processes. Indeed returning to the literature following data 
collection showed re-innovation (Rothwell & Gardiner 1985) as a concept describing this 
broader performance management process. They discuss how needs of the user of an 
innovative product have consequences for design strategy. A re-design is the outcome of 
user requirements, development by the supplier and even improved designs by 
competitors. Correspondingly, the empirical data highlighted much redesign of the product 
in response to gathering feedback from users or measuring performance. Returning to the 
innovation literature in the light of the empirical findings has highlighted that re-innovation 
is occurring in practice and taking the performance literature into account shows that re-
innovation is a performance management process. 
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Further to decision-making in purchasing and re-innovation, data originally gathered on the 
influences of the processes for Research Question B highlighted that compliance with 
using the product by the customer is another key performance management process. This 
performance management process was not discovered through the original literature review 
however. Again, the process involves follow up action to performance measurement 
(Globerson 1985) and in the light of the performance literature is about planning and 
control (Mintzberg & Lampel 1999) or more specifically improving (Slack et al. 2007 
pp582-607) the patient’s condition through using the innovative product. 
 
The conceptual framework was revised to show the key performance measurement and 
performance management processes identified following discussion of the empirical 
findings in the context of the literature, which necessitated drawing on some new sources 
and topics to interpret the findings. Some of the processes were identified as performance 
reporting processes and after discussion these were included as such in the revised 
framework. Together, the literature and empirical work help describe and understand the 
processes that are used to measure and manage the performance of innovative products 
during their implementation. Although the original literature review gave some 
background to concepts of performance measurement and performance management, the 
empirical data both reinforced and extended these, such as when processes identified in the 
innovation and purchasing and supply management literatures were viewed again in the 
light of the performance literature. Specifically, the findings are limited to innovative 
healthcare products during their implementation and this and other limitations are 
discussed in the next chapter, along with the contribution. The roles of the processes, the 
subject of Research Question B, are discussed in the next sub-section. Along with this 
response to Question A they also help respond to Question C below. 
 
8.4. Revisiting Research Question B: How do the processes used to measure and manage 
the performance of innovative healthcare products during their implementation influence 
their performance? 
 
This second research question investigated the influences of the performance measurement 
and performance management processes identified in Question A on performance of the 
product. As outlined in the above discussion of the overall research aim, much work so far 
has focussed on performance measurement on themes such as the choice of performance 
measures, however the literature shows an increasing interest in the worth of performance 
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measurement and the influence or impact of performance measurement on performance. 
Neely (2004) highlights that a key issue for current and future research in the performance 
measurement field is whether performance measurement is worth it. In discussing this he 
describes how while exact answers cannot be given about linking performance 
measurement to ROI for example, there are a number of ways in which performance 
measurement adds value, such as providing a route map to check if objectives will be 
achieved, focussing minds on performance, influencing behaviour and challenging 
organisational strategy. In a similar vein, Bourne et al. (2005) discuss managing through 
measures, focussing upon the impact of measures on performance, again highlighting that 
impact of measurement systems depends on how measures are used in managing. These 
papers suggest that there is currently limited and conflicting evidence of the impact of 
performance measurement on performance (Davis & Albright 2004, Ittner et al. 2003, 
Banker et al. 2000, Perera et al. 1997, Neely et al. 2004). However much of this research 
focuses on formal measurement systems and is positivistic and quantitative in design. 
Kaplan and Norton (1996) echo the move in the literature towards managing through 
measurement systems, discussing how the BSC can be used as the cornerstone in a 
strategic management system, through using leading as well as lagging indicators. Indeed 
the original BSC publication (Kaplan & Norton 1992) refers to measures that drive 
performance. 
 
Further to the interest in the worth or influence of performance measurement, the literature 
review exposed some papers that imply a conceptual distinction can be drawn between 
performance measurement and performance management as they have different influences 
on performance. While the work mentioned above (Davis & Albright 2004, Ittner et al. 
2003, Banker et al. 2000, Perera et al. 1997, Neely et al. 2004) suggests limited and 
conflicting evidence about the impact of performance measurement on performance, other 
work has emphasised that performance measurement has behavioural (Neely et al. 2005) 
and dysfunctional consequences (Ridgway 1956). Deeper investigation in the literature 
review suggested that performance measurement alone cannot alter performance, but that 
follow up planning and control action, or performance management, is needed to do this. 
For example Bourne et al. (2005) emphasised that differences in performance occur 
according to how performance is managed with the measures. Hume and Wright (2006) are 
more blunt, stating that to deliver sustained performance improvement a performance 
management system is needed, not just performance monitoring. Similarly, Globerson 
(1985) states the importance of using feedback to respond to discrepancies between 
measured and desired performance, suggesting that it is performance management rather 
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than measurement that has an influence on performance. Further, a cornerstone of Pfeffer 
and Sutton’s (2006) concept of evidence-based management is that evidence of 
performance, or information from performance measurement, is then used in follow up 
management action. 
 
As before, the question was addressed through the literature review, then empirical work. 
The empirical work drew on this literature by exploring the influences that the particular 
performance measurement and performance management processes identified in Question 
A had in influencing different aspects of performance, then questioning respondents about 
any possible influences of performance measurement and performance management 
processes in general. The cases showed a variety of influences that the processes have and 
also highlighted when the processes do not have an influence. 
 
The empirical data was analyzed, identifying that processes have influences in financial, 
technical and customer performance, regarding for example purchasing outcomes, the 
design of the product and meeting the needs of the customer. Having identified where 
some influences were conceptually similar, for example in relation to changing the product 
design, an iterative process then grouped the influences in different ways. Although there 
were some grounds for grouping the influences according to the type of performance they 
had an influence in, the clearest grouping was based on the literature suggestion that 
performance measurement processes do not have an influence on performance alone, 
performance management processes are also required (Bourne et al. 2005), reinforcing 
how the influences discovered empirically reflect the literature. Where performance 
measurement processes occurred alone, respondents in the cases described no influence on 
performance; though there was an influence where broader performance management 
processes (Globerson 1985, Mintzberg & Lampel 1999) occurred. However, the data raised 
the issue that some of these broader, follow up management processes did not have an 
influence on performance on their own, such as dissemination of information from 
performance measurement and feedback. The concept of broader processes in the literature 
suggests that these are performance management processes, however the empirical data 
shows that they do not have the influence on performance expected. Having returned to the 
literature and viewed these influences in the light of Radnor and Barnes’ (2007) 
performance reporting concept, they were grouped with performance measurement. This 
issue highlighted how the processes such as dissemination and feedback could not be 
clearly interpreted as either performance measurement or performance management in the 
light of existing literature, however the empirical results and revisiting the literature has 
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clarified the concepts. Studying the influences also highlighted the importance of 
compliance with use of the product by the end user or patient, grouped as a further 
performance management process as it was described as being necessary if the other 
processes of performance measurement and performance management were to have an 
influence on performance. In describing the influences of the processes, the findings in 
response to question B aid clarification of the worth of performance measurement, a key 
issue in the existing literature as stated above (Neely 2004). Further, it places a focus on 
performance management as well as performance measurement, also a concern of recent 
performance literature (Bourne et al. 2005, Kaplan & Norton 1996). 
 
Additional discoveries were made about the influences of the processes in the empirical 
work, which illuminate existing theory. Where processes had an influence, some of these 
influenced performance beneficially, others non-beneficially. Where the influence was 
beneficial for at least one of the customer or supplier, both performance measurement, 
including reporting, and performance management occurred as described above; however 
where the influence was non-beneficial for both customer and supplier stakeholders the 
empirical data suggested that although performance management occurred, it involved 
limited or inappropriate performance measurement and reporting. This concept was 
reinforced by returning to literature on the implications of cost-based versus broader 
measures (Ittner & Larcker 2003a, 2003b) and evidence-based management (Pfeffer & 
Sutton 2006). The latter emphasises the use of the best available internal and external 
evidence in management decision-making and the empirical findings of the thesis support 
this existing work, standing on it to describe evidence-based management from the point of 
view of concepts of performance measurement and performance management. 
 
The empirical findings and literature work aid illustrating and understanding the influences 
of performance measurement and performance management processes, within the 
limitations of the implementation of innovative healthcare products. This builds upon 
questions in recent existing literature about the worth of performance measurement. 
Further, the empirical findings describe some of the more behavioural, less mechanistic 
influences of performance measurement that the literature has highlighted as important 
(Bourne et al. 2005). In describing the various influences of the performance measurement 
and performance management processes and indeed when there is an influence or not, the 
findings add some clarity and evidence to the limited and conflicting existing findings of 
the impact of performance measurement on performance (Davis & Albright 2004, Ittner et 
al. 2003, Banker et al. 2000, Perera et al. 1997, Neely et al. 2004). 
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 The conceptual framework was updated with the benefit of analysing the empirical data in 
the light of returning to the literature. The processes and the beneficial, non-beneficial or 
no influences on performance are shown; with the distinction between performance 
measurement, including performance reporting, and performance management on this 
basis being illustrated by showing dissemination of performance measurement information 
as a performance measurement and reporting process. The two by two matrix in the 
discussion chapter was developed as a further illustration of the findings about influences 
of performance measurement, reporting and management. The conceptual distinction 
between performance measurement and performance management is discussed further in 
the next sub-section with respect to Question C. 
 
8.5. Revisiting Research Question C: How should performance measurement and 
performance management during the implementation of innovative healthcare products be 
differentiated? 
 
The final research question tackles a key issue identified in the review of the existing 
literature, namely differentiating the concepts of performance measurement and 
performance management. To do this it draws on the literature review and findings from 
the previous two research questions. Publications have highlighted that use of the two 
terms is conceptually loose and that they are often used interchangeably (Radnor & 
McGuire 2004), as found through much of the existing performance literature. Given the 
increasing focus on performance management as well as performance measurement in the 
existing literature (Kaplan & Norton 1996), clarifying the two concepts is of particular 
importance and interest to emerging research in the area (Radnor & McGuire ibid.).  
 
Although existing research states that the distinction drawn between the two concepts is 
not clear, the literature review suggested two possible ways of drawing a difference. These 
are that performance management has been described as broader or follow up planning and 
control action than performance measurement, or that performance management has an 
influence on performance, unlike performance measurement alone. 
 
Firstly, previous work described performance management as broader than performance 
measurement. Halachmi (2005) refers to performance management as: “…a broader and 
more meaningful concept than simple performance measurement.”, also referring to 
performance measurement as a sub-system of broader performance management effort, or 
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processes. Radnor & McGuire (2004) agree, suggesting that despite interchangeable use of 
the two terms, “…performance measurement is the act of measuring the performance 
whereas performance management aims to react to the “outcome” measure using it in 
order to manage the performance”. Elaborating, the paper argues that a performance 
measurement system needs to be considered in terms of broader performance management 
also consisting of processes, people and strategy. Lebas (1995), specifically studying 
performance management and performance measurement, concurs by defining the first as 
broader than the latter, displaying this graphically. Although Lebas (ibid.) states that 
performance measurement and performance management cannot be separated, he also 
states that the processes involved in each are not the same and that they feed and comfort 
each other, suggesting that there is indeed a difference. Further, this concept fits with the 
literature theme of using performance measurement systems as part of a broader process of 
performance management (Kaplan & Norton 1996) or improvement (Slack et al. 2007 
pp582-607), as part of effective planning and control (Globerson 1985). 
 
Empirical investigation occurred in response to these concurring literature suggestions that 
performance management is broader than performance measurement. The empirical work 
observed processes that meet basic definitions of performance measurement as given in the 
conceptualisation, drawing on Neely et al. (2005) and Farbey et al. (1993 pp75-94). It also 
observed many broader processes involving follow up action on information from 
performance measurement, as addressed in Question A. These broader processes identified 
in the case studies involve the performance improvement part of management planning and 
control actions and can be described as performance management processes in the light of 
the literature discussed in the previous paragraph, so the findings concurred with the 
existing work in this respect. The empirical work confirms Halachmi’s (2005) suggestion 
of broader processes, which react to the outcome of the measure in order to manage 
performance as in the concepts described by Radnor & McGuire (2004).  
 
However some of the empirical findings implied that the boundary between the two 
concepts is blurred. Lebas’ (1995) conceptualisation of performance measurement and 
performance management is of some use here, as it discusses how the two cannot be 
separated and feed off each other, suggesting that they are closely intertwined. However 
the issue still remains that the processes in question could be defined as either performance 
measurement or performance management processes according to Halachmi (2005) and 
Radnor and McGuire (2004), as they can be considered as either a fundamental 
measurement process or a broader process. Usefully, Randor and Barnes’ (2007) 
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performance reporting concept provides some new clarity on the matter by introducing a 
third concept. This section now moves onto the second rationale from the existing 
literature for differentiating performance measurement and performance management. 
 
The second explanation in the literature of how the two concepts can be differentiated 
suggests that performance management processes have an influence on performance 
through the action taken (Halachmi 2005, Bourne et al. 2005), whereas performance 
measurement processes alone do not. Halachmi (2005) explicitly draws a difference 
between performance measurement and performance management on this basis, stating 
how measurement alone is incapable of improving performance, management is also 
required. This is echoed by Hume & Wright (2006), as above. In contrasting the two 
concepts, Radnor and McGuire (2004) refer to performance management as reacting to 
performance measurement in order to manage performance. In line with Halachmi (2005), 
they again suggest that performance management, unlike performance measurement, has 
an influence on performance as it consists of the improvement part of management 
planning and control activities that can change performance. A number of other 
publications agree, such as Globerson (1985), Melnyk et al. (2005) and Kaplan and Norton 
(1996). This fits with the moves in the performance literature from studying performance 
measurement to researching performance management and the worth of measurement. 
Some other publications, such as Kaplan and Norton (1992) and Bourne et al. (2005) 
include discussion of the influence of performance measurement on performance, however 
performance management is also involved in the examples where these publications 
suggest measurement influences performance, for example Bourne et al. (ibid.) referring to 
the way management occurred with measures. 
 
The empirical findings discussed above under Question B agree with the literature here, 
suggesting that performance measurement and reporting processes alone do not have an 
influence on performance, whereas proactive performance management processes do have 
an influence on performance of the innovative product. This bears out Halachmi’s (2005) 
argument for example, as well as describing the planning and control processes of 
performance management more clearly in line with the increasing focus on performance 
management in the performance literature (Globerson 1985, Melnyk et al. 2005, Kaplan & 
Norton 1996). Also, the findings shed some light on the publications discussing the 
influence of performance measurement on performance, through emphasizing that 
performance management also occurs where there is an influence (Kaplan & Norton 1992, 
Bourne et al. 2005). As such, the thesis findings agree with and add to the suggestions in 
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the existing literature that performance measurement and performance management can be 
differentiated by their influences on performance, though the current work has been more 
explicit than previous studies in drawing conceptual differences through pursuing the 
concepts, in response to question C. 
 
When considered together, the literature and findings of the empirical work suggest that 
the most convincing way of describing and understanding the difference between the 
concepts of performance measurement and performance management can be made on the 
basis that the former alone does not have an influence on performance, whereas the latter 
does. The suggestion that performance management includes broader processes than 
performance measurement still holds, but is less clear cut on the boundary between the two 
and the analysis had to interpret the reporting processes as similar conceptually to 
performance measurement in the respect that neither had an influence on performance on 
their own to develop this conceptual lesson. Also, the discussion identified that it is 
specifically the performance improvement, or non measurement, parts of performance 
management that are needed for there to be an influence on performance. Altogether, the 
findings in response to question C and the revised definitions given at the end of the 
discussion section provide a clearer conceptualisation of performance measurement and 
performance management with respect to one another by building upon suggestions in the 
existing literature. This is in response to the key issue highlighted in the developing 
performance literature of a lack of clarity between the two concepts which are often used 
interchangeably (Radnor & McGuire 2004). 
 
In dealing with potentially broad concepts of performance measurement and performance 
management, the limitations of the thesis must be remembered in addressing the research 
questions and assessing how the findings stand upon existing work. In particular, the 
response to this research question has helped understand and describe the conceptual 
difference between performance measurement and performance management but this 
understanding is limited to the implementation of innovative healthcare products, the 
context of this research. This limitation is discussed further in the next chapter, along with 
a description of the contribution of the thesis, having revisited the research questions and 
findings in the context of key existing literature publications in this chapter. 
 
As a summary, Table 38 summarises how the thesis has responded to the three research 
questions, also highlighting how the responses of the thesis stand upon existing knowledge. 
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Research Question Thesis Response to Research 
Question 
How Response Stands on Existing 
Research 
A: What processes 
are used to measure 
and manage the 
performance of 
innovative 
healthcare products 
during their 
implementation? 
Financial, technical and customer 
aspects of performance are measured 
by various actors in formal and 
informal ways, often as part of the 
purchasing process. 
Performance reporting processes 
identified. 
Performance management processes 
identified: making the purchasing 
decision, re-innovation of the product 
and compliance with use of the 
product. 
Conceptual framework revised. 
Formal performance measurement 
reflects fundamental concept in 
literature (Farbey et al. 1993 pp75-94, 
Neely et al. 2005), however thesis also 
highlights less discussed informal 
measurement processes (eg Zaltman et 
al. 1973 pp53-55). 
Existing literature describes broader or 
follow up processes that were 
identified empirically (Zaltman et al. 
ibid., Rothwell & Gardiner 1985, Tidd 
et al. 2005 pp88-97), however 
performance literature (Mintzberg & 
Lampel 1999, Globerson 1985) 
presents these as performance 
management processes. 
B: How do the 
processes used to 
measure and 
manage the 
performance of 
innovative 
healthcare products 
during their 
implementation 
influence their 
performance? 
Processes described in A have 
variety of influences. 
Where performance measurement 
processes occurred alone, no 
influence occurred, however there 
was an influence where performance 
management processes also occurred 
(influence being beneficial for at 
least one organisational actor). A 
non-beneficial influence occurred 
with performance management, but 
little or no measurement. 
Conceptual framework revised and 
further two by two matrix developed. 
Findings about process influences add 
to debate about worth of performance 
measurement (Neely 2004) and 
increasing study of managing, not just 
measuring, performance (Kaplan & 
Norton 1996). 
Also, findings clarify some less 
mechanistic and more behavioural 
influences, a point described as 
important (Bourne et al. 2005).  
C: How should 
performance 
measurement and 
performance 
management during 
the implementation 
of innovative 
healthcare products 
be differentiated? 
Empirical data and responses to 
A&B suggest that performance 
measurement and performance 
management best differentiated by 
their influence/lack of influence on 
performance. 
Performance management, unlike 
performance measurement, has an 
influence on performance. 
Conceptual framework and 
definitions revised. 
Clarifying definitions helps resolve 
conceptual looseness (Radnor & 
McGuire 2004). 
Thesis builds on literature explanation 
that the concepts can be differentiated 
by their influence/lack of influence on 
performance (Halachmi 2005, Bourne 
et al. 2005), rather than the explanation 
of one being a broader or follow up 
process to the other (Halachmi 2005, 
Lebas 1995). 
Table 38. Thesis Response to the Research Questions in the Light of Existing 
Research 
 
8.6. Summary 
This chapter returned to the research questions in the light of existing work and the 
empirical findings. Discussion of the findings in the context of key publications in the 
existing literature highlighted key performance measurement and performance 
management processes, as well as their influences on performance. The findings are 
reflected in some themes in the existing research, though some less expected findings were 
also made about performance measurement and performance management processes, such 
as the less formal, more subjective processes identified, which required broader 
investigation of the literature to understand. Altogether these findings about performance 
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measurement and performance management processes as well as their influences were 
used to improve the conceptual framework and provide a response to the first two research 
questions. The additional concept of performance reporting was identified and helps 
answer the original research questions about performance measurement and management, 
as well as being a key focus for taking the work forward. The findings about the influences 
of the processes in performance stand on questions in the literature about the worth of 
performance measurement and the increasing move to studying performance management. 
The findings highlight some of the more behavioural, less mechanistic influences than are 
described in the literature and add some evidence to the limited and conflicting findings in 
existing work about the impact of performance measurement on performance by discussing 
the circumstances in which beneficial, non-beneficial or no influences occur. 
 
Discussion of the findings from the first two research questions found a basis for 
differentiating the concepts of performance measurement and performance management, 
responding to the third research question. Of two suggestions from the existing literature 
about how this could be done, the suggestion that performance measurement alone does 
not have an influence on performance, but performance management does, is the stronger 
conceptually, as discussed in the previous chapter. Thus the findings and response to 
question C add some clarity to the issue in the literature of differentiating the two concepts, 
by drawing on the most appropriate of the two suggestions in the existing literature of how 
this might be done. 
 
Having drawn conclusions about the findings of the thesis by returning to the research 
questions in the light of the existing literature, the final chapter discusses the contributions 
and limitations of the thesis, reflecting on the research and looking to future implications. 
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CHAPTER NINE: IMPLICATIONS AND REFLECTIONS 
 
9.1. Introduction 
This final chapter of the thesis begins by discussing the implications of the research, with 
reference to revisiting the research questions in the previous chapter. It then states the 
contribution of the thesis and discusses the limitations. This reflection concludes the thesis 
by discussing opportunities for future research. 
 
9.2. Implications 
This section reflects upon the variety of implications of the thesis, looking back at the 
conceptual framework, methodology, findings and conclusions. This sets the scene for a 
broader discussion of future research opportunities, below. Conceptual, managerial and 
policy implications are described in turn in the following sub-sections. 
 
9.2.1. Conceptual Implications 
The thesis has taken an iterative approach to building theory, drawing on both existing 
literature and the empirical work in conceptual development. This involved developing and 
refining a conceptual model, with implications for the concepts of performance 
measurement and performance management in the field of the research. These concepts 
were also represented in development of a two by two matrix. This sub-section describes 
some of the key conceptual implications, which are picked up again in stating the 
contribution, below. Conceptual implications are summarised in Table 39. 
 
The thesis findings about the processes used to measure and manage the performance of 
innovative products have conceptual implications. Although the thesis findings identified 
measurement of a variety of aspects of performance as suggested in existing work, the 
research has clarified that performance measurement processes are not only formal and 
quantitative as suggested in existing literature (Farbey et al. 1993 pp75-94, Neely et al. 
2005) but also less formal and subjective. Farbey et al.’s (ibid.) conceptualisation of 
measurement focuses on a procedure of mapping and preserving differences in attributes, 
while Neely et al. (ibid.) define measurement as involving quantification. In contrast the 
thesis has discussed findings of performance measurement that focus on subjective 
assessment of an innovative product by a clinician for example, including through 
communication with other actors. The finding about less formal and subjective 
measurement processes implies a broader concept of performance measurement than is 
found in much of the existing literature, suggesting that future research is required to 
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investigate these less formal and more subjective aspects of performance measurement. 
The concept of performance measurement could then be revised and expanded, with 
implications for the underlying concepts and definitions used in future research on 
performance measurement. In discussing performance measurement and performance 
management, performance reporting was also identified as a key concept. It is grouped 
with performance measurement in this research as it is similar conceptually in terms of a 
lack of influence on performance, however the concept has had implications for the 
findings about performance measurement and management, as well as for future research. 
 
Conceptual Findings of Thesis Conceptual Basis in Existing 
Literature 
Conceptual Implications of 
Thesis 
Performance measurement 
processes:  
Involve measuring financial, 
technical and customer aspects 
and dissemination of 
information. 
Are not only formal and 
quantitative but also less formal 
and subjective. Performance 
reporting is also a key concept. 
Describes measurement of a 
variety of aspects of 
performance (Kaplan & Norton 
1992). Focuses on formal and 
quantitative concepts of 
performance measurement 
(Farbey et al. 1993 pp75-94, 
Neely et al. 2005). 
Performance reporting (Radnor 
& Barnes 2007) 
Broader concept of performance 
measurement than in much of 
the existing literature has 
implications for underlying 
concepts of performance 
measurement. 
Performance reporting concept 
identified as important. 
Concept of performance 
management involves: 
-Purchasing 
-Product innovation 
-Compliance with using the 
product 
Performance management is a 
loose concept in the existing 
literature (Radnor & McGuire 
2004). 
Thesis adds clarity to the loose 
concept of performance 
management by suggesting new 
definitions, stating the strongest 
basis for differentiating 
performance measurement from 
performance management. 
Discovered a variety of 
influences of the above 
processes on performance.  
Influences of processes were 
found to group most clearly 
depending on amount of 
measurement and/or 
management: 
-Beneficial 
-Non-beneficial 
-None 
Increasing interest in 
performance management rather 
than just performance 
measurement (Kaplan & Norton 
1996) and a focus on the worth 
of performance measurement 
(Bourne et al. 2005). 
Existing work has focussed on 
mechanistic, positivistic links to 
performance. 
Thesis adds to existing research 
on how performance 
measurement and performance 
management processes have an 
influence on performance, 
highlights the importance of 
both occurring. This is a basis 
for further research on the worth 
of both performance 
measurement and management 
processes together. 
Thesis has focussed on less 
mechanistic and more 
behavioural influences. 
Thesis differentiates 
performance measurement 
processes from performance 
management processes on basis 
of their respective lack of 
influence, or influence on 
performance. 
There is little clear distinction 
between the two concepts 
(Radnor & McGuire 2004). 
Performance management could 
be differentiated from 
performance measurement as it: 
-Involves broader or follow up 
processes (Halachmi 2005, 
Lebas 1995), or: 
-Has an influence on 
performance which performance 
measurement does not 
(Halachmi 2005, Bourne et al. 
2005). 
Best basis for differentiating the 
two concepts is their respective 
influence or lack of influence on 
performance.  
Future research can be based on 
clearer definitions and avoid 
interchangeable use of terms. 
Table 39. Summary of Conceptual Implications of the Thesis 
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The findings of this research about performance management processes add to 
understanding the loose concept of performance management in the existing literature. 
Further to existing work describing performance management as involving broader or 
follow up planning and control (Mintzberg & Lampel 1999) processes than performance 
measurement (Halachmi 2005, Lebas 1995), the thesis findings described performance 
management as involving purchasing,  product innovation and compliance with using the 
product, as shown on the conceptual framework. As such, the thesis illustrates the concept 
of performance management in more detail than in the broad and loose description in the 
existing literature. Having returned to the innovation and purchasing and supply literatures, 
the findings imply that concepts from those fields, such as re-innovation (Rothwell & 
Gardiner 1985) and purchasing decision-making (Zaltman et al. 1973 pp53-55) require 
attention in future academic work on performance management. Overall, the variety of 
performance management processes that were identified in the empirical work highlight 
the breadth and depth of the performance management concept. Future research that is 
based on definitions or concepts of performance management can look to this research to 
give a clearer definition of the concept of performance management. Given that 
performance management is described in existing literature as a loose concept that is 
frequently used interchangeably with performance measurement, these findings about the 
nature of performance management help provide a distinction between the two concepts, as 
described in more detail below. 
 
In discovering a variety of influences of the performance measurement and performance 
management processes described above, the thesis explored a conceptual topic that has 
been of increasing interest in the existing literature. Kaplan and Norton (1996) highlights 
the move from studying performance measurement to performance management, while 
Bourne et al. (2005) emphasises an increasing focus on researching the worth of 
performance measurement. Whereas Bourne et al. state that existing work has focussed on 
mechanistic links between processes and performance using quantitative, positivistic 
methods, the thesis has focussed on less mechanistic and more behavioural influences than 
in much existing work. For example the thesis has established some understanding about 
the influences of the processes in purchasing outcomes, the design of the product and 
meeting the needs of the customer. This has provided an understanding about the 
influences of the processes which is appropriate for exploratory conceptual development 
work, rather than a causal study of mechanistic impact on performance. By revealing that 
performance measurement and management processes together had a beneficial influence 
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on performance, that performance management with limited measurement had a non-
beneficial influence on performance and that performance measurement alone had no 
influence; the thesis has conceptually illustrated the influences of the processes. The thesis 
has emphasised the conceptual importance of both performance measurement and 
management occurring, a basis for further research in future investigating when and how 
they are most worthwhile. 
 
Overall, the thesis has clarified concepts of performance measurement and performance 
management by drawing a difference between them on the basis of their influence or 
otherwise on performance, giving new definitions of the concepts as shown in the 
discussion. Extant literature (Radnor & McGuire 2004) highlighted that there is little clear 
conceptual distinction between performance measurement and performance management, 
the terms often being used interchangeably. The literature suggested two possible 
conceptual bases for differentiating between performance measurement and performance 
management, namely that the latter involves broader or follow up processes (Halachmi 
2005, Lebas 1995) or as the latter has an influence on performance which performance 
measurement does not (Halachmi 2005, Bourne et al. 2005). The thesis used empirical 
findings to demonstrate that the two terms can best be distinguished on the basis of their 
influence, or lack of influence, on performance. This finding clarifies key concepts in the 
performance literature by differentiating the concepts and describing the basis for doing so. 
Given the points just made, the conceptual implication for research in the field is that 
performance measurement and performance management are more clearly defined as the 
basis for future research which is based on concepts of performance measurement and 
performance management. Indeed, interchangeable use of the terms as in past research can 
be avoided. Further, the increasing moves in the literature towards studying performance 
management rather than just measurement (Kaplan & Norton 1996) and focussing on the 
worth of performance measurement (Bourne et al. 2005) is underpinned by clearer 
definitions of the basic concepts, as discussed above. The conceptual implications of the 
thesis could assist future research in assessing the worth of performance measurement and 
performance management processes, and investigate more deeply their behavioural 
implications and causal links to changing performance. 
 
In discussing these conceptual implications for future research, the limitations of this 
research should be borne in mind, which are described in more detail below. The 
conceptual developments of the thesis that are discussed in this sub-section also have 
managerial implications, as discussed in the next sub-section. 
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9.2.2. Managerial Implications 
The thesis has been an academic project, so has concentrated on the development of a 
research project and contribution, rather than normative findings for practitioners. Now 
that the research process has been described, discussed and conclusions drawn, it is 
worthwhile to identify some key implications of the study for managerial practitioners, in 
line with the ‘double hurdle test’ of academic rigour and practical relevance (Tranfield & 
Starkey 1998 p353). 
 
The processes shown in the conceptual framework and discussed in the thesis describe 
different ways in which individuals and organisations can measure, report and manage 
performance. Notwithstanding limitations to the context of the cases and in developing the 
processes in the empirical work, they could be used as a checklist of generic ideas for 
practitioners who wish to ensure that they are measuring performance in appropriate ways 
and taking proactive improvement action on performance measures. Further, they 
demonstrate that performance measurement and management do not always have to be 
quantitative, systematic processes as some literature would suggest. Given the focus in the 
existing literature on appropriate selection and implementation of performance measures 
(Neely et al. 1997), this research implies that managers should be aware of the possibility 
that performance can be measured through communicating with others and making 
informal assessments as well as through more formal traditional systems. In an 
organisation as large as the NHS the current study opens the eyes of managers to what 
actually goes on at the local level and in the multitude of constituent organisations, such as 
informal, subjective performance measurement. Also, the study emphasises that a wide 
variety of aspects of performance should be measured in practice, a point of interest to 
practitioners such as CEP who are trying to broaden the aspects of performance that they 
report upon and are looking for methods to achieve this. 
 
The literature and empirical work both reinforce the importance for practitioners of looking 
beyond the boundaries of their own organisation and actions when procuring, innovating, 
measuring or managing performance. For example, there was widespread exchange of 
performance measurement information between actors who measured performance through 
social exchange and who disseminated and fed back information from their own 
performance measurement processes. Further, the performance measurement and 
performance management processes identified usually involved more than one 
organisation or actor, echoing the point in the literature about how innovation must involve 
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more than one organisation for success (Ritter & Gemunden 2004, Chapman & Corso 
2005, Grandori & Soda 1995). Overall, the implication for practice is that managers must 
endeavour to look and work beyond their own organisation when managing performance. 
Established social science research tools such as drawing network pictures (Oberg et al. 
2007) and constructing matrices (Miles & Huberman 1983 pp151-189) may help the 
practitioner in appreciating and reconciling the activities of different stakeholders. 
 
The influences of the performance measurement and reporting, as well as performance 
management processes provide a key implication for practitioners. Much research and 
many respondents described how practitioners measure and report performance, yet there 
is limited appreciation that these processes have no influence on performance without 
taking some sort of management action to improve performance. Hume and Wright’s 
(2006) analogy expresses the point neatly for practitioners: “You don’t make a pig fatter by 
weighing it”. In other words if practitioners want to influence performance, measurement 
and reporting are not worthwhile unless management action is also taken. Also the findings 
emphasise the importance of ensuring sufficiently broad performance measurement occurs 
as well as performance management. The two by two matrix illustrates the implication that 
managers must ensure that extensive performance measurement or performance 
management both occur if they wish their efforts to have a beneficial influence on 
performance. 
 
Drawing a conceptual difference between the terms ‘performance measurement’ and 
‘performance management’ is predominantly an exercise of academic interest, however the 
difference drawn had implications for whether certain processes carried out by individuals 
and organisations were worthwhile. The distinction can help practitioners realise the 
importance of follow up management action if they wish to improve performance. 
 
Figures 27 and 28 in the discussion chapter showing when performance measurement and 
performance management processes do and do not have an influence on performance is a 
useful tool for managers in practice. They provide a visual reference and describe 
examples of the processes that should be implemented for effective performance 
measurement and management, in the top right corner of the matrix for example. The 
matrix could be used by managers to check performance measurement and management 
processes for a particular innovative product or even their organisation against those in the 
matrix, then positioning it in the matrix. When compared with the desired position in the 
top right of the matrix where there is most beneficial influence on performance, the 
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manager can then implement processes shown to close the gap between the current and 
desired status of performance measurement and performance management for the 
innovative product. Although the matrix is currently presented from the point of view of an 
academic concept, it could be operationalised for managers through a series of questions 
based on the interview guide and literature review that are used to position the status of 
performance measurement and performance management on the axes. The example 
processes in the boxes could also be expanded to include all examples from the revised 
conceptual framework in a fully developed applied tool. 
 
In addition to the managerial implications, policy implications are drawn out in the next 
sub-section. 
 
9.2.3. Policy Implications 
Further to the managerial implications, the thesis has implications for policy, given the 
setting in the public sector context. The managerial implications above are of relevance for 
determining policy about management practice in the public sector, though the thesis could 
have broader implications for policy making in the fields of performance, purchasing and 
supply management and innovation, particularly in the context of the relevant UK 
Government policy documents as discussed in the literature review. Overall the thesis 
implies that policy making in the field of managing the purchasing and supply of 
innovative products should focus not only on performance measurement but also on 
performance management. 
 
Recent policy documents have focussed on gaining efficiencies through procurement 
(Gershon 2004 pp5-8, 35-36, Bourne 2006 pp2-11, H.M. Treasury 2007 p3), placing a 
focus on measuring financial performance. However the documents also place an emphasis 
on evidence-based policy as a lever for improving performance (Gershon ibid.) reinforcing 
the policy implication of the thesis that both performance measurement and performance 
management are necessary to improve performance. It is interesting to note that Bourn 
(2006 pp2-11) discusses how measurement of financial performance and savings has 
occurred, but there is doubt over the £4.7bn savings, describing how verification of this 
aspect of performance is necessary. The issue suggests that either performance 
measurement and reporting have been insufficient, or that more follow up performance 
management is also required. 
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The thesis findings also imply support for the HITF recommendations (2004 pp5-7) 
supported by other policy documents (DTI 2003 pp7-16, Cooksey 2006 pp3-8) about 
encouraging innovation through procurement and the setting up of CEP. Measuring a 
broad variety of aspects of performance as intended by CEP is wise, while the approach of 
evidence-based purchasing relies on both performance measurement and subsequent 
performance management as advocated by the thesis findings. However the case studies 
suggest that CEP is measuring performance through the evaluation centres and reporting it, 
but that the information is not always used in follow up management by purchasing and 
innovating actors in the networks. The thesis findings imply that policy should focus on 
ensuring that CEP performance measurement outputs are used by purchasers in the NHS, 
as well as by suppliers to re-innovate their products. 
 
Public policy has encouraged innovation (HITF 2004 pp5-7, DTI 2003 pp7-16), however 
the thesis implies that encouraging re-innovation, given the incrementally innovative 
nature of the products is important. This implies that policy should focus on the public 
sector aiding suppliers to re-innovate their products through the provision of appropriate 
feedback information from performance measurement and possible incentives for suppliers 
to improve the design of the product by longer term purchasing agreements, or more 
dynamic evaluations that recognise that innovative products keep improving. For example 
the ECG monitor supplier expressed frustration that technical evaluation of the product by 
CEP only took a snapshot in time of the product’s performance, ignoring improvements 
made in response to the evaluation. 
 
Finding that compliance with use of the product was a performance management process 
has the implication that the public sector should focus on policy making that promotes 
compliance with use of products, as well as appropriate purchasing and innovation 
practices. Only then will the innovative product perform for the user by improving their 
healthcare. Policy could promote working with suppliers to distribute guidelines and 
advice on use such as those produced by the blood glucose meter supplier, centralised 
training to ensure that the many local level users in the NHS are using the product 
appropriately and running campaigns to ensure patients use the product as intended. 
 
Having discussed a variety of implications of the thesis and previously concluded the 
thesis through reviewing the research questions, the next section of this chapter continues 
by stating the contribution of the thesis. 
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9.3. Contribution 
In general terms, the thesis has contributed to understanding performance measurement 
and management processes and their influence, with respect to innovative products. In 
particular, the contribution concerns clarifying the concepts of performance measurement 
and performance management, describing when they are worthwhile and have an influence 
on performance. The contribution is made in the context of the implementation of 
innovative healthcare products. 
 
The research has explored processes of performance measurement and performance 
management in the implementation of innovative healthcare products, identifying key 
processes that occur. In addition to the formal, quantitative performance measurement 
processes in the literature, the research has identified less formal subjective processes 
involving social and information exchange in assessing financial, technical and customer 
aspects of performance. Performance reporting was also identified as a concept closely 
associated with performance measurement. The research has also identified purchasing, 
product innovation and compliance with use of the product as key performance 
management processes, shedding some light on the performance improvement part of the 
broader or follow up planning and control actions that are suggested as performance 
management in the literature. 
 
The thesis has contributed to the emerging debate in the literature about whether 
performance measurement and performance management processes are worthwhile by 
their having a role in influencing performance. The findings give indications that 
performance measurement and reporting alone cannot be expected to have an influence on 
performance, however if performance management processes occur too then they can be 
expected to have an influence on performance of the innovative healthcare product. Also, 
sufficient performance measurement and reporting was found to be necessary if 
performance management is to have a beneficial influence on performance. The two by 
two matrix is a conceptual contribution demonstrating the beneficial, non-beneficial and 
lack of influences on performance that occur with limited or extensive performance 
measurement and performance management. 
 
Taken together, the findings have contributed to understanding how concepts of 
performance measurement and performance management of the innovative healthcare 
product during its implementation can be differentiated, by looking at their influence on 
performance. The thesis suggests that performance measurement and reporting are 
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processes that do not have an influence on performance alone, but do when broader 
performance management processes, of which they are a subset, also occur. 
 
The research has some important limitations, which must be born in mind when 
considering the contribution. These limitations are discussed in the next section. 
 
9.4. Limitations 
A key part of presenting the contribution of the study is to understand the limitations of the 
contribution. The thesis has conceptual and methodological limitations, as well as 
limitations of the findings. These are discussed below, including an outline of the 
limitations to the validity and reliability of the study. 
 
A core lesson from the PhD is the imperative of taking an iterative, reflective approach to 
the process, which ultimately results in better research. Another key learning experience in 
the early days was that the scope of the research and contribution must be modest and that 
there are likely to be many limitations. These lessons have helped the author develop as a 
researcher and have implications for the possible future of the research, as well as 
potentially pursuing other opportunities for research in the future, described below. 
 
Most immediately, the limitations of this research have highlighted ways it would be best 
to continue and improve the research. Retrospect is a powerful lens and highlights the 
value of the learning experience, so priorities in continuing the research would be to 
improve the design of the research with the benefit of hindsight and the iterative learning 
process, with the benefit of improving rigour. Having had the input of the empirical work 
and discussion in the light of the literature, the concepts in the conceptual framework are 
sounder than those drawn from the original literature review. Additionally, the new two by 
two matrix gives a new conceptual representation of performance measurement and 
management processes and their influence on performance. There is an opportunity for 
further research based on a more rigorous conceptual framework or the new two by to 
matrix, constructed with the benefit of this research and further literature review. For 
example the concepts of performance reporting and of performance improvement warrant 
deeper investigation in the next phase of the research. Limitations of the analysis process 
and software in the thesis imply that it would be wise to pursue any continuation of the 
research by using a more widely recognised software package such as NVivo and full 
transcription. 
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A limitation of this research was the restricted ability to take account of contextual issues 
in the cases, a limitation found also in other recent research in the field (Bourne et al. 
2005). There is an opportunity for future research that either controls for contextual issues 
by pursuing different cases within and outside the NHS context, or studies the role of that 
context. Further, the discussions and limitations suggested that increasing the number of 
cases would not only improve the analytical generalisability, but the selection of 
contrasting cases would provide opportunities to explore more rival explanations for the 
findings about the NHS context and the individual aspects of the different products and 
suppliers involved in the cases. 
 
9.4.1. Key Limitations 
Firstly, the thesis is limited to the context of the empirical research, namely the 
implementation of innovative healthcare products. The broad concepts in the performance 
literature suggest that it could be possible to generalise the findings to other types of 
innovative products, or even beyond to the performance measurement and management of 
projects or organisations themselves. However, the focus of the empirical case studies 
suggests that additional case studies would be required in broader contexts, to develop 
analytic generalisability of the findings using a replication logic (Yin 2003 pp31-33). 
 
The empirical work used a multiple case study design to enable replication of findings 
across cases, improving the analytical generalisability of the work. Using four cases, the 
analysis was able to demonstrate some amount of analytical generalisability, however a 
greater number of cases would have been advantageous to expose the findings to greater 
scrutiny and open up the possibility of improving further analytical generalisability. In 
particular, the individual cases mainly produced similar findings, so the selection of 
extreme or outlier cases to test rival theories in the analysis was often challenging, though 
all the empirical evidence was attended to. Although each case had particular themes, none 
of the four was very different from the others. The similar findings across all four cases 
mean that the findings cannot be generalised to a context other than that chosen in this 
thesis. Nonetheless, differences in the individual aspects of the cases, such as the size of 
the supplier organisation mean that the basis for replication across similar cases can be 
challenged and represent another limitation, despite the use of screening questions. While 
some differences between cases were drawn, such as whether the product was used by a 
clinician or end user, gathering greater amounts of scoping data for each case at the outset 
would have reduced this limitation. 
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Adopting the innovative product as unit of analysis was a decision made after the initial 
literature review and discussions with practitioners, given that innovation is inherently an 
inter-organisational process and that many respondents inherently focussed their responses 
on products. However a large amount of work in the performance and innovation 
literatures concentrates on the organisation as a unit of analysis, presenting the challenge of 
finding existing work with the same unit of analysis that is directly relevant to the current 
work. Thus the findings were by necessity based in part on generic concepts of 
performance measurement and management, rather than performance measurement and 
management of innovative products.  
 
Further, the research highlights that it is difficult to empirically investigate performance 
measurement and performance management of a particular innovative healthcare product 
without understanding the broader context of the network of organisations involved. The 
empirical work sought to acknowledge this issue by interviewing stakeholder respondents 
from a variety of organisations, however the size and complexity of the networks involved 
mean that the research was limited in ability to consider the role of the broader context of 
organisations, relationships and networks in analysis. This meant that the research was 
limited by not being able to check out rival explanations for the findings on the basis that 
the context was having some sort of role in performance, for example. By choosing cases 
of products that are all supplied to the NHS, many aspects of the context of the products 
and processes studied are kept constant, as has been attempted in previous research which 
studied processes in different business units within the same organisation (Bourne et al. 
2005). However the similar nature of the cases meant that limited contrasts could be drawn 
within the context, as discussed above. The dynamic nature of the healthcare context, and 
the NHS organisations at the national and regional levels in particular mean that the 
findings of the empirical work are also limited to the particular temporal cross section, as 
organisations and therefore processes may have evolved since. For example the rise of 
evidence-based medicine and the Centre of Evidence-based Purchasing suggests there may 
be pressure in future to reduce the number of clinicians who measure product performance 
in subjective ways based on their own internal experience, a finding of the empirical work. 
Validation of the case study descriptions by key Evaluation Centre and PASA respondents 
suggested that their more recent output reports following the CEP change programme may 
be more useful to buyers. However analysis in this research was limited to focussing on 
cross sectional data gathered before many new CEP and Evaluation Centre outputs had 
been fully introduced. 
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Another limitation concerns how the conceptualisation explored the influences of the 
processes, rather than studying conclusive links to performance. The research was carried 
out in this way due to the limited existing literature in the area, making a more conclusive 
study less appropriate, however in future such a study would provide a more thorough 
understanding of actual effects on performance. There were also difficulties 
operationalizing some aspects of the conceptual framework, for example the roles of the 
performance measurement and performance management processes in performance. 
Although the research design was exploratory and iterative, many roles only became clear 
throughout the empirical work and analysis, suggesting that more operationalisation of the 
concepts in the conceptual framework would have been useful to gain a clearer 
understanding when the research turned to the empirical work. The abductive research 
approach proved useful in combining the findings of the literature review and empirical 
work in a process of iterative learning, though it was challenging to improve the 
conceptual structure as suggested, because the literature is developing rapidly and still not 
clear in the area of performance measurement and management processes. This meant that 
interpretations of the empirical findings and the return to the literature following the 
empirical work played a large role in revising the conceptual framework, compared to the 
initial literature review. 
 
The performance measurement and performance management processes shown at the 
centre of the conceptual framework were based on the empirical findings, reinforced by 
their examination in the context of the literature and highlight how the processes occur. 
They also helped provide the basis for the discussions of drawing a conceptual distinction 
between performance measurement and performance management. However the processes 
described are generic and may not be applicable to particular product case studies. The 
qualitative nature of many of the processes found, such as social exchange for example, 
made it difficult to determine whether important aspects of the processes were missing or 
included in the descriptions given in the conceptual framework so the research cannot 
describe a conclusive, complete or final set of processes. 
 
Analysis of the empirical data used HyperRESEARCH, a relatively recent and lesser 
known software package than widespread NVivo for example. Various versions of 
HyperRESEARCH have been used successfully in recent social science research (Lewis et 
al. 2004, Ngwenyama & Sullivan 2007), including research on organisations that used 
interview methods (Eversole et al. 2007). Using the programme has had benefits for the 
validity, reliability and generalisability of the analysis (Hesse-Biber et al. 1991), as well as 
 245
challenging the researcher conceptually (Staller 2002). It was found to be particularly 
useful for analysing the mood and feeling of respondents when coding as their voice could 
be heard, giving a direct link to original data, though the coding process required long 
periods of time to repeatedly listen to the same file. However, the lack of complete written 
transcripts as used in NVivo is unusual when compared to much contemporary qualitative 
analysis and could be perceived as a limitation of the research, given that the audit trail for 
the analysis instead relies on the raw sound files, HyperResearch project files, the various 
matrices and additional notes made at the interviews. 
 
The analytic strategy set out to gather evidence from both semi-structured interviews and 
supplementary documentary evidence with the aim of triangulating between them. While 
some documentary evidence was available to back up the data from the interviews, the 
amount of documentary evidence was limited, particularly given the qualitative, subjective 
nature of many of the performance measurement processes described by interview 
respondents, for example. Harder, quantitative processes such as tender processes are 
described in better detail in the literature, though also presented limited documentary 
evidence as respondents rarely wanted to reveal commercially sensitive information 
outside an interview discussion. The limitations regarding documentary evidence meant 
that the analysis drew more heavily on the interview data and existing literature when 
attempting to triangulate data than would have been preferred if sufficient documentary 
evidence had been available. 
 
Given that the literature on performance measurement and management is new and 
developing, the research had to draw on literature from several different topics and areas of 
theory. Drawing on different areas of theory mean that the research is widely informed, 
however it presented issues of how to reconcile the varying concepts of performance, for 
example between quantitative, financial aspects of performance in the economics literature 
and more subjective aspects elsewhere. The study is also limited by the limitations of each 
of the areas of literature that it draws upon, for example the loose nature and lack of 
conceptual clarity in much of the performance literature and the challenges of researching 
complex relationships and networks in the purchasing and supply and innovation 
literatures, the latter as innovation is an inter-organisational process. 
 
Seeing that much research in the performance field is emergent, research with exploratory 
aspects could potentially be criticised as being tautological and of limited worth if it makes 
key findings that are closely related to the existing literature the study draws on, it being 
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inevitable that outcomes of the research would be a particular finding. For example, the 
criticism could possibly be levelled at the finding that a key performance management 
process involves innovation, when the research drew on innovation process literature. 
However the loose structure of many questions in the interview guide encouraged 
respondents to give open answers that were not just related to the underlying literature and 
the serendipitous findings of unexpected performance management processes, such as 
compliance with use of the product, reinforce this. Further, the thesis drew on a variety of 
different literature topics for breadth, tested different theories about how the conceptual 
difference between performance measurement and performance management could be 
drawn and later drew on new literature in the discussion to interpret the empirical work. 
 
9.4.2. Outline of Limitations to Validity & Reliability 
As described in the methodology, attempts were made to encourage a valid and reliable 
study. However the key limitations above highlight the limitations to the validity and 
reliability, which are summarised as follows. 
 
Construct Validity 
Although the operational measures were based on the initial literature review, multiple 
sources of evidence were used, effort was made to establish a chain of evidence and the 
work was reviewed by respondents and other researchers as shown in the Appendix; there 
were some limits to construct validity. Restrictions in the original literature on which the 
study was based, limited documentary evidence available and limitations of 
HyperResearch compared to NVivo present various limitations. 
 
Internal Validity 
The empirical work improved after expediting the CT scanner case as a pilot case and the 
research was able to test some rival explanations, however the fairly similar findings of all 
the cases suggest that outlier or extreme cases would have been useful to reduce the 
limitations of internal validity and provided some more challenging rival explanations to 
test. Discussing the interview guide and findings with fellow researchers assisted internal 
validity however. 
 
External Validity 
Despite comparing empirical findings across multiple cases and with the existing literature, 
the research has limited analytical generalisability beyond the context of this research due 
to the similar nature of the existing case contexts and the particular organisational context 
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of the dynamic NHS. Additional and extreme cases in other contexts, as suggested above, 
would help improve external validity. 
 
Reliability 
Discussions with research participants and other researchers aided reliability of the project, 
as did a test of the data by another researcher and the use of HyperResearch, however the 
limitations of the software mean that NVivo may be perceived as more helpful to ensuring 
reliability to some researchers. 
 
Having described key limitations of the thesis and current research, the next section 
discusses opportunities for future research, including extensions to the research that could 
reduce some of these limitations. 
 
9.5. Future Research 
Researching a focused PhD thesis has also developed an appreciation of the large number 
of broader future opportunities for research that could be pursued, dependent upon building 
a publication record, time and resources. 
 
The thesis focussed on innovative healthcare products as a unit of analysis, however it 
would be interesting to carry out further cases to see if the findings could be generalised to 
pharmaceuticals for example, or innovative products in other sectors. Indeed, there is the 
opportunity of generalising the findings of the research using different units of analysis, 
studying the performance measurement and management of organisations, projects, 
relationships or product portfolios for example. Much existing performance literature and 
seminal work in the area concentrates on the organisation (Neely et al. 2005, Kaplan & 
Norton 1992), rather than the product, so future research with the organisation as unit of 
analysis will be key to externally validating the findings to generic concepts of 
performance measurement and performance management. Given the inherent role of 
purchasing and supply management in the innovation process, the emerging interest in the 
performance of supply relationships in the literature (Lamming et al. 1996, Johnsen et al. 
2008) is an opportunity for future research. 
 
The evidence-based literature is receiving increasing interest and the concept has grown 
dramatically during the time of this research. Evidence-based issues share some conceptual 
similarity with performance measurement issues in the literature and helped in the 
literature review and conceptual discussions of this research. The nascent concept of 
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evidence-based purchasing is likely to be a key theme of future research, investigating 
what evidence-based purchasing is, what might constitute evidence and the role of 
evidence-based purchasing in achieving public policy objectives (Harland et al. 2007). 
Performance reporting (Radnor & Barnes 2007) was also discovered as a key concept 
deserving of future research. Further, the performance improvement part of performance 
management will also require additional research when studying evidence-based issues. 
This field of future research also raises the issue of defining value, a concept that has 
similarities to performance. There is an opportunity for further research in defining the 
concept of value or performance, in the performance field in general and with respect to 
the purchasing of innovations in particular, the latter being demanding of further research 
as multiple stakeholders are involved who are likely to have different perceptions of value. 
 
There is also the need for future research using a different research design and methods. 
Given the nature of existing research in the field, this research has had a strong exploratory 
element; however in the longer-term as the field develops there may be the opportunity for 
more conclusive research designs. Software such as HyperResearch and NVivo have a 
variety of powerful tools for modelling and testing hypotheses that were beyond the scope 
of the current study, but could add value in the future if the research design deemed their 
use appropriate to understand the field more conclusively as it develops. More conclusive 
research in the future could involve studying the actual effects of performance 
measurement and performance management processes on performance; rather than the 
processes themselves and their influences as is the current focus in the field. Also in the 
longer term, a longitudinal study is an ambition that would shed valuable light on the 
processes observed in this cross-sectional research, given the dynamic nature of the NHS, 
innovation and purchasing in practice. For example, respondents validating the case 
descriptions suggested the CEP change programme was producing more influential 
evaluation outputs and reports, which could be investigated in a longitudinal study, unlike 
the current cross-sectional one. 
 
9.6. Summary 
This chapter concluded the thesis by discussing the implications, contribution and 
limitations of the thesis, before describing opportunities for future research.  
 
On reflection the overarching point emphasised is the learning process of carrying out PhD 
research and the development of the author as a researcher. A key strength of the thesis is 
that it has implications for academic theory by exploring and differentiating concepts 
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which were identified as key issues in the existing literature. The thesis also has 
implications for managers by highlighting processes that can be used to measure and 
manage performance and when these processes are worthwhile, meeting a key practical 
concern. Additionally, the thesis has implications for policy makers in the fields of 
performance, purchasing and supply and innovation, given the recent focus on encouraging 
uptake of innovations by the NHS and making efficiencies through purchasing. When 
reviewing decisions made over the course of the research, retrospect can seem all too 
powerful, however it is from such learning experiences that the iterative research process 
has developed a contribution, within stated limitations. 
 
In line with answering the research questions, overall the contribution of the thesis is in 
understanding performance measurement processes, performance management processes 
and their influence. Especially, the thesis has clarified the concepts and described when 
performance measurement and management are worthwhile, key areas of concern 
highlighted in existing research. The contribution is made in, and limited to, the context of 
the implementation of innovative healthcare products. Further limitations to the research 
were discussed, about the focus of the research, unit of analysis and the methodology 
selected, with consequences for reliability and validity. Further, the complex nature of the 
subject of study in the public sector and the restricted, piecemeal nature of existing work in 
the performance field have limited some aspects of operationalisation and analysis of the 
study. The limitations of this research provide fertile ground for many opportunities to 
extend the research in future by improving reliability and validity and eventually extending 
the focus, a challenging and exciting prospect. 
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Case Study Interview Guide of 
Performance Measurement in 
Customer-Supplier Relationships 
 
 
 
Interview / Case No:………………………………………………………………….. 
 
Respondent:  ………………………………………………………………….. 
 
Organisation: ………………………………………………………………….. 
 
Respondent Role: ………………………………………………………………….. 
 
Interviewer:  ………………………………………………………………….. 
 
Date:   ………………………………………………………………….. 
 
 
 
 
Interview respondents may request a copy of the aggregate research findings 
and analysis – a valuable aid to benchmark your own organisation. 
 
This PhD research is supported by the Engineering & Physical Sciences 
Research Council. 
 
 
 
If you need further information about the study, please contact: 
 
Graham Dickinson 
Email: G.T.Dickinson@bath.ac.uk 
Tel: +44 (0) 1225 383147 
Fax: +44 (0) 1225 383223 
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Part A: The Innovative Product 
 
The first questions ask about your role, the organisation and an innovative 
product in which the organisation has been involved. 
 
A1: Describe what your organisation does? 
 
 
• Description of activities? 
• Industrial sector / market? 
• Turnover? 
• No. Employees? 
 
 
A2: Describe an innovative product that both your organisation and supplier or 
customer organisations have been involved in implementing. (Zheng Zhou 2006, 
Tidd et al. 2005 pp88-97) 
 
 
 
A3: In what way is the product new? (Tidd et al. 2005 pp5-13) 
 
 
• How is it new to the market?  
• How is it new to the firm? 
 
A4: How might your organisation benefit from the new product? (Tidd et al. 2005 
pp5-13) 
 
 
A5: To what extent does the new product have an impact on the NHS 
system? (Harland et al. 2007) 
 
 
A6: To what extent does the product improve health? (Harland et al. 2007) 
 
 
A7: What is the importance of purchasing the product for the NHS? 
(Cost of product and consumables, value added profile). (Kraljic 1983) 
 
A8: How complex is the supply market for the product? 
(No. of suppliers, pace of technological advance, entry barriers, complexity). 
(Kraljic 1983) 
 
A9: Can you also tell me about this and other product innovation projects in 
the past?  
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Part B: The Supply Relationship  
 
The next questions ask about how the supply relationship has a role in 
performance measurement and performance management of the innovative 
product. 
 
B1: Describe the customers and suppliers involved in producing this product.  
 
 
 
• Draw a map of stakeholder actors. (Oberg et al. 2007) 
 
B2: Describe what goes on in the relationships with customers / suppliers you 
mentioned earlier with whom you have been involved in implementing the 
innovative product. 
 
 
 
• Is there interaction between the producer and the user of the innovative 
product? (Thomke & Von Hippel 2002) 
 
• Are suppliers involved early in the development of the innovative 
product? (Dowlatshahi 1998) 
 
• Are purchasing or supply involved in research partnerships as part of 
implementing the innovative product? (Hagedoorn & Link 2000) 
 
• Is there sharing of profits and/or costs? (Teece 1986) 
 
• Is the relationship collaborative? (Swink 2006) 
 
- Is there trust? 
- To what extent is there communication? 
- How are problems solved? 
- To what extent are there mutual objectives? 
 
B3: How does the supply relationship have a role in performance 
measurement and performance management of the particular innovative 
product? 
 
 
 
 
B4: Can you also tell me about supply relationships in the past? 
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Part C: Performance Measurement of the Innovative Product 
 
The next questions ask about performance measurement of the product 
innovation project we discussed above. 
 
C1: Do you measure the performance of this product? (Neely et al. 2005, Farbey 
et al. 1993 pp75-94, Zheng Zhou 2006) 
 
 
C2: How do you measure the performance of this product? 
 
 
• Who is involved with measuring performance? 
• What are the activities needed to measure performance? 
• What are the resources needed to measure performance? 
 
C3: What kinds of performance measures of the innovative product are used? 
 
 
• Financial measures? (Hendricks & Singhal 2003) 
• Technical measures and operational measures? (Kaplan & Norton 1992, 
Ittner and Larcker 1998a) 
• Quality of life measures? (Skevington 1999) 
• Input, process, output or outcome measures? (Slack et al. p10, Godwin et al. 
1989) 
 
C4: What kinds of performance measurement systems are used? 
 
 
• Balanced scorecards? (Kaplan & Norton 1992) 
• Supplier/vendor assessment systems? (Timmerman 1986, Lamming et al. 
1996) 
 
C5: Who (organisations, individuals) carries out these performance 
measurement processes? 
 
 
• The customer &/or supplier organisation? 
• Which individuals in each organisation? 
 
C6: What resources are necessary for these performance measurement 
activities? 
 
 
C7: What performance measurement of innovative products happened in the 
past? 
 
 
C8: Are there any other performance measurement processes we have not 
discussed? 
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Part D: Performance Management of the Innovative Product 
 
 
Having asked about performance measurement, the next set of questions 
asks about performance management of the innovative product we mentioned 
above. 
 
D1: What kinds of processes (activities, actors, resources) are used to 
manage performance? (Radnor & McGuire 2004, Mintzberg & Lampel 1999, Halachmi 
2005, Lebas 1995) 
 
 
 
• Who is involved with managing performance? 
 
• What are the activities needed to manage performance? 
 
• What are the resources needed to manage performance? 
 
 
D2: Are the performance measurement processes we discussed earlier 
followed up by any performance management processes? (Halachmi 2005, Lebas 
1995) 
 
 
 
• Do you do anything with the performance measurement data once it is 
collected? 
 
• Who sees the performance measurement data and how do they use it? 
 
• Is performance measurement visible to anyone outside the 
organisation? 
 
• Do your supplier or customer organisations do anything with the 
performance measurement data? (eg development, training) 
 
• Are any rewards or penalties issued following performance 
measurement? 
 
 
D3: What product innovation project performance management has occurred 
in the past? 
 
 
 
D4: Are there any other performance management processes we have not 
discussed? 
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Part E: Innovative Product Performance  
 
The next questions ask about performance itself of the innovative product we 
mentioned above. 
 
E1: How do you describe the performance of the innovative product? (Lebas 
1995) 
 
 
 
 
E2: How does the innovative product perform? 
 
 
 
 
E3: What would the innovative product look like if it was performing well or 
badly? 
 
 
 
 
E4: How successful has the innovative product been for the customer / for you 
as a customer? 
(Customer satisfaction, customer acceptance, market share goals, revenue 
goals, revenue growth goals, unit volume goals, no. of customers). (Griffin & 
Page 1996) 
 
 
 
E5: Has the innovative product been a financial success?  
(Met profit goals, met margin goals, IRR or ROI, break-even time). (Griffin & 
Page 1996) 
 
 
 
 
E6: Has the innovative product been a technical success?  
(Competitive advantage, met performance specs, speed to market, 
development cost, met quality specs, launch on time, innovativeness). (Griffin 
& Page 1996) 
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E7: How does measuring and managing the performance of the innovative 
product help or hinder the performance? (Halachmi 2005, Bourne et al. 2005) 
 
 
 
 
 Customer-based 
Success  
(E4) 
Financial Success  
(E5) 
Technical 
Performance 
Success  
(E6) 
Other 
Performance 
Effects Mentioned 
(E7) 
Performance 
Measurement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Performance 
Management 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
E8: Can you tell me how innovative products in the past have performed, 
including whether this was helped or hindered by performance measurement 
and performance management? 
 
 
 
Do you have any other comments on this topic? 
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Table of Interviews Carried Out for the Case Studies 
 
Respondent 
(Job Role) 
Organisation Type of 
Stakeholder 
Role 
Length 
of 
Interview 
Date Location Cases to 
Which 
Interview 
Relevant 
Notes 
Head of 
Medical 
Physics 
Imaging 
Equipment 
Evaluation 
Centre 
Customer. 
Influencer 
(national 
level) 
0:50 12 
Sep 
06 
Imaging 
Equipment 
Evaluation 
Centre 
CT 
Scanner 
 
Head of Group Imaging 
Equipment 
Evaluation 
Centre 
Customer. 
Influencer 
(national 
level) 
1:00 12 
Sep 
06 
Imaging 
Equipment 
Evaluation 
Centre 
CT 
Scanner 
 
Category 
Manager, 
Radiotherapy 
& Imaging 
NHS PASA / 
Supply Chain 
Customer. 
Buyer, 
Influencer 
(national 
level) 
1:00 21 
Nov 
06 
Telephone CT 
Scanner 
 
Category 
Manager, 
Medical 
Maintenance 
NHS PASA Customer. 
Buyer, 
Influencer 
(national 
level) 
0:20 20 
Dec 
06 
Telephone CT 
Scanner 
 
Consultant 
Radiologist, 
Clinical Lead 
Radiology 
Hospital 
Trust 
Customer. 
User, Buyer, 
Decider 
(local level) 
0:35 14 
Dec 
06 
Hospital 
Trust Site 
CT 
Scanner 
Head 
Group Eval 
Centre & E. 
Bakker also 
present 
Consultant 
Gastrointestinal 
Radiologist 
Hospital 
Trust 
Customer. 
User, Buyer, 
Decider 
(local level) 
0:35 14 
Dec 
06 
Hospital 
Trust Site 
CT 
Scanner 
Head 
Group Eval 
Centre & E. 
Bakker also 
present 
Consultant 
Cross-sectional 
and 
Radionuclide 
Radiologist 
Hospital 
Trust 
Customer. 
User, Buyer, 
Decider 
(local level) 
0:50 15 
Jan 
07 
Hospital 
Trust Site 
CT 
Scanner 
Head 
Group Eval 
Centre also 
present 
CT 
Superintendent 
Radiographer 
Hospital 
Trust 
Customer. 
User, Buyer, 
Decider 
(local level) 
0:55 14 
Dec 
06 
Hospital 
Trust Site 
CT 
Scanner 
Head 
Group Eval 
Centre & E. 
Bakker also 
present 
Radiology 
Business 
Manager 
Hospital 
Trust 
Customer. 
Buyer, 
Decider 
(local level) 
1:15 15 
Jan 
07 
Hospital 
Trust Site 
CT 
Scanner 
Head 
Group Eval 
Centre also 
present 
Purchasing 
Manager 
Hospital 
Trust 2 
Customer. 
Buyer, 
Decider 
(local level) 
1:35 10 
May 
07 
Hospital 
Trust 2 Site 
CT 
Scanner 
 
Account 
Executive, CT, 
X-Ray, MRI & 
Connectivity, 
Southern 
CT Scanner 
Supplier 
Supplier 
(regional 
level) 
0:45 14 
Dec 
06 
Hospital 
Trust Site 
CT 
Scanner 
Head 
Group Eval 
Centre & E. 
Bakker also 
present 
Account 
Executive, 
South West 
CT Scanner 
Supplier 
Supplier 
(regional 
level) 
1:00 17 
Jan 
07 
BMI Clinic, 
Bath 
CT 
Scanner 
E. Bakker 
also present 
Head & 
Biochemistry 
Director 
Pathology 
Devices 
Evaluation 
Centre  
Customer. 
Influencer 
(national 
level) 
1:10 31 
Aug 
06 
Pathology 
Devices 
Evaluation 
Centre  
Blood 
Glucose 
Meter 
Interviewed 
at same 
time as M. 
Batki 
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Technical 
Evaluation 
Leader 
Pathology 
Devices 
Evaluation 
Centre  
Customer. 
Influencer 
(national 
level) 
1:10 31 
Aug 
06 
Pathology 
Devices 
Evaluation 
Centre  
Blood 
Glucose 
Meter 
Interviewed 
at same 
time as G. 
Thorpe 
Category 
Manager, 
Pathology 
NHS Supply 
Chain 
Customer. 
Buyer, 
Influencer 
(national 
level) 
0:25 20 
Dec 
06 
Telephone Blood 
Glucose 
Meter 
 
Category 
Specialist, 
Pathology 
NHS Supply 
Chain 
Customer. 
Buyer, 
Influencer 
(national 
level) 
1:10 30 
Nov 
06 
Telephone Blood 
Glucose 
Meter 
 
Pharmaceutical 
Services 
Manager 
NHS 
Prescription 
Pricing 
Division 
Customer. 
Decider, 
Gatekeeper 
(national 
level) 
0:50 19 
Jan 
07 
Telephone Blood 
Glucose 
Meter 
 
Manager, Point 
of Care Testing 
Team 
Hospital 
NHS 
Foundation 
Trust 
Customer. 
Influencer, 
Buyer, 
Decider 
(local level) 
0:50 22 
Jan 
07 
Telephone Blood 
Glucose 
Meter 
 
Diabetic 
Specialist 
Nurse 
Hospital 
NHS 
Foundation 
Trust 2 
Customer. 
User, 
Decider 
(local level) 
0:35 7 
Feb 
07 
Hospital 
NHS 
Foundation 
Trust 2 Site 
Blood 
Glucose 
Meter 
 
Diabetic 
Specialist 
Nurse 
Primary Care 
Trust 
Customer. 
User, 
Decider 
(local level) 
1:15 23 
Feb 
07 
Telephone Blood 
Glucose 
Meter 
 
Service 
Development 
Manager 
Pharmacy Plc Customer. 
Buyer, 
Decider 
(national 
level) 
0:50 25 
Jan 
07 
Telephone Blood 
Glucose 
Meter 
 
Director Care 
and Policy 
Diabetes UK Patient 
Body. 
(national 
level) 
1:00 17 
Jan 
07 
Telephone Standing 
Frame 
Diabetic 
himself 
Senior 
Marketing 
Manager 
Blood 
Glucose 
Meter 
Supplier 
Supplier 
(national 
level) 
1:30 11 
Jan 
07 
CRiSPS, 
Bath 
Blood 
Glucose 
Meter 
E. Bakker 
also present 
Director 
General 
British In-
Vitro 
Diagnostics 
Association 
(BIVDA) 
Supplier 
Industry 
Body 
(national 
level) 
1:15 15 
Jan 
07 
BIVDA, 
London 
Blood 
Glucose 
Meter 
 
Director General 
Medical 
Devices 
Evaluation 
Centre  
Customer. 
Influencer, 
Decider 
(national 
level) 
0:45 27 
Sep 
06 
Telephone ECG 
Monitor 
 
Category 
Manager, 
Cardiology 
NHS Supply 
Chain 
Customer. 
Buyer, 
Influencer 
(national 
level) 
0:50 29 
Jan 
07 
Telephone ECG 
Monitor 
 
Category 
Specialist, 
Cardiology 
NHS Supply 
Chain 
Customer. 
Buyer, 
Influencer 
(national 
1:00 12 
Jan 
07 
Telephone ECG 
Monitor 
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level) 
General 
Practitioner 
GP Surgery Customer. 
User, Buyer, 
Decider 
(local level) 
0:20 26 
Mar 
07 
GP Surgery ECG 
Monitor 
Trained as a 
cardiologist 
but has 
since 
worked as a 
GP 
Practice Nurse GP Surgery Customer. 
User (local 
level) 
0:25 26 
Mar 
07 
GP Surgery ECG 
Monitor 
 
CEO ECG Monitor 
Supplier 
Supplier 
(national 
level) 
0:35 10 
Jan 
07 
ECG 
Monitor 
Supplier 
ECG 
Monitor 
Interviewed 
at same 
time as P. 
Needham 
Chief 
Technology 
Officer 
ECG Monitor 
Supplier 
Supplier 
(national 
level) 
0:50 15 
Mar 
06 
ECG 
Monitor 
Supplier 
ECG 
Monitor 
 
Chief 
Technology 
Officer 
ECG Monitor 
Supplier 
Supplier 
(national 
level) 
1:25 10 
Jan 
07 
ECG 
Monitor 
Supplier 
ECG 
Monitor 
Nick 
Rawling 
joined for 
part of 
interview 
(0:10-0:45) 
Research 
Director 
Evaluation 
Centre, 
Assistive 
Technology 
Customer. 
Influencer 
(national 
level) 
1:35 26 
Sep 
06 
Evaluation 
Centre, 
Assistive 
Technology 
Standing 
Frame 
Interviewed 
at same 
time as M. 
Clift 
Centre 
Manager 
Evaluation 
Centre, 
Assistive 
Technology 
Customer. 
Influencer 
(national 
level) 
1:35 26 
Sep 
06 
Evaluation 
Centre, 
Assistive 
Technology 
Standing 
Frame 
Interviewed 
at same 
time as L. 
Pinnington 
Centre 
Manager / 
Occupational 
Therapist 
Evaluation 
Centre, 
Assistive 
Technology / 
University 
Customer. 
Influencer 
(national 
level) / 
User, Buyer, 
Decider 
(local level) 
0:40 3 
Nov 
06 
Telephone Standing 
Frame 
 
Lead Category 
Manager, 
Assistive 
Technology / 
Special 
Projects 
NHS PASA / 
DH 
Customer. 
Buyer, 
Influencer 
(national 
level) 
1:00 01 
Jan 
07 
Telephone Standing 
Frame 
 
Category 
Specialist, 
Mobility & 
Telecare 
NHS PASA Customer. 
Buyer, 
Influencer 
(national 
level) 
1:00 16 
Jan 
07 
Telephone Standing 
Frame 
Also parent 
of child 
using 
standing 
products 
Paediatric 
Physiotherapist 
Hospital 
NHS 
Foundation 
Trust 2 
Customer. 
User, Buyer, 
Decider 
(local level) 
0:40 7 
Feb 
07 
Hospital 
NHS 
Foundation 
Trust 2 Site 
Standing 
Frame 
 
Paediatric 
Physiotherapist 
Primary Care 
Trust 2 
Customer. 
User, Buyer, 
Decider 
(local level) 
1:35 16 
Feb 
07 
Telephone Standing 
Frame 
 
Physiotherapist Primary Care 
Trust 3 
Customer. 
User, Buyer, 
Decider 
(local level) 
0:40 20 
Feb 
07 
Telephone Standing 
Frame 
 
Managing 
Director 
Standing 
Frame 
Supplier 
Supplier 
(national 
level) 
1:30 15 
Nov 
06 
Standing 
Frame 
Supplier 
Standing 
Frame 
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Site 
 
Director 
General 
British 
Health 
Trades 
Association 
Supplier 
Industry 
Body 
(national 
level) 
1:05 5 
Feb 
07 
Telephone Standing 
Frame 
Interviewed 
at same 
time as P. 
Charlton-
Smith 
Chairman of 
Seating & 
Positioning 
Division 
British 
Health 
Trades 
Association 
Supplier 
Industry 
Body 
(national 
level) 
1:05 5 
Feb 
07 
Telephone Standing 
Frame 
Interviewed 
at same 
time as R. 
Hodgkinson 
Policy and 
Innovation 
Director 
NHS PASA Customer. 
Influencer 
(national 
level) 
1:25 26 
Jan 
07 
NHS 
PASA, 
Reading 
All  
Senior 
Collaborative 
Development 
Manager 
NHS PASA Customer. 
Influencer 
(national 
level) 
0:40 21 
Nov 
06 
CRiSPS, 
Bath 
All  
Head of R&D NHS PASA Customer. 
Influencer 
(national 
level) 
1:20 1 
Dec 
06 
CRiSPS, 
Bath 
All  
Senior 
Manager for 
Technology 
Introduction 
NHS Institute 
for 
Innovation 
and Institute 
Customer. 
Influencer 
(national 
level) 
0:55 6 
Feb 
07 
Telephone All  
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List of Codes Used in HyperResearch 
 
Code Name (& 
Group) 
Code Description from HyperResearch Type of Code 
(Miles & 
Huberman 
1984 p56) 
Research 
Questions 
Code is 
Relevant 
to 
PMeas – Expert 
actors required 
Marks passages where respondent mentions that 
actors with expertise in a particular area are involved 
in performance measurement processes. 
Code developed during initial coding. Refers to the 
actors involved in performance measurement 
processes (actors, activities & resources). 
Descriptive A,C 
PMeas – 
Measuring 
customer perf 
Marks passages where the respondent describes 
processes of measuring customer performance 
(Griffin & Page 1996) of the product. The customer 
performance measures used may also be described as 
part of this. Quality of life measures are also 
included as part of customer performance measures 
(Skevington 1999). This code also includes customer 
actors using the product if they have already bought 
one, where they measure performance through use, 
the information from which may be used in a rebuy 
situation. 
Descriptive A,C 
PMeas – 
Measuring 
financial perf 
Marks passages where the respondent describes 
processes of measuring financial performance 
(Griffin & Page 1996) of, or in relation to the 
product. The financial performance measures used 
may also be described as part of this. (Hendricks & 
Singhal 2003) 
Descriptive A,C 
PMeas – 
Measuring 
technical perf 
Marks passages where the respondent describes 
processes of measuring customer performance 
(Griffin & Page 1996) of the product. The technical 
performance measures used may also be described as 
part of this. Examples include traditional technical 
evaluation in the CEP Evaluation Centres (Menes et 
al. 2006) and measuring technical performance of the 
product during initial development (Tidd et al. 2005 
pp561-569). 
Descriptive A,C 
PMeas – 
Resources 
required 
Marks passages where respondent mentions that 
resources such as time, money and physical 
resources are required for performance measurement 
processes. 
Code developed during initial coding. Refers to the 
resources involved in performance measurement 
processes (actors, activities & resources). 
Descriptive A,C 
PMgmt  - 
Advice or 
policy guidance 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement involving issuing advice to actors 
(Hume & Wright 2006) This code also includes 
issuing policy guidelines, such as on a national level. 
Descriptive A,C 
PMgmt – 
Checking perf 
against expected 
Marks passages where the respondent mentions a 
broader or follow up process to performance 
measurement, involving checking the results of 
performance measurement against expected 
performance (Globerson 1985). The code includes 
processes such as benchmarking, quality control and 
post sales monitoring of performance. 
Descriptive A,C 
PMgmt - 
Feedback 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement involving feedback between actors in 
the case (Globerson 1985). 
 
 
Descriptive A,C 
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PMgmt – 
Improving 
product design 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement involving making improvements to the 
product design, which are featured in all subsequent 
products produced or served. An example is re-
innovation of the product (Rothwell & Gardiner 
1988, Tidd et al. 2005 p96). 
Descriptive A,C 
PMgmt – 
Involving senior 
organisations 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement of involving more senior level 
organisations or bodies. 
Code developed during initial coding. 
Descriptive A,C 
PMgmt – 
Product training 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement involving training of actors in product 
use (Lebas 1995). 
Descriptive A,C 
PMgmt – 
Publications 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement involving producing or disseminating 
publications based upon performance measurement.  
This code was developed during initial coding. 
Descriptive A,C 
PMgmt – 
Purchasing or 
marketing 
decision-
making 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement involving the decision-making process 
in purchasing a product (Webster & Wind 1972 
pp28-39, 89-98, Biemans 1992 pp129-140). This 
code also includes processes from the supplier side 
that may be involved in the purchasing decision-
making process, such as use of performance 
measurement information in marketing materials. 
Descriptive A,C 
PMgmt  - Tailor 
to customer 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement involving tailoring the product to the 
needs of a particular customer in a particular product 
exchange (Stump et al. 2002). 
Descriptive A,C 
PMgmt – Web 
tools 
Marks passages where respondents mention a 
broader, or follow up, process to performance 
measurement involving producing or disseminating 
information based upon performance measurement in 
a format of web based tools or applications, for 
example a database of products.  
This code was developed during initial coding. 
Descriptive A,C 
PMeas or 
PMgmt assists 
rules 
compliance 
Marks passages where respondents mention that 
performance measurement or performance 
management processes have assisted in complying 
with rules, regulations or legislation.  This code was 
developed during initial coding. 
A descriptive 
or interpretive 
code 
B,C 
PMeas or 
PMgmt buyers 
use in 
purchasing 
Marks passages where respondents mention that 
performance measurement or performance 
management processes are used, or need to be used 
by actors such as buyers in making a purchasing 
decision (Webster & Wind 1972 pp28-39, 89-98, 
Biemans 1992 pp129-140). 
A descriptive 
or interpretive 
code 
B,C 
PMeas or 
PMgmt 
dysfunctional 
consequences 
Marks passages where respondents mention that 
performance measurement or performance 
management processes have dysfunctional 
consequences for performance (Ridgway 1956). 
A descriptive 
or interpretive 
code 
B,C 
PMeas or 
PMgmt no role 
in customer perf 
Marks passages where respondents mention that 
performance measurement or performance 
management processes do not have an influence on 
customer performance (Griffin & Page 1996) itself. 
This code was developed form the conceptual 
framework, in turn based upon the literature review. 
 
An 
explanatory or 
pattern code 
B,C 
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PMeas or 
PMgmt no role 
in financial perf 
Marks passages where respondents mention that 
performance measurement or performance 
management processes do not have an influence on 
financial performance (Griffin & Page 1996) itself.  
This code was developed form the conceptual 
framework, in turn based upon the literature review. 
An 
explanatory or 
pattern code 
B,C 
PMeas or 
PMgmt no role 
in perf 
Marks passages where respondents mention that 
performance measurement or performance 
management processes do not have an influence on 
performance itself. This code was developed form 
the conceptual framework, in turn based upon the 
literature review. 
An 
explanatory or 
pattern code 
B,C 
PMeas or 
PMgmt no role 
in technical perf 
Marks passages where respondents mention that 
performance measurement or performance 
management processes do not have an influence on 
technical performance (Griffin & Page 1996) itself. 
This code was developed form the conceptual 
framework, in turn based upon the literature review. 
An 
explanatory or 
pattern code 
B,C 
PMeas or 
PMgmt re-
designed 
product 
improved 
Marks passages where respondents mention that 
performance measurement or performance 
management processes have improved the technical 
design of the product (Rothwell & Gardiner 1988, 
Tidd et al. 2005 pp96). The code is also used where 
general product faults during the life of the product 
are rectified. 
A descriptive 
or interpretive 
code 
B,C 
PMeas or 
PMgmt role in 
customer perf 
Marks passages where respondents mention an 
influence of performance measurement or 
performance management processes in customer 
performance (Griffin & Page 1996) itself. This code 
was developed form the conceptual framework, in 
turn based upon the literature review. 
An 
explanatory or 
pattern code 
B,C 
PMeas or 
PMgmt role in 
financial perf 
Marks passages where respondents mention an 
influence of performance measurement or 
performance management processes in financial 
performance (Griffin & Page 1996) itself. This code 
was developed form the conceptual framework, in 
turn based upon the literature review. 
An 
explanatory or 
pattern code 
B,C 
PMeas or 
PMgmt role in 
perf 
Marks passages where respondents mention an 
influence of performance measurement or 
performance management processes on performance 
itself. This code was developed form the conceptual 
framework, in turn based upon the literature review. 
An 
explanatory or 
pattern code 
B,C 
PMeas or 
PMgmt role in 
technical perf 
Marks passages where respondents mention an 
influence of performance measurement or 
performance management processes on technical 
performance (Griffin & Page 1996) itself. This code 
was developed form the conceptual framework, in 
turn based upon the literature review. 
An 
explanatory or 
pattern code 
B,C 
PMeas or 
PMgmt supplier 
competitive 
about 
Marks passages where respondents mention that 
suppliers are competitive about performance 
measurement or performance management processes 
or their outputs, suggesting they believe it has an 
influence on performance. Code developed during 
initial coding. 
A descriptive 
or interpretive 
code 
B,C 
PMeas or 
PMgmt tailored 
product 
appropriate 
customer 
Marks passages where respondents mention that 
performance measurement or performance 
management processes have tailored the product 
making it more appropriate for the customer 
(Athaide & Stump 1999). 
A descriptive 
or interpretive 
code 
B,C 
Context – 
complex supply 
market 
Marks passages where respondents mention that the 
supply market for the product is complex (Kraljic 
1983). 
 
 
Descriptive B,C 
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Context – low 
complexity 
supply market 
Marks passages where respondents mention that the 
supply market for the product is not complex, or has 
low complexity (Kraljic 1983). 
Descriptive B,C 
Context – rel 
collaboration 
Marks passages where respondents mention that the 
supply relationship is collaborative (Swink 2006, 
Hagedoorn & Link 2000). It may be long term, be 
described as a partnership or at a high or strategic 
level of development, and may feature mutual 
objectives and trust. 
Descriptive A,C 
Context – rel 
communication 
Marks passages where respondents mention that 
communication, or information exchange (IMP 
Group 1982) occurs in the supply relationship. Initial 
coding highlighted that communication is a 
performance measurement process. 
Descriptive A,C 
Context – rel 
different perf 
claims 
Marks passages where the respondent mentions that 
some actors in the case made different performance 
claims to others. This code was developed during 
initial coding. 
Descriptive B,C 
Context – rel 
role in perf 
Marks passages where respondents mention that the 
supply relationship has an influence on performance 
(Ritter & Gemunden 2004, Chapman & Corso 2005, 
Grandori & Soda 1995). 
An 
explanatory or 
pattern code 
B,C 
Context – rel 
social exchange 
Marks passages where respondents mention that a 
process of social exchange (IMP Group 1982), such 
as visits between customer and supplier actors occurs 
in the supply relationship. Initial coding highlighted 
that social exchange is a performance measurement 
process. 
Descriptive A,C 
NB Abbreviations: ‘Perf’ is Performance, ‘PMeas’ is Performance Measurement, ‘PMgmt’ is Performance 
Management, ‘Rel’ is Relationship as in the supply relationship. 
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Respondent / Research Question (RQ) 
Theme 
Performance Measurement (RQs:A,C) Performance Management (RQs:A,C) Performance Measurement/Performance 
Management Influence on Performance 
(RQs:B,C) 
Head Medical Physics, Evaluation Centre Technical evaluation of technical parameters is carried 
out by Evaluation Centre, attended by supplier 
representatives. 
Evaluation reports and data are published and put on the 
internet. 
Suppliers show concern that evaluation results affect 
purchasing of the scanner 
Head Group, Evaluation Centre Technical evaluation of technical parameters is carried 
out by Evaluation Centre, data is shared between the 
Centre and supplier during and after the evaluation. 
Evaluation reports & tools for scanner users are 
produced, also in a web based form. 
Trusts use technical evaluation outputs when purchasing 
a scanner, suppliers show concern over the results of the 
evaluations. 
Category Manager Imaging, NHS 
PASA/Supply Chain 
Upfront cost, revenue costs & utilisation are all 
measured. Trust clinicians make site visits to assess 
performance of the scanner, information is exchanged 
with supplier 
Purchasing decisions about the scanner are made, 
supplier tailors scanner package to Trust needs, 
feedback on measurement is given to supplier, the 
scanner design has been improved 
Hardware & service improved. Information from 
performance measurement is used in making purchasing 
decisions, scrutinising pricing and technical 
performance. 
Category Manager, Maintenance,  NHS 
PASA 
Cost of maintenance is measured. Service surveys are 
carried out, focussing on scanner uptime. 
Feedback of performance information to supplier, 
supplier makes improvements to service package. 
Service configuration has been improved. Measures can 
be unreliable in describing performance. 
Radiologist (Lead), Hospital Trust Determining if scanner package meets clinical 
specialisms, packages are compared against set budget, 
experts are consulted. Clinicians make site visits, trial 
use of the scanner. Post-tender discussion occurs with 
suppliers. 
Purchasing tender process, purchasing team discuss 
scanner packages on offer, compromise over their 
various interests in deciding which scanner to purchase. 
Clinical benefits are gained from the particular scanner 
package purchased through the tender process. 
Feedback has been given to the supplier, but has not 
been used to change the scanner design as Trust is a 
small customer. 
Gastrointestinal Radiologist, Hospital 
Trust 
Assesses the ease of interpreting scanner images for 
specialist clinical work. Site visits are made to look at 
scanners and talk to users. 
Clinicians in the Trust go through a decision-making 
process about which scanner to purchase. 
Processes have no influence as not enough time to 
gather information needed to make a purchasing 
decision. Would not decide on the basis of supplier 
demos. 
Cross-sectional & Radionucleide 
Radiologist, Hospital Trust 
Scanners are compared against a set budget, assesses if 
scanner meets clinical specialisms, technical criteria are 
measured. Site visits are made to assess scanner 
performance, calls are made to colleagues in other 
Trusts. 
A purchasing tender process involves decision-making, 
bids from scanner suppliers are scored, though flexible 
use is made of the scoring system. The supplier and 
competitors are given feedback following the outcome 
of the tender process. 
The purchasing tender process means the best scanner 
for needs of the Trust is bought, however cost impacts 
whether the scanner or a competing product is chosen. 
Superintendent Radiographer, Hospital 
Trust 
Looks at scanner dose, ease of training radiographers to 
use it and ease of use for Trust’s needs. Site visits are 
made to trial use of the scanner, tell the supplier what is 
needed in the package. 
Decisions are made to purchase the scanner or a 
competing scanner through discussion of bids against 
the tender specification. Supplier staff train users in 
operation of the scanner. Feedback about scanner 
performance is given to the supplier. 
An improved scanner over the existing one is bought for 
the Trust following assessment of scanner performance 
and the tender process. The influence of feedback is 
unclear as good scanner features can be maintained, 
however other suggested improvements have not been 
made. 
Radiology Business Manager, Hospital 
Trust 
Technical parameters of the scanner are assessed, ease 
of use in Trust specialisms and uptime. Site visits are 
made, actors talk to colleagues, long-term maintenance 
cost is assessed as servicing involved. 
A purchasing decision is made, the performance of the 
scanner and competing products is checked against the 
specification, feedback is requested by and given to the 
supplier. 
Assessing performance and the tender process helps 
purchase the best scanner for Trust. Performance 
measurement information is used in acceptance testing 
and to get repairs made. 
Purchasing Manager, Hospital Trust 2 Lifetime costs are assessed of purchasing v leasing the 
scanner. User and technical assessments are made. 
Clinicians make site visits for scoring scanner. 
 
 
A purchasing tender process includes scoring & ranking 
of scanner attributes to make purchasing decision. CEP 
reports are produced following technical evaluations. 
Information gathered in the tender process and scoring 
are used to decide which scanner is purchased. CEP 
reports are too late, purchasers knowledgeable anyway. 
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Account Executive SE, Supplier Technical parameters are measured in design 
specifications, purchasers include technical & financial 
measures in tender specification, user opinions about 
the scanner are gathered by the supplier. Supplier visits 
Trust, demonstrates the scanner. 
Purchasing decisions are made by Trusts, feedback 
occurs from test sites, users and evaluation centre, 
improved scanner software has been developed by the 
supplier. 
Purchases are made and the scanner sold or not on the 
basis of information from performance measurement. 
Scanner software & radiation dose have been improved 
following feedback. Evaluation centre evaluation 
outputs are late, not novel and have no influence. 
Account Executive SW, Supplier Budget, functionality for particular needs of Trust are 
assessed. Two way site visits occur to understand Trust 
needs, trial use. Study days are arranged for users. 
Purchasers decide between the scanner and competing 
scanners. Every scanner package tendered is tailored to 
the Trust. Training of users. Re-design of the scanner. 
Processes have a limited influence as each purchasing 
decision is made on a different basis, the supplier 
cannot always influence the outcome. 
Policy & Innovation Director, NHS PASA Savings & line price models to measure financial 
performance of products. Broader value, of innovations 
sometimes measured. 
Purchasing decision-making. Evaluation Centre 
publication outputs to evaluations. 
Processes do not currently have an influence as more 
proactive evidence of value needed, integrated into 
NHS. 
Senior Collaborative Development 
Manager, NHS PASA 
Clinical experts are consulted for their views. 
Stakeholder communication has been a key way of 
gathering information in setting up CPHs. 
Decision-making about products to purchase by 
purchasers in the NHS. 
Processes have limited influences as purchasing 
decisions are often made for other, short term reasons. 
Head R&D, NHS PASA Measurement of savings and budgets are key, supplier 
KPIs and policy targets are used. Category staff 
specialists keep up with market, communicating with 
suppliers. 
Decision-making about products to purchase by 
purchasers in the NHS. National level advice provided 
to local level purchasers by PASA staff. 
Products are purchased without advice and information 
from performance measurement. Although evidence of 
technical performance may exist, budget holder still has 
to be convinced to pay if product is to be purchased. 
Senior Manager for Technology 
Introduction, NHS III 
Assessment is made of the technical nature of product 
including patents, business plan of the supplier to 
exploit it. 
III staff make the decision of whether to back a product 
financially. 
Information gathered on a product and decision results 
in it being backed financially or not. Checking 
performance against regulations encourages the supplier 
to ensure product meets claims. 
Summary Matrix of Key Findings Discovered in Coding in Multi-Slice CT Scanner Case (Cut 1: by respondent, cut 2: by theme in conceptual framework) 
 
Method to Produce the Summary Table: 
The table is a display format summarising  the large amount of data from the original intra-case table that was produced from the respondent interviews coded using HyperResearch. The 
table is an un-ordered meta-matrix showing all the respondents in the case. The matrix is ordered by role in the rows and conceptual framework theme in the columns, the latter determined 
by the research questions, as recommended by Miles & Huberman (1984 pp79-80). 
The cells in the matrix show “…short quote and summarising remarks…” (Miles & Huberman 1984 p80) qualitatively describing the data coded in relation to the research questions in the 
original table. Code frequencies within the case are shown in a separate table. The qualitative remarks are produced following data reduction and weighting as suggested by Miles & 
Huberman. The latter was according to a decision rule where only findings relating to general codes that are matched by more than one respondent within the case are included, in 
accordance with the pattern matching analytic strategy used (Yin 2003 pp116-120). Miles and Huberman (1984 pp104) advocated the following example, using the same method as in 
entering the data in the matrix here: “…the data being entered in each cell are a brief summary of what the analyst found for each respondent in the field notes. The main decision rule 
appears to be this: if it’s in the notes, summarise it and enter a phrase reflecting the summary.” Given the large amount of data to be reduced into this matrix, the process has where 
necessary involved what Miles and Huberman refer to as standardisation of cell entries to a more generic descriptor and taking the modal response. 
The research questions look at performance measurement and performance management processes. Performance measurement processes are also represented in the table by mention of the 
measures used, firstly for brevity, secondly because measurement procedures have been described as mapping and preserving the difference in a set of symbols and a collection of entities 
(Farbey et al. 1993 pp75-94), and finally because many respondents answered the questions about performance measurement processes by listing the measures that are used. 
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CODE Head 
Med 
Phys 
Head 
Group, 
Eval 
Centre 
Cat 
Mangr 
Imaging 
Cat 
Mangr, 
Maint 
Radiol 
(Lead) 
Radiol, 
Gastro 
Radiol, 
X sect 
Radiog Radiol 
Business 
Mangr 
Purch 
Manager, 
Trust 
Acct 
Exec 
SE. 
Supplr 
Acct 
Exec 
SW. 
Supplr 
Policy & 
Innov 
Director, 
PASA 
Collab 
Devpt 
Mangr, 
PASA 
Head 
R&D 
PASA 
NHS 
III 
Mangr 
Expt 
actors 
1 2   3 2  1 1     2  1 
Meas 
cust perf 
1  2 3 7 3 9 8 7  9 9 1 6 4 2 
Meas 
finc perf 
  5 1 2  5  8 4 2 5 3  1 2 
Meas 
tech perf 
13 23 9 2 7 1 5 11 16 5 8 3 6 1 3 5 
Resorc 2 3       1        
Advice 
policy 
guid 
 3 2      1    1  1  
Check 
expctd 
1 7 3  4  1 3 5  3 1  1  1 
Feedbck 1 4 3 1 3  2 3 3  10 2     
Imp 
prdct 
design 
 1 3 1 1    2  3 1     
Senior 
org 
1  1            1  
Prdct 
traing 
       1  1 4      
Publctn 2 15 1      1 4   3  1  
Purch 
mktg dec 
5 10 7  9 2 8  9 13 7 3 2 4 3 3 
Tailor 
cust 
 1 2  3  1 1 2  1 2     
Web 
tools 
 
 
 
1 6 1              
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Assist 
rule 
compl 
 1       1        
Buyers 
use 
4 7 2  5  5 3 8 10 7 1 1 1 2 2 
Dysfunc 
conseq 
   1 1  1 1  3 1 1    1 
No role 
cust perf 
1           1     
No role 
finc perf 
1           1     
No role 
perf 
2    1 2 2 2 1 5 4 3 7 2 1 1 
No role 
tech perf 
    1  1    3   2   
Re-des 
prdct 
impvd 
 1 3      1  3      
Role cust 
perf 
 3 1  5  4 3 1 1 6    1  
Role finc 
perf 
4 2 3  1    6 2 4 2    2 
Role perf 9 17 10 1 7  6 3 11 8 9 2 1 1 3 3 
Role 
tech perf 
3 7 5  2  1  6 5 2 1 1  1 1 
Supplrs 
competv 
5 4 1  1    1        
Tailord 
appropt 
 1       1        
Cplx 
Mkt 
                
Low 
cplx mkt 
                
Collab   1      1  1  1   1 
Comm 2 3 1  1  5 2 1 1 4 1  2 1 1 
 299 
 
 
Diff 
claims 
   1             
Rel role 
perf 
  1      2  2      
Soc 
xchange 
3 2 2  1 1 4 2 2 1 6 5  1   
Code Occurrences by Respondent in Multi-Slice CT Scanner Case 
 
Data compiled from HyperResearch Report Function. 
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Notes and Key to the Network Pictures 
 
Definitions 
Flows in the diagram are categorised according to the major flows described by 
interviewees. They include the following: 
• Product: A product, normally the medical device, passes from one actor in the 
network to another. 
• Finance: A flow of money from one actor in the network to another. 
• Commissioning: Refers to the activities of delivering healthcare in the NHS at a 
local level. The term is also used in particular cases in practice, such as the setting 
up of a new CT Scanner, though the definition used here is that of the NHS for 
consistency. 
• Assignment: The term is used to describe situations where one network actor 
assigns, requests or tasks another actor to an activity. For example CEP assigns 
evaluation centres to carry out evaluations. 
• Information: Many of the flows between actors are of information. 
• Care: Care flows describe the actual physical delivery of care to the patient, for 
example by clinicians. 
 
Abbreviations 
ISTC-Independent Sector Treatment Centre, CEP-Centre for Evidence Based Purchasing, 
DoH-Department of Health, SHA-Strategic Health Authority, PASA/CD-Purchasing & 
Supply Agency/Commercial Directorate, OGC-Office of Government Commerce, NIC – 
National Innovation Centre, GP-General Practitioner, PPD(NHSBSA)-Prescription Pricing 
Division (NHS Business Services Authority), DES-Department for Education & Skills, 
BHTA-British Healthcare Trades Association, NAEP – National Association of Equipment 
Providers 
 
Notes 
Circled items on the network map represent stakeholders or actors. Flows between actors 
represent activities. Committees involving multiple actors or initiatives are often described 
as stakeholders by respondents, but must be included as activities so are represented by 
arrows. 
The size of circles around actors is not significant 
Public sector actors are shown in plain type, private sector organisations in italics 
Interviewees or their organisations are indicated by yellow highlighting. 
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Influence Respondents 
who Described 
Influence 
Performance 
Measurement 
Predecessors 
Performance 
Management 
Predecessors 
Researcher 
Explanation 
Product is 
purchased or not 
+/- 
F/C 
Head Med Phys, 
Head Group, Cat 
Mangr Imaging, 
Radiol (Lead), 
Radiol, X sect, 
Radiog, Radiol 
Business Mangr, 
Purch Manager, 
Acct Exec SE., 
Acct Exec SW., 
Policy & Innov 
Director, Collab 
Devpt Mangr, 
Head R&D, NHS 
III Mangr 
Clinicians in the 
Trust purchasing 
team assess 
scanner 
performance for 
their particular 
needs & interests. 
Communication 
and visits between 
customer and 
supplier. 
Technical 
evaluation by 
Evaluation 
Centre. 
Assessment of 
purchase and 
maintenance 
costs. 
Use of 
performance 
measurement 
information such 
as clinician’s 
assessments, 
evaluation centre 
outputs. Making 
the purchasing 
decision. 
Marketing the 
scanner to the 
customer. 
Purchasing tender 
process with 
scoring and 
weighting, 
checking tenders 
against 
specification, 
committee 
discussion, 
compromise. 
The decision to 
purchase the 
product or not on 
the basis of 
performance 
measurement 
information gives 
the supplier sales 
or not and the 
customer the 
benefit of a 
product that 
performs best for 
healthcare. 
The best product 
for the needs of 
the user is 
purchased 
+ 
C 
Radiol (Lead), 
Radiol, X sect, 
Radiol Business 
Mangr 
Assessing the 
customer 
performance of 
the CT scanner. 
Making 
purchasing 
decision, tender 
process in Trust. 
The tender 
process of 
assessing 
performance of 
the various 
scanners available 
and decision-
making gives the 
Trust the best CT 
scanner for their 
particular needs. 
Product can be 
purchased or not 
for short-term, 
cost based rather 
than broader 
reasons 
- 
C 
Radiol, X sect, 
Policy & Innov 
Director, Radiol, 
X sect, Purch 
Manager, Acct 
Exec SE., Collab 
Devpt Mangr, 
Head R&D 
Assessing cost of 
scanner. 
Purchasing 
decision-making 
processes by Trust 
buyers. 
The product is 
bought or not in a 
decision made on 
the basis of cost 
performance 
measurement 
information with a 
short term view. 
Evidence of 
broader aspects of 
performance is 
not used 
proactively or 
integrated back to 
buyers. 
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Information not 
used in the 
purchasing 
decision 
None 
Head Med Phys, 
Radiol (Lead), 
Purch Manager, 
Acct Exec SW., 
Collab Devpt 
Mangr, Head 
R&D 
Technical 
evaluation by 
Evaluation 
Centre, supplier 
product 
information, 
demonstrations 
and visits. 
Technical 
evaluation 
outputs. 
Information from 
performance 
measurement and 
management 
processes is not 
used in the 
purchasing 
decision. The 
product may be 
bought for all 
sorts of reasons 
other than on the 
basis of 
performance 
measurement 
information. 
Technical 
evaluation reports 
are too late, 
clinicians know 
already or do not 
have time to use 
info. 
Product design 
improved 
+ 
T 
Cat Mangr, 
Maint, Acct Exec 
SE. 
Customer 
surveys, technical 
assessment. 
Feedback to 
supplier, supplier 
makes design 
changes, free 
upgrades given by 
supplier to 
reference site. 
The design of the 
CT scanner and 
associated 
package is 
permanently 
improved, for 
example through 
new software 
releases, an 
improved service 
package. 
Feedback to the 
supplier is not 
used 
None 
Radiol (Lead), 
Radiog 
Assessing 
customer 
performance. 
Feedback to 
supplier. 
Feedback on 
performance 
measurement 
information given 
to the supplier is 
not used. 
Customer is 
small. 
Used in 
acceptance 
testing 
+ 
T 
Head Group, 
Radiol Business 
Mangr 
Technical 
evaluation by 
Evaluation 
Centre. 
Checking 
performance of 
the scanner 
against what was 
promised in the 
supplier’s tender 
returns. 
Performance 
measurement 
outputs such as 
technical 
evaluation reports 
are used to ensure 
a scanner meets 
the promised 
specification on 
installation, 
before full 
payment is made 
to the supplier. 
Useful for 
repairs 
+ 
T 
Head Group, 
Radiol Business 
Mangr 
Technical 
evaluation by 
Evaluation 
Centre. 
Checking of 
scanner 
performance 
against expected. 
Customer’s own 
performance data 
makes the case to 
the supplier to 
come and make 
repairs to the 
scanner. 
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Supplier ensures 
product 
performs to their 
specification & 
regulations, as it 
will be tested and 
then purchased 
or not 
+ 
T 
Cat Mangr 
Imaging, NHS III 
Mangr 
Technical 
evaluation by 
Evaluation 
Centre. 
Checking 
performance of 
product against 
claims. Feedback 
to supplier. 
Making 
purchasing 
decision. 
Performance 
measurement and 
management 
processes mean 
that the supplier 
know and ensure 
that the product 
must meet a 
certain standard. 
Supplier shows 
concern over 
performance 
measurement 
* 
+/- 
F 
Head Med Phys, 
Head Group, 
Radiol Business 
Mangr 
Technical 
evaluation by 
Evaluation 
Centre. 
Technical 
evaluation 
outputs, 
information given 
to suppliers as 
part of tender 
process. 
Suppliers show 
concern that 
performance 
measurement data 
will affect their 
competitive 
position or sales. 
Effects Matrix Showing Influences of Performance Measurement and Performance 
Management Processes, as Described by Respondents in the Multi-Slice CT Scanner 
Case.  
 
(KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial 
performance, ‘T’ is an influence on Technical performance and ‘C’ is an influence on Customer performance 
(After Griffin & Page 1996). ‘None’ means there is no influence on performance. ‘*’ denotes an influence 
inferred by researcher rather than specifically described by respondent). 
Constructing the matrix: Cell entries are brief phrases highlighting inflluences coded in the case study and 
shown in the original large matrix of findings from respondents in the case. Processes with the influences, or 
implicit predecessors are shown. Intended outcomes or those that will occur are also shown (Miles & 
Huberman 1984 pp114-118). Only those influences that were seen in a pattern across more than one 
respondent in the code occurrences by respondent in the case are included, in accordance with the pattern 
matching analytic strategy used (Yin 2003 pp116-120). Given the large amount of data to be reduced into this 
matrix, the process has where necessary involved what Miles and Huberman refer to as standardisation of 
cell entries to a more generic descriptor and taking the modal response, guided by those in the summary 
matrices of findings for each case. 
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Respondent / Research Question (RQ) 
Theme 
Performance Measurement (RQs:A,C) Performance Management (RQs:A,C) Performance Measurement/Performance 
Management Influence on Performance 
(RQs:B,C) 
Head & Biochem Director, Evaluation 
Centre 
Technical evaluation of technical parameters, liaison 
between Evaluation Centre and supplier over results. 
High cost and resource demand of evaluation. 
Evaluation reports produced. Purchasing. Referral to 
MHRA if a problem found with the product. 
Purchasers use reports to decide which meter to 
purchase. A bad evaluation report affects sales. Patient 
must act on meter result otherwise meter does not 
perform for them by managing their disease. 
Technical Evaluation Leader, Evaluation 
Centre 
Technical evaluation of technical parameters, experts 
are involved, supplier checks evaluation data. 
Purchasers use technical evaluation outputs when 
making purchasing decisions. 
Supplier willing to be evaluated suggesting the 
evaluation has an influence on product performance. 
Positive feedback on reports received from purchasers. 
Category Manager Pathology, NHS 
Supply Chain 
Clinical specification, cost implications, service 
delivery by supplier are measured. Ongoing 
communication with Evaluation Centre and supplier at 
local level unless a problem occurs. 
Purchasers use performance measurement information 
in making decisions about which meter to buy, checking 
meter meets description. Referral to MHRA or NHS 
Supply Chain if problem with meter. 
Meters purchased or not following purchasing decision. 
Suppliers know meter must perform if it will be 
measured. Training is necessary if users are to operate 
meter correctly and it is to perform for them. 
Category Specialist Pathology, NHS 
Supply Chain 
Technical specification of the meter and strip price are 
assessed. Regular meetings between NHS Supply Chain 
and supplier, data gathered locally for problem solving. 
Advice and guides given to purchasers. Purchasing 
decision-making. 
Meter bought or not. Little management of meters or 
disease after purchase and patient testing. Little use has 
been made of technical evaluation reports. 
Pharmaceutical Services Manager, NHS 
PPD 
Strip price and % reduction, meter service package 
measured. CE mark checked as technical assessment. 
Supplier provides all evidence to PPD to evaluate. 
Performance checked against existing strips. Decision 
made by committee using performance information to 
list strip on NHS drug tariff or not. 
Blood glucose meter strip available on prescription. 
12% price cut achieved by PPD. Listing process does 
not aid listing innovative strips, only similar to existing. 
Manager Point of Care Testing Team, 
Hospital NHS Foundation Trust 
Ease of use and making mistakes by clinicians trialling 
meter. QA data gathered. Evaluation data shared with 
supplier. 
Purchasers make decisions on basis of performance 
measurement information. Checking meter results are as 
expected. Training users. 
Meters bought or not following purchasing decisions 
and performance measurement. Measurement identifies 
problems to solve and meters to avoid using. 
DSN, Hospital NHS Foundation Trust 2 Accuracy, simplicity, are assessed in a subjective 
evaluation for particular patient. Supplier visits. 
Choosing a meter with patient. User feedback to 
supplier reps. Performance measurement publications. 
Patient given preferred meter. Design of the meter 
improved following feedback and recall. 
DSN, PCT Assessment of suitability of the meter for a particular 
patient. Increasingly measuring cost of strips and 
monitoring. Communication with supplier via feedback 
line and visits. 
Feedback is given to and gathered by the supplier from 
users. User training by DSNs and the supplier. Decision 
making occurs about which meter is best for a particular 
patient. 
Currently there is little evidence on benefits for patient 
of testing with a meter and little action is taken on test 
results, with no influence on performance. Sales are 
made following the measurement and management 
processes. 
Service Development Manager, Pharmacy Measurement of margin on meter sales and ease of use. 
Evaluation Centre conduct technical evaluation. 
Supplier gives product information to pharmacy, 
pharmacy give information to patients. 
Pharmacy committee and clinicians make purchasing 
decisions. Reports and a formulary have been produced 
using information from performance measurement. 
The scales on the meter and ease of use have been 
improved following performance measurement. The 
meter is purchased following processes. Evaluation 
Centre reports were used in decision making. 
Director Care & Policy, Diabetes UK Current research is measuring effectiveness of testing 
with meter. QA and quality of life measurement. 
Evaluation Centre technical evaluation. 
Helplines, publications and advice are offered by 
Diabetes UK. Checking meter performs as expected by 
comparing information from performance measurement. 
Little clinical guidance on testing with meter, action on 
meter results. Little report use. CE mark on the meter 
cannot be relied upon as a performance indicator. 
Senior Marketing Manager, Supplier Sales, market share, profit are measured. User forums & 
surveys, clinical trials are used. Communication 
between supplier and users occurs day to day in field. 
Education programmes are provided. Feedback from 
users about product performance is gathered. Product 
re-design has occurred. 
Training package has helped empower patients to 
manage their disease, not just monitor it. New 
display/scale has been introduced, meters replaced free. 
Director General, BIVDA Strip price and % cut are measured, technical 
evaluations occur, service package is assessed. 
Communication for information about product occurs 
with suppliers, NHS on national level, Diabetes UK. 
 
Negotiations occurred over % cut in strip price. 
Decision making about purchasing the meter. Reports 
are produced using information from performance 
measurement. 
A 12% cut strip price has occurred. Suppliers use 
information about meter performance to compete with 
rivals. Performance measurement has an influence on 
gaining regulatory approval for meter. 
Continued overleaf 
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Policy & Innovation Director, NHS PASA Savings & line price models to measure financial 
performance of products. Broader value, of innovations 
sometimes measured. 
Purchasing decision-making. Evaluation Centre 
publication outputs to evaluations. 
Processes do not currently have an influence as more 
proactive evidence of value needed, integrated into 
NHS. 
Senior Collaborative Development 
Manager, NHS PASA 
Clinical experts are consulted for their views. 
Stakeholder communication has been a key way of 
gathering information in setting up CPHs. 
Decision-making about products to purchase by 
purchasers in the NHS. 
Processes have limited influences as purchasing 
decisions are often made for other, short term reasons. 
Head R&D, NHS PASA Savings and budgets key, supplier KPIs. Category staff 
specialists keep up with market & suppliers 
Decision-making about products to purchase by 
purchasers in the NHS. National level advice provided 
to local level purchasers by PASA staff. 
Products are purchased without advice and information 
from performance measurement. Although evidence of 
technical performance may exist, budget holder still has 
to be convinced to pay if product is to be purchased. 
Senior Manager for Technology 
Introduction, NHS III 
Assessment is made of the technical nature of product 
including patents, business plan of the supplier to 
exploit it. 
III staff make the decision of whether to back a product 
financially. 
Information gathered on a product and decision results 
in it being backed financially or not. Checking 
performance against regulations encourages the supplier 
to ensure product meets claims. 
Summary Matrix of Key Findings Discovered in Coding in Blood Glucose Meter Case (Cut 1: by respondent, cut 2: by theme in conceptual framework) 
 
Method to Produce the Summary Table: 
The table is a display format summarising  the large amount of data from the original intra-case table that was produced from the respondent interviews coded using HyperResearch. The 
table is an un-ordered meta-matrix showing all the respondents in the case. The matrix is ordered by role in the rows and conceptual framework theme in the columns, the latter determined 
by the research questions, as recommended by Miles & Huberman (1984 pp79-80). 
The cells in the matrix show “…short quote and summarising remarks…” (Miles & Huberman 1984 p80) qualitatively describing the data coded in relation to the research questions in the 
original table. Code frequencies within the case are shown in a separate table. The qualitative remarks are produced following data reduction and weighting as suggested by Miles & 
Huberman. The latter was according to a decision rule where only findings relating to general codes that are matched by more than one respondent within the case are included, in 
accordance with the pattern matching analytic strategy used (Yin 2003 pp116-120). Miles and Huberman (1984 pp104) advocated the following example, using the same method as in 
entering the data in the matrix here: “…the data being entered in each cell are a brief summary of what the analyst found for each respondent in the field notes. The main decision rule 
appears to be this: if it’s in the notes, summarise it and enter a phrase reflecting the summary.” Given the large amount of data to be reduced into this matrix, the process has where 
necessary involved what Miles and Huberman refer to as standardisation of cell entries to a more generic descriptor and taking the modal response. 
The research questions look at performance measurement and performance management processes. Performance measurement processes are also represented in the table by mention of the 
measures used, firstly for brevity, secondly because measurement procedures have been described as mapping and preserving the difference in a set of symbols and a collection of entities 
(Farbey et al. 1993 pp75-94), and finally because many respondents answered the questions about performance measurement processes by listing the measures that are used. 
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CODE Head, 
Eval 
Centre 
Tech 
Eval 
Leader, 
Eval 
Centre 
Cat 
Mangr 
Path 
Cat 
Spec, 
Path 
Pharm 
Serv 
Mangr, 
PPD 
Mangr, 
Pt 
Care 
Test 
Team 
DSN, 
Found 
Trust 
DSN, 
PCT 
Serv 
Devpt 
Mangr, 
Pharcy 
Direct 
Care & 
Policy, 
Diabetes 
UK 
Senr 
Mktg 
Mangr, 
Supplr 
Direct 
Generl, 
In-
vitro 
Diag 
Assoc 
Policy & 
Innov 
Director, 
PASA 
Collab 
Devpt 
Mangr, 
PASA 
Head 
R&D 
PASA 
NHS 
III 
Mangr 
Expt 
actors 
 1    1     1   2  1 
Meas 
cust perf 
   2 2 10 8 7 2 3 7 2 1  3 2 
Meas 
finc perf 
  2 2 8 2  3 3 1 2 6 3  1 2 
Meas 
tech perf 
12 2 5 3 5 10 3 5 9 7 6 7 6 1 2 5 
Resorc 2      1  1  1      
Advice 
policy 
guid 
  1 6    1 2 3 1  1  1  
Check 
expctd 
  3  5 6  1 1 3 2 1   1 1 
Feedbck 1  1   4 3 4 2 3 3      
Imp 
prdct 
design 
     1 1 1 1  3 2     
Senior 
org 
4  2   1 1    2    1  
Prdct 
traing 
  2 2   2 3  1 6      
Publctn 5 1  1  2 1 1 1 5  2 3  1  
Purch 
mktg dec 
6 2 3 3 7 8 4 2 9  1 6 2 4 2 3 
Tailor 
cust 
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Web 
tools 
 
 
         1       
Assist 
rule 
compl 
1   1  1     1 2     
Buyers 
use 
5 1 1  6 5 2 2 5   1 1 1 1 2 
Dysfunc 
conseq 
                
No role 
cust perf 
     1 1 3  1 1      
No role 
finc perf 
                
No role 
perf 
2   7  1 1 5 2 8 3  7 2 3 1 
No role 
tech perf 
   1 2    1 3    2 1  
Re-des 
prdct 
impvd 
     1 1  2  1      
Role cust 
perf 
1 2 1 1 1 3 4 2  3 3    1  
Role finc 
perf 
3  1 2 6 4  2 2  1 3    2 
Role perf 7 3 3 3 7 8 5 4 8 4 6 6 1 1 3 3 
Role 
tech perf 
2  2 1 1 4 1  5 1 3 3 1   1 
Supplrs 
competv 
3  1         4     
Tailord 
appropt 
                
Cplx 
Mkt 
 
         1 1 1     
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Low 
cplx mkt 
                
Collab 3 1  1  1 1 1   1 1 1   1 
Comm 
 
 
3 1 3 2 2 2 1  3 1 2 8  2 1 1 
Diff 
claims 
                
Rel role 
perf 
   1   1          
Soc 
xchange 
   2  1 1 2      1   
Code Occurrences by Respondent in Blood Glucose Meter Case 
 
Data compiled from HyperResearch Report Function. 
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Processes, as Described by Respondents in the Blood Glucose Meter Case 
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Influence Respondents 
who Described 
Influence 
Performance 
Measurement 
Predecessors 
Performance 
Management 
Predecessors 
Researcher 
Explanation 
Product is 
purchased or not 
+/- 
F/C 
Head Eval Centre, 
Tech Eval Leader, 
Cat Mangr Path, 
Pharm Serv 
Mangr PPD, 
Mangr Pt Care 
Test Team, DSN 
Found Trust, DSN 
PCT, Serv Devpt 
Mangr Pharcy, 
Direct Generl In-
vitro Diag Assoc,  
Policy & Innov 
Director, Collab 
Devpt Mangr, 
Head R&D, NHS 
III Mangr 
Clinicians assess 
with individual 
patients whether 
meter is 
appropriate for 
their needs. Other 
local level 
evaluation in 
Trusts. 
Communication 
and visits between 
customer and 
supplier. 
Technical 
evaluation by 
Evaluation 
Centre. National 
level assessment 
of costs, service 
package. Clinical 
studies, trials. 
Pharmacy 
assesses margins, 
technical aspects. 
PPD gathers 
information on 
product from 
supplier. 
Use of 
performance 
measurement 
information such 
as clinician’s 
assessments, 
evaluation centre 
outputs, 
information from 
the supplier. 
Making the 
purchasing 
decision, or 
decision to use, 
list or stock the 
meter or strips, 
resulting in 
eventual sales. 
The decision to 
purchase the 
product or not on 
the basis of 
performance 
measurement 
information gives 
the supplier sales 
or not and the 
customer the 
benefit of a 
product that 
performs best for 
healthcare. 
Selection of a free 
meter will mean 
the patient then 
buys the strips for 
the meter, while 
decisions to list 
the meter on the 
NHS drug tariff 
and for sale in the 
pharmacy also 
enable sales of 
strips or meters to 
users to take 
place. 
The best product 
for the needs of 
the user is 
purchased 
+ 
C 
DSN Found Trust, 
DSN PCT 
DSN assesses 
with patient 
whether the meter 
or a competing 
product is most 
suitable for their 
needs. 
Making with 
patient about 
which product to 
give them. 
Assessment with 
patient enables the 
patient to choose 
their preferred 
meter from the 
options available 
to take away. 
Performance 
measurement 
information is 
not involved in 
the purchasing 
decision 
None 
Cat Spec Path, 
Head R&D, Serv 
Devpt Mangr 
Pharcy 
Technical 
evaluation by 
Evaluation 
Centre. 
Technical 
evaluation reports. 
There is little use 
of information 
from the technical 
evaluation in the 
purchasing 
decision. 
Supplier shows 
concern over 
performance 
measurement 
* 
+/- 
F 
Head Eval Centre, 
Direct Generl In-
vitro Diag Assoc 
Technical 
evaluation by 
Evaluation 
Centre. 
Technical 
evaluation 
outputs. 
Reports are a 
good sales device 
for suppliers, or 
for competing 
suppliers. 
Suppliers have a 
good relationship 
with Eval Centre 
when results are 
good and vice 
versa. 
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Supplier ensures 
product 
performs to their 
specification & 
regulations, as it 
will be tested and 
then purchased 
or not 
+ 
T 
Cat Mangr Path, 
Direct Generl In-
vitro Diag Assoc, 
NHS III Mangr, 
Senr Mktg Mangr 
Technical 
evaluation, 
clinical trials by 
supplier. 
Checking the 
technical 
performance of 
the meter against 
promised & 
against 
regulations. 
Feedback to 
supplier. 
Making 
purchasing 
decision. 
Performance 
measurement and 
management 
processes mean 
that the supplier 
knows the meter 
must perform as 
promised and to 
regulations it must 
meet if it is to be 
sold – IVD, CE 
marked. 
CE marking 
does not 
necessarily 
signify a product 
that performs to 
a sufficient 
standard 
- 
F/T/C 
Direct Care & 
Policy Diabetes 
UK, Direct Generl 
In-vitro Diag 
Assoc, Serv 
Devpt Mangr 
Pharcy 
Assessment of 
technical 
performance of 
product during 
development of 
product by 
supplier. 
Information about 
product gathered 
by buyers, PPD 
before purchase 
or listing decision 
made. 
Supplier puts CE 
mark on product. 
Buyers make 
decision to 
purchase the 
product on the 
basis of CE mark. 
Although some 
respondents 
suggested 
processes help the 
meter meet 
standards and 
perform well, 
other respondents 
suggested that the 
standards are not 
a good guide to 
performance and a 
product that does 
not perform well 
may be bought on 
the basis of 
limited 
information. 
Used to reduce 
product cost 
+/- 
F 
Serv Devpt 
Mangr Pharcy, 
Pharm Serv 
Mangr PPD, 
Direct Generl In-
vitro Diag Assoc 
Measuring costs 
of strips 
prescribed on the 
NHS. 
Negotiation 
between actors 
over % reduction 
in strip prices. 
A % reduction in 
strip price on 
national drug 
tariff was 
negotiated and 
achieved on the 
basis of cost 
information 
measured by the 
NHS on a national 
level. 
Product can be 
purchased or not 
for short-term, 
cost based rather 
than broader 
reasons 
- 
F/T/C 
Policy & Innov 
Director, Collab 
Devpt Mangr, 
Head R&D, 
Pharm Serv 
Mangr PPD, DSN 
PCT 
Assessing cost of 
blood glucose 
meter, evaluation 
and assessment of 
broader aspects of 
meter 
performance. 
Purchasing, use 
decisions by 
DSNs with 
patients, PPD 
decision to list 
meter on NHS 
drug tariff. 
The product is 
bought or not in a 
decision made on 
the basis of cost 
performance 
measurement 
information with a 
short term view. 
Evidence of 
broader aspects of 
performance is 
not used 
proactively or 
integrated back to 
buyers. 
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Compliance with 
use of the 
product is 
needed 
None 
Head Eval Centre, 
Cat Spec Path, 
DSN PCT, Direct 
Care & Policy 
Diabetes UK, 
Senr Mktg Mangr 
Supplr 
Assessment of 
which meter to 
use or buy with 
DSN. 
Meter purchased, 
used by patient. 
The meter can be 
bought, but if the 
patient does not 
use it or the 
patient does not 
act upon the blood 
glucose meter 
results given by 
the meter, it will 
have no benefit 
for their health. 
Training is 
necessary for 
patient to gain 
benefits of 
product use 
+ 
C 
Cat Mangr Path, 
Senr Mktg Mangr 
Supplr, Mangr Pt 
Care Test Team, 
DSN PCT, Direct 
Care & Policy 
Diabetes UK 
Clinical studies, 
technical and 
customer 
evaluations. 
Training in use of 
the meter, as part 
of package 
provided by 
supplier, or 
provided by other 
local level users. 
Users require 
training on the 
meter if they are 
to gain the correct 
results and be able 
to interpret them, 
benefitting their 
health. 
Currently little 
evidence on the 
effectiveness of 
the healthcare 
procedure the 
product uses 
None 
DSN PCT, Direct 
Care & Policy 
Diabetes UK 
Clinical trials, 
technical 
evaluations. 
Purchase, use of 
the meter. 
There is currently 
limited evidence 
of the 
effectiveness of 
blood glucose 
testing as a 
discipline in 
gaining beneficial 
health outcomes, 
so effort in 
measuring and 
managing the 
performance of 
the meter may 
mean that a 
useless product is 
procured. 
Product design 
improved 
+ 
T 
DSN Found Trust, 
Mangr Pt Care 
Test Team, Senr 
Mktg Mangr 
Supplr, Serv 
Devpt Mangr 
Pharcy 
Assessing 
customer 
performance, 
customer forums. 
Feedback to 
supplier, MHRA 
device alert, 
product 
innovation, free 
replacement. 
The design of the 
blood glucose 
meter is 
permanently 
improved with a 
new display and 
hard locked scale. 
Effects Matrix Showing Influences of Performance Measurement and Performance 
Management Processes, as Described by Respondents in the Blood Glucose Meter 
Case.  
 
(KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial 
performance, ‘T’ is an influence on Technical performance and ‘C’ is an influence on Customer performance 
(After Griffin & Page 1996). ‘None’ means there is no influence on performance. ‘*’ denotes an influence 
inferred by researcher rather than specifically described by respondent). 
Constructing the matrix: Cell entries are brief phrases highlighting roles coded in the case study and shown in 
the original large matrix of findings from respondents in the case. Processes with the influences, or implicit 
predecessors are shown. Intended outcomes or those that will occur are also shown (Miles & Huberman 1984 
pp114-118). Only those influences that were seen in a pattern across more than one respondent in the code 
occurrences by respondent in the case are included, in accordance with the pattern matching analytic strategy 
used (Yin 2003 pp116-120). Given the large amount of data to be reduced into this matrix, the process has 
where necessary involved what Miles and Huberman refer to as standardisation of cell entries to a more 
generic descriptor and taking the modal response, guided by those in the summary matrices of findings for 
each case. 
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Respondent / Research Question (RQ) 
Theme 
Performance Measurement (RQs:A,C) Performance Management (RQs:A,C) Performance Measurement/Performance 
Management Influence on Performance 
(RQs:B,C) 
Director, Evaluation Centre Technical evaluation of value of ECG monitor for NHS 
use, by experts in laboratory. 
Performance measurement information published, 
advice offered to purchasers in NHS. 
Sales are affected by evaluation results. Supplier may 
ignore results, though evolution can occur following 
technical evaluations. 
Category Manager Cardiology, NHS 
Supply Chain 
Technical evaluations, assessment of ECG monitor 
against clinical criteria, lifetime costs are assessed. 
Purchasing process and decision making, involving 
stakeholders. Publication in reports and case study. 
Sales hindered by budget silos despite evidence of 
performance. Information use in purchasing varies. 
Category Specialist Cardiology, NHS 
Supply Chain 
Price, budget, lifetime costs are measured. Technical 
evaluation. Ease of use assessed. Information is shared 
between actors. Supplier demo to users. 
Purchasing advice and information is given. Feedback 
given to suppliers. Making the decision to purchase the 
ECG monitor. 
Information about performance is used to improve 
product. Performance data is of interest to competitors. 
GP, GP Surgery Tried ECG monitor on himself, assessed use for his 
cardiac interest and consulted colleagues. Asked for 
feedback by the supplier. 
Decision making to use the ECG monitor. Supplier 
publication of performance information, audits 
performance of free monitors given to some users. 
Uses the product having assessed performance of the 
meter. The product is a helpful clinical tool. Supplier 
sorted out product problems, improving performance. 
Practice Nurse, GP Surgery Assessed ease of use, cost and accuracy of ECG 
monitor. Supplier gave the surgery free product in 
return for feedback as part of supplier audit. 
The supplier improves the design of the product. 
Supplier gathers feedback from audit involving the GP 
surgery. 
A free upgrade to new version of the product with 
improved design features was given. Product purchased 
following assessment, would do so again. 
CEO, Supplier Cost of products and training to the NHS, comparing 
commodity versus high value items. 
Clinical trial data used in promotion. Supplier visits 
clinician users to carry out training. 
Evidence of product performance for sales through 
CPHs. The NHS is diverse locally, so costing difficult. 
Chief Technology Officer, Supplier Pre-production testing of product on users. 
Measurement of technical parameters to protocols, 
regulations and project measures as part of innovation. 
Review of measures and taking product improvement 
actions as part of quality system, CAPA. 
Performance information has improved product quality. 
Simple measurement and management processes add 
value, not complex ones. 
Chief Technology Officer, Supplier, (2nd 
Interview) 
Number of different evaluations of care pathway costs  
and of technical performance aspects focussing on 
accuracy. Clinical trial conducted by supplier. Supplier 
has been asked for information. 
External audit of performance information for standards 
& MHRA. Performance measurement information 
included in reports, business case produced for GPs. 
CAPA system. Purchasing and trial purchase scheme. 
Sales are made or not. Compliance with regulations 
achieved. Technical and customer performance has been 
improved by revised product design. Evaluation not 
dynamic like product so of limited use. 
Policy & Innovation Director, NHS PASA Technical Evaluation. Savings & line price models to 
measure financial performance of products. Broader 
value, of innovations sometimes measured. 
Purchasing decision-making. Checking supplier’s 
claims against results of technical evaluation, supplier 
challenged evaluation findings. Changes made to 
product design. 
Processes do not currently have an influence as more 
proactive evidence of value needed, integrated into 
NHS. 
Senior Collaborative Development 
Manager, NHS PASA 
Clinical experts are consulted for their views. 
Stakeholder communication has been a key way of 
gathering information in setting up CPHs. 
Decision-making about products to purchase by 
purchasers in the NHS. 
Processes have limited influences as purchasing 
decisions are often made for other, short term reasons. 
Head R&D, NHS PASA Savings and budgets key, supplier KPIs. Performance 
measured to check supplier’s evidence. Category staff 
specialists keep up with market & suppliers. 
Decision-making about products to purchase by 
purchasers in the NHS. National level advice provided 
to local level purchasers by PASA staff. Trying to 
convince purchasers with evidence of performance. 
Products are purchased without advice and information 
from performance measurement. It has been difficult to 
convince budget holder of evidence of technical 
performance, to pay and purchase product. 
Senior Manager for Technology 
Introduction, NHS III 
Assessment is made of the technical nature of product 
including patents, business plan of the supplier to 
exploit it. 
III staff make the decision of whether to back a product 
financially. 
Information gathered on a product and decision results 
in it being backed financially or not. Checking 
performance against regulations encourages the supplier 
to ensure product meets claims. 
Summary Matrix of Key Findings Discovered in Coding in ECG Monitor Case (Cut 1: by respondent, cut 2: by theme in conceptual framework) 
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Method to Produce the Summary Table: 
The table is a display format summarising  the large amount of data from the original intra-case table that was produced from the respondent interviews coded using HyperResearch. The 
table is an un-ordered meta-matrix showing all the respondents in the case. The matrix is ordered by influence in the rows and conceptual framework theme in the columns, the latter 
determined by the research questions, as recommended by Miles & Huberman (1984 pp79-80). 
The cells in the matrix show “…short quote and summarising remarks…” (Miles & Huberman 1984 p80) qualitatively describing the data coded in relation to the research questions in the 
original table. Code frequencies within the case are shown in a separate table. The qualitative remarks are produced following data reduction and weighting as suggested by Miles & 
Huberman. The latter was according to a decision rule where only findings relating to general codes that are matched by more than one respondent within the case are included, in 
accordance with the pattern matching analytic strategy used (Yin 2003 pp116-120). Miles and Huberman (1984 pp104) advocated the following example, using the same method as in 
entering the data in the matrix here: “…the data being entered in each cell are a brief summary of what the analyst found for each respondent in the field notes. The main decision rule 
appears to be this: if it’s in the notes, summarise it and enter a phrase reflecting the summary.” Given the large amount of data to be reduced into this matrix, the process has where 
necessary involved what Miles and Huberman refer to as standardisation of cell entries to a more generic descriptor and taking the modal response. 
The research questions look at performance measurement and performance management processes. Performance measurement processes are also represented in the table by mention of the 
measures used, firstly for brevity, secondly because measurement procedures have been described as mapping and preserving the difference in a set of symbols and a collection of entities 
(Farbey et al. 1993 pp75-94), and finally because many respondents answered the questions about performance measurement processes by listing the measures that are used. 
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CODE Director, 
Eval Centre 
Cat Mangr, 
NHS 
Supply 
Chain 
Cat Specst, NHS 
Supply Chain 
GP Practice 
Nurse 
CEO, 
Supplr 
CTO, 
Supplr 
CTO, 
Supplr, 
(2nd) 
Policy & 
Innov 
Director, 
PASA 
Collab 
Devpt 
Mangr, 
PASA 
Head 
R&D 
PASA 
NHS 
III 
Mangr 
Expt 
actors 
1       1  2  1 
Meas 
cust perf 
  2 5 2 1 1 3 1  3 2 
Meas 
finc perf 
 4 2 1 1 1 1 2 3  1 2 
Meas 
tech perf 
11 7 5 9 2  7 14 9 1 6 5 
Resorc        1     
Advice 
policy 
guid 
7  6      1    
Check 
expctd 
1 1 2  1  4 5 1  1 1 
Feedbck 1 2 2 3 1   4 1    
Imp 
prdct 
design 
1 1  2 2  4 8 1    
Senior 
org 
          1  
Prdct 
traing 
     2       
Publctn 5 2 1 2  1  5 3  3  
Purch 
mktg dec 
8 5 3 5 1 1  5 2 4 3 3 
Tailor 
cust 
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Web 
tools 
 
 
 
 
       1     
Assist 
rule 
compl 
       1    1 
Buyers 
use 
6 2  2    3 1 1 1 2 
Dysfunc 
conseq 
            
No role 
cust perf 
           1 
No role 
finc perf 
 2    1 1  1    
No role 
perf 
4  3   1 1 2 8 2 2 1 
No role 
tech perf 
4       1  2   
Re-des 
prdct 
impvd 
   1 2  1 7 1    
Role cust 
perf 
   3       1  
Role finc 
perf 
4  1 1 1   3    2 
Role perf 9 2 4 8 3 1 1 10 2 1 3 3 
Role 
tech perf 
6  2 4 2  1 7 2  1 1 
Supplrs 
competv 
2  1 1         
Tailord 
appropt 
 
            
 323 
Cplx 
Mkt 
            
Low 
cplx mkt 
            
Collab    1        1 
Comm 
 
 
2  6 3 1   1 1 2 1 1 
Diff 
claims 
3       2 2    
Rel role 
perf 
            
Soc 
xchange 
2  1 1  1    1   
Code Occurrences by Respondent in ECG Monitor Case 
 
Data compiled from HyperResearch Report Function. 
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Influence Respondents 
who Described 
Influence 
Performance 
Measurement 
Predecessors 
Performance 
Management 
Predecessors 
Researcher 
Explanation 
Product is 
purchased or not 
+/- 
F/C 
Director Eval 
Centre, Cat 
Mangr, GP, CEO 
Supplr, CTO 
Supplr, Policy & 
Innov Director, 
Collab Devpt 
Mangr, Head 
R&D PASA, 
NHS III Mangr 
Communication 
and visits between 
customer and 
supplier, GP calls 
colleague, tests 
device on himself, 
technical 
evaluation by 
Evaluation 
Centre, clinical 
trials. 
GP makes 
decision to 
purchase the ECG 
monitor, 
Dissemination of 
technical 
evaluation 
information. 
Supplier try 
before you buy 
scheme, business 
case for GPs, 
distribution of 
performance data. 
The decision to 
purchase the 
product or not on 
the basis of 
performance 
measurement 
information gives 
the supplier sales 
or not and the 
customer the 
benefit of a 
product that 
performs best for 
healthcare by 
offering a new 
care pathway, or 
remaining with 
the existing 
pathway if better.  
So far sales have 
been low. 
Product design 
improved 
+ 
T 
GP, Practice 
Nurse, CTO 
Supplr, Policy & 
Innov Director 
PASA 
Supplier trials 
product with GP 
surgeries, 
conducts clinical 
trial, 
communication 
between supplier 
and users. 
Feedback to 
supplier, supplier 
innovates product. 
The latest ECG 
Monitor comes 
with improved 
battery life, ability 
to interface with 
NHS patient 
records and 
automated 
connectivity 
checking to 
ensure electrodes 
are attached. 
Suppliers get 
better by 
evolution after 
technical 
evaluation. 
Teething 
problems also 
sorted by the 
supplier 
Performance 
measurement 
information not 
used in the 
purchasing 
decision 
None 
Director Eval 
Centre, Cat 
Mangr, Cat 
Specst, CTO 
Supplr, Head 
R&D PASA 
Technical 
evaluation by 
Evaluation 
Centre. 
Technical 
evaluation reports. 
Information from 
the technical 
evaluation is not 
always used in the 
purchasing 
decision. Product 
well publicised 
but not bought. 
Easy for supplier 
to get 
overburdened 
with measurement 
procedures that do 
not add value. 
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Feedback to the 
supplier is not 
used 
None 
Director Eval 
Centre, CTO 
Supplr 
Technical 
evaluation by 
Evaluation 
Centre. 
Technical 
evaluation reports, 
feedback to 
supplier. 
The supplier 
ignores or does 
not use technical 
evaluation data as 
it is not dynamic. 
 
Product can be 
purchased or not 
for short-term, 
cost based rather 
than broader 
reasons 
- 
F/T/C 
Policy & Innov 
Director PASA, 
Collab Devpt 
Mangr, CEO 
Supplr, Head 
R&D PASA 
Technical 
evaluation by 
Evaluation 
Centre, buyers. 
Clinical trial, 
other evaluations 
produced by 
supplier. 
Purchasing 
decision making 
by buyers. 
The product is 
bought or not in a 
decision made on 
the basis of cost 
performance 
measurement 
information with a 
short term view. 
Evidence of 
broader aspects of 
performance is 
not used 
proactively or 
integrated back to 
buyers, hindering 
uptake. Budget 
silos. Difficult for 
supplier to cost 
training at varied 
local level. 
Supplier shows 
concern over 
performance 
measurement 
* 
+/- 
F 
Cat Specst NHS 
Supply Chain, 
GP, Director Eval 
Centre 
Technical 
evaluation by 
Evaluation 
Centre. 
Technical 
evaluation 
outputs. 
Evaluation data is 
of interest to 
competitors. 
Evaluation Centre 
conclusions were 
not acceptable to 
supplier. 
Supplier ensures 
product 
performs to their 
specification & 
regulations, as it 
will be tested and 
then purchased 
or not 
+ 
T 
CTO Supplr, NHS 
III Mangr 
Clinical trial by 
supplier. Supplier 
keeps technical 
records, quality 
manual. ISO 
notified body 
assesses supplier 
records. 
Checking the 
technical 
performance of 
the meter against 
regulations. 
Making 
purchasing 
decision. 
Performance 
measurement 
processes mean 
that the supplier 
knows the meter 
must perform to 
regulations, as 
policed by a 
notified body -  
ISO13485, MDD 
(42/93/EU). 
Effects Matrix Showing Influences of Performance Measurement and Performance 
Management Processes, as Described by Respondents in the ECG Monitor Case.  
 
(KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial 
performance, ‘T’ is an influence on Technical performance and ‘C’ is an influence on Customer performance 
(After Griffin & Page 1996). ‘None’ means there is no influence on performance. ‘*’ denotes an influence 
inferred by researcher rather than specifically described by respondent). 
Constructing the matrix: Cell entries are brief phrases highlighting influences coded in the case study and 
shown in the original large matrix of findings from respondents in the case. Processes with the influences, or 
implicit predecessors are shown. Intended outcomes or those that will occur are also shown (Miles & 
Huberman 1984 pp114-118). Only those influences that were seen in a pattern across more than one 
respondent in the code occurrences by respondent in the case are included, in accordance with the pattern 
matching analytic strategy used (Yin 2003 pp116-120). Given the large amount of data to be reduced into this 
matrix, the process has where necessary involved what Miles and Huberman refer to as standardisation of 
cell entries to a more generic descriptor and taking the modal response, guided by those in the summary 
matrices of findings for each case. 
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Respondent / Research Question (RQ) 
Theme 
Performance Measurement (RQs:A,C) Performance Management (RQs:A,C) Performance Measurement/Performance 
Management Influence on Performance 
(RQs:B,C) 
Research Director, Evaluation Centre Technical evaluation by Evaluation Centre, also 
including user evaluation. Involves visits by supplier 
representatives. 
Variety of publications produced using performance 
measurement information. Purchasing decision making. 
Feedback to supplier, making product changes. 
Evaluation outputs assist purchasers and users of the 
frame, raises profile of the clinical area. Training and 
use of the frame are important if it is to perform for the 
child. 
Centre Manager, Evaluation Centre Technical evaluation of frames by Evaluation Centre, 
supplier visits during evaluation, which requires time 
and engineers. Sales data shared. 
Variety of publications, web database produced using 
information from evaluation. Feedback given to supplier 
as part of evaluation process. 
Suppliers care about evaluation process and results, 
suggesting it has an influence on performance. However 
evaluation outputs are late and may not be used. 
Centre Manager, Evaluation Centre / 
Therapist 
Technical evaluation, assessing quantitative and 
qualitative aspects of technical and customer 
performance. Evaluation is resource intensive, supplier 
was involved and report drafts were shared. 
Frame is individualised for the needs of a particular 
child using it. Reports are produced using performance 
measurement information. Feedback passed to and fro 
with supplier. 
Frame design has been updated following feedback 
from the evaluation. However it is difficult to evaluate 
individual child needs effectively. 
Lead Category Manager Assistive 
Technology / Special Projects, NHS PASA, 
DH 
Evaluation of frame for clinical purpose. Cost and 
savings are key measures. Ad-hoc clinician feedback is 
used to learn about performance of the frame. 
Publishing national level performance measurement 
data. Advice given to purchasers. Purchasing decision 
making. 
Suppliers are sensitive to performance measurement 
outputs. Purchasing decisions are made on the basis of 
cost, limiting influence of processes measuring broader 
aspects of performance. 
Category Specialist Mobility & Telecare, 
NHS PASA 
User consultation by NHS PASA and suppliers. Product 
standards are researched with BHTA. Cost of product is 
measured with respect to annual budget. 
Suppliers use feedback from users in making changes to 
product design, including for individual users. Advice 
given to purchasers. 
Frame meets needs of user with changed design. 
Feedback must be used if it is to have an influence. 
Measures have a cost and may not always add value. 
Paediatric Physiotherapist, Hospital NHS 
Foundation Trust 2 
Therapists assess suitability of frame for individual 
child subjectively, with help of demonstration from 
supplier representative. 
Therapist making decision to purchase frame. Producing 
funding justification letters. Supplier agreeing to sell 
product only if it is appropriate. 
Frame has been purchased and benefits child following 
assessment and decision-making. However cost can 
prevent purchase of an appropriate product for child. 
Paediatric Physiotherapist, PCT 2 Therapist assesses suitability of frame for needs of child 
using quantitative and qualitative techniques, supplier 
reps visit and work jointly with clinician. 
Therapist purchasing decision making. Supplier 
customises and improves design of frame. Supplier does 
not push sales. Feedback to supplier during assessment. 
Frame has been purchased. Design customised with 
headrest and straps. Split knee block available following 
feedback. Measurement aids compliance by user. 
Physiotherapist, PCT 3 Therapist assesses frame for individual need of child 
and cost. Talking to supplier representatives, who also 
visit. 
Therapist making purchasing decision. Supplier 
modification of old frame rather than sell new. 
Feedback to supplier. Evaluation report produced. 
Frames have been purchased by the therapist for 
children, however cost can prevent some purchases. 
Child changes, making accurate measurement difficult. 
Managing Director, Supplier Clinical evidence of benefits of standing with frame. 
Cost of frame or surgery measured. User views of the 
frame are gathered. BHTA meets NHS PASA. 
Report and funding justification documents produced. 
Feedback gathered is sent to head office. Making 
changes to product design by supplier. 
Evaluation Centre evaluation had no conclusions so was 
no use. Therapist input is used to develop the product, if 
funding is available. 
Director General, BHTA Clinician assesses frame for clinical needs of a 
particular child. Cost and technical aspects of frame 
performance are measured. 
Checking performance measures against standards. 
Tailoring the product design to the needs of a particular 
child. Improving the basic product design. 
Purchasing decisions made on basis of performance 
measurement information. Tailored frame benefits 
child. Frame meets technical criteria. 
Chair Seat Divis, BHTA Technical evaluation, assessment of clinical benefits. 
Financial measurement of longevity & warranties. Two 
way flow of information and visits between suppliers, 
BHTA and CEP. 
Dissemination of technical evaluation data. Purchasing 
decision making by NHS purchasers. Making changes 
to the design of the product. 
Performance measurement outputs affect the purchasing 
decision and have an influence on sales of the standing 
frame. Suppliers change products to gain an edge over 
competitors. 
Policy & Innovation Director, NHS PASA Savings & line price models to measure financial 
performance of products. Broader value, of innovations 
sometimes measured. 
Purchasing decision-making. Evaluation Centre 
publication outputs to evaluations. 
Processes do not currently have an influence as more 
proactive evidence of value needed, integrated into 
NHS. 
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Senior Collaborative Development 
Manager, NHS PASA 
Clinical experts are consulted for their views. 
Stakeholder communication has been a key way of 
gathering information in setting up CPHs. 
Decision-making about products to purchase by 
purchasers in the NHS. 
Processes have limited influences as purchasing 
decisions are often made for other, short term reasons. 
Head R&D, NHS PASA Savings and budgets key, total costs, supplier KPIs. 
Category staff specialists keep up with market & 
suppliers 
Decision-making about products to purchase by 
purchasers in the NHS. National level advice provided 
to local level purchasers by PASA staff. 
Products are purchased without advice and information 
from performance measurement. Although evidence of 
technical performance may exist, budget holder still has 
to be convinced to pay if product is to be purchased. 
Senior Manager for Technology 
Introduction, NHS III 
Assessment is made of the technical nature of product 
including patents, business plan of the supplier to 
exploit it. 
III staff make the decision of whether to back a product 
financially. 
Information gathered on a product and decision results 
in it being backed financially or not. Checking 
performance against regulations encourages the supplier 
to ensure product meets claims. 
Summary Matrix of Key Findings Discovered in Coding in Standing Frame Case (Cut 1: by respondent, cut 2: by theme in conceptual framework) 
 
Method to Produce the Summary Table: 
The table is a display format summarising  the large amount of data from the original intra-case table that was produced from the respondent interviews coded using HyperResearch. The 
table is an un-ordered meta-matrix showing all the respondents in the case. The matrix is ordered by role in the rows and conceptual framework theme in the columns, the latter determined 
by the research questions, as recommended by Miles & Huberman (1984 pp79-80). 
The cells in the matrix show “…short quote and summarising remarks…” (Miles & Huberman 1984 p80) qualitatively describing the data coded in relation to the research questions in the 
original table. Code frequencies within the case are shown in a separate table. The qualitative remarks are produced following data reduction and weighting as suggested by Miles & 
Huberman. The latter was according to a decision rule where only findings relating to general codes that are matched by more than one respondent within the case are included, in 
accordance with the pattern matching analytic strategy used (Yin 2003 pp116-120). Miles and Huberman (1984 pp104) advocated the following example, using the same method as in 
entering the data in the matrix here: “…the data being entered in each cell are a brief summary of what the analyst found for each respondent in the field notes. The main decision rule 
appears to be this: if it’s in the notes, summarise it and enter a phrase reflecting the summary.” Given the large amount of data to be reduced into this matrix, the process has where 
necessary involved what Miles and Huberman refer to as standardisation of cell entries to a more generic descriptor and taking the modal response. 
The research questions look at performance measurement and performance management processes. Performance measurement processes are also represented in the table by mention of the 
measures used, firstly for brevity, secondly because measurement procedures have been described as mapping and preserving the difference in a set of symbols and a collection of entities 
(Farbey et al. 1993 pp75-94), and finally because many respondents answered the questions about performance measurement processes by listing the measures that are used. 
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CODE Resrch 
Dirctr, 
Eval 
Centre 
Centre 
Mngr, 
Eval 
Centre 
Centre 
Mangr, 
Eval 
Centre / 
Therapist 
Lead 
Cat 
Mangr, 
Assist 
Tech 
Cat 
Speclst, 
Mobility 
Paed 
Physio, 
Found 
Trust 
Paed 
Physio, 
PCT 
Physio, 
PCT 2 
MD, 
Supplr 
Direc 
General, 
BHTA 
Chair 
Seat 
Divis, 
BHTA 
Policy & 
Innov 
Director, 
PASA 
Collab 
Devpt 
Mangr, 
PASA 
Head 
R&D 
PASA 
NHS 
III 
Mangr 
Expt 
actors 
 1 1    1    2  2  1 
Meas 
cust perf 
1 4 2 2 4 14 19 11 4 1  1  3 2 
Meas 
finc perf 
 1 1 4 1 2 1 2 3 2 2 3  2 2 
Meas 
tech perf 
8 5 8 2 2 1 9 6 14 5 3 6 1 3 5 
Resorc 1 2 2  1 1 1  1 1      
Advice 
policy 
guid 
   1        1  1  
Check 
expctd 
 1 1 1      3    1 1 
Feedbck 1 2 6 2 2 1 3 1 5  2     
Imp 
prdct 
design 
2  4  1  2  5  2     
Senior 
org 
        1  1   1  
Prdct 
traing 
1 3              
Publctn 4 2 8 3  3 2 1 5   3  1  
Purch 
mktg dec 
1 1 2 4  10 3 4 1 1 2 2 4 2 3 
Tailor 
cust 
 
 
 
 
  2  1  4   1      
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Web 
tools 
 
 
 
1 3 2 1   1  1       
Assist 
rule 
compl 
1         2 1     
Buyers 
use 
  1 2  7 2 5  1 2 1 1 1 2 
Dysfunc 
conseq 
   1     1       
No role 
cust perf 
1 1    1 1 3       1 
No role 
finc perf 
   1  1          
No role 
perf 
1 2 1 2 1 2 2 3 8   7 2 1 1 
No role 
tech perf 
 1     1  5    2   
Re-des 
prdct 
impvd 
    1  1         
Role cust 
perf 
1 2  1 3 4 6 2  1    1  
Role finc 
perf 
1 1 1 4 1 1   1 1 3    2 
Role perf 4 5 4 5 4 7 8 4 3 4 5 1 1 3 3 
Role 
tech perf 
1 1 2  1 1 2 2 2 2 2 1  1 1 
Supplrs 
competv 
1 2  2       1     
Tailord 
appropt 
    1  2   1      
Cplx 
Mkt 
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Low 
cplx mkt 
   2  1 1   1      
Collab 1 1 1   1 3 1       1 
Comm 
 
 
 2 2 5 1 1 1 2 1  2  2 1 1 
Diff 
claims 
               
Rel role 
perf 
  1             
Soc 
xchange 
1 4 1   3 3 2 4  1  1   
Code Occurrences by Respondent in Standing Frame Case 
 
Data compiled from HyperResearch Report Function. 
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Influence Respondents 
who Described 
Influence 
Performance 
Measurement 
Predecessors 
Performance 
Management 
Predecessors 
Researcher 
Explanation 
Product is 
purchased or not 
+/- 
Centre Mangr 
Eval Centre / 
Therapist, Lead 
Cat Mangr Assist 
Tech, Paed Physio 
Found Trust, Paed 
Physio PCT, 
Physio PCT 2, 
Direc General 
BHTA, Chair Seat 
Divis BHTA, 
Policy & Innov 
Director, Collab 
Devpt Mangr, 
Head R&D, NHS 
III Mangr 
Therapists assess 
performance of 
the standing 
frame for the 
particular needs 
of the child 
concerned. 
Communication 
and visits between 
customer and 
supplier. 
Technical 
evaluation by 
Evaluation 
Centre. 
Use of 
performance 
measurement 
information such 
as therapist’s 
assessments, 
evaluation centre 
outputs. Making 
the purchasing 
decision. 
Marketing the 
scanner to the 
customer, 
producing funding 
justification. 
The decision to 
purchase the 
product or not on 
the basis of 
performance 
measurement 
information gives 
the supplier sales 
or not and the 
customer the 
benefit of a 
product that 
performs best for 
healthcare by 
offering a new 
care pathway.  
So far sales have 
been low. 
The best product 
for the needs of 
the user is 
purchased 
+ 
Cat Speclst 
Mobility, Paed 
Physio Found 
Trust, Paed 
Physio PCT, 
Direc General 
BHTA  
Therapists assess 
performance of 
the standing 
frame for the 
particular needs 
of the child 
concerned, with 
supplier. 
Communication 
and visits between 
customer and 
supplier. 
Technical 
evaluation by 
Evaluation 
Centre. 
Use of 
performance 
measurement 
information such 
as therapist’s 
assessments, 
evaluation centre 
outputs. Making 
the purchasing 
decision.  
The performance 
information used 
and the process of 
making the 
purchasing 
decision gives a 
particular child 
the best standing 
frame for their 
individual needs.  
Product meets 
needs of 
individual user 
as it has been 
customised with 
special features 
for the 
particular 
purchase 
+ 
Paed Physio PCT, 
Cat Specialist, 
Direc General 
BHTA 
Therapists assess 
performance of 
the standing 
frame for the 
particular needs 
of the child 
concerned, with 
supplier. 
Communication 
and visits between 
customer and 
supplier. 
Supplier tailors 
frame features for 
a particular child. 
Supplier 
customises the 
frame with 
features such as 
alternative 
headrests and 
straps to tailor it 
to meet the needs 
of a particular 
child. 
Product can be 
purchased or not 
for short-term, 
cost based rather 
than broader 
reasons 
- 
Lead Cat Mangr 
Assist Tech, Paed 
Physio Found 
Trust, Paed 
Physio PCT,  
Physio PCT 2, 
Policy & Innov 
Director PASA, 
Collab Devpt 
Mangr PASA,  
Head R&D PASA 
Purchasing 
decision makers 
assess cost of 
standing frame, 
especially on 
national level of 
NHS. 
Purchasing 
decision making 
by NHS actors. 
The product is 
bought or not in a 
decision made on 
the basis of cost 
performance 
measurement 
information with a 
short term view. 
Evidence of 
broader aspects of 
performance is 
not used 
proactively or 
integrated back to 
buyers. 
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Information not 
used in the 
purchasing 
decision 
None 
Centre Mngr Eval 
Centre, Centre 
Mangr Eval 
Centre / 
Therapist, Physio 
PCT 2, MD 
Supplr, Direc 
General BHTA, 
Policy & Innov 
Director, Collab 
Devpt Mangr, 
Head R&D 
Technical 
evaluation by 
Evaluation 
Centre, 
assessment of 
frame for needs of 
child by 
therapists. 
Technical 
evaluation 
outputs. 
Purchasing 
decision by buyer. 
Information from 
performance 
measurement and 
management 
processes is not 
used in the 
purchasing 
decision. The 
product may be 
bought for all 
sorts of reasons 
other than on the 
basis of 
performance 
measurement 
information. 
Technical 
evaluation outputs 
may be late, not 
prescriptive 
enough. 
Assessing the 
frame for 
children’s diverse 
and changing 
needs is 
challenging. 
Product design 
improved 
+ 
Resrch Dirctr 
Eval Centre, 
Centre Mangr 
Eval Centre / 
Therapist, Paed 
Physio PCT, 
Chair Seat Divis 
BHTA 
Communication 
between supplier 
representatives 
and users. 
Technical 
evaluation by 
Evaluation 
Centre. 
Feedback to 
supplier, supplier 
makes design 
changes. 
The design of the 
standing frame 
has been 
permanently 
improved, for 
example through 
new split knee 
blocks in response 
to user feedback. 
Feedback to the 
supplier is not 
used 
None 
Cat Speclst 
Mobility, Physio 
PCT 2 
Communication 
between users and 
supplier, technical 
evaluation by 
Evaluation 
Centre. 
Feedback to 
supplier, supplier 
makes design 
changes to 
product. 
If feedback of 
performance 
measurement 
information to the 
supplier is not 
used proactively, 
it will not have an 
influence on 
performance. 
Compliance with 
use of the 
product is 
needed 
None 
Resrch Dirctr 
Eval Centre, Paed 
Physio PCT 
Therapist assesses 
with child and 
carers whether the 
standing frame is 
appropriate for 
particular needs. 
Standing frame 
purchased, used 
by patient. 
If the standing 
frame is to 
perform for a 
child and be 
effective in aiding 
their health, it 
must be used once 
purchased.  
Training is 
necessary for 
patient to gain 
benefits of 
product use 
+ 
Resrch Dirctr, 
Centr Mangr Eval 
Centre 
Communication 
between users and 
supplier. 
Standing frame 
purchased, 
training in use, 
used. 
Training of users 
is important if the 
standing frame is 
to be used 
correctly and the 
child is to gain the 
healthcare 
benefits of using 
the frame. 
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Supplier ensures 
product 
performs to their 
specification & 
regulations, as it 
will be tested and 
then purchased 
or not 
+ 
Lead Cat Mangr 
Assist Tech, Direc 
General BHTA, 
Chair Seat Divis 
BHTA, NHS III 
Mangr, Head 
R&D 
Technical 
evaluation by 
Evaluation 
Centre. Supplier 
designs product to 
technical 
specification. 
Supplier and 
Evaluation Centre 
check product 
meets regulations. 
Feedback to 
supplier. 
Making 
purchasing 
decision. 
Checking 
performance 
against 
regulations mean 
that the supplier 
know and ensure 
that the product 
must meet a 
certain standard. 
Evaluation by the 
customer 
encourages the 
supplier to ensure 
the frame 
performs as they 
claim. 
Supplier shows 
concern over 
performance 
measurement 
* 
+/- 
Resrch Dirctr 
Eval Centre, 
Centre Mngr Eval 
Centre, Lead Cat 
Mangr Assist 
Tech, Chair Seat 
Divis BHTA 
Technical 
evaluation by 
Evaluation 
Centre. 
Technical 
evaluation 
outputs. 
Suppliers show 
concern that 
performance 
measurement data 
will affect their 
competitive 
position or sales. 
Supplier use 
evaluation 
information to 
make their 
product more 
competitive 
compared to 
others 
Technical 
evaluation raises 
the profile of 
assistive 
technology and 
organisations 
involved. 
Effects Matrix Showing Influences of Performance Measurement and Performance 
Management Processes, as Described by Respondents in the Standing Frame Case.  
 
(KEY: ‘+’ is a beneficial influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial 
performance, ‘T’ is an influence on Technical performance and ‘C’ is an influence on Customer performance 
(After Griffin & Page 1996). ‘None’ means there is no influence on performance. ‘*’ denotes an influence 
inferred by researcher rather than specifically described by respondent). 
Constructing the matrix: Cell entries are brief phrases highlighting influences coded in the case study and 
shown in the original large matrix of findings from respondents in the case. Processes with the influences, or 
implicit predecessors are shown. Intended outcomes or those that will occur are also shown (Miles & 
Huberman 1984 pp114-118). Only those influences that were seen in a pattern across more than one 
respondent in the code occurrences by respondent in the case are included, in accordance with the pattern 
matching analytic strategy used (Yin 2003 pp116-120). Given the large amount of data to be reduced into this 
matrix, the process has where necessary involved what Miles and Huberman refer to as standardisation of 
cell entries to a more generic descriptor and taking the modal response, guided by those in the summary 
matrices of findings for each case. 
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Case / Research 
Question (RQ) 
Theme 
Performance Measurement (RQs:A,C) Performance Management (RQs:A,C) Performance Measurement/Performance 
Management Influence on Performance 
(RQs:B,C) 
CT Scanner Financial: Purchase and maintenance costs are measured. 
Technical: Technical evaluation and measurement of technical aspects of 
performance. 
Customer: Clinicians in Trust assess if scanner package meets their clinical needs and 
functionality for Trust. Actors gather and survey user opinions. Site visits are made, 
clinicians talk to current users, demonstrations are given, clinicians try using the 
scanner, supplier learns about purchaser’s needs. 
Information Dissemination: Technical evaluation 
reports and tools produced using information from 
performance measurement. Feedback of performance 
information to supplier. Supplier trains scanner users. 
Purchasing: Trust purchasing tender process including 
scoring, ranking, decision making. 
Product innovation: Supplier customises scanner 
package to Trust needs and continually makes changes 
to improve scanner software design. 
 
Influence on financial performance: Scanner bought 
or not. Purchasing decisions may be influenced by 
other, local reasons than performance measurement 
information. Technical evaluation reports may be used 
but also may not be used as they are late and clinicians 
have knowledge already. Suppliers are concerned about 
technical evaluation results, suggesting they affect sales. 
Influence on technical Performance: Software has 
been re-engineered and radiation dose reduced. 
Performance measurement data has assisted 
maintenance, getting supplier to make repairs.  
Influence on customer performance: Scanners 
purchased are suitable for Trust needs. 
Blood Glucose 
Meter 
Financial: Sales and trends measured by supplier. Strip price and % reduction 
discussed. 
Technical: Technical evaluation and measurement of technical aspects of 
performance, of accuracy, reliability for example, requires a lot of resources. 
Quality assurance testing of technical aspects of performance. Trials conducted by 
supplier. 
Customer: DSN subjectively assesses product suitability with individual patient for 
their particular clinical needs, looking at ease of use for example. Service package 
measured nationally. User forums are conducted. Communication and information 
sharing between actors. 
Information Dissemination: Evaluation Centre 
publications using performance measurement 
information. Feedback of information on product 
performance to supplier. Supplier educates users, offers 
advice and help lines. 
Purchasing: DSN chooses meter with patient. PPD 
evaluates strip for inclusion on drug tariff. Pharmacy 
actors decide to stock meter for sale. 
Product innovation: MHRA referral, recalling, re-
designing and replacing the meter. 
Influence on financial performance: The meter is 
given or bought and then strips are bought. Drug tariff 
and IVD approval enables prescription and purchase. 
Pharmacy decided to stock meter for sale. Many 
purchasers use reports. 12% cut in strip price occurred. 
Influence on technical performance: The meter 
display and scale have been improved. 
Influence on customer performance: More evidence 
of blood glucose testing benefits is needed. Little follow 
up action is taken after testing. Training benefits users. 
ECG Monitor Financial: Lifetime costs, costs of care pathways are evaluated. 
Technical: Technical evaluation of clinical criteria, accuracy, ease of use and supplier 
claims. Supplier conducted pre-production tests, clinical trial, uses innovation project 
measures. 
Customer: GP tried product on self, assessed use for own clinical interest. Supplier 
demo to users, discussion & gathers feedback. 
Information Dissemination: Report production. 
Advice to buyers. Supplier offers training. 
Purchasing: Decision making by purchaser. A business 
case is produced for GPs. Trial purchase scheme. 
Clinical trial data is used in promotion. External 
technical audit of measurement information for MHRA. 
Product innovation: Supplier operates quality system 
including CAPA, product design changes are made. GPs 
are also involved in a supplier audit. 
 
Influence on financial performance: Monitor is 
bought or not. Compliance with regulations is needed 
for sales to occur. Evaluation Centre evaluation was not 
dynamic so of little use. Purchasing decisions are often 
made for short-term reasons. Limited broad 
performance measurement information, integrated into 
NHS at local level, advice or data not used. 
Influence on technical performance: Monitor has 
improved interface with NHS records system, 
connectivity, battery life. 
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Standing Frame Financial: Cost and budget are measured on national level. 
Technical: Technical evaluation, also including user evaluation. 
Evidence of clinical benefits is scarce and being investigated. 
Customer:  Therapists assess suitability of frame for individual child, a mainly 
subjective process. Supplier reps visit clinicians with product to assess suitability for 
the clinical needs of a particular child. Communication between actors. 
Information Dissemination:  
Evaluation Centre publications, database tool produced. 
Feedback of measurement information to supplier. 
Advice given to buyers. 
Purchasing: Therapist making buying decision. 
Product innovation: Making changes in product design 
by supplier with new split knee blocks. Supplier 
customises frame to individual child, by adding head 
rest, straps for example. 
 
Influence on financial performance: Frame bought or 
not, is compliant with regulations. However short-term 
reasons and cost influence buying as well as 
measurement outputs. Mixed use is made of reports, 
which may be late, inconclusive limiting their influence. 
Suppliers are sensitive to evaluation suggesting it 
affects sales. 
Influence on technical performance: Frame design 
has been improved with split knee block. Feedback 
must be used if technical changes are to be made. 
Influence on customer performance: Frame that is 
most appropriate for a particular child is bought. 
Compliance in use needed if product is to perform for 
user. 
Summary Matrix of Key Cross Case Findings Discovered in Coding (Cut 1: by case, cut 2: by theme in conceptual framework) 
 
Method to Produce the Summary Table: 
The table is a display format summarising the large amount of data from each of the four intra-case summary matrices. The table is an un-ordered meta-matrix showing all the cases in the 
empirical work. The matrix is ordered by case in the rows and conceptual framework theme in the columns, the latter determined by the research questions, as recommended by Miles & 
Huberman (1984 pp79-80). 
The cells in the matrix show “…short quote and summarising remarks…” (Miles & Huberman 1984 p80) qualitatively describing the data coded in relation to the research questions in the 
intra-case tables. Code frequencies across the four cases are shown in a separate table. The qualitative remarks are produced following data reduction and prioritising high frequency codes 
and concepts across the respondents in each case, in accordance with the pattern matching analytic strategy used (Yin 2003 pp116-120). Given the large amount of data to be reduced into 
this matrix, the process has where necessary involved what Miles and Huberman refer to as standardisation of cell entries to a more generic descriptor and taking the modal response. 
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Multi-slice CT Scanner Case Blood Glucose Meter Case ECG Monitor Case Standing Frame Case Research 
Question Area 
CODE 
Total 
instances of 
code in case 
No 
respondents 
mentioned 
code (of 16) 
Total 
instances of 
code in case 
No 
respondents 
mentioned 
code (of 16) 
Total 
instances of 
code in case 
No 
respondents 
mentioned 
code (of 12) 
Total 
instances of 
code in case 
No 
respondents 
mentioned 
code (of 15) 
Expt actors 13 8 6 5 5 4 8 6 
Meas cust perf 71 14 49 12 20 9 68 13 
Meas finc perf 38 11 35 12 18 10 26 13 
Meas tech perf 118 16 88 16 76 11 79 15 
Resorc 6 3 5 4 1 1 10 8 
Comm 25 13 32 14 18 9 21 12 
Soc xchange 30 12 7 5 6 5 20 9 
Advice policy 
guid 
8 5 16 8 14 3 3 3 
Check expctd 30 11 24 10 17 9 8 6 
Feedbck 32 10 21 8 14 7 25 10 
Imp prdct 
design 
12 7 9 6 19 7 16 6 
Senior org 3 3 11 6 1 1 3 3 
Prdct traing 6 3 16 6 2 1 4 2 
Publctn 27 7 23 11 22 8 32 10 
Purch mktg dec 92 14 62 15 40 11 40 14 
Tailor cust 13 8 - - - - 8 4 
A: How are 
processes used 
to measure and 
manage the 
performance of 
innovative 
healthcare 
products during 
their 
implementation? 
C: How can 
performance 
measurement 
and 
performance 
management 
processes during 
the 
implementation 
of innovative 
healthcare 
products be 
differentiated? 
Web tools 8 3 1 1 1 1 9 6 
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Assist rule 
compl 
2 2 6 5 2 2 4 3 
Buyers use 58 14 33 13 18 8 25 11 
Dysfunc 
conseq 
10 8 - - - - 2 2 
No role cust 
perf 
2 2 7 5 1 1 8 6 
No role finc 
perf 
2 2 - - 5 4 2 2 
No role perf 32 13 42 12 24 9 33 13 
No role tech 
perf 
7 4 10 6 7 3 9 4 
Re-des prdct 
impvd 
8 4 5 4 12 5 2 2 
Role cust perf 26 9 22 11 4 2 21 9 
Role finc perf 26 9 26 10 13 6 16 10 
Role perf 91 15 72 16 47 12 61 15 
Role tech perf 35 12 25 12 26 9 19 13 
Supplrs 
competv 
12 5 8 3 4 3 6 4 
B: How do the 
processes used 
to measure and 
manage the 
performance of 
innovative 
healthcare 
products during 
their 
implementation 
influence their 
performance? 
C: How can 
performance 
measurement 
and 
performance 
management 
processes during 
the 
implementation 
of innovative 
healthcare 
products be 
differentiated? 
Tailord appropt 2 2 - - - - 4 3 
Code Occurrences by Case 
 
Data compiled from HyperResearch Report Function 
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Effects Matrix Showing the Influences of Performance Measurement and Performance Management 
Processes as Mentioned by Respondents and Cross Case Patterns 
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Cases Where Found  Influence 
CT BGM ECG SF 
Performance 
Measurement 
Predecessors 
Performance 
Management 
Predecessors 
Researcher 
Explanation 
Product is 
purchased or 
not 
+/- 
F/C 
Y Y Y Y Actors measure 
various aspects 
of product 
performance. 
Use of 
performance 
information 
from 
measurement in 
making a 
purchasing 
decision. 
Supplier markets 
product to 
customer. 
The decision to 
purchase the 
product or not 
on the basis of 
performance 
measurement 
information 
gives the 
supplier sales or 
not and the 
customer Trust 
the benefit of a 
product that 
performs best 
for healthcare. 
The best 
product for 
the needs of 
the user is 
purchased 
+ 
C 
Y Y N Y Actors measure 
various aspects 
of product 
performance. 
Use of 
performance 
information 
from 
measurement in 
making a 
purchasing 
decision. 
The best 
product for the 
needs of the 
Trust or patient 
user is 
purchased when 
performance of 
the product and 
any competing 
products is 
measured and 
this information 
used to make a 
purchasing 
decision. 
Product can 
be purchased 
or not for 
short-term, 
cost based 
rather than 
broader 
reasons 
- 
F/T/C 
Y Y Y Y Actors measure 
cost aspects of 
product 
performance. 
Use of 
performance 
information 
from 
measurement in 
making a 
purchasing 
decision. 
The product is 
bought or not in 
a decision made 
on the basis of 
cost 
performance 
measurement 
information 
with a short 
term view. 
Evidence of 
broader aspects 
of performance 
is not used 
proactively or 
integrated back 
to buyers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Continued 
overleaf 
 346
Performance 
measurement 
information 
not used in 
the 
purchasing 
decision 
None 
Y Y Y Y Actors measure 
various aspects 
of product 
performance. 
Dissemination 
of information 
from 
performance 
measurement. 
Information 
from 
performance 
measurement 
and 
management 
processes is not 
used in the 
purchasing 
decision. The 
product may be 
bought for all 
sorts of reasons 
other than on 
the basis of 
performance 
measurement 
information. 
Product 
design 
improved 
+ 
T 
Y Y Y Y Actors measure 
various aspects 
of product 
performance. 
Feedback to 
supplier. 
Product 
innovation by 
supplier. 
The design of 
the product is 
permanently 
improved. 
Feedback to 
the supplier 
is not used 
None 
Y N Y Y Actors measure 
various aspects 
of product 
performance. 
Feedback to the 
supplier. 
Feedback on 
performance 
measurement 
information 
given to the 
supplier is not 
used. 
Used in 
acceptance 
testing 
+ 
T 
Y N N N Actors measure 
various aspects 
of product 
performance. 
Use of 
performance 
information 
from 
measurement in 
making a 
purchasing 
decision. 
Dissemination 
of information 
from 
performance 
measurement. 
Checking 
performance of 
the product 
against 
specification. 
Performance 
measurement 
outputs are used 
to ensure the 
product meets 
the promised 
specification 
when it arrives 
at the supplier, 
before being 
accepted and 
paid for. 
Useful for 
repairs 
+ 
T 
Y N N N Technical 
evaluation by 
Evaluation 
Centre. 
Checking of 
scanner 
performance 
against 
expected. 
Customer’s own 
performance 
data makes the 
case to the 
supplier to 
come and make 
repairs to the 
scanner. 
 
 
 
 
 
 
Continued 
overleaf 
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Supplier 
ensures 
product 
performs to 
their 
specification 
& 
regulations, 
as it will be 
tested and 
then 
purchased or 
not 
+ 
T 
Y Y Y Y Technical 
evaluation by 
Evaluation 
Centre. 
Checking 
performance of 
product against 
claims. 
Feedback to 
supplier. 
Use of 
performance 
information 
from 
measurement in 
making a 
purchasing 
decision. 
Performance 
measurement 
and 
management 
processes mean 
that the supplier 
know and 
ensure that the 
product must 
meet a certain 
standard. 
Supplier 
shows 
concern over 
performance 
measurement 
* 
+/- 
F 
Y Y Y Y Actors measure 
technical 
aspects of 
product 
performance. 
Dissemination 
of information 
from 
performance 
measurement. 
Suppliers show 
concern that 
performance 
measurement 
data will affect 
their 
competitive 
position or 
sales. 
CE marking 
does not 
necessarily 
signify a 
product that 
performs to a 
sufficient 
standard 
- 
F/T/C 
N Y N N Assessment of 
technical 
performance of 
product during 
development of 
product by 
supplier. 
Information 
about product 
gathered by 
buyers, PPD 
before purchase 
or listing 
decision made. 
Supplier puts CE 
mark on 
product. 
Buyers make 
decision to 
purchase the 
product on the 
basis of CE 
mark. 
Although some 
respondents 
suggested 
processes help 
the meter meet 
standards and 
perform well, 
other 
respondents 
suggested that 
the standards 
are not a good 
guide to 
performance 
and a product 
that does not 
perform well 
may be bought 
on the basis of 
limited 
information. 
Used to 
reduce 
product cost 
+/- 
F 
N Y N N Customer 
measures cost 
performance of 
product. 
Negotiation 
between 
customer and 
supplier over % 
reduction in cost 
of product. 
A % reduction 
in product price 
was negotiated 
and achieved on 
the basis of cost 
information 
measured by the 
customer. 
 
 
 
 
 
 
 
 
 
 
Continued 
overleaf 
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Compliance 
with use of 
the product 
is needed 
None 
N Y N Y Actors measure 
various aspects 
of product 
performance. 
Decision made 
to purchase 
product, product 
is used or not. 
The product 
may be 
purchased, but 
if the patient 
does not use it 
or take any 
necessary 
follow up 
healthcare 
measures, it will 
not have a 
benefit for their 
health. 
Training is 
necessary for 
patient to 
gain benefits 
of product 
use 
+ 
C 
N Y N Y Actors measure 
various aspects 
of product 
performance. 
Training in use 
of the product. 
Users require 
training in use 
of the product if 
they are to use it 
properly, 
benefitting their 
health. 
Currently 
little 
evidence on 
the 
effectiveness 
of the 
healthcare 
procedure 
the product 
is part of 
None 
N Y N N Actors measure 
technical 
aspects of 
product 
performance. 
Purchase, use of 
the product. 
If there is 
currently 
limited 
evidence of the 
effectiveness of 
the healthcare 
procedure the 
product uses in 
gaining 
beneficial 
health 
outcomes, so 
effort in 
measuring and 
managing the 
performance of 
the product may 
mean that a 
useless product 
is procured. 
Product 
meets needs 
of individual 
user as it has 
been 
customised 
with special 
features for 
the 
particular 
purchase 
+ 
C 
N N N Y Actors measure 
customer 
aspects of 
product 
performance. 
Supplier tailors 
product features 
for a particular 
child. 
Supplier 
customises the 
product with 
different 
features such as 
alternative 
headrests and 
additional straps 
to tailor it to 
meet the needs 
of a particular 
child. 
Effects Matrix Showing the Influences of Performance Measurement and 
Performance Management Processes as Mentioned by Respondents and Cross Case 
Patterns.  
(KEY: ‘Y’=Yes, influence found in case, ‘N’= No, influence not found in the case. ‘+’ is a beneficial 
influence, ‘-‘ is a non-beneficial influence. ‘F’ is an influence on Financial performance, ‘T’ is an influence 
on Technical performance and ‘C’ is an influence on Customer performance (After Griffin & Page 1996). 
‘None’ means there is no influence on performance. ‘*’ denotes an influence inferred by researcher rather 
than specifically described by respondent). 
Constructing the matrix: The matrix is compiled from the findings in the intra-case effects matrices showing 
influences of performance measurement and performance management processes. 
